Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	json	split
To further dissect p95vav involvement in TCR signaling, we analyzed various Jurkat mutants deficient in TCR signaling function or TCR expression and showed that an intact TCR signaling pathway is required for p95vav to function.	p95vav,19,25,Gene/Protein	TCR,41,44,Gene/Protein	TCR,104,107,Gene/Protein	TCR,130,133,Gene/Protein	TCR,171,174,Gene/Protein	p95vav,209,215,Gene/Protein	"[{""token"": ""p95vav"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""p95vav"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
In erythroid cells most of the transcription activity was contained in a 150 bp promoter fragment with binding sites for transcription factors AP2, Sp1 and the erythroid - specific GATA - 1.	150 bp promoter,73,88,Gene/Protein	binding sites,103,116,Gene/Protein	transcription factors,121,142,Gene/Protein	AP2,143,146,Gene/Protein	Sp1,148,151,Gene/Protein	erythroid - specific GATA - 1,160,189,Gene/Protein	"[{""token"": ""150 bp promoter"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 121, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""AP2"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific GATA - 1"", ""start_span"": 160, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
NO also decreased the endothelial expression of other leukocyte adhesion molecules ( E - selectin and to a lesser extent, intercellular adhesion molecule - 1) and secretable cytokines ( IL - 6 and IL - 8).	leukocyte adhesion molecules,54,82,Gene/Protein	E - selectin,85,97,Gene/Protein	intercellular adhesion molecule - 1,122,157,Gene/Protein	cytokines,174,183,Gene/Protein	IL - 6,186,192,Gene/Protein	IL - 8,197,203,Gene/Protein	"[{""token"": ""leukocyte adhesion molecules"", ""start_span"": 54, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 122, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 186, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
However, unlike another tumor suppressor protein, p53, Rb did not have any significant effect on basal levels of transcription, suggesting that Rb specifically interacts with IE2 rather than other cellular factors involved in the general transcription machinery.	tumor suppressor protein,24,48,Gene/Protein	p53,50,53,Gene/Protein	Rb,55,57,Gene/Protein	Rb,144,146,Gene/Protein	IE2,175,178,Gene/Protein	cellular factors,197,213,Gene/Protein	"[{""token"": ""tumor suppressor protein"", ""start_span"": 24, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 55, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IE2"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""cellular factors"", ""start_span"": 197, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Recently, transcription factors known as STATs ( signal transducers and activators of transcription) have been shown to be tyrosine phosphorylated and activated in response to a number of cytokines that bind hematopoietin receptors and activate JAK kinases.	transcription factors,10,31,Gene/Protein	STATs,41,46,Gene/Protein	signal transducers and activators of transcription,49,99,Gene/Protein	cytokines,188,197,Gene/Protein	hematopoietin receptors,208,231,Gene/Protein	JAK kinases,245,256,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 10, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 49, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""hematopoietin receptors"", ""start_span"": 208, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
The AP - 1 binding proteins contained c - Jun, Jun - D, and Fra - 1, but marginal amounts of Jun - B and c - Fos.	AP - 1 binding proteins,4,27,Gene/Protein	c - Jun,38,45,Gene/Protein	Jun - D,47,54,Gene/Protein	Fra - 1,60,67,Gene/Protein	Jun - B,93,100,Gene/Protein	c - Fos,105,112,Gene/Protein	"[{""token"": ""AP - 1 binding proteins"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Jun - D"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""Jun - B"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
The CK - 1 / CD28RE of GM - CSF shows a high degree of similarity to the IL - 2 CD28RE and the IL - 3 gene also contains a related region.	CK - 1,4,10,Gene/Protein	/ CD28RE,11,19,Gene/Protein	GM - CSF,23,31,Gene/Protein	IL - 2,73,79,Gene/Protein	CD28RE,80,86,Gene/Protein	IL - 3 gene,95,106,Gene/Protein	"[{""token"": ""CK - 1"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""/ CD28RE"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 gene"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}]"	train
To test these hypotheses, we studied several tat mutants, including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type or mutant LTRs with modifications in the NF - kappa B and / or Sp1 binding sites.	tat mutants,45,56,Gene/Protein	stop codon mutants,72,90,Gene/Protein	deletion mutant,99,114,Gene/Protein	replication - competent HIV - 1 constructs,121,163,Gene/Protein	wild - type or mutant LTRs,173,199,Gene/Protein	NF - kappa B and / or Sp1 binding sites,226,265,Gene/Protein	"[{""token"": ""tat mutants"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""stop codon mutants"", ""start_span"": 72, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""deletion mutant"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""replication - competent HIV - 1 constructs"", ""start_span"": 121, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""wild - type or mutant LTRs"", ""start_span"": 173, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B and / or Sp1 binding sites"", ""start_span"": 226, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
Core binding factor ( CBF), also known as polyomavirus enhancer - binding protein 2 and SL3 enhancer factor 1, is a mammalian transcription factor that binds to an element termed the core within the enhancers of the murine leukemia virus family of retroviruses.	Core binding factor,0,19,Gene/Protein	CBF,22,25,Gene/Protein	polyomavirus enhancer - binding protein 2,42,83,Gene/Protein	SL3 enhancer factor 1,88,109,Gene/Protein	mammalian transcription factor,116,146,Gene/Protein	enhancers,199,208,Gene/Protein	"[{""token"": ""Core binding factor"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""CBF"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""polyomavirus enhancer - binding protein 2"", ""start_span"": 42, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""SL3 enhancer factor 1"", ""start_span"": 88, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""mammalian transcription factor"", ""start_span"": 116, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 199, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
A truncated Tat protein ( Tat1 - 72), known to transactivate the HIV - 1 long terminal repeat ( LTR), no longer affected Mn - SOD expression, the cellular redox state or TNF - mediated cytotoxicity.	Tat protein,12,23,Gene/Protein	Tat1 - 72,26,35,Gene/Protein	HIV - 1 long terminal repeat,65,93,Gene/Protein	LTR,96,99,Gene/Protein	Mn - SOD,121,129,Gene/Protein	TNF,170,173,Gene/Protein	"[{""token"": ""Tat protein"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Tat1 - 72"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 65, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Mn - SOD"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
We cultured M - TAT cells long term ( > 1 year) in the continuous presence of erythropoietin ( EPO), granulocyte - macrophage colony - stimulating factor ( GM - CSF), or stem cell factor ( SCF).	erythropoietin,78,92,Gene/Protein	EPO,95,98,Gene/Protein	granulocyte - macrophage colony - stimulating factor,101,153,Gene/Protein	GM - CSF,156,164,Gene/Protein	stem cell factor,170,186,Gene/Protein	SCF,189,192,Gene/Protein	"[{""token"": ""erythropoietin"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 101, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""stem cell factor"", ""start_span"": 170, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
These redox - regulated enzymes trigger signal cascades for NF kappa B activation and transduce signals from the T cell antigen receptor, from CD4 and CD8 molecules, and from the IL - 2 receptor beta - chain.	redox - regulated enzymes,6,31,Gene/Protein	NF kappa B,60,70,Gene/Protein	T cell antigen receptor,113,136,Gene/Protein	CD4,143,146,Gene/Protein	CD8 molecules,151,164,Gene/Protein	IL - 2 receptor beta - chain,179,207,Gene/Protein	"[{""token"": ""redox - regulated enzymes"", ""start_span"": 6, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 113, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""CD8 molecules"", ""start_span"": 151, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor beta - chain"", ""start_span"": 179, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
Although we detected no IL - 2 mRNA in ALD - treated cells, the nuclei of these cells contain proteins capable of binding to three regulatory sequences in the IL - 2 promoter region: NFAT, NF kappa B, and AP - 1.	IL - 2 mRNA,24,35,Gene/Protein	regulatory sequences,131,151,Gene/Protein	IL - 2 promoter region,159,181,Gene/Protein	NFAT,183,187,Gene/Protein	NF kappa B,189,199,Gene/Protein	AP - 1,205,211,Gene/Protein	"[{""token"": ""IL - 2 mRNA"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""regulatory sequences"", ""start_span"": 131, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter region"", ""start_span"": 159, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Surprisingly, even p65, but not c - rel, was phosphorylated after induction in vivo, suggesting that TNF - alpha selectively activates only specific NF - kappa B heteromers and that modifications regulate not only I kappa B molecules but also NF - kappa B molecules.	p65,19,22,Gene/Protein	c - rel,32,39,Gene/Protein	TNF - alpha,101,112,Gene/Protein	NF - kappa B,149,161,Gene/Protein	I kappa B molecules,214,233,Gene/Protein	NF - kappa B,243,255,Gene/Protein	"[{""token"": ""p65"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B molecules"", ""start_span"": 214, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 243, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
The IL - 2 octamer motif is a composite cis - element which binds Oct - 1 and Oct - 2 as well as a TPA / Ca ( 2 +) - inducible nuclear factor, previously termed octamer - associated protein ( OAP40).	IL - 2 octamer motif,4,24,Gene/Protein	cis - element,40,53,Gene/Protein	Oct - 1,66,73,Gene/Protein	Oct - 2,78,85,Gene/Protein	octamer - associated protein,161,189,Gene/Protein	OAP40,192,197,Gene/Protein	"[{""token"": ""IL - 2 octamer motif"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""cis - element"", ""start_span"": 40, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""octamer - associated protein"", ""start_span"": 161, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""OAP40"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Furthermore, retinoic acid receptor ( RAR) alpha is able to inhibit in vitro the formation of the complex between the nuclear AP - 1 / OAP and its specific binding site, resulting in the interference with Oct - 2 - dependent cis - regulatory function of this AP - 1 element.	retinoic acid receptor,13,35,Gene/Protein	RAR,38,41,Gene/Protein	AP - 1,126,132,Gene/Protein	/ OAP,133,138,Gene/Protein	Oct - 2,205,212,Gene/Protein	AP - 1,259,265,Gene/Protein	"[{""token"": ""retinoic acid receptor"", ""start_span"": 13, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""/ OAP"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 259, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
The EBV - encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF - kappa B site but not the intact element, suggesting that the latent membrane protein 1 - driven activation of NF - kappa B / Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.	EBV - encoded latent membrane protein 1,4,43,Gene/Protein	CD48,87,91,Gene/Protein	NF - kappa B site,92,109,Gene/Protein	intact element,122,136,Gene/Protein	latent membrane protein 1,158,183,Gene/Protein	NF - kappa B / Rel,207,225,Gene/Protein	"[{""token"": ""EBV - encoded latent membrane protein 1"", ""start_span"": 4, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD48"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 92, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""intact element"", ""start_span"": 122, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane protein 1"", ""start_span"": 158, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 207, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
Southern analysis using a human progesterone receptor ( hPR) cDNA probe identified a germline TaqI restriction fragment length polymorphism ( RFLP) defined by two alleles: T1, represented by a 2. 7 kb fragment; and T2, represented by a 1. 9 kb fragment and characterised by an additional TaqI restriction site with respect to T1.	germline TaqI restriction fragment length polymorphism,85,139,Gene/Protein	RFLP,142,146,Gene/Protein	T1,172,174,Gene/Protein	T2,215,217,Gene/Protein	TaqI restriction site,288,309,Gene/Protein	T1,326,328,Gene/Protein	"[{""token"": ""germline TaqI restriction fragment length polymorphism"", ""start_span"": 85, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""RFLP"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""T1"", ""start_span"": 172, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""T2"", ""start_span"": 215, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""TaqI restriction site"", ""start_span"": 288, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""T1"", ""start_span"": 326, ""end_span"": 328, ""type"": ""Gene/Protein""}]"	train
Biochemical studies demonstrate that OBF - 1 has no intrinsic DNA - binding activity and recognizes the POU domains of Oct - 1 and Oct - 2, but not those of Oct - 4 and Oct - 6.	OBF - 1,37,44,Gene/Protein	POU domains,104,115,Gene/Protein	Oct - 1,119,126,Gene/Protein	Oct - 2,131,138,Gene/Protein	Oct - 4,157,164,Gene/Protein	Oct - 6,169,176,Gene/Protein	"[{""token"": ""OBF - 1"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""POU domains"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 4"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 6"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
Steel factor is one of the growth factors that controls the proliferation and differentiation of hematopoietic cells and SCL, also known as Tcl - 5 or Tal - 1, is a transcription factor involved in erythropoiesis.	Steel factor,0,12,Gene/Protein	growth factors,27,41,Gene/Protein	SCL,121,124,Gene/Protein	Tcl - 5,140,147,Gene/Protein	Tal - 1,151,158,Gene/Protein	transcription factor,165,185,Gene/Protein	"[{""token"": ""Steel factor"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Tcl - 5"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Tal - 1"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 165, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
Transactivation of the ICAM - I promoter by TaxI was further shown by co - transfection of a CAT reporter construct with the ICAM - I promoter and a plasmid expressing TaxI.	ICAM - I promoter,23,40,Gene/Protein	TaxI,44,48,Gene/Protein	CAT reporter construct,93,115,Gene/Protein	ICAM - I promoter,125,142,Gene/Protein	plasmid,149,156,Gene/Protein	TaxI,168,172,Gene/Protein	"[{""token"": ""ICAM - I promoter"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""TaxI"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CAT reporter construct"", ""start_span"": 93, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I promoter"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""plasmid"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TaxI"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Detailed structural analysis of the first 12 cDNAs ( HZF 1 - 10) and a partial characterization of HZF 11 - 42 revealed that a common feature of human Kruppel - related zinc finger proteins is the presence of tandem arrays of zinc fingers ranging in number from 3 to over 20 that are preferentially located in the carboxy - terminal regions of the proteins.	cDNAs,45,50,Gene/Protein	HZF 1 - 10,53,63,Gene/Protein	HZF 11 - 42,99,110,Gene/Protein	human Kruppel - related zinc finger proteins,145,189,Gene/Protein	zinc fingers,226,238,Gene/Protein	carboxy - terminal regions,314,340,Gene/Protein	"[{""token"": ""cDNAs"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""HZF 1 - 10"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""HZF 11 - 42"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""human Kruppel - related zinc finger proteins"", ""start_span"": 145, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""zinc fingers"", ""start_span"": 226, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""carboxy - terminal regions"", ""start_span"": 314, ""end_span"": 340, ""type"": ""Gene/Protein""}]"	train
Three binding sites for the Ets family of transcription factors are found in this region: two adjacent sites at positions - 50 and - 54 bp and a more 5 ' site at position - 67 bp.	binding sites,6,19,Gene/Protein	Ets family,28,38,Gene/Protein	transcription factors,42,63,Gene/Protein	- 50 and - 54 bp,122,138,Gene/Protein	5 ' site,150,158,Gene/Protein	- 67 bp,171,178,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 6, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Ets family"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""- 50 and - 54 bp"", ""start_span"": 122, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""5 ' site"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""- 67 bp"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Gene for a tissue - specific transcriptional activator ( EBF or Olf - 1), expressed in early B lymphocytes, adipocytes, and olfactory neurons, is located on human chromosome 5, band q34, and proximal mouse chromosome 11.	tissue - specific transcriptional activator,11,54,Gene/Protein	EBF,57,60,Gene/Protein	Olf - 1,64,71,Gene/Protein	human chromosome 5,157,175,Gene/Protein	band q34,177,185,Gene/Protein	proximal mouse chromosome 11,191,219,Gene/Protein	"[{""token"": ""tissue - specific transcriptional activator"", ""start_span"": 11, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""EBF"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Olf - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 5"", ""start_span"": 157, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""band q34"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""proximal mouse chromosome 11"", ""start_span"": 191, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
By Southern hybridization analyses of somatic cell hybrid panels with murine cDNA probe, fluorescence chromosomal in situ hybridization ( FISH) of human genomic clones, and analysis of recombinant inbred mouse strains, we have found single sites for EBF homologous sequences on human Chromosome ( Chr) 5, band q34, and on proximal mouse Chr 11, in an evolutionarily conserved region.	murine cDNA probe,70,87,Gene/Protein	human genomic clones,147,167,Gene/Protein	EBF homologous sequences,250,274,Gene/Protein	band q34,305,313,Gene/Protein	proximal mouse Chr 11,322,343,Gene/Protein	evolutionarily conserved region,351,382,Gene/Protein	"[{""token"": ""murine cDNA probe"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""human genomic clones"", ""start_span"": 147, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""EBF homologous sequences"", ""start_span"": 250, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""band q34"", ""start_span"": 305, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""proximal mouse Chr 11"", ""start_span"": 322, ""end_span"": 343, ""type"": ""Gene/Protein""}, {""token"": ""evolutionarily conserved region"", ""start_span"": 351, ""end_span"": 382, ""type"": ""Gene/Protein""}]"	train
In contrast, cotransfection with a combination of NF - kappa B and AP - 1 significantly augmented transcription from the GM - CSF promoter containing the GM - kappa B / GC - box and the CLE0 ( AP - 1 / NF - AT).	NF - kappa B,50,62,Gene/Protein	AP - 1,67,73,Gene/Protein	GM - CSF promoter,121,138,Gene/Protein	GM - kappa B / GC - box,154,177,Gene/Protein	CLE0,186,190,Gene/Protein	AP - 1 / NF - AT,193,209,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 121, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GM - kappa B / GC - box"", ""start_span"": 154, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""CLE0"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 / NF - AT"", ""start_span"": 193, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
This bipartite motif consists of an N - terminal POU - specific domain ( POUs), a flexible linker, and a C - terminal POU - specific homeodomain ( POUHD).	bipartite motif,5,20,Gene/Protein	N - terminal POU - specific domain,36,70,Gene/Protein	POUs,73,77,Gene/Protein	flexible linker,82,97,Gene/Protein	C - terminal POU - specific homeodomain,105,144,Gene/Protein	POUHD,147,152,Gene/Protein	"[{""token"": ""bipartite motif"", ""start_span"": 5, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal POU - specific domain"", ""start_span"": 36, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""POUs"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""flexible linker"", ""start_span"": 82, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal POU - specific homeodomain"", ""start_span"": 105, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""POUHD"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Fos kinase phosphorylates c - Fos at a site near the C - terminus, as well as a peptide derived from this region ( residues 359 - 370, RKGSSSNEPSSD), and Fos peptide competitively inhibited c - Fos phosphorylation.	Fos kinase,0,10,Gene/Protein	c - Fos,26,33,Gene/Protein	C - terminus,53,65,Gene/Protein	residues 359 - 370,115,133,Gene/Protein	RKGSSSNEPSSD,135,147,Gene/Protein	c - Fos,190,197,Gene/Protein	"[{""token"": ""Fos kinase"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""residues 359 - 370"", ""start_span"": 115, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""RKGSSSNEPSSD"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
The t ( 17; 19) translocation in acute lymphoblastic leukemias results in creation of E2A - hepatic leukemia factor ( HLF) chimeric proteins that contain the DNA - binding and protein dimerization domains of the basic leucine zipper ( bZIP) protein HLF fused to a portion of E2A proteins with transcriptional activation properties.	E2A - hepatic leukemia factor,86,115,Gene/Protein	HLF,118,121,Gene/Protein	chimeric proteins,123,140,Gene/Protein	DNA - binding and protein dimerization domains,158,204,Gene/Protein	HLF,249,252,Gene/Protein	E2A proteins,275,287,Gene/Protein	"[{""token"": ""E2A - hepatic leukemia factor"", ""start_span"": 86, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""chimeric proteins"", ""start_span"": 123, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding and protein dimerization domains"", ""start_span"": 158, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""E2A proteins"", ""start_span"": 275, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Antibodies against the NF - kappa B and Rel proteins and UV cross - linking studies revealed the presence of c - Rel and p65 and the absence of p50 in the TF complex and further showed that c - Rel / p65 heterodimers selectively bound to the TF kappa B - like site.	NF - kappa B,23,35,Gene/Protein	c - Rel,109,116,Gene/Protein	p50,144,147,Gene/Protein	TF complex,155,165,Gene/Protein	c - Rel / p65 heterodimers,190,216,Gene/Protein	TF kappa B - like site,242,264,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""TF complex"", ""start_span"": 155, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel / p65 heterodimers"", ""start_span"": 190, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""TF kappa B - like site"", ""start_span"": 242, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
On the basis of cross - linking results with 21 different EMCV IRES fragments and cytoplasmic HeLa extract or rabbit reticulocyte lysate as the source of polypeptides, consensus binding sites for p52, p57, p70, and p100 are proposed.	EMCV IRES fragments,58,77,Gene/Protein	consensus binding sites,168,191,Gene/Protein	p52,196,199,Gene/Protein	p57,201,204,Gene/Protein	p70,206,209,Gene/Protein	p100,215,219,Gene/Protein	"[{""token"": ""EMCV IRES fragments"", ""start_span"": 58, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sites"", ""start_span"": 168, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""p57"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""p70"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
The gene encoding the 105 - kDa protein ( p105) precursor of the p50 subunit of transcription factor NF - kappa B also encodes a p70 I kappa B protein, I kappa B gamma, which is identical to the C - terminal 607 amino acids of p105.	p50,65,68,Gene/Protein	NF - kappa B,101,113,Gene/Protein	p70 I kappa B protein,129,150,Gene/Protein	I kappa B gamma,152,167,Gene/Protein	C - terminal 607 amino acids,195,223,Gene/Protein	p105,227,231,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""p70 I kappa B protein"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal 607 amino acids"", ""start_span"": 195, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
One 63 - kDa isoform, termed I kappa B gamma - 1, which lacks 59 amino acids C - terminal to ankyrin repeat 7, has a novel 35 - amino acid C terminus encoded by an alternative reading frame of the p105 gene.	63 - kDa isoform,4,20,Gene/Protein	I kappa B gamma - 1,29,48,Gene/Protein	ankyrin repeat 7,93,109,Gene/Protein	35 - amino acid C terminus,123,149,Gene/Protein	alternative reading frame,164,189,Gene/Protein	p105 gene,197,206,Gene/Protein	"[{""token"": ""63 - kDa isoform"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 1"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin repeat 7"", ""start_span"": 93, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""35 - amino acid C terminus"", ""start_span"": 123, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""alternative reading frame"", ""start_span"": 164, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""p105 gene"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
The absence in I kappa B gamma - 1 and I kappa B gamma - 2 of a protein kinase A site whose phosphorylation modulates p70 I kappa B gamma inhibitory activity suggests that alternative RNA splicing may be used to generate I kappa B gamma isoforms that respond differently to intracellular signals.	I kappa B gamma - 1,15,34,Gene/Protein	I kappa B gamma - 2,39,58,Gene/Protein	protein kinase A site,64,85,Gene/Protein	p70,118,121,Gene/Protein	I kappa B gamma,122,137,Gene/Protein	I kappa B gamma isoforms,221,245,Gene/Protein	"[{""token"": ""I kappa B gamma - 1"", ""start_span"": 15, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 39, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A site"", ""start_span"": 64, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""p70"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma isoforms"", ""start_span"": 221, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Finally, we show that a DNA fragment containing the human GATA3 transcription unit, 3 kb upstream from the initiation site and 4 kb downstream from the polyadenylation site, displays T - cell specificity.	DNA fragment,24,36,Gene/Protein	human GATA3 transcription unit,52,82,Gene/Protein	3 kb upstream,84,97,Gene/Protein	initiation site,107,122,Gene/Protein	4 kb downstream,127,142,Gene/Protein	polyadenylation site,152,172,Gene/Protein	"[{""token"": ""DNA fragment"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""human GATA3 transcription unit"", ""start_span"": 52, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""3 kb upstream"", ""start_span"": 84, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""initiation site"", ""start_span"": 107, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""4 kb downstream"", ""start_span"": 127, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""polyadenylation site"", ""start_span"": 152, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
LBR ' s nucleoplasmic domain is encoded by exons 1 - 4, and its hydrophobic domain, with eight putative transmembrane segments, is encoded by exons 5 - 13.	LBR,0,3,Gene/Protein	nucleoplasmic domain,8,28,Gene/Protein	exons 1 - 4,43,54,Gene/Protein	hydrophobic domain,64,82,Gene/Protein	transmembrane segments,104,126,Gene/Protein	exons 5 - 13,142,154,Gene/Protein	"[{""token"": ""LBR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""nucleoplasmic domain"", ""start_span"": 8, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""exons 1 - 4"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""hydrophobic domain"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane segments"", ""start_span"": 104, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""exons 5 - 13"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
LIF induces the production of other cytokines in monocytes but its effects on HIV replication were not inhibited by antibodies to IL - 1, TNF, or IL - 6.	LIF,0,3,Gene/Protein	cytokines,36,45,Gene/Protein	antibodies,116,126,Gene/Protein	IL - 1,130,136,Gene/Protein	TNF,138,141,Gene/Protein	IL - 6,146,152,Gene/Protein	"[{""token"": ""LIF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 116, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
In this study we investigated the effect of IL - 4 on the expression of cytokine genes in monocytes evoked by other T - helper cell cytokines: IL - 2, IL - 3, and GM - CSF.	IL - 4,44,50,Gene/Protein	cytokine genes,72,86,Gene/Protein	T - helper cell cytokines,116,141,Gene/Protein	IL - 2,143,149,Gene/Protein	IL - 3,151,157,Gene/Protein	GM - CSF,163,171,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""T - helper cell cytokines"", ""start_span"": 116, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
IL - 4 did not exert significant influence on the induction of expression of IL - 1 - RA or various CSFs by IL - 2, IL - 3, and GM - CSF.	IL - 4,0,6,Gene/Protein	IL - 1 - RA,77,88,Gene/Protein	CSFs,100,104,Gene/Protein	IL - 2,108,114,Gene/Protein	IL - 3,116,122,Gene/Protein	GM - CSF,128,136,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 - RA"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""CSFs"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
Secretion of IL - 2 and TNF - alpha, surface expression of IL - 2R, and DNA - binding activity of NF - kappa B and AP - 1 ( Fos / Jun) complex in response to phorbol myristate acetate, TNF - alpha, or immobilized antibodies to CD3 were monitored.	IL - 2,13,19,Gene/Protein	TNF - alpha,24,35,Gene/Protein	IL - 2R,59,66,Gene/Protein	NF - kappa B,98,110,Gene/Protein	TNF - alpha,185,196,Gene/Protein	CD3,227,230,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 98, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Based on peptide matches covering more than 10% of the TBP7 sequence, and the fact that the migration of S6 on SDS - PAGE is consistent with the estimated molecular mass for TBP7, we conclude that subunit 6 of the 26S protease is TBP7.	TBP7,55,59,Gene/Protein	S6,105,107,Gene/Protein	TBP7,174,178,Gene/Protein	subunit 6,197,206,Gene/Protein	26S protease,214,226,Gene/Protein	TBP7,230,234,Gene/Protein	"[{""token"": ""TBP7"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""S6"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TBP7"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""subunit 6"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""26S protease"", ""start_span"": 214, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""TBP7"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
The Tax protein of HTLV - I, a positive transcriptional activator of HTLV - I gene expression, is a viral oncogene that also increases transcription of cellular genes including GM - CSF, IL - 2R alpha and IL - 2.	Tax protein,4,15,Gene/Protein	positive transcriptional activator,31,65,Gene/Protein	cellular genes,152,166,Gene/Protein	GM - CSF,177,185,Gene/Protein	IL - 2R alpha,187,200,Gene/Protein	IL - 2,205,211,Gene/Protein	"[{""token"": ""Tax protein"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""positive transcriptional activator"", ""start_span"": 31, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""cellular genes"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 187, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Both sIgM - and sIgD - crosslinking with antibodies induced elevation of cAMP levels, phosphatidylinositol turnover, PKC activation and expression of Egr - 1 and c - fos mRNA, although sIgM - crosslinking was more effective than sIgD - crosslinking, presumably due to the higher expression of sIgM than of sIgD.	PKC,117,120,Gene/Protein	Egr - 1 and c - fos mRNA,150,174,Gene/Protein	sIgM,185,189,Gene/Protein	sIgD,229,233,Gene/Protein	sIgM,293,297,Gene/Protein	sIgD,306,310,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 and c - fos mRNA"", ""start_span"": 150, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""sIgM"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""sIgD"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""sIgM"", ""start_span"": 293, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""sIgD"", ""start_span"": 306, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes, lymphocytes, and polymorphonucleate cells, but is markedly induced by interferon; that PML and PML / RAR alpha expression is augmented by interferon in the NB4 APL cell line, which carries the t ( 15; 17), and in APL blasts from patients; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA; that interferons alone have minimal maturation effect on NB4 cells; and, finally, that interferon gamma, but not alpha or beta, induces maturation and growth suppression of NB4 cells with de novo retinoid resistance, and partially restores RA response.	PML,20,23,Gene/Protein	interferon,177,187,Gene/Protein	PML,194,197,Gene/Protein	PML / RAR alpha,202,217,Gene/Protein	interferon,245,255,Gene/Protein	interferon,351,361,Gene/Protein	"[{""token"": ""PML"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 177, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""PML"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""PML / RAR alpha"", ""start_span"": 202, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 245, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 351, ""end_span"": 361, ""type"": ""Gene/Protein""}]"	train
Nevertheless, the simian EBV LMP1s retain most functions in common with EBV LMP1, including the ability to induce NF - ( kappa) B activity in human cells, to bind the tumor necrosis factor - associated factor 3 ( TRAF3) in vitro, and to induce expression of tumor necrosis factor - responsive genes, such as ICAM1, in human B lymphocytes.	simian EBV LMP1s,18,34,Gene/Protein	LMP1,76,80,Gene/Protein	tumor necrosis factor - associated factor 3,167,210,Gene/Protein	TRAF3,213,218,Gene/Protein	tumor necrosis factor - responsive genes,258,298,Gene/Protein	ICAM1,308,313,Gene/Protein	"[{""token"": ""simian EBV LMP1s"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - associated factor 3"", ""start_span"": 167, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - responsive genes"", ""start_span"": 258, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""ICAM1"", ""start_span"": 308, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
Rather, IFN - gamma antagonized the effect of IL - 4 and suppressed the DC and MGC formation induced by GM - CSF + IL - 4 and M - CSF + IL - 4, respectively.	IFN - gamma,8,19,Gene/Protein	IL - 4,46,52,Gene/Protein	GM - CSF,104,112,Gene/Protein	IL - 4,115,121,Gene/Protein	M - CSF,126,133,Gene/Protein	IL - 4,136,142,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 8, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
The SCMV SNE sites contain potential overlapping core recognition binding motifs for SRF, Rel / NFkappaB, ETS, and YY1 class transcription factors but fail to respond to either serum or tumor necrosis factor alpha.	SCMV SNE sites,4,18,Gene/Protein	SRF,85,88,Gene/Protein	Rel / NFkappaB,90,104,Gene/Protein	ETS,106,109,Gene/Protein	YY1 class transcription factors,115,146,Gene/Protein	serum or tumor necrosis factor alpha,177,213,Gene/Protein	"[{""token"": ""SCMV SNE sites"", ""start_span"": 4, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""Rel / NFkappaB"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""ETS"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""YY1 class transcription factors"", ""start_span"": 115, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""serum or tumor necrosis factor alpha"", ""start_span"": 177, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
However, the TPA responsiveness of both CMV elements proved to involve synergistic interactions between the core SRF binding site ( CCATATATGG) and the adjacent inverted ETS binding motifs ( TTCC), which correlated directly with formation of a bound tripartite complex containing both the cellular SRF and ELK - 1 proteins.	CMV elements,40,52,Gene/Protein	SRF binding site,113,129,Gene/Protein	ETS binding motifs,170,188,Gene/Protein	tripartite complex,250,268,Gene/Protein	SRF,298,301,Gene/Protein	ELK - 1 proteins,306,322,Gene/Protein	"[{""token"": ""CMV elements"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""SRF binding site"", ""start_span"": 113, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""ETS binding motifs"", ""start_span"": 170, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""tripartite complex"", ""start_span"": 250, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 298, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""ELK - 1 proteins"", ""start_span"": 306, ""end_span"": 322, ""type"": ""Gene/Protein""}]"	train
In exerting their antiproliferative effects, GCS diffuse into target cells where they bind their cytoplasmic receptor, which in turn translocates to the nucleus where it inhibits transcription of cytokine genes through direct binding to the glucocorticoid response elements ( GRE), which are located in the promoter region of cytokine genes or, alternatively, through antagonism of the action of transcription factors required for optimal transcriptional activation.	cytoplasmic receptor,97,117,Gene/Protein	cytokine genes,196,210,Gene/Protein	glucocorticoid response elements,241,273,Gene/Protein	GRE,276,279,Gene/Protein	cytokine genes,326,340,Gene/Protein	transcription factors,396,417,Gene/Protein	"[{""token"": ""cytoplasmic receptor"", ""start_span"": 97, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 196, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid response elements"", ""start_span"": 241, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""GRE"", ""start_span"": 276, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 326, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 396, ""end_span"": 417, ""type"": ""Gene/Protein""}]"	train
A highly conserved 19 - bp element located immediately 5 ' of the human GM - CSF TATA box ( bp - 34 to - 52), herein called purine box 1 ( PB1), has been shown to bind a T - cell nuclear protein complex and to be required for transcriptional induction of the GM - CSF gene following T - cell activation.	human GM - CSF TATA box,66,89,Gene/Protein	bp - 34 to - 52,92,107,Gene/Protein	purine box 1,124,136,Gene/Protein	PB1,139,142,Gene/Protein	T - cell nuclear protein complex,170,202,Gene/Protein	GM - CSF gene,259,272,Gene/Protein	"[{""token"": ""human GM - CSF TATA box"", ""start_span"": 66, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""bp - 34 to - 52"", ""start_span"": 92, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""purine box 1"", ""start_span"": 124, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""PB1"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""T - cell nuclear protein complex"", ""start_span"": 170, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 259, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
The constitutive association of TRAFs with LMP1 through the aa 187 to 231 domain which is important in NF - kappaB activation and primary B - lymphocyte growth transformation implicates TRAF aggregation in LMP1 signaling.	TRAFs,32,37,Gene/Protein	LMP1,43,47,Gene/Protein	aa 187 to 231 domain,60,80,Gene/Protein	NF - kappaB,103,114,Gene/Protein	TRAF,186,190,Gene/Protein	LMP1,206,210,Gene/Protein	"[{""token"": ""TRAFs"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""aa 187 to 231 domain"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""TRAF"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
The IL - 12 nonresponsiveness of the Th2 clones was further evident by the total lack of IL - 12 - induced phosphorylation of STAT4 ( signal transducer and activator of transcription - 4), a transcription factor that is typically involved in IL - 12 signaling.	IL - 12,4,11,Gene/Protein	IL - 12,89,96,Gene/Protein	STAT4,126,131,Gene/Protein	signal transducer and activator of transcription - 4,134,186,Gene/Protein	transcription factor,191,211,Gene/Protein	IL - 12,242,249,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription - 4"", ""start_span"": 134, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 191, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
In fact, while the NH2 regulatory domain is sufficient to mediate CD4 accessory function, we show here that the catalytic domain of pp56 ( lck) is sufficient for induction of IL - 2 production, mimicking TCR ligation.	NH2,19,22,Gene/Protein	regulatory domain,23,40,Gene/Protein	CD4,66,69,Gene/Protein	catalytic domain,112,128,Gene/Protein	IL - 2,175,181,Gene/Protein	TCR,204,207,Gene/Protein	"[{""token"": ""NH2"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""regulatory domain"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""catalytic domain"", ""start_span"": 112, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.	DR3,0,3,Gene/Protein	intracellular signaling molecules,52,85,Gene/Protein	TRADD,96,101,Gene/Protein	TRAF2,103,108,Gene/Protein	FADD,110,114,Gene/Protein	FLICE,120,125,Gene/Protein	"[{""token"": ""DR3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""intracellular signaling molecules"", ""start_span"": 52, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""FADD"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""FLICE"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
SLP - 76 ( SH2 domain leukocyte protein of 76 kDa) is a recently identified substrate of the TCR - stimulated protein tyrosine kinases that functions in the signal transduction cascade linking the TCR with IL - 2 gene expression.	SLP - 76,0,8,Gene/Protein	SH2 domain leukocyte protein,11,39,Gene/Protein	TCR - stimulated protein,93,117,Gene/Protein	tyrosine kinases,118,134,Gene/Protein	TCR,197,200,Gene/Protein	IL - 2,206,212,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain leukocyte protein"", ""start_span"": 11, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TCR - stimulated protein"", ""start_span"": 93, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinases"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
We previously identified and analyzed a 45 - nucleotide sequence ( downstream regulatory element 1 [ DRE 1]), + 195 to + 240, at the boundary of the R / U5 region of the long terminal repeat which is required for HTLV - I basal transcription.	45 - nucleotide sequence,40,64,Gene/Protein	downstream regulatory element 1,67,98,Gene/Protein	DRE 1,101,106,Gene/Protein	+ 195 to + 240,110,124,Gene/Protein	R / U5 region,149,162,Gene/Protein	long terminal repeat,170,190,Gene/Protein	"[{""token"": ""45 - nucleotide sequence"", ""start_span"": 40, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""downstream regulatory element 1"", ""start_span"": 67, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""DRE 1"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""+ 195 to + 240"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""R / U5 region"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 170, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Using monospecific antibodies, the 80 - kDa tyrosine - phosphorylated protein has been shown to be p80c - rel, a proto - oncogene belonging to a family of transcriptional regulators which include NF - kB.	monospecific antibodies,6,29,Gene/Protein	tyrosine - phosphorylated protein,44,77,Gene/Protein	p80c - rel,99,109,Gene/Protein	proto - oncogene,113,129,Gene/Protein	transcriptional regulators,155,181,Gene/Protein	NF - kB,196,203,Gene/Protein	"[{""token"": ""monospecific antibodies"", ""start_span"": 6, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine - phosphorylated protein"", ""start_span"": 44, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""p80c - rel"", ""start_span"": 99, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene"", ""start_span"": 113, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 155, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
The findings presented here link an atheogenic lipoprotein, LDL, with the induction of an adhesion molecule important in atherogenesis Human LDL induces the vascular cell adhesion molecule - 1 ( VCAM - 1) transcriptionally with an increase in mRNA levels through activation of the VCAM promoter.	atheogenic lipoprotein,36,58,Gene/Protein	LDL,60,63,Gene/Protein	LDL,141,144,Gene/Protein	vascular cell adhesion molecule - 1,157,192,Gene/Protein	VCAM - 1,195,203,Gene/Protein	VCAM promoter,281,294,Gene/Protein	"[{""token"": ""atheogenic lipoprotein"", ""start_span"": 36, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""LDL"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""LDL"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 157, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""VCAM promoter"", ""start_span"": 281, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
RelA ( p65) functions as the critical transactivating component of the heterodimeric p50 - p65 NF - kappa B complex and contains a high - affinity binding site for its cytoplasmic inhibitor, I kappa B alpha.	RelA,0,4,Gene/Protein	p65,7,10,Gene/Protein	heterodimeric p50 - p65 NF - kappa B complex,71,115,Gene/Protein	high - affinity binding site,131,159,Gene/Protein	cytoplasmic inhibitor,168,189,Gene/Protein	I kappa B alpha,191,206,Gene/Protein	"[{""token"": ""RelA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""heterodimeric p50 - p65 NF - kappa B complex"", ""start_span"": 71, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity binding site"", ""start_span"": 131, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitor"", ""start_span"": 168, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 191, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Earlier studies on the IL - 2 gene expression showed that overexpression of calcineurin ( CN), a Ca2 + / calmodulin - dependent protein phosphatase, can stimulate transcription from the IL - 2 promoter through the NF - AT - binding site.	IL - 2,23,29,Gene/Protein	calcineurin,76,87,Gene/Protein	CN,90,92,Gene/Protein	Ca2 + / calmodulin - dependent protein phosphatase,97,147,Gene/Protein	IL - 2 promoter,186,201,Gene/Protein	NF - AT - binding site,214,236,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CN"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + / calmodulin - dependent protein phosphatase"", ""start_span"": 97, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 186, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - binding site"", ""start_span"": 214, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
By multimerizing the regulatory elements of the GM - CSF promoter, we found that one of the target sites for the CN action is the conserved lymphokine element 0 ( CLE0), located at positions between - 54 and - 40.	regulatory elements,21,40,Gene/Protein	GM - CSF promoter,48,65,Gene/Protein	target sites,92,104,Gene/Protein	CN,113,115,Gene/Protein	conserved lymphokine element 0,130,160,Gene/Protein	CLE0,163,167,Gene/Protein	"[{""token"": ""regulatory elements"", ""start_span"": 21, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""target sites"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CN"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""conserved lymphokine element 0"", ""start_span"": 130, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""CLE0"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
These results suggest that CN is involved in the coordinated induction of the GM - CSF and IL - 2 genes and that the CLE0 sequence of the GM - CSF gene is a functional analogue of the NF - AT - binding site in the IL - 2 promoter, which mediates signals downstream of T cell activation.	CN,27,29,Gene/Protein	GM - CSF and IL - 2 genes,78,103,Gene/Protein	CLE0 sequence,117,130,Gene/Protein	GM - CSF gene,138,151,Gene/Protein	NF - AT - binding site,184,206,Gene/Protein	IL - 2 promoter,214,229,Gene/Protein	"[{""token"": ""CN"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF and IL - 2 genes"", ""start_span"": 78, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CLE0 sequence"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 138, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - binding site"", ""start_span"": 184, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 214, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Predicted peptide sequence of ORF2 contained a zinc finger domain which showed significant homology to GC box binding proteins BTEB2 and SP1.	Predicted peptide sequence,0,26,Gene/Protein	ORF2,30,34,Gene/Protein	zinc finger domain,47,65,Gene/Protein	GC box binding proteins,103,126,Gene/Protein	BTEB2,127,132,Gene/Protein	SP1,137,140,Gene/Protein	"[{""token"": ""Predicted peptide sequence"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""ORF2"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger domain"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""GC box binding proteins"", ""start_span"": 103, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""BTEB2"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""SP1"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
These blast cells express lineage - specific transcription factors such as GATA - 1 common to these lineages and frequently express erythroid - specific mRNAs such as gamma - globin and erythroid delta - aminolevulinate synthase ( ALAS - E), indicating that most of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes.	lineage - specific transcription factors,26,66,Gene/Protein	GATA - 1,75,83,Gene/Protein	erythroid - specific mRNAs,132,158,Gene/Protein	gamma - globin,167,181,Gene/Protein	erythroid delta - aminolevulinate synthase,186,228,Gene/Protein	ALAS - E,231,239,Gene/Protein	"[{""token"": ""lineage - specific transcription factors"", ""start_span"": 26, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific mRNAs"", ""start_span"": 132, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 167, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""erythroid delta - aminolevulinate synthase"", ""start_span"": 186, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""ALAS - E"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Previously we and others showed by targeted gene disruption that the zinc finger gene, erythroid Kruppel - like factor ( EKLF), is required for expression of the beta - globin gene in mice, presumably through interaction with a high - affinity binding site in the proximal promoter.	zinc finger gene,69,85,Gene/Protein	erythroid Kruppel - like factor,87,118,Gene/Protein	EKLF,121,125,Gene/Protein	beta - globin gene,162,180,Gene/Protein	high - affinity binding site,228,256,Gene/Protein	proximal promoter,264,281,Gene/Protein	"[{""token"": ""zinc finger gene"", ""start_span"": 69, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""erythroid Kruppel - like factor"", ""start_span"": 87, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin gene"", ""start_span"": 162, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity binding site"", ""start_span"": 228, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 264, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	train
This loss of activity was shown to correlate with deletion of two CCAAT boxes, a proximal CCAAT box located at bp - 61 to - 65 and a distal CCAAT box located at bp - 253 to - 257, upstream of Cp.	CCAAT boxes,66,77,Gene/Protein	proximal CCAAT box,81,99,Gene/Protein	bp - 61 to - 65,111,126,Gene/Protein	CCAAT box,140,149,Gene/Protein	- 253 to - 257,164,178,Gene/Protein	Cp,192,194,Gene/Protein	"[{""token"": ""CCAAT boxes"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""proximal CCAAT box"", ""start_span"": 81, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""bp - 61 to - 65"", ""start_span"": 111, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT box"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""- 253 to - 257"", ""start_span"": 164, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 192, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Recombinant NFAT1 can mediate transcription of the interleukin - 2, interleukin - 4, tumor necrosis factor alpha, and granulocyte - macrophage colony - stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA - sensitive transcription of these genes during the immune response.	NFAT1,12,17,Gene/Protein	interleukin - 2,51,66,Gene/Protein	tumor necrosis factor alpha,85,112,Gene/Protein	granulocyte - macrophage colony - stimulating factor promoters,118,180,Gene/Protein	NFAT1,209,214,Gene/Protein	genes,273,278,Gene/Protein	"[{""token"": ""NFAT1"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 51, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 85, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor promoters"", ""start_span"": 118, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 273, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
The cDNA encoding hTAFII105 reveals a highly conserved C - terminal domain shared by hTAFII130 and oTAFII110, while the N - terminal coactivator domain has diverged significantly.	cDNA,4,8,Gene/Protein	hTAFII105,18,27,Gene/Protein	C - terminal domain,55,74,Gene/Protein	hTAFII130,85,94,Gene/Protein	oTAFII110,99,108,Gene/Protein	N - terminal coactivator domain,120,151,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""hTAFII105"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal domain"", ""start_span"": 55, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hTAFII130"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""oTAFII110"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal coactivator domain"", ""start_span"": 120, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
The close homology of the basic region / leucine zipper ( bZIP) DNA - binding and dimerization domain of HLF to that of the CES - 2 cell - death specification protein of Caenorhabditis elegans suggests a model of leukaemogenesis in which E2A - HLF blocks an early step within an evolutionarily conserved cell - death pathway.	basic region / leucine zipper,26,55,Gene/Protein	bZIP,58,62,Gene/Protein	dimerization domain,82,101,Gene/Protein	HLF,105,108,Gene/Protein	CES - 2 cell - death specification protein,124,166,Gene/Protein	E2A - HLF,238,247,Gene/Protein	"[{""token"": ""basic region / leucine zipper"", ""start_span"": 26, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""bZIP"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""dimerization domain"", ""start_span"": 82, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""CES - 2 cell - death specification protein"", ""start_span"": 124, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 238, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
The EBNA transcription was initiated from one of three EBNA promoters, Qp: by contrast, both Cp and Wp were silent, thus resulting in the lack of EBNA2 mRNA.	EBNA,4,8,Gene/Protein	EBNA promoters,55,69,Gene/Protein	Qp,71,73,Gene/Protein	Cp,93,95,Gene/Protein	Wp,100,102,Gene/Protein	EBNA2 mRNA,146,156,Gene/Protein	"[{""token"": ""EBNA"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""EBNA promoters"", ""start_span"": 55, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Qp"", ""start_span"": 71, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Wp"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""EBNA2 mRNA"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
An IL - 2 response element in the human IL - 2 receptor alpha chain promoter is a composite element that binds Stat5, Elf - 1, HMG - I ( Y) and a GATA family protein.	IL - 2 response element,3,26,Gene/Protein	human IL - 2 receptor alpha chain promoter,34,76,Gene/Protein	composite element,82,99,Gene/Protein	Stat5,111,116,Gene/Protein	Elf - 1,118,125,Gene/Protein	GATA family protein,146,165,Gene/Protein	"[{""token"": ""IL - 2 response element"", ""start_span"": 3, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 2 receptor alpha chain promoter"", ""start_span"": 34, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""composite element"", ""start_span"": 82, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""GATA family protein"", ""start_span"": 146, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
A construct termed PFP5a containing - 795 bp exhibited the highest CAT activity, and PFP9a20 containing only - 73 bp also produced significantly high CAT activity in CTLL - R8 cells.	PFP5a,19,24,Gene/Protein	- 795 bp,36,44,Gene/Protein	CAT,67,70,Gene/Protein	PFP9a20,85,92,Gene/Protein	- 73 bp,109,116,Gene/Protein	CAT,150,153,Gene/Protein	"[{""token"": ""PFP5a"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""- 795 bp"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""PFP9a20"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""- 73 bp"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
To confirm the importance of the three cis - acting elements in the perforin gene expression, point mutation was introduced again to each proximal GC box, EBS, and GT box of PFP5a.	cis - acting elements,39,60,Gene/Protein	perforin gene,68,81,Gene/Protein	proximal GC box,138,153,Gene/Protein	EBS,155,158,Gene/Protein	GT box,164,170,Gene/Protein	PFP5a,174,179,Gene/Protein	"[{""token"": ""cis - acting elements"", ""start_span"": 39, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""perforin gene"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""proximal GC box"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""GT box"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""PFP5a"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
In this work, we report that these anergic T cells are defective in their ability to up - regulate protein binding and transactivation at two critical IL - 2 DNA enhancer elements: NF - AT ( nuclear factor of activated T cells; a sequence that binds a heterotrimeric NFATp, Fos, and Jun protein complex) and Activator Protein - 1 ( AP - 1) ( that binds Fos and Jun heterodimers).	IL - 2 DNA enhancer elements,151,179,Gene/Protein	NF - AT,181,188,Gene/Protein	nuclear factor of activated T cells,191,226,Gene/Protein	Activator Protein - 1,308,329,Gene/Protein	AP - 1,332,338,Gene/Protein	Fos and Jun heterodimers,353,377,Gene/Protein	"[{""token"": ""IL - 2 DNA enhancer elements"", ""start_span"": 151, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 191, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""Activator Protein - 1"", ""start_span"": 308, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 332, ""end_span"": 338, ""type"": ""Gene/Protein""}, {""token"": ""Fos and Jun heterodimers"", ""start_span"": 353, ""end_span"": 377, ""type"": ""Gene/Protein""}]"	train
The recognition of both the POU domain and the octamer sequence by OCA - B provides a mechanism for differential regulation of octamer sites containing genes by the ubiquitous factor Oct - 1.	POU domain,28,38,Gene/Protein	octamer sequence,47,63,Gene/Protein	OCA - B,67,74,Gene/Protein	octamer sites,127,140,Gene/Protein	ubiquitous factor,165,182,Gene/Protein	Oct - 1,183,190,Gene/Protein	"[{""token"": ""POU domain"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""octamer sequence"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""octamer sites"", ""start_span"": 127, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous factor"", ""start_span"": 165, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
The cytokines IFN - beta, IFN - gamma, IL - 4, and LPS, although unable to induce sialoadhesin expression by themselves, were able to enhance GC - mediated induction of sialoadhesin.	cytokines,4,13,Gene/Protein	IFN - beta,14,24,Gene/Protein	IFN - gamma,26,37,Gene/Protein	IL - 4,39,45,Gene/Protein	sialoadhesin,82,94,Gene/Protein	sialoadhesin,169,181,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
The requirements for induction of transcription factors reflected the requirements for the secretion of multiple cytokines, including IL - 2, TNF - alpha, IFN - gamma, and granulocyte macrophage - CSF.	transcription factors,34,55,Gene/Protein	cytokines,113,122,Gene/Protein	IL - 2,134,140,Gene/Protein	TNF - alpha,142,153,Gene/Protein	IFN - gamma,155,166,Gene/Protein	granulocyte macrophage - CSF,172,200,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 34, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte macrophage - CSF"", ""start_span"": 172, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
By using run - on assays, ACLA was shown to induce an enhancement of the transcription of erythroid genes, including gamma - globin, PBGD, erythropoietin receptor, and GATA - 1 transcription factor.	erythroid genes,90,105,Gene/Protein	gamma - globin,117,131,Gene/Protein	PBGD,133,137,Gene/Protein	erythropoietin receptor,139,162,Gene/Protein	GATA - 1,168,176,Gene/Protein	transcription factor,177,197,Gene/Protein	"[{""token"": ""erythroid genes"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 117, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""PBGD"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin receptor"", ""start_span"": 139, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 177, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
IL - 7 also induced STAT / DNA binding in BCP - ALL cases that failed to proliferate in response to IL - 7, suggesting that the ability of IL - 7R to activate the JAK / STAT pathway per se is not sufficient for proliferation induction.	IL - 7,0,6,Gene/Protein	STAT,20,24,Gene/Protein	IL - 7,100,106,Gene/Protein	IL - 7R,139,146,Gene/Protein	JAK,163,166,Gene/Protein	/ STAT,167,173,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7R"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
InterleUkin 2 expression requires several transcription factors of which nuclear translocation of NFAT ( nuclear factor of activated T cells) and NFAT - mediated transactivation were impaired by BCL - 2.	InterleUkin 2,0,13,Gene/Protein	transcription factors,42,63,Gene/Protein	NFAT,98,102,Gene/Protein	nuclear factor of activated T cells,105,140,Gene/Protein	NFAT,146,150,Gene/Protein	BCL - 2,195,202,Gene/Protein	"[{""token"": ""InterleUkin 2"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 105, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 2"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Importantly, two previously characterized mutants with point mutations in Tax, M32 ( Y196A, K197S) and M41 ( H287A, P288S), which were shown to be defective in Tax - activated transcription were unable to interact with TFIIA in this assay.	mutants,42,49,Gene/Protein	Tax,74,77,Gene/Protein	M32,79,82,Gene/Protein	M41,103,106,Gene/Protein	Tax,160,163,Gene/Protein	TFIIA,219,224,Gene/Protein	"[{""token"": ""mutants"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""M32"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""M41"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""TFIIA"", ""start_span"": 219, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Pb - induced activation of NF - kappa B is blocked by antibodies for p65 and p50 subunits but not cRel, indicating that the p65: p50 heterodimer ( NF - kappa B) is involved.	NF - kappa B,27,39,Gene/Protein	antibodies,54,64,Gene/Protein	p65,69,72,Gene/Protein	p50,77,80,Gene/Protein	cRel,98,102,Gene/Protein	NF - kappa B,147,159,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""cRel"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 147, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Finally, IL - 2 induced tyrosine phosphorylation of JAK1 and JAK3, while IL - 12 induced phosphorylation of JAK2 and TYK2 in both preactivated primary NK and NK3. 3 cells.	IL - 2,9,15,Gene/Protein	JAK1,52,56,Gene/Protein	JAK3,61,65,Gene/Protein	IL - 12,73,80,Gene/Protein	JAK2,108,112,Gene/Protein	TYK2,117,121,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""TYK2"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
Granulocyte - macrophage colony - stimulating factor ( GM - CSF) induces immediate effects in monocytes by activation of the Janus kinase ( JAK2) and STAT transcription factor ( STAT5) pathway.	Granulocyte - macrophage colony - stimulating factor,0,52,Gene/Protein	GM - CSF,55,63,Gene/Protein	Janus kinase,125,137,Gene/Protein	JAK2,140,144,Gene/Protein	STAT transcription factor,150,175,Gene/Protein	STAT5,178,183,Gene/Protein	"[{""token"": ""Granulocyte - macrophage colony - stimulating factor"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""STAT transcription factor"", ""start_span"": 150, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
The translocation found in acute promyelocytic leukemia rearranges the promyelocytic leukemia gene ( PML) on chromosome 15 with the retinoic acid receptor alpha ( RARalpha) on chromosome 17.	promyelocytic leukemia gene,71,98,Gene/Protein	PML,101,104,Gene/Protein	chromosome 15,109,122,Gene/Protein	retinoic acid receptor alpha,132,160,Gene/Protein	RARalpha,163,171,Gene/Protein	chromosome 17,176,189,Gene/Protein	"[{""token"": ""promyelocytic leukemia gene"", ""start_span"": 71, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""PML"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""chromosome 15"", ""start_span"": 109, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor alpha"", ""start_span"": 132, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""RARalpha"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""chromosome 17"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Although transcriptional factors AP - 1 and nuclear factor of activated T cells ( NF - AT) are important for the normal induction of IL - 2, it is unknown if the age - related decline in IL - 2 production by activated human T cells may be associated with aberrancies in transcriptional regulatory proteins.	transcriptional factors,9,32,Gene/Protein	AP - 1,33,39,Gene/Protein	NF - AT,82,89,Gene/Protein	IL - 2,133,139,Gene/Protein	IL - 2,187,193,Gene/Protein	transcriptional regulatory proteins,270,305,Gene/Protein	"[{""token"": ""transcriptional factors"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory proteins"", ""start_span"": 270, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
Thus, these results show that age - related impairments in the activation of AP - 1 and NF - AT are closely associated with decreased expression of IL - 2 and further suggest that aberrancies in the signaling pathways important for the induction of transcriptionally active c - Fos / c - Jun AP - 1 may contribute to the impaired activation of NF - AT.	AP - 1,77,83,Gene/Protein	NF - AT,88,95,Gene/Protein	IL - 2,148,154,Gene/Protein	c - Fos / c - Jun,274,291,Gene/Protein	AP - 1,292,298,Gene/Protein	NF - AT,344,351,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos / c - Jun"", ""start_span"": 274, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 292, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 344, ""end_span"": 351, ""type"": ""Gene/Protein""}]"	train
In addition, IL - 13 phosphorylated insulin response substrate - 1, IL - 4R p140, JAK1, and Tyk2, but not JAK3 kinase.	IL - 13,13,20,Gene/Protein	insulin response substrate - 1,36,66,Gene/Protein	IL - 4R p140,68,80,Gene/Protein	JAK1,82,86,Gene/Protein	Tyk2,92,96,Gene/Protein	JAK3 kinase,106,117,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""insulin response substrate - 1"", ""start_span"": 36, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R p140"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""JAK3 kinase"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift assays showed that IL - 4, but not IL - 10, inhibited nuclear NF - kappaB activity, and that IL - 4 and IL - 10 did not affect NF - IL - 6 activity.	IL - 4,50,56,Gene/Protein	IL - 10,66,73,Gene/Protein	NF - kappaB,93,104,Gene/Protein	IL - 4,124,130,Gene/Protein	IL - 10,135,142,Gene/Protein	IL - 6,163,169,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Transient expression experiments of 5 ' - deletion fragments of the CD36 promoter coupled to luciferase demonstrated that as few as 158 base pairs upstream from the transcription initiation site were sufficient to direct the monocyte - specific transcription of the reporter gene.	5 ' - deletion fragments,36,60,Gene/Protein	CD36 promoter,68,81,Gene/Protein	luciferase,93,103,Gene/Protein	158 base pairs upstream,132,155,Gene/Protein	transcription initiation site,165,194,Gene/Protein	reporter gene,266,279,Gene/Protein	"[{""token"": ""5 ' - deletion fragments"", ""start_span"": 36, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD36 promoter"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""158 base pairs upstream"", ""start_span"": 132, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 165, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 266, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
We conclude that the MAP kinase signal transduction pathway consisting of Raf - 1, MEK1, and ERK1 and ERK2 functions in the stimulation IL - 2 gene transcription in activated T lymphocytes.	MAP kinase,21,31,Gene/Protein	Raf - 1,74,81,Gene/Protein	MEK1,83,87,Gene/Protein	ERK1,93,97,Gene/Protein	ERK2,102,106,Gene/Protein	IL - 2 gene,136,147,Gene/Protein	"[{""token"": ""MAP kinase"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Costimulation of cells with LPS plus GM - CSF induced the production of proinflammatory cytokines, IL - 8, IL - 1 beta and IL - 6, but not TNF - alpha.	GM - CSF,37,45,Gene/Protein	proinflammatory cytokines,72,97,Gene/Protein	IL - 8,99,105,Gene/Protein	IL - 1 beta,107,118,Gene/Protein	IL - 6,123,129,Gene/Protein	TNF - alpha,139,150,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""proinflammatory cytokines"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Interestingly, the processing rate of p105 is markedly inhibited in cells co - transfected with p50 or other NF - kappaB subunits, including RelA and c - Rel, that physically interact with p105.	p105,38,42,Gene/Protein	p50,96,99,Gene/Protein	NF - kappaB subunits,109,129,Gene/Protein	RelA,141,145,Gene/Protein	c - Rel,150,157,Gene/Protein	p105,189,193,Gene/Protein	"[{""token"": ""p105"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 109, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
We found that two IL - 1alpha kappaB - like sites ( positions - 1, 065 to - 1, 056 and + 646 to + 655) specifically formed a complex with NF - kappaB - containing nuclear extract from MT - 2 cells and that NF - kappaB bound with higher affinity to the 3 ' NF - kappaB binding site than to the 5 ' NF - kappaB site.	IL - 1alpha kappaB - like sites,18,49,Gene/Protein	+ 646 to + 655,87,101,Gene/Protein	NF - kappaB,138,149,Gene/Protein	NF - kappaB,206,217,Gene/Protein	3 ' NF - kappaB binding site,252,280,Gene/Protein	5 ' NF - kappaB site,293,313,Gene/Protein	"[{""token"": ""IL - 1alpha kappaB - like sites"", ""start_span"": 18, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""+ 646 to + 655"", ""start_span"": 87, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""3 ' NF - kappaB binding site"", ""start_span"": 252, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""5 ' NF - kappaB site"", ""start_span"": 293, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
On the other hand, the up - regulation of CD80 Ag, found on monocytes obtained from PBMC incubated with OKT3, is not detected after addition of IL - 10, and the anti - CD28 mAb CLB - CD28 / 1 restores the NF - kappa B / Rel nuclear activity in IL - 10 - inhibited lymphocytes.	CD80 Ag,42,49,Gene/Protein	OKT3,104,108,Gene/Protein	IL - 10,144,151,Gene/Protein	anti - CD28 mAb,161,176,Gene/Protein	CLB - CD28 / 1,177,191,Gene/Protein	NF - kappa B / Rel,205,223,Gene/Protein	"[{""token"": ""CD80 Ag"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""OKT3"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""CLB - CD28 / 1"", ""start_span"": 177, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 205, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
In the present study we demonstrate that also the signal transducers and activators of transcription ( STAT) family members STAT1 p91 and STAT3 p92 and the product of the c - fps / fes protooncogene become tyrosine - phosphorylated upon GM - CSF stimulation and physically associated with both GM - CSF receptor beta common subunit and JAK2.	STAT1 p91,124,133,Gene/Protein	STAT3 p92,138,147,Gene/Protein	c - fps / fes protooncogene,171,198,Gene/Protein	GM - CSF,237,245,Gene/Protein	GM - CSF,294,302,Gene/Protein	JAK2,336,340,Gene/Protein	"[{""token"": ""STAT1 p91"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 p92"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""c - fps / fes protooncogene"", ""start_span"": 171, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 237, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 294, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 336, ""end_span"": 340, ""type"": ""Gene/Protein""}]"	train
The gammac chain is a subunit of multiple cytokine receptors ( interleukin ( IL) - 2, IL - 4, IL - 7, IL - 9, and IL - 15), the expression of which is restricted to hematopoietic lineages.	gammac chain,4,16,Gene/Protein	cytokine receptors,42,60,Gene/Protein	IL - 4,86,92,Gene/Protein	IL - 7,94,100,Gene/Protein	IL - 9,102,108,Gene/Protein	IL - 15,114,121,Gene/Protein	"[{""token"": ""gammac chain"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""cytokine receptors"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
The functional Ets binding site was found to bind Ets family proteins, principally GA - binding protein and Elf - 1 and could be transactivated by GABPalpha and - beta synergistically.	Ets binding site,15,31,Gene/Protein	Ets family proteins,50,69,Gene/Protein	GA - binding protein,83,103,Gene/Protein	Elf - 1,108,115,Gene/Protein	GABPalpha,147,156,Gene/Protein	- beta,161,167,Gene/Protein	"[{""token"": ""Ets binding site"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Ets family proteins"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GA - binding protein"", ""start_span"": 83, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""GABPalpha"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""- beta"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Expression of either the cyclic AMP response element - binding protein ( CREB) or CREB fused to the GAL4 activation domain ( GAD) in this strain did not modify the expression of the reporter gene.	cyclic AMP response element - binding protein,25,70,Gene/Protein	CREB,73,77,Gene/Protein	CREB,82,86,Gene/Protein	GAL4 activation domain,100,122,Gene/Protein	GAD,125,128,Gene/Protein	reporter gene,182,195,Gene/Protein	"[{""token"": ""cyclic AMP response element - binding protein"", ""start_span"": 25, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 activation domain"", ""start_span"": 100, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""GAD"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Using synthetic ligands to retinoic acid receptors ( RARs) and retinoid X receptors ( RXRs) that selectively bind and activate RAR - RXR or RXR - RXR dimers, respectively, we dissected the involvement of the two retinoid response pathways in the regulation of normal myeloid and erythroid progenitor cell growth.	retinoic acid receptors,27,50,Gene/Protein	RARs,53,57,Gene/Protein	retinoid X receptors,63,83,Gene/Protein	RXRs,86,90,Gene/Protein	RAR - RXR,127,136,Gene/Protein	RXR - RXR,140,149,Gene/Protein	"[{""token"": ""retinoic acid receptors"", ""start_span"": 27, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 63, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""RAR - RXR"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RXR"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
We hypothesized that an intracellular vitamin D binding protein ( IDBP), present in both nuclear and cytoplasmic fractions of NWP cells, or another protein ( s) may cause or contribute to the steroid hormone - resistant state in NWP by disruption of the receptor dimerization process and / or by interference of receptor complex binding to the consensus response elements present in the enhancer regions of steroid - responsive genes.	intracellular vitamin D binding protein,24,63,Gene/Protein	IDBP,66,70,Gene/Protein	receptor complex,312,328,Gene/Protein	consensus response elements,344,371,Gene/Protein	enhancer regions,387,403,Gene/Protein	steroid - responsive genes,407,433,Gene/Protein	"[{""token"": ""intracellular vitamin D binding protein"", ""start_span"": 24, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IDBP"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""receptor complex"", ""start_span"": 312, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""consensus response elements"", ""start_span"": 344, ""end_span"": 371, ""type"": ""Gene/Protein""}, {""token"": ""enhancer regions"", ""start_span"": 387, ""end_span"": 403, ""type"": ""Gene/Protein""}, {""token"": ""steroid - responsive genes"", ""start_span"": 407, ""end_span"": 433, ""type"": ""Gene/Protein""}]"	train
Despite the dual specificity of HTLV - 1 Tax for IkappaBalpha and IkappaBbeta at the protein level, Tax selectively stimulates NF - kappaB - directed transcription of the IkappaBalpha gene.	Tax,41,44,Gene/Protein	IkappaBalpha,49,61,Gene/Protein	IkappaBbeta,66,77,Gene/Protein	Tax,100,103,Gene/Protein	NF - kappaB,127,138,Gene/Protein	IkappaBalpha gene,171,188,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha gene"", ""start_span"": 171, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Phosphorylation of the retinoblastoma protein by cyclin - dependent kinases 4 and 6 prevents its interaction with the transcription factor E2F, which subsequently promotes the expression of S phase regulated genes, such as thymidine kinase.	retinoblastoma protein,23,45,Gene/Protein	cyclin - dependent kinases 4 and 6,49,83,Gene/Protein	transcription factor,118,138,Gene/Protein	E2F,139,142,Gene/Protein	S phase regulated genes,190,213,Gene/Protein	thymidine kinase,223,239,Gene/Protein	"[{""token"": ""retinoblastoma protein"", ""start_span"": 23, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinases 4 and 6"", ""start_span"": 49, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 118, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""S phase regulated genes"", ""start_span"": 190, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase"", ""start_span"": 223, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Analysis of long terminal repeat - driven secreted alkaline phosphatase activity in transient assays showed that, unlike human immunodeficiency virus type 1, the SIV long terminal repeat possesses an enhancer region just upstream of the NF - kappaB element which maintains significant levels of basal transcription in the absence of NF - kappaB and Sp1 sites.	long terminal repeat,12,32,Gene/Protein	alkaline phosphatase,51,71,Gene/Protein	SIV long terminal repeat,162,186,Gene/Protein	enhancer region,200,215,Gene/Protein	NF - kappaB element,237,256,Gene/Protein	NF - kappaB and Sp1 sites,333,358,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 12, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""alkaline phosphatase"", ""start_span"": 51, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""SIV long terminal repeat"", ""start_span"": 162, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""enhancer region"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB element"", ""start_span"": 237, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB and Sp1 sites"", ""start_span"": 333, ""end_span"": 358, ""type"": ""Gene/Protein""}]"	train
In Rel - / - splenic T cell cultures stimulated with phorbol 12 - myristate 13 - acetate and ionomycin, the levels of IL - 3, IL - 5, granulocyte - macrophage colony - stimulating factor ( GM - CSF), tumor necrosis factor alpha ( TNF - alpha), and gamma interferon ( IFN - gamma) were only 2 - to 3 - fold lower compared with normal T cells.	granulocyte - macrophage colony - stimulating factor,134,186,Gene/Protein	GM - CSF,189,197,Gene/Protein	tumor necrosis factor alpha,200,227,Gene/Protein	TNF - alpha,230,241,Gene/Protein	gamma interferon,248,264,Gene/Protein	IFN - gamma,267,278,Gene/Protein	"[{""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 134, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 200, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 230, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""gamma interferon"", ""start_span"": 248, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 267, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
Deletion constructs containing as little as 72 bp of 5 ' - flanking sequence of the collagenase promoter were sufficient for LPS - or zymosan - mediated transcriptional induction, whereas phorbol inducibility exhibited an absolute requirement for upstream elements including the polyoma enhancer A - binding protein - 3 site ( - 83 to - 91) and TTCA sequence ( - 102 to - 105) in both monocytic cells and fibroblasts.	5 ' - flanking sequence,53,76,Gene/Protein	collagenase promoter,84,104,Gene/Protein	polyoma enhancer A - binding protein - 3 site,279,324,Gene/Protein	- 83 to - 91,327,339,Gene/Protein	TTCA sequence,345,358,Gene/Protein	- 102 to - 105,361,375,Gene/Protein	"[{""token"": ""5 ' - flanking sequence"", ""start_span"": 53, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""collagenase promoter"", ""start_span"": 84, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""polyoma enhancer A - binding protein - 3 site"", ""start_span"": 279, ""end_span"": 324, ""type"": ""Gene/Protein""}, {""token"": ""- 83 to - 91"", ""start_span"": 327, ""end_span"": 339, ""type"": ""Gene/Protein""}, {""token"": ""TTCA sequence"", ""start_span"": 345, ""end_span"": 358, ""type"": ""Gene/Protein""}, {""token"": ""- 102 to - 105"", ""start_span"": 361, ""end_span"": 375, ""type"": ""Gene/Protein""}]"	train
Specifically, we examined nuclear factor - kappa B ( NF - kappa B) activation because it is crucial in transcriptional regulation of many inflammatory cytokine genes including TNF, IL - 1, and IL - 6.	nuclear factor - kappa B,26,50,Gene/Protein	NF - kappa B,53,65,Gene/Protein	inflammatory cytokine genes,138,165,Gene/Protein	TNF,176,179,Gene/Protein	IL - 1,181,187,Gene/Protein	IL - 6,193,199,Gene/Protein	"[{""token"": ""nuclear factor - kappa B"", ""start_span"": 26, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory cytokine genes"", ""start_span"": 138, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Truncated c - Jun and c - Fos mutant proteins including wbJun and wbFos were also ubiquitinylated under the same conditions, suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos.	Truncated c - Jun and c - Fos mutant proteins,0,45,Gene/Protein	wbJun,56,61,Gene/Protein	wbFos,66,71,Gene/Protein	dimerization and DNA binding domains,189,225,Gene/Protein	c - Jun,229,236,Gene/Protein	c - Fos,241,248,Gene/Protein	"[{""token"": ""Truncated c - Jun and c - Fos mutant proteins"", ""start_span"": 0, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""wbJun"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""wbFos"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""dimerization and DNA binding domains"", ""start_span"": 189, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
In this study, we investigated the ability of the major envelope glycoprotein of HIV, glycoprotein 120 ( gp120), to regulate intercellular adhesion molecule - 1 ( ICAM - 1) expression in glial cells, because ICAM - 1 is important in mediating immune responsiveness in the CNS, facilitating entry of HIV - infected cells into the CNS, and promoting syncytia formation.	major envelope glycoprotein,50,77,Gene/Protein	glycoprotein 120,86,102,Gene/Protein	gp120,105,110,Gene/Protein	intercellular adhesion molecule - 1,125,160,Gene/Protein	ICAM - 1,163,171,Gene/Protein	ICAM - 1,208,216,Gene/Protein	"[{""token"": ""major envelope glycoprotein"", ""start_span"": 50, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""glycoprotein 120"", ""start_span"": 86, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 125, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
The effects of the two cytokines were distinguishable functionally since pretreatment with TNF - alpha attenuated the cytokine cooperativity, while pretreatment with IL - 10 potentiated their cooperativity, suggesting that IL - 10 and TNF - alpha play different roles in the activation of virus.	cytokines,23,32,Gene/Protein	TNF - alpha,91,102,Gene/Protein	cytokine,118,126,Gene/Protein	IL - 10,166,173,Gene/Protein	IL - 10,223,230,Gene/Protein	TNF - alpha,235,246,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
Pretreatment with the broad serine / threonine kinase inhibitor staurosporine partly blocked the calyculin A - induced STAT3 phosphorylation, whereas inhibitors of serine / threonine kinases, such as mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase, mitogen - activated protein p38 kinase, and phosphatidylinositol 3 - kinase, did not.	calyculin A,97,108,Gene/Protein	STAT3,119,124,Gene/Protein	serine / threonine kinases,164,190,Gene/Protein	mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase,200,280,Gene/Protein	mitogen - activated protein p38 kinase,282,320,Gene/Protein	phosphatidylinositol 3 - kinase,326,357,Gene/Protein	"[{""token"": ""calyculin A"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""serine / threonine kinases"", ""start_span"": 164, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase"", ""start_span"": 200, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein p38 kinase"", ""start_span"": 282, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 326, ""end_span"": 357, ""type"": ""Gene/Protein""}]"	train
The mechanism of this effect is that Bcl - 2 prevents the nuclear translocation of NFAT ( nuclear factor of activated T lymphocytes, a transcription factor activated by microtubule damage) by binding and sequestering calcineurin, a calcium - dependent phosphatase that must dephosphorylate NFAT to move to the nucleus.	Bcl - 2,37,44,Gene/Protein	NFAT,83,87,Gene/Protein	nuclear factor of activated T lymphocytes,90,131,Gene/Protein	transcription factor,135,155,Gene/Protein	microtubule,169,180,Gene/Protein	NFAT,290,294,Gene/Protein	"[{""token"": ""Bcl - 2"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T lymphocytes"", ""start_span"": 90, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 135, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""microtubule"", ""start_span"": 169, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 290, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
In electrophoretic mobility shift assays using the E1 oligonucleotide as probe, nuclear extracts from unstimulated T and B cell lines formed a constitutive complex termed complex I, while nuclear extracts from stimulated SCM - 1 - producer T cell lines formed a higher mobility complex termed complex II with a concomitant decrease in complex I.	E1,51,53,Gene/Protein	constitutive complex,143,163,Gene/Protein	complex I,171,180,Gene/Protein	higher mobility complex,262,285,Gene/Protein	complex II,293,303,Gene/Protein	complex I,335,344,Gene/Protein	"[{""token"": ""E1"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""constitutive complex"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""complex I"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""higher mobility complex"", ""start_span"": 262, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""complex II"", ""start_span"": 293, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""complex I"", ""start_span"": 335, ""end_span"": 344, ""type"": ""Gene/Protein""}]"	train
However, in contrast with TNF - alpha, dopamine treatment did not affect NF - kappaB DNA binding activity nor the concentrations of p50, p65 and IkappaB - alpha proteins, which suggests a distinct NF - kappaB activation mechanism.	TNF - alpha,26,37,Gene/Protein	NF - kappaB,73,84,Gene/Protein	p50,132,135,Gene/Protein	p65,137,140,Gene/Protein	IkappaB - alpha proteins,145,169,Gene/Protein	NF - kappaB,197,208,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha proteins"", ""start_span"": 145, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus latency BamHI - Q promoter is positively regulated by STATs and Zta interference with JAK / STAT activation leads to loss of BamHI - Q promoter activity.	Epstein - Barr virus latency BamHI - Q promoter,4,51,Gene/Protein	STATs,79,84,Gene/Protein	Zta,89,92,Gene/Protein	JAK,111,114,Gene/Protein	/ STAT,115,121,Gene/Protein	BamHI - Q promoter,150,168,Gene/Protein	"[{""token"": ""Epstein - Barr virus latency BamHI - Q promoter"", ""start_span"": 4, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Zta"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""BamHI - Q promoter"", ""start_span"": 150, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
CD3 - mediated activation of Stat3 is almost completely inhibited by a Src kinase inhibitor ( PP1), whereas IL - 2 - induced Stat3 activation is unaffected.	CD3,0,3,Gene/Protein	Stat3,29,34,Gene/Protein	Src kinase inhibitor,71,91,Gene/Protein	PP1,94,97,Gene/Protein	IL - 2,108,114,Gene/Protein	Stat3,125,130,Gene/Protein	"[{""token"": ""CD3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Src kinase inhibitor"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
While CD40 ligation strongly activates the SAPKs ( up to 25 - fold), it does not affect members of the mitogen - activated protein kinase family ( MAPK; ERK1 and ERK2).	CD40,6,10,Gene/Protein	SAPKs,43,48,Gene/Protein	mitogen - activated protein kinase family,103,144,Gene/Protein	MAPK,147,151,Gene/Protein	ERK1,153,157,Gene/Protein	ERK2,162,166,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""SAPKs"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase family"", ""start_span"": 103, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
Tumor necrosis factor ( TNF) and interleukin - 7 ( IL - 7), secreted during this interaction, are critical cytokines for HIV long terminal repeat transactivation through NF - kappaB - dependent activation.	Tumor necrosis factor,0,21,Gene/Protein	TNF,24,27,Gene/Protein	interleukin - 7,33,48,Gene/Protein	IL - 7,51,57,Gene/Protein	HIV long terminal repeat,121,145,Gene/Protein	NF - kappaB,170,181,Gene/Protein	"[{""token"": ""Tumor necrosis factor"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 7"", ""start_span"": 33, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 121, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
This peptide potently inhibited NFAT activation and NFAT - dependent expression of endogenous cytokine genes in T cells, without affecting the expression of other cytokines that require calcineurin but not NFAT.	NFAT,32,36,Gene/Protein	NFAT,52,56,Gene/Protein	endogenous cytokine genes,83,108,Gene/Protein	cytokines,163,172,Gene/Protein	calcineurin,186,197,Gene/Protein	NFAT,206,210,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""endogenous cytokine genes"", ""start_span"": 83, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Other peroxisome proliferator activated receptor ( PPAR) ligands, 15d - PGJ ( 2) and troglitazone ( PPARgamma), Wy14, 643 ( PPARalpha), and PD195599 ( PPARbeta) inhibited the induction of MCP - 1 by RA.	peroxisome proliferator activated receptor,6,48,Gene/Protein	PPAR,51,55,Gene/Protein	PPARgamma,100,109,Gene/Protein	PPARalpha,124,133,Gene/Protein	PPARbeta,151,159,Gene/Protein	MCP - 1,188,195,Gene/Protein	"[{""token"": ""peroxisome proliferator activated receptor"", ""start_span"": 6, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""PPAR"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 100, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""PPARalpha"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""PPARbeta"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 188, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
A dominant - negative version of STAT5b, but not of STAT5a, interfered with IL - 4 - induced DNA synthesis in Ba / F3 cells, suggesting an involvement of STAT5b in the control of cell proliferation through IL - 4R.	dominant - negative version,2,29,Gene/Protein	STAT5b,33,39,Gene/Protein	STAT5a,52,58,Gene/Protein	IL - 4,76,82,Gene/Protein	STAT5b,154,160,Gene/Protein	IL - 4R,206,213,Gene/Protein	"[{""token"": ""dominant - negative version"", ""start_span"": 2, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
SHP1 - DeltaSH2 also inhibited events downstream of ZAP - 70 and Syk, such as activation of the mitogen - activated protein kinase Erk2 and the transcriptional activation of the interleukin - 2 gene.	SHP1 - DeltaSH2,0,15,Gene/Protein	ZAP - 70,52,60,Gene/Protein	Syk,65,68,Gene/Protein	mitogen - activated protein kinase,96,130,Gene/Protein	Erk2,131,135,Gene/Protein	interleukin - 2 gene,178,198,Gene/Protein	"[{""token"": ""SHP1 - DeltaSH2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 96, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 gene"", ""start_span"": 178, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Expression of FOG ( riend ATA), which binds to GATA - 1 and acts as a cofactor for GATA - binding proteins, decreased transactivation activity of GATA - 1 for the MBP promoter in a dose - dependent manner.	FOG,14,17,Gene/Protein	riend ATA,20,29,Gene/Protein	GATA - 1,47,55,Gene/Protein	GATA - binding proteins,83,106,Gene/Protein	GATA - 1,146,154,Gene/Protein	MBP promoter,163,175,Gene/Protein	"[{""token"": ""FOG"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""riend ATA"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding proteins"", ""start_span"": 83, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""MBP promoter"", ""start_span"": 163, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
These results indicate that within the TCR / CD3 signal transduction pathway both PKC and calcineurin are required for the effective activation of the IKK complex and NF - kappaB in T lymphocytes.	TCR,39,42,Gene/Protein	/ CD3,43,48,Gene/Protein	PKC,82,85,Gene/Protein	calcineurin,90,101,Gene/Protein	IKK complex,151,162,Gene/Protein	NF - kappaB,167,178,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""/ CD3"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IKK complex"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
The product of the B - cell - specific B29 gene ( B29, Ig beta, CD79b) is essential for Ig - mediated B - cell activation via the B - cell antigen receptor complex ( BCR) on human and murine B lymphocytes.	B - cell - specific B29 gene,19,47,Gene/Protein	B29,50,53,Gene/Protein	Ig beta,55,62,Gene/Protein	CD79b,64,69,Gene/Protein	B - cell antigen receptor complex,130,163,Gene/Protein	BCR,166,169,Gene/Protein	"[{""token"": ""B - cell - specific B29 gene"", ""start_span"": 19, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""B29"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Ig beta"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD79b"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""B - cell antigen receptor complex"", ""start_span"": 130, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""BCR"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Activation of the CDC42 effector N - WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2 / 3 complex and bacterial actin - based motility.	CDC42 effector,18,32,Gene/Protein	N - WASP,33,41,Gene/Protein	Shigella flexneri IcsA protein,49,79,Gene/Protein	actin,89,94,Gene/Protein	Arp2 / 3 complex,109,125,Gene/Protein	actin,140,145,Gene/Protein	"[{""token"": ""CDC42 effector"", ""start_span"": 18, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""N - WASP"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Shigella flexneri IcsA protein"", ""start_span"": 49, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Arp2 / 3 complex"", ""start_span"": 109, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
The isolated COOH - terminal domain of N - WASP containing a verprolin - homology region, a cofilin - homology sequence, and an acidic terminal segment ( VCA) interacts with G - actin in a unique profilin - like functional fashion.	COOH - terminal domain,13,35,Gene/Protein	N - WASP,39,47,Gene/Protein	verprolin - homology region,61,88,Gene/Protein	acidic terminal segment,128,151,Gene/Protein	VCA,154,157,Gene/Protein	G - actin,174,183,Gene/Protein	"[{""token"": ""COOH - terminal domain"", ""start_span"": 13, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""N - WASP"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""verprolin - homology region"", ""start_span"": 61, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""acidic terminal segment"", ""start_span"": 128, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""VCA"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""G - actin"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
We have studied the effects of prednisone ( PDN), deflazacort ( DFC), and dexamethasone ( DXM) on the production of cytokines ( IL - 2, IL - 6, TNF - alpha, IL - 10) by peripheral T lymphocytes, and the effects on the inhibition of NF - kB DNA binding activity by activated Jurkat cell line.	cytokines,116,125,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 6,136,142,Gene/Protein	TNF - alpha,144,155,Gene/Protein	IL - 10,157,164,Gene/Protein	NF - kB,232,239,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Forty - one HD samples ( 19 NLPHD, 12 nodular sclerosis, and 10 mixed cellularity) were immunostained with the monoclonal antibodies PG - B6 and PG - B6p that react with a fixative - sensitive and a formalin - resistant epitope on the aminoterminal region of the BCL - 6 gene product, respectively.	monoclonal antibodies,111,132,Gene/Protein	PG - B6,133,140,Gene/Protein	PG - B6p,145,153,Gene/Protein	formalin - resistant epitope,199,227,Gene/Protein	aminoterminal region,235,255,Gene/Protein	BCL - 6 gene product,263,283,Gene/Protein	"[{""token"": ""monoclonal antibodies"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""PG - B6"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""PG - B6p"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""formalin - resistant epitope"", ""start_span"": 199, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""aminoterminal region"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 6 gene product"", ""start_span"": 263, ""end_span"": 283, ""type"": ""Gene/Protein""}]"	train
Exposure to LPS or TNF led to differential patterns of IkappaB - alpha and IkappaB - epsilon disappearance from and reassembly with the signalsome, whereas IKK - alpha, IKK - beta, and NIK remained complex - associated.	TNF,19,22,Gene/Protein	IkappaB - alpha,55,70,Gene/Protein	IkappaB - epsilon,75,92,Gene/Protein	IKK - alpha,156,167,Gene/Protein	IKK - beta,169,179,Gene/Protein	NIK,185,188,Gene/Protein	"[{""token"": ""TNF"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - epsilon"", ""start_span"": 75, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IKK - alpha"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""IKK - beta"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
NIK can not phosphorylate IkappaB - alpha directly, but it appears to be a functionally important subunit, because mutated NIK inhibited stimulus - induced kappaB - dependent transcription more effectively than mutated IKK - alpha or - beta.	NIK,0,3,Gene/Protein	IkappaB - alpha,26,41,Gene/Protein	NIK,123,126,Gene/Protein	kappaB,156,162,Gene/Protein	IKK - alpha,219,230,Gene/Protein	- beta,234,240,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""IKK - alpha"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""- beta"", ""start_span"": 234, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
We show here that in addition to the strong N - terminal trans - activation domain, TAD - A, which is common to all three NF - ATc isoforms, NF - ATc / C contains a second trans - activation domain, TAD - B, in its C - terminal peptide.	strong N - terminal trans - activation domain,37,82,Gene/Protein	TAD - A,84,91,Gene/Protein	NF - ATc isoforms,122,139,Gene/Protein	NF - ATc / C,141,153,Gene/Protein	trans - activation domain,172,197,Gene/Protein	TAD - B,199,206,Gene/Protein	"[{""token"": ""strong N - terminal trans - activation domain"", ""start_span"": 37, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""TAD - A"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc isoforms"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc / C"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""trans - activation domain"", ""start_span"": 172, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""TAD - B"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
We have introduced a small deletion within beta - catenin ( Delta19) that disrupts binding to LEF - 1, E - cadherin, and APC but not axin.	beta - catenin,43,57,Gene/Protein	Delta19,60,67,Gene/Protein	LEF - 1,94,101,Gene/Protein	E - cadherin,103,115,Gene/Protein	APC,121,124,Gene/Protein	axin,133,137,Gene/Protein	"[{""token"": ""beta - catenin"", ""start_span"": 43, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Delta19"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""E - cadherin"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""axin"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	train
We show that the BR3 sequence contains a novel negative regulatory element located at positions - 90 to - 79 of the hIL - 5 promoter, which binds Oct1, octamer - like, and YY1 nuclear factors.	BR3,17,20,Gene/Protein	negative regulatory element,47,74,Gene/Protein	hIL - 5 promoter,116,132,Gene/Protein	Oct1,146,150,Gene/Protein	octamer - like,152,166,Gene/Protein	YY1 nuclear factors,172,191,Gene/Protein	"[{""token"": ""BR3"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""negative regulatory element"", ""start_span"": 47, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hIL - 5 promoter"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Oct1"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""octamer - like"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""YY1 nuclear factors"", ""start_span"": 172, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
CONCLUSION: We suggest that Oct1, YY1, and octamer - like factors binding to the - 90 / - 79 sequence within the proximal IL - 5 promoter are involved in suppression of IL - 5 transcription in T cells.	Oct1,28,32,Gene/Protein	YY1,34,37,Gene/Protein	octamer - like factors,43,65,Gene/Protein	- 90 / - 79 sequence,81,101,Gene/Protein	proximal IL - 5 promoter,113,137,Gene/Protein	IL - 5,169,175,Gene/Protein	"[{""token"": ""Oct1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""YY1"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""octamer - like factors"", ""start_span"": 43, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""- 90 / - 79 sequence"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""proximal IL - 5 promoter"", ""start_span"": 113, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Binding of NF - AT, NF - kappaB, and AP - 1 was induced by T - cell receptor ( TcR) stimulation, although there was no significant upregulation of binding by IL - 2 stimulation.	NF - AT,11,18,Gene/Protein	NF - kappaB,20,31,Gene/Protein	AP - 1,37,43,Gene/Protein	T - cell receptor,59,76,Gene/Protein	TcR,79,82,Gene/Protein	IL - 2,158,164,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor"", ""start_span"": 59, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TcR"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
We found that the spontaneous production of tumor necrosis factor alpha and other pro - inflammatory cytokines is NF - kappaB - dependent in rheumatoid synovial tissue, in contrast to the main anti - inflammatory mediators, like IL - 10 and - 11, and the IL - 1 receptor antagonist.	tumor necrosis factor alpha,44,71,Gene/Protein	pro - inflammatory cytokines,82,110,Gene/Protein	NF - kappaB,114,125,Gene/Protein	anti - inflammatory mediators,193,222,Gene/Protein	IL - 10 and - 11,229,245,Gene/Protein	IL - 1 receptor antagonist,255,281,Gene/Protein	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 44, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""pro - inflammatory cytokines"", ""start_span"": 82, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""anti - inflammatory mediators"", ""start_span"": 193, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 and - 11"", ""start_span"": 229, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor antagonist"", ""start_span"": 255, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	train
We have previously shown that the membrane - proximal portion in the cytoplasmic domain of the human IL - 4R alpha ( hIL - 4R alpha) is critical for proliferation, generation of germline epsilon transcript, and activation of STAT6, based on analyses of truncated hIL - 4R alphas.	membrane - proximal portion,34,61,Gene/Protein	cytoplasmic domain,69,87,Gene/Protein	human IL - 4R alpha,95,114,Gene/Protein	hIL - 4R alpha,117,131,Gene/Protein	STAT6,225,230,Gene/Protein	truncated hIL - 4R alphas,253,278,Gene/Protein	"[{""token"": ""membrane - proximal portion"", ""start_span"": 34, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 69, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 4R alpha"", ""start_span"": 95, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""hIL - 4R alpha"", ""start_span"": 117, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""truncated hIL - 4R alphas"", ""start_span"": 253, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
Protein kinase B ( c - Akt), phosphatidylinositol 3 - kinase, and STAT5 are activated by erythropoietin ( EPO) in HCD57 erythroid cells but are constitutively active in an EPO - independent, apoptosis - resistant subclone ( HCD57 - SREI cells).	Protein kinase B,0,16,Gene/Protein	c - Akt,19,26,Gene/Protein	phosphatidylinositol 3 - kinase,29,60,Gene/Protein	STAT5,66,71,Gene/Protein	erythropoietin,89,103,Gene/Protein	EPO,106,109,Gene/Protein	"[{""token"": ""Protein kinase B"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""c - Akt"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 29, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
We found that erythropoietin ( EPO) and stem cell factor ( SCF) activated protein kinase B ( PKB / Akt) in EPO - dependent HCD57 erythroid cells.	erythropoietin,14,28,Gene/Protein	EPO,31,34,Gene/Protein	stem cell factor,40,56,Gene/Protein	SCF,59,62,Gene/Protein	activated protein kinase B,64,90,Gene/Protein	PKB / Akt,93,102,Gene/Protein	"[{""token"": ""erythropoietin"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""stem cell factor"", ""start_span"": 40, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""activated protein kinase B"", ""start_span"": 64, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	train
All three steps progressively helpX? ed to discriminate T - cell - specific promoter sequences against other functional regions ( coding and intronic sequences) of the same genes, against promoters of muscle - specific genes or against random sequences.	T - cell - specific promoter sequences,56,94,Gene/Protein	functional regions,109,127,Gene/Protein	coding and intronic sequences,130,159,Gene/Protein	promoters,188,197,Gene/Protein	muscle - specific genes,201,224,Gene/Protein	random sequences,236,252,Gene/Protein	"[{""token"": ""T - cell - specific promoter sequences"", ""start_span"": 56, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""functional regions"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""coding and intronic sequences"", ""start_span"": 130, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""muscle - specific genes"", ""start_span"": 201, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""random sequences"", ""start_span"": 236, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
Using this approach, we identified potential NFAT composite elements in promoters of cytokine genes and their receptors as well as in promoters of genes for AP - 1 family members, Ca2 + - binding proteins and some other components of the regulatory network operating in activated T - cells and other immune cells.	NFAT composite elements,45,68,Gene/Protein	promoters,72,81,Gene/Protein	cytokine genes,85,99,Gene/Protein	promoters,134,143,Gene/Protein	AP - 1 family members,157,178,Gene/Protein	Ca2 + - binding proteins,180,204,Gene/Protein	"[{""token"": ""NFAT composite elements"", ""start_span"": 45, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 family members"", ""start_span"": 157, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + - binding proteins"", ""start_span"": 180, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
The composite motif binds a multi - protein hematopoietic - specific transcription factor complex which includes GATA - 1, SCL / tal - 1, E2A, Lmo2 and Ldb - 1.	composite motif,4,19,Gene/Protein	multi - protein hematopoietic - specific transcription factor complex,28,97,Gene/Protein	GATA - 1,113,121,Gene/Protein	E2A,138,141,Gene/Protein	Lmo2,143,147,Gene/Protein	Ldb - 1,152,159,Gene/Protein	"[{""token"": ""composite motif"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""multi - protein hematopoietic - specific transcription factor complex"", ""start_span"": 28, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Lmo2"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Ldb - 1"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
In addition to activating transcription from the viral long terminal repeat ( LTR) through the cyclic AMP response element binding protein / activating transcription factor ( CREB / ATF) family of transcription factors, Tax activates the expression of multiple cellular promoters through the NF - kappaB pathway of transcriptional activation.	viral long terminal repeat,49,75,Gene/Protein	LTR,78,81,Gene/Protein	transcription factors,197,218,Gene/Protein	Tax,220,223,Gene/Protein	multiple cellular promoters,252,279,Gene/Protein	NF - kappaB,292,303,Gene/Protein	"[{""token"": ""viral long terminal repeat"", ""start_span"": 49, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 197, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""multiple cellular promoters"", ""start_span"": 252, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 292, ""end_span"": 303, ""type"": ""Gene/Protein""}]"	train
RanBP1 as well as Ran - binding domains of the cytoplasmic nucleoporin RanBP2 promote the release of CRM1 from the NPC.	RanBP1,0,6,Gene/Protein	Ran - binding domains,18,39,Gene/Protein	cytoplasmic nucleoporin,47,70,Gene/Protein	RanBP2,71,77,Gene/Protein	CRM1,101,105,Gene/Protein	NPC,115,118,Gene/Protein	"[{""token"": ""RanBP1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""Ran - binding domains"", ""start_span"": 18, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic nucleoporin"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""RanBP2"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	train
Taken together, our results indicate that Ran GTP is important for the targeting of export complexes to the cytoplasmic side of the NPC and that RanBP1 and probably RanBP2 are involved in the dissociation of nuclear export complexes from the NPC in a terminal step of transport.	Ran,42,45,Gene/Protein	NPC,132,135,Gene/Protein	RanBP1,145,151,Gene/Protein	RanBP2,165,171,Gene/Protein	nuclear export complexes,208,232,Gene/Protein	NPC,242,245,Gene/Protein	"[{""token"": ""Ran"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""RanBP1"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""RanBP2"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""nuclear export complexes"", ""start_span"": 208, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 242, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
In early to intermediate stages of erythroid differentiation we monitored the induction of CD36, Tal1, EKLF, NF - E2, and GATA - 1 that preceeded expression of EpoR.	CD36,91,95,Gene/Protein	Tal1,97,101,Gene/Protein	EKLF,103,107,Gene/Protein	NF - E2,109,116,Gene/Protein	GATA - 1,122,130,Gene/Protein	EpoR,160,164,Gene/Protein	"[{""token"": ""CD36"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Tal1"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""EpoR"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Previous studies have implicated activation of both protein kinase C ( PKC) and protein tyrosine kinases ( PTK) in LPS - induced NF - kappaB activation and TNF - alpha production.	protein kinase C,52,68,Gene/Protein	PKC,71,74,Gene/Protein	protein tyrosine kinases,80,104,Gene/Protein	PTK,107,110,Gene/Protein	NF - kappaB,129,140,Gene/Protein	TNF - alpha,156,167,Gene/Protein	"[{""token"": ""protein kinase C"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine kinases"", ""start_span"": 80, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Nonspecific protein kinase inhibition inhibited NF - kappaB activation and TNF - alpha release, while specific PKC inhibition with Bis had no effect on LPS - induced NF - kappaB DNA binding or TNF - alpha release.	protein kinase,12,26,Gene/Protein	NF - kappaB,48,59,Gene/Protein	TNF - alpha,75,86,Gene/Protein	PKC,111,114,Gene/Protein	NF - kappaB,166,177,Gene/Protein	TNF - alpha,193,204,Gene/Protein	"[{""token"": ""protein kinase"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
Binding of interferon - gamma ( IFN - gamma) to its heterodimeric receptor induces activation of the tyrosine kinases JAK1 and JAK2 followed by tyrosine phosphorylation of STAT1alpha.	interferon - gamma,11,29,Gene/Protein	IFN - gamma,32,43,Gene/Protein	tyrosine kinases,101,117,Gene/Protein	JAK1,118,122,Gene/Protein	JAK2,127,131,Gene/Protein	STAT1alpha,172,182,Gene/Protein	"[{""token"": ""interferon - gamma"", ""start_span"": 11, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinases"", ""start_span"": 101, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""STAT1alpha"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Overexpression of hematopoietic protein - tyrosine phosphatase ( HePTP) results in suppression of T lymphocyte activation as measured by T cell antigen receptor - induced activation of transcription factors binding to the 5 ' promoter of the interleukin - 2 gene.	hematopoietic protein - tyrosine phosphatase,18,62,Gene/Protein	HePTP,65,70,Gene/Protein	T cell antigen receptor,137,160,Gene/Protein	transcription factors,185,206,Gene/Protein	5 ' promoter,222,234,Gene/Protein	interleukin - 2 gene,242,262,Gene/Protein	"[{""token"": ""hematopoietic protein - tyrosine phosphatase"", ""start_span"": 18, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""HePTP"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 137, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 185, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""5 ' promoter"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 gene"", ""start_span"": 242, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The specificity of HePTP correlated with its physical association through its noncatalytic N terminus with Erk and another MAP kinase, p38, but not Jnk or other proteins.	HePTP,19,24,Gene/Protein	N terminus,91,101,Gene/Protein	Erk,107,110,Gene/Protein	MAP kinase,123,133,Gene/Protein	p38,135,138,Gene/Protein	Jnk,148,151,Gene/Protein	"[{""token"": ""HePTP"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""N terminus"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Jnk"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
However, we found that RA opposed anti - apoptotic effects of G - CSF and GM - CSF on CD34 + cells ( G - CSF: 8% dead cells at day 6; G - CSF + RA: 20%; GM - CSF: 12%; GM - CSF + RA: 27%).	G - CSF,62,69,Gene/Protein	GM - CSF,74,82,Gene/Protein	G - CSF,101,108,Gene/Protein	G - CSF,134,141,Gene/Protein	GM - CSF,153,161,Gene/Protein	GM - CSF,168,176,Gene/Protein	"[{""token"": ""G - CSF"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
PHA stimulates IL - 2R alpha -, beta -, and gamma - chain expression and their signaling pathway molecules Jak1, Jak3, Stat1, Stat3, and Stat5.	PHA,0,3,Gene/Protein	signaling pathway molecules,79,106,Gene/Protein	Jak1,107,111,Gene/Protein	Jak3,113,117,Gene/Protein	Stat3,126,131,Gene/Protein	Stat5,137,142,Gene/Protein	"[{""token"": ""PHA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""signaling pathway molecules"", ""start_span"": 79, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
We propose a model in which stimulation of monocytes by IFN activates de novo synthesis of an inhibitory factor, possibly one or more members of the SOCS / SSI / CIS gene family, capable of suppressing activation of STAT6 by IL - 4 and IL - 13.	IFN,56,59,Gene/Protein	inhibitory factor,94,111,Gene/Protein	SOCS / SSI / CIS gene family,149,177,Gene/Protein	STAT6,216,221,Gene/Protein	IL - 4,225,231,Gene/Protein	IL - 13,236,243,Gene/Protein	"[{""token"": ""IFN"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory factor"", ""start_span"": 94, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""SOCS / SSI / CIS gene family"", ""start_span"": 149, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
HLA class I - mediated inactivation of Rb can be inhibited specifically by neutralizing Abs to basic fibroblast growth factor ( bFGF), suggesting a role for FGF receptors in the signaling process.	HLA class I,0,11,Gene/Protein	Rb,39,41,Gene/Protein	neutralizing Abs,75,91,Gene/Protein	basic fibroblast growth factor,95,125,Gene/Protein	bFGF,128,132,Gene/Protein	FGF receptors,157,170,Gene/Protein	"[{""token"": ""HLA class I"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""neutralizing Abs"", ""start_span"": 75, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 95, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""bFGF"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""FGF receptors"", ""start_span"": 157, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL - 4 via cooperative NF - kappa B and STAT - 6 binding sites.	evolutionarily conserved sequence,4,37,Gene/Protein	human Ig heavy chain S gamma 3 region,54,91,Gene/Protein	inducible promoter,98,116,Gene/Protein	CD40 ligand,144,155,Gene/Protein	IL - 4,160,166,Gene/Protein	NF - kappa B and STAT - 6 binding sites,183,222,Gene/Protein	"[{""token"": ""evolutionarily conserved sequence"", ""start_span"": 4, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""human Ig heavy chain S gamma 3 region"", ""start_span"": 54, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""inducible promoter"", ""start_span"": 98, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""CD40 ligand"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B and STAT - 6 binding sites"", ""start_span"": 183, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Reporter luciferase gene vectors containing the human gamma 3 ECS were used to transfect CL - 01 cells, which have been shown to undergo Smu - - > S gamma 3 DNA recombination, upon engagement of CD40 by CD40 ligand ( CD40L) and exposure to IL - 4.	Reporter luciferase gene vectors,0,32,Gene/Protein	human gamma 3 ECS,48,65,Gene/Protein	CD40,195,199,Gene/Protein	CD40 ligand,203,214,Gene/Protein	CD40L,217,222,Gene/Protein	IL - 4,240,246,Gene/Protein	"[{""token"": ""Reporter luciferase gene vectors"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""human gamma 3 ECS"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""CD40 ligand"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 240, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
Targeted mutational analysis demonstrated that a tandem NF - kappa B / Rel binding motif is critical for the gamma 3 ECS responsiveness to both CD40L and IL - 4, while a STAT - 6 - binding site is additionally required for IL - 4 inducibility.	NF - kappa B / Rel binding motif,56,88,Gene/Protein	gamma 3 ECS,109,120,Gene/Protein	CD40L,144,149,Gene/Protein	IL - 4,154,160,Gene/Protein	STAT - 6 - binding site,170,193,Gene/Protein	IL - 4,223,229,Gene/Protein	"[{""token"": ""NF - kappa B / Rel binding motif"", ""start_span"": 56, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""gamma 3 ECS"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 6 - binding site"", ""start_span"": 170, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Increased expression of IFNgamma - induced IP - 10 mRNA following the differentiation of U937 cells was mediated largely by augmented transcriptional activity of the gene and was related to differentiation - dependent changes of the proteins bound to IFN stimulus response element ( ISRE) and kB sites, suggesting that these nuclear proteins may determine the IP - 10 mRNA inducibility by IFNgamma.	IFNgamma,24,32,Gene/Protein	IP - 10 mRNA,43,55,Gene/Protein	kB sites,293,301,Gene/Protein	nuclear proteins,325,341,Gene/Protein	IP - 10 mRNA,360,372,Gene/Protein	IFNgamma,389,397,Gene/Protein	"[{""token"": ""IFNgamma"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IP - 10 mRNA"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""kB sites"", ""start_span"": 293, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 325, ""end_span"": 341, ""type"": ""Gene/Protein""}, {""token"": ""IP - 10 mRNA"", ""start_span"": 360, ""end_span"": 372, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 389, ""end_span"": 397, ""type"": ""Gene/Protein""}]"	train
After tyrosine phosphorylation by src and possibly syk protein tyrosine kinases SIT recruits the SH2 domain - containing tyrosine phosphatase SHP2 via an immunoreceptor tyrosine - based inhibition motif.	src,34,37,Gene/Protein	syk,51,54,Gene/Protein	protein tyrosine kinases,55,79,Gene/Protein	SIT,80,83,Gene/Protein	SH2 domain - containing tyrosine phosphatase,97,141,Gene/Protein	SHP2,142,146,Gene/Protein	"[{""token"": ""src"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""syk"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine kinases"", ""start_span"": 55, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""SIT"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain - containing tyrosine phosphatase"", ""start_span"": 97, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""SHP2"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
The multiple biologic activities of retinoic acid ( RA) are mediated through RAR and retinoid X receptor ( RXR) nuclear receptors that interact with specific DNA target sequences as heterodimers ( RXR - RAR) or homodimers ( RXR - RXR).	RAR,77,80,Gene/Protein	DNA target sequences,158,178,Gene/Protein	heterodimers,182,194,Gene/Protein	RXR - RAR,197,206,Gene/Protein	homodimers,211,221,Gene/Protein	RXR - RXR,224,233,Gene/Protein	"[{""token"": ""RAR"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""DNA target sequences"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""heterodimers"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RAR"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""homodimers"", ""start_span"": 211, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RXR"", ""start_span"": 224, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
The functional synergy between IL - 2 and IL - 12 is also associated with a prominent increase in STAT1 and STAT3 serine phosphorylation over that observed with IL - 12 or IL - 2 alone.	IL - 2,31,37,Gene/Protein	IL - 12,42,49,Gene/Protein	STAT1,98,103,Gene/Protein	STAT3,108,113,Gene/Protein	IL - 12,161,168,Gene/Protein	IL - 2,172,178,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
A specific inhibitor of p38 MAP kinase completely inhibits the serine phosphorylation of STAT1 and STAT3 induced by IL - 12 and IL - 2 and abrogates the functional synergy between IL - 12 and IL - 2 without affecting STAT tyrosine phosphorylation.	STAT1,89,94,Gene/Protein	STAT3,99,104,Gene/Protein	IL - 12,116,123,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 12,180,187,Gene/Protein	IL - 2,192,198,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
One of the prominent substrates for these kinases is the adaptor protein Cbl [ 3] and recent studies suggest that Cbl negatively regulates upstream kinases such as Syk and Zap - 70 [ 4] [ 5].	kinases,42,49,Gene/Protein	adaptor protein,57,72,Gene/Protein	Cbl,73,76,Gene/Protein	upstream kinases,139,155,Gene/Protein	Syk,164,167,Gene/Protein	Zap - 70,172,180,Gene/Protein	"[{""token"": ""kinases"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""adaptor protein"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""upstream kinases"", ""start_span"": 139, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""Zap - 70"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
Our data suggest that Grf40 is an adaptor molecule involved in TCR - mediated signaling through a more efficient interaction than Grb2 with SLP - 76 and LAT.	Grf40,22,27,Gene/Protein	adaptor molecule,34,50,Gene/Protein	TCR,63,66,Gene/Protein	Grb2,130,134,Gene/Protein	SLP - 76,140,148,Gene/Protein	LAT,153,156,Gene/Protein	"[{""token"": ""Grf40"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""adaptor molecule"", ""start_span"": 34, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""LAT"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Our previous results show that recombinant gp41 ( aa565 - 647), the extracellular domain of HIV - 1 transmembrane glycoprotein, stimulates interleukin - 10 ( IL - 10) production in human monocytes.	recombinant gp41,31,47,Gene/Protein	aa565 - 647,50,61,Gene/Protein	extracellular domain,68,88,Gene/Protein	HIV - 1 transmembrane glycoprotein,92,126,Gene/Protein	interleukin - 10,139,155,Gene/Protein	IL - 10,158,165,Gene/Protein	"[{""token"": ""recombinant gp41"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""aa565 - 647"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 transmembrane glycoprotein"", ""start_span"": 92, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 10"", ""start_span"": 139, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
In contrast, gp41 failed to stimulate NF - kappaB binding activity in as much as no NF - kappaB bound to the main NF - kappaB - binding site 2 of the IL - 10 promoter after addition of gp41.	gp41,13,17,Gene/Protein	NF - kappaB,38,49,Gene/Protein	NF - kappaB,84,95,Gene/Protein	main NF - kappaB - binding site,109,140,Gene/Protein	IL - 10 promoter,150,166,Gene/Protein	gp41,185,189,Gene/Protein	"[{""token"": ""gp41"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""main NF - kappaB - binding site"", ""start_span"": 109, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 promoter"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""gp41"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
We show here that in circulating monocytes, NF - Y binding activity is not detected on the CCAAT motif present in the promoters of genes such as major histocompatibility complex ( MHC) class II, gp91 - phox, mig, and fibronectin, whereas during macrophage differentiation, a progressive increase in NF - Y binding activity is observed on these promoters.	NF - Y,44,50,Gene/Protein	CCAAT motif,91,102,Gene/Protein	promoters of genes,118,136,Gene/Protein	gp91 - phox,195,206,Gene/Protein	mig,208,211,Gene/Protein	NF - Y,299,305,Gene/Protein	"[{""token"": ""NF - Y"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT motif"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""promoters of genes"", ""start_span"": 118, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""gp91 - phox"", ""start_span"": 195, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""mig"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 299, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
This is manifested by the ability of Delta to restore induction of calcium fluxes and mitogen - activated protein kinase activation and by the ability of dominant negative Ras and FK506 to block the induction of NF - AT activity mediated by Delta.	Delta,37,42,Gene/Protein	mitogen - activated protein kinase,86,120,Gene/Protein	Ras,172,175,Gene/Protein	FK506,180,185,Gene/Protein	NF - AT,212,219,Gene/Protein	Delta,241,246,Gene/Protein	"[{""token"": ""Delta"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 86, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""FK506"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""Delta"", ""start_span"": 241, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
In an attempt to find such elusive Oct2 target genes and to understand the molecular function of Oct2 in B cell development, we isolated cDNAs for Oct2 target genes.	Oct2,35,39,Gene/Protein	target genes,40,52,Gene/Protein	Oct2,97,101,Gene/Protein	cDNAs,137,142,Gene/Protein	Oct2,147,151,Gene/Protein	target genes,152,164,Gene/Protein	"[{""token"": ""Oct2"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""Oct2"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""cDNAs"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""Oct2"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift assay revealed that the potential NF - kappaB binding sequence which is located around 120 bp upstream of the transcription initiation site in murine and human p40 genes formed an NF - kappaB complex with nuclear extract from Daudi cells stimulated by CD40 ligation.	NF - kappaB binding sequence,65,93,Gene/Protein	120 bp upstream,118,133,Gene/Protein	transcription initiation site,141,170,Gene/Protein	murine and human p40 genes,174,200,Gene/Protein	NF - kappaB complex,211,230,Gene/Protein	CD40,283,287,Gene/Protein	"[{""token"": ""NF - kappaB binding sequence"", ""start_span"": 65, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""120 bp upstream"", ""start_span"": 118, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 141, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""murine and human p40 genes"", ""start_span"": 174, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB complex"", ""start_span"": 211, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
These results suggest that the NF - kappaB binding site located around 120 bp upstream of the transcription initiation site in murine and human p40 promoter regions could be important for the p40 induction by CD40 ligation via activation of NF - kappaB.	NF - kappaB binding site,31,55,Gene/Protein	transcription initiation site,94,123,Gene/Protein	murine and human p40 promoter regions,127,164,Gene/Protein	p40,192,195,Gene/Protein	CD40,209,213,Gene/Protein	NF - kappaB,241,252,Gene/Protein	"[{""token"": ""NF - kappaB binding site"", ""start_span"": 31, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 94, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""murine and human p40 promoter regions"", ""start_span"": 127, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""p40"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
We also showed that tumor necrosis factor ( TNF) and to a lesser extent interleukin - 1 ( IL - 1), secreted within the coculture, induce NF - kappaB activity and a correlative LTR transactivation.	tumor necrosis factor,20,41,Gene/Protein	TNF,44,47,Gene/Protein	interleukin - 1,72,87,Gene/Protein	IL - 1,90,96,Gene/Protein	NF - kappaB,137,148,Gene/Protein	LTR,176,179,Gene/Protein	"[{""token"": ""tumor necrosis factor"", ""start_span"": 20, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
In concert with the coactivator CREB binding protein / p300, which interacts with GABPalpha, the binding of GABPalpha and - beta to the dyad symmetry element controls the induction of IL - 16 promoter in T cells.	coactivator CREB binding protein / p300,20,59,Gene/Protein	GABPalpha,82,91,Gene/Protein	GABPalpha,108,117,Gene/Protein	- beta,122,128,Gene/Protein	dyad symmetry element,136,157,Gene/Protein	IL - 16 promoter,184,200,Gene/Protein	"[{""token"": ""coactivator CREB binding protein / p300"", ""start_span"": 20, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GABPalpha"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""GABPalpha"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""- beta"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""dyad symmetry element"", ""start_span"": 136, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""IL - 16 promoter"", ""start_span"": 184, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
The mammalian NF - kappaB and octamer binding sites seem to be absent, although there are alternative potential NF - kappaB and octamer - binding elements in the chicken IL2 promoter, in close proximity to their mammalian homologues.	mammalian NF - kappaB,4,25,Gene/Protein	octamer binding sites,30,51,Gene/Protein	NF - kappaB,112,123,Gene/Protein	octamer - binding elements,128,154,Gene/Protein	chicken IL2 promoter,162,182,Gene/Protein	mammalian homologues,212,232,Gene/Protein	"[{""token"": ""mammalian NF - kappaB"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""octamer binding sites"", ""start_span"": 30, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding elements"", ""start_span"": 128, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""chicken IL2 promoter"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""mammalian homologues"", ""start_span"": 212, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
IL - 12 induced STAT4 and IL - 2 and IL - 15 induced STAT5 binding to the GAS elements.	IL - 12,0,7,Gene/Protein	STAT4,16,21,Gene/Protein	IL - 2,26,32,Gene/Protein	IL - 15,37,44,Gene/Protein	STAT5,53,58,Gene/Protein	GAS elements,74,86,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""GAS elements"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}]"	train
Over the next week, this cell population accumulates phenotypic markers of osteoclasts ( vitronectin receptor [ VR], calcitonin receptor, TRAP, cathepsin K protein, and mRNA) with increased nuclearity, covering the entire surface by 15 days.	vitronectin receptor,89,109,Gene/Protein	VR,112,114,Gene/Protein	calcitonin receptor,117,136,Gene/Protein	TRAP,138,142,Gene/Protein	cathepsin K protein,144,163,Gene/Protein	mRNA,169,173,Gene/Protein	"[{""token"": ""vitronectin receptor"", ""start_span"": 89, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""VR"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""calcitonin receptor"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""TRAP"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin K protein"", ""start_span"": 144, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
The stability of already formed complexed was somewhat different in the HLA - A3 and HLA - Cw * 0702 system: both were more stable at 26 degrees C than at 37 degrees C but while the beta 2 - m and FCS did not influence the stability of the HLA - A3 / peptide complex, they seemed to cause opposite effects in the HLA - Cw * 0702 system ( beta 2 - m stabilized and FCS destabilized the complex).	HLA - A3,72,80,Gene/Protein	HLA - Cw * 0702,85,100,Gene/Protein	beta 2 - m,182,192,Gene/Protein	HLA - A3 / peptide complex,240,266,Gene/Protein	HLA - Cw * 0702,313,328,Gene/Protein	beta 2 - m,338,348,Gene/Protein	"[{""token"": ""HLA - A3"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""HLA - Cw * 0702"", ""start_span"": 85, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""beta 2 - m"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""HLA - A3 / peptide complex"", ""start_span"": 240, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""HLA - Cw * 0702"", ""start_span"": 313, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""beta 2 - m"", ""start_span"": 338, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
The modulation by anti - LPS mAbs of mCD14 - mediated LPS uptake was associated with inhibition of LPS - induced nuclear factor - kappaB ( NF - kappaB) translocation and TNF - alpha secretion in CHO - CD14 cells and monocytes, respectively, while mAb enhancement of non - mCD14 - mediated LPS uptake stimulated these activities.	anti - LPS mAbs,18,33,Gene/Protein	mCD14,37,42,Gene/Protein	LPS - induced nuclear factor - kappaB,99,136,Gene/Protein	NF - kappaB,139,150,Gene/Protein	TNF - alpha,170,181,Gene/Protein	mCD14,272,277,Gene/Protein	"[{""token"": ""anti - LPS mAbs"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""mCD14"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""LPS - induced nuclear factor - kappaB"", ""start_span"": 99, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""mCD14"", ""start_span"": 272, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
We used reverse transcriptase - polymerase chain reaction to examine both fetal and term neonatal cord bloods for mRNA expression of three transcription factors implicated in T - cell activation: c - jun, c - fos, and NF kappa B ( p50 subunit).	reverse transcriptase,8,29,Gene/Protein	transcription factors,139,160,Gene/Protein	c - jun,196,203,Gene/Protein	c - fos,205,212,Gene/Protein	NF kappa B,218,228,Gene/Protein	p50 subunit,231,242,Gene/Protein	"[{""token"": ""reverse transcriptase"", ""start_span"": 8, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 139, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 218, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 231, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
Since the DSE and TRE sites can not bind CREB / ATF homodimers, we propose a mechanism in which the HIV - 1 DSE bind heterodimers composed of both AP - 1 and CREB / ATF proteins.	DSE,10,13,Gene/Protein	TRE,18,21,Gene/Protein	CREB / ATF homodimers,41,62,Gene/Protein	DSE,108,111,Gene/Protein	heterodimers,117,129,Gene/Protein	AP - 1 and CREB / ATF proteins,147,177,Gene/Protein	"[{""token"": ""DSE"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""TRE"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF homodimers"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""DSE"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""heterodimers"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 and CREB / ATF proteins"", ""start_span"": 147, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
IgE germline promoter reporter gene constructs carrying point mutations in the NF kappa B2 site were largely unresponsive to IL - 4 stimulation in transient transfection experiments, while plasmids with similar mutations in the NF kappa B1 site responded to cytokine stimulation better than the wild - type promoter.	IgE germline promoter reporter gene constructs,0,46,Gene/Protein	NF kappa B2,79,90,Gene/Protein	IL - 4,125,131,Gene/Protein	NF kappa B1,228,239,Gene/Protein	cytokine,258,266,Gene/Protein	wild - type promoter,295,315,Gene/Protein	"[{""token"": ""IgE germline promoter reporter gene constructs"", ""start_span"": 0, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B2"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B1"", ""start_span"": 228, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 258, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""wild - type promoter"", ""start_span"": 295, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
In addition, alpha G2S exhibited increased expression of CD11b and CD54, while alpha B5A cells showed increased expression of CD102, suggesting that RXR - alpha has a role in regulating expression of cell adhesion molecules in U937 cells.	alpha G2S,13,22,Gene/Protein	CD11b,57,62,Gene/Protein	CD54,67,71,Gene/Protein	CD102,126,131,Gene/Protein	RXR - alpha,149,160,Gene/Protein	cell adhesion molecules,200,223,Gene/Protein	"[{""token"": ""alpha G2S"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD54"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD102"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""RXR - alpha"", ""start_span"": 149, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cell adhesion molecules"", ""start_span"": 200, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
The distinct N - terminal half of MZF - 2 carries two characteristic domains, a leucine - rich domain called LeR and an acidic domain, which suggests a unique function of MZF - 2 in neutrophil development.	N - terminal half,13,30,Gene/Protein	MZF - 2,34,41,Gene/Protein	leucine - rich domain,80,101,Gene/Protein	LeR,109,112,Gene/Protein	acidic domain,120,133,Gene/Protein	MZF - 2,171,178,Gene/Protein	"[{""token"": ""N - terminal half"", ""start_span"": 13, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""MZF - 2"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""leucine - rich domain"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""LeR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""acidic domain"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""MZF - 2"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Serum ACTH and IgE were measured by immunoradiometric assay, and IL - 2, IL - 4, and IL - 10 cytokines and interferon - gamma were measured by enzyme - linked immunosorbent assay.	IgE,15,18,Gene/Protein	IL - 2,65,71,Gene/Protein	IL - 4,73,79,Gene/Protein	IL - 10,85,92,Gene/Protein	cytokines,93,102,Gene/Protein	interferon - gamma,107,125,Gene/Protein	"[{""token"": ""IgE"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 107, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
During CD30 signal transduction, we found that binding of TRAF2 to the cytoplasmic domain of CD30 results in the rapid depletion of TRAF2 and the associated protein TRAF1 by proteolysis.	CD30,7,11,Gene/Protein	TRAF2,58,63,Gene/Protein	cytoplasmic domain,71,89,Gene/Protein	CD30,93,97,Gene/Protein	TRAF2,132,137,Gene/Protein	TRAF1,165,170,Gene/Protein	"[{""token"": ""CD30"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 71, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""CD30"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""TRAF1"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
The highly specific granulomonocyte - associated lysosomal proteins myeloperoxidase ( MPO) and lysozyme ( LZ), as well as the transcription factor PU. 1, were already detectable in the most immature CD34 + Thy - 1 + subset.	granulomonocyte - associated lysosomal proteins,20,67,Gene/Protein	myeloperoxidase,68,83,Gene/Protein	MPO,86,89,Gene/Protein	lysozyme,95,103,Gene/Protein	LZ,106,108,Gene/Protein	transcription factor,126,146,Gene/Protein	"[{""token"": ""granulomonocyte - associated lysosomal proteins"", ""start_span"": 20, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""myeloperoxidase"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""MPO"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""lysozyme"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""LZ"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 126, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
The binding site for nuclear factor - kappaB ( NF - kappaB) is present at the promoter region of the germline Cepsilon gene, but there is little information on whether this factor is involved in regulating IgE synthesis by human B cells.	binding site,4,16,Gene/Protein	nuclear factor - kappaB,21,44,Gene/Protein	NF - kappaB,47,58,Gene/Protein	promoter region,78,93,Gene/Protein	germline Cepsilon gene,101,123,Gene/Protein	IgE,206,209,Gene/Protein	"[{""token"": ""binding site"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 21, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""germline Cepsilon gene"", ""start_span"": 101, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Although IL - 4 activated signal transducers and activators of transcription ( STAT) 6 in addition to NF - kappaB, NAC treatment or the transfection of decoy oligodeoxynucleotide for NF - kappaB or STAT6 only partly blocked IL - 4 - induced germline Cepsilon transcription.	IL - 4,9,15,Gene/Protein	NF - kappaB,102,113,Gene/Protein	NF - kappaB,183,194,Gene/Protein	STAT6,198,203,Gene/Protein	IL - 4,224,230,Gene/Protein	germline,241,249,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 241, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
Using protein - DNA interaction assays we show that the H4 promoter contains two ATF / CREB recognition motifs which interact with CREB, ATF1, and ATF2 but not with ATF4 / CREB2.	H4 promoter,56,67,Gene/Protein	CREB,87,91,Gene/Protein	CREB,131,135,Gene/Protein	ATF1,137,141,Gene/Protein	ATF2,147,151,Gene/Protein	ATF4 / CREB2,165,177,Gene/Protein	"[{""token"": ""H4 promoter"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""ATF1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""ATF2"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""ATF4 / CREB2"", ""start_span"": 165, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
LMP - 1 effects on AP - 1 are mediated through activation of the c - Jun N - terminal kinase ( JNK) cascade, but not the extracellular signal - regulated kinase ( Erk) pathway.	LMP - 1,0,7,Gene/Protein	AP - 1,19,25,Gene/Protein	c - Jun,65,72,Gene/Protein	JNK,95,98,Gene/Protein	extracellular signal - regulated kinase,121,160,Gene/Protein	Erk,163,166,Gene/Protein	"[{""token"": ""LMP - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 121, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
To characterize the regulation of NGAL further, we have cloned and sequenced a 5869 - bp region of the NGAL gene including 1695 bp of the 5 ' nontranscribed region and a 3696 - bp coding region encompassing seven exons and six introns.	NGAL,34,38,Gene/Protein	5869 - bp region,79,95,Gene/Protein	NGAL gene,103,112,Gene/Protein	5 ' nontranscribed region,138,163,Gene/Protein	3696 - bp coding region,170,193,Gene/Protein	seven exons and six introns,207,234,Gene/Protein	"[{""token"": ""NGAL"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""5869 - bp region"", ""start_span"": 79, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NGAL gene"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""5 ' nontranscribed region"", ""start_span"": 138, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""3696 - bp coding region"", ""start_span"": 170, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""seven exons and six introns"", ""start_span"": 207, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
Moreover, the mechanism of action of BHRF1 resembled that of Bcl - 2 and Bcl - xL as it inhibited TNF - and anti - Fas - induced activation of two enzymes participating in the apoptosis pathway, cytosolic phospholipase A2 and caspase - 3 / CPP32, but did not interfere with the activation of NF - kappaB - like transcription factors.	BHRF1,37,42,Gene/Protein	Bcl - 2,61,68,Gene/Protein	Bcl - xL,73,81,Gene/Protein	cytosolic phospholipase A2,195,221,Gene/Protein	caspase - 3 / CPP32,226,245,Gene/Protein	NF - kappaB - like transcription factors,292,332,Gene/Protein	"[{""token"": ""BHRF1"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic phospholipase A2"", ""start_span"": 195, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""caspase - 3 / CPP32"", ""start_span"": 226, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - like transcription factors"", ""start_span"": 292, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	train
To investigate whether the molar ratio of HSF2 - alpha and HSF2 - beta isoforms is crucial for the activation of HSF2 and whether the HSF2 isoforms play functionally distinct roles during the hemin - mediated erythroid differentiation, we generated cell clones expressing different levels of HSF2 - alpha and HSF2 - beta.	HSF2 - alpha,42,54,Gene/Protein	HSF2 - beta,59,70,Gene/Protein	HSF2,113,117,Gene/Protein	HSF2,134,138,Gene/Protein	HSF2 - alpha,292,304,Gene/Protein	HSF2 - beta,309,320,Gene/Protein	"[{""token"": ""HSF2 - alpha"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - beta"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""HSF2"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""HSF2"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - alpha"", ""start_span"": 292, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - beta"", ""start_span"": 309, ""end_span"": 320, ""type"": ""Gene/Protein""}]"	train
These results indicate that Bcl - 2 acts downstream of MAPK kinase - 1 but upstream of MAPK and suggest that, in the signaling pathway of the apoptotic process induced by bufalin, the transcriptional activity of activator protein - 1 may be down - regulated through the inhibition of MAPK activity by Bcl - 2.	Bcl - 2,28,35,Gene/Protein	MAPK kinase - 1,55,70,Gene/Protein	MAPK,87,91,Gene/Protein	activator protein - 1,212,233,Gene/Protein	MAPK,284,288,Gene/Protein	Bcl - 2,301,308,Gene/Protein	"[{""token"": ""Bcl - 2"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""MAPK kinase - 1"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 212, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 284, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 301, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	train
Fab fragment of anti - E. chaffeensis immunoglobulin G complexed with E. chaffeensis did not induce any of these three cytokines, indicating that ehrlichial binding is required for IL - 1beta mRNA expression and that binding of the immune complex to the Fc gamma receptor is required for TNF - alpha and IL - 6 mRNA expression and enhanced IL - 1beta mRNA expression.	IL - 1beta mRNA,181,196,Gene/Protein	immune complex,232,246,Gene/Protein	Fc gamma receptor,254,271,Gene/Protein	TNF - alpha,288,299,Gene/Protein	IL - 6 mRNA,304,315,Gene/Protein	IL - 1beta mRNA,340,355,Gene/Protein	"[{""token"": ""IL - 1beta mRNA"", ""start_span"": 181, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""immune complex"", ""start_span"": 232, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma receptor"", ""start_span"": 254, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 288, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 mRNA"", ""start_span"": 304, ""end_span"": 315, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta mRNA"", ""start_span"": 340, ""end_span"": 355, ""type"": ""Gene/Protein""}]"	train
This activation domain of CIITA interacts with the 32 kDa subunit of the general transcription complex TFIID, TAFII32.	activation domain,5,22,Gene/Protein	CIITA,26,31,Gene/Protein	32 kDa subunit,51,65,Gene/Protein	general transcription complex,73,102,Gene/Protein	TFIID,103,108,Gene/Protein	TAFII32,110,117,Gene/Protein	"[{""token"": ""activation domain"", ""start_span"": 5, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""32 kDa subunit"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""general transcription complex"", ""start_span"": 73, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TFIID"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TAFII32"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
To gain a better understanding of the mechanism of binding to the human mineralocorticoid receptor ( hMR), we developed a new monoclonal antibody ( mAb) raised against the hormone - binding domain ( HBD).	human mineralocorticoid receptor,66,98,Gene/Protein	hMR,101,104,Gene/Protein	monoclonal antibody,126,145,Gene/Protein	mAb,148,151,Gene/Protein	hormone - binding domain,172,196,Gene/Protein	HBD,199,202,Gene/Protein	"[{""token"": ""human mineralocorticoid receptor"", ""start_span"": 66, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""hMR"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibody"", ""start_span"": 126, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""hormone - binding domain"", ""start_span"": 172, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Interestingly, we find that in contrast to SLP - 76, overexpression of SLAP - 130 diminishes T cell antigen receptor - induced activation of the interleukin - 2 promoter in Jurkat T cells and interferes with the augmentation of interleukin - 2 promoter activity seen when SLP - 76 is overexpressed in these cells.	SLP - 76,43,51,Gene/Protein	SLAP - 130,71,81,Gene/Protein	T cell antigen receptor,93,116,Gene/Protein	interleukin - 2 promoter,145,169,Gene/Protein	interleukin - 2 promoter,228,252,Gene/Protein	SLP - 76,272,280,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""SLAP - 130"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 promoter"", ""start_span"": 145, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 promoter"", ""start_span"": 228, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 272, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	train
Emphasis is placed on cytokines that have been studied in periodontitis, principally TNF - alpha, IL - 1, IL - 6, IL - 8 and beta - interferon.	cytokines,22,31,Gene/Protein	TNF - alpha,85,96,Gene/Protein	IL - 1,98,104,Gene/Protein	IL - 6,106,112,Gene/Protein	IL - 8,114,120,Gene/Protein	beta - interferon,125,142,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""beta - interferon"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
We show that IFN - alpha and IFN - gamma rapidly and efficiently enhanced STAT1, STAT2, p48, and IRF - 1 gene expression.	IFN - alpha,13,24,Gene/Protein	IFN - gamma,29,40,Gene/Protein	STAT1,74,79,Gene/Protein	STAT2,81,86,Gene/Protein	p48,88,91,Gene/Protein	IRF - 1 gene,97,109,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p48"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 gene"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
Overexpression of BXB, a constitutive active version of c - Raf, and of further members of the Ras - Raf - Erk signal cascade exerted an increase of GABP - mediated promoter - enhancer induction.	BXB,18,21,Gene/Protein	c - Raf,56,63,Gene/Protein	Ras,95,98,Gene/Protein	Raf,101,104,Gene/Protein	Erk,107,110,Gene/Protein	GABP,149,153,Gene/Protein	"[{""token"": ""BXB"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""c - Raf"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""GABP"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Two regions were identified: region I ( - 182 to - 162 bp) contained an overlapping Sp1 / Egr - 1 site, and region II ( - 119 to - 88) contained CRE and NF - kappaB ( designated kappaB3) sites.	region I,29,37,Gene/Protein	- 182 to - 162 bp,40,57,Gene/Protein	Sp1 / Egr - 1 site,84,102,Gene/Protein	region II,108,117,Gene/Protein	- 119 to - 88,120,133,Gene/Protein	CRE,145,148,Gene/Protein	"[{""token"": ""region I"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""- 182 to - 162 bp"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 / Egr - 1 site"", ""start_span"": 84, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""region II"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""- 119 to - 88"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
To further explore the involvement of PI3 - K in T cell activation, we created a set of potentially dominant negative PI3 - K constructs comprising individual or tandem domains of the regulatory p85 subunit and tested their effect on downstream signaling events like Erk2 activation and transcription from an NFAT ( nuclear factor of activated T cells) element taken from the interleukin - 2 promoter.	PI3 - K,38,45,Gene/Protein	dominant negative PI3 - K constructs,100,136,Gene/Protein	tandem domains,162,176,Gene/Protein	regulatory p85 subunit,184,206,Gene/Protein	Erk2,267,271,Gene/Protein	interleukin - 2 promoter,376,400,Gene/Protein	"[{""token"": ""PI3 - K"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative PI3 - K constructs"", ""start_span"": 100, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""tandem domains"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""regulatory p85 subunit"", ""start_span"": 184, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 promoter"", ""start_span"": 376, ""end_span"": 400, ""type"": ""Gene/Protein""}]"	train
We propose a model where basal transcription is maintained by binding of various transcription factors to the IFN - gamma promoter, whereas PMA + PHA - inducible IFN - gamma transcription in CD45R0 T cells is associated with binding of AP - 1 to the C - site.	transcription factors,81,102,Gene/Protein	IFN - gamma promoter,110,130,Gene/Protein	PHA,146,149,Gene/Protein	IFN - gamma,162,173,Gene/Protein	AP - 1,236,242,Gene/Protein	C - site,250,258,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma promoter"", ""start_span"": 110, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 236, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""C - site"", ""start_span"": 250, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
The CHEMR1 gene Scya3r2 is a single - copy gene whose open reading frame may be in a single exon and maps to the distal region of mouse Chr 9 where the mouse macrophage inflammatory protein - 1alpha ( MIP - 1alpha) receptor gene Scya3r and two related C - C chemokine receptor - like genes reside.	CHEMR1 gene,4,15,Gene/Protein	Scya3r2,16,23,Gene/Protein	single - copy gene,29,47,Gene/Protein	mouse Chr 9,130,141,Gene/Protein	Scya3r,229,235,Gene/Protein	C - C chemokine receptor - like genes,252,289,Gene/Protein	"[{""token"": ""CHEMR1 gene"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Scya3r2"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""single - copy gene"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mouse Chr 9"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Scya3r"", ""start_span"": 229, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""C - C chemokine receptor - like genes"", ""start_span"": 252, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	train
Previous reports have suggested the CD28 stimulation contributes to the activation of the IL - 2 promoter by up - regulating the activity of several transcription factors, including AP - 1 and nuclear factor - kappaB ( NF - kappaB) / Rel family members as well as an uncharacterized transcription factor called CD28 response complex.	CD28,36,40,Gene/Protein	IL - 2 promoter,90,105,Gene/Protein	transcription factors,149,170,Gene/Protein	AP - 1,182,188,Gene/Protein	uncharacterized transcription factor,267,303,Gene/Protein	CD28,311,315,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 149, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""uncharacterized transcription factor"", ""start_span"": 267, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 311, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
Of the NF - kappaB / Rel family members tested, this CD28RE / AP - 1 - specific complex contains predominantly c - Rel, despite the fact that both p50 and RelA can efficiently bind to the CD28RE.	NF - kappaB / Rel family members,7,39,Gene/Protein	CD28RE / AP - 1 - specific complex,53,87,Gene/Protein	c - Rel,111,118,Gene/Protein	p50,147,150,Gene/Protein	RelA,155,159,Gene/Protein	CD28RE,188,194,Gene/Protein	"[{""token"": ""NF - kappaB / Rel family members"", ""start_span"": 7, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE / AP - 1 - specific complex"", ""start_span"": 53, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Tax1, a transcriptional trans - activator of the Human T - cell leukemia virus type I ( HTLV - I), induces the expression of many cellular genes through interaction with at least three distinct cellular transcription factors; CREB / ATF, NF - kappaB, and SRF.	Tax1,0,4,Gene/Protein	transcriptional trans - activator,8,41,Gene/Protein	cellular transcription factors,194,224,Gene/Protein	CREB / ATF,226,236,Gene/Protein	NF - kappaB,238,249,Gene/Protein	SRF,255,258,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional trans - activator"", ""start_span"": 8, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""cellular transcription factors"", ""start_span"": 194, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF"", ""start_span"": 226, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 238, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
Mutations in the AT box or in the BSAP sites did not affect CD19 reporter construct activity, while a mutation of the GC box reduced it modestly, and a PyG box mutation reduced it dramatically.	AT box,17,23,Gene/Protein	BSAP sites,34,44,Gene/Protein	CD19,60,64,Gene/Protein	reporter construct,65,83,Gene/Protein	GC box,118,124,Gene/Protein	PyG box,152,159,Gene/Protein	"[{""token"": ""AT box"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""BSAP sites"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""reporter construct"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""GC box"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""PyG box"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
In combination, EBF and E47 induce efficient expression of the endogenous immunoglobulin surrogate light chain genes, lambda5 and VpreB, whereas other pre - B cell - specific genes remain silent.	EBF,16,19,Gene/Protein	E47,24,27,Gene/Protein	endogenous immunoglobulin surrogate light chain genes,63,116,Gene/Protein	lambda5,118,125,Gene/Protein	VpreB,130,135,Gene/Protein	pre - B cell - specific genes,151,180,Gene/Protein	"[{""token"": ""EBF"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""endogenous immunoglobulin surrogate light chain genes"", ""start_span"": 63, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""lambda5"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""VpreB"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""pre - B cell - specific genes"", ""start_span"": 151, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
That the signal transduction pathways used by the cytokines IL - 2 and IL - 15 are identical would suggest that these cytokines have redundant roles in lymphoid development; instead, IL - 2 is the guardian of thymus - derived T - cell homeostasis, while interleukin - 15 promotes extrathymic development of T and NK cells.	cytokines,50,59,Gene/Protein	IL - 2,60,66,Gene/Protein	IL - 15,71,78,Gene/Protein	cytokines,118,127,Gene/Protein	IL - 2,183,189,Gene/Protein	interleukin - 15,254,270,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 15"", ""start_span"": 254, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Together, these data demonstrate that the IL - 4R alpha cytoplasmic domain is sufficient to activate JAK - 1 and STAT6 and to induce expression of IL - 4 target genes, thus identifying a mechanism by which IL - 4 signaling can proceed in the absence of JAK - 3 and gamma ( c).	IL - 4R alpha cytoplasmic domain,42,74,Gene/Protein	JAK - 1,101,108,Gene/Protein	STAT6,113,118,Gene/Protein	IL - 4 target genes,147,166,Gene/Protein	IL - 4,206,212,Gene/Protein	JAK - 3,253,260,Gene/Protein	"[{""token"": ""IL - 4R alpha cytoplasmic domain"", ""start_span"": 42, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""JAK - 1"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 target genes"", ""start_span"": 147, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""JAK - 3"", ""start_span"": 253, ""end_span"": 260, ""type"": ""Gene/Protein""}]"	train
Reduction of IL - 2 production is secondary to the inability to phosphorylate the cAMP response element binding protein, CREB, and induce expression of the immediate early genes such as Fos B that are required to transactivate the IL - 2 promoter.	IL - 2,13,19,Gene/Protein	cAMP response element binding protein,82,119,Gene/Protein	CREB,121,125,Gene/Protein	immediate early genes,156,177,Gene/Protein	Fos B,186,191,Gene/Protein	IL - 2 promoter,231,246,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""cAMP response element binding protein"", ""start_span"": 82, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""immediate early genes"", ""start_span"": 156, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Fos B"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 231, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
The SRG3 protein contains an acidic NH2 terminus, a myb - like DNA binding domain, a leucine - zipper motif, and a proline - and glutamine - rich region at its COOH terminus.	SRG3 protein,4,16,Gene/Protein	acidic NH2 terminus,29,48,Gene/Protein	myb - like DNA binding domain,52,81,Gene/Protein	leucine - zipper motif,85,107,Gene/Protein	proline - and glutamine - rich region,115,152,Gene/Protein	COOH terminus,160,173,Gene/Protein	"[{""token"": ""SRG3 protein"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""acidic NH2 terminus"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""myb - like DNA binding domain"", ""start_span"": 52, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""leucine - zipper motif"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""proline - and glutamine - rich region"", ""start_span"": 115, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""COOH terminus"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Unlike full - sized NOTCH1, two such truncated forms of the protein either lacking a major portion of the extracellular domain ( DeltaE) or consisting only of the intracellular domain ( ICN) were found to activate transcription in cultured cells, presumably through RBP - Jkappa response elements within DNA.	NOTCH1,20,26,Gene/Protein	extracellular domain,106,126,Gene/Protein	DeltaE,129,135,Gene/Protein	intracellular domain,163,183,Gene/Protein	ICN,186,189,Gene/Protein	RBP - Jkappa,266,278,Gene/Protein	"[{""token"": ""NOTCH1"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 106, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""DeltaE"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""intracellular domain"", ""start_span"": 163, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""ICN"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""RBP - Jkappa"", ""start_span"": 266, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
Human T cell lymphotropic virus type I ( HTLV - I) encodes the transactivator protein, Tax, which facilitates viral transcription from three 21 bp repeated elements within the U3 region of the long terminal repeat ( LTR).	transactivator protein,63,85,Gene/Protein	Tax,87,90,Gene/Protein	21 bp repeated elements,141,164,Gene/Protein	U3 region,176,185,Gene/Protein	long terminal repeat,193,213,Gene/Protein	LTR,216,219,Gene/Protein	"[{""token"": ""transactivator protein"", ""start_span"": 63, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""21 bp repeated elements"", ""start_span"": 141, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 193, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Competition EMS analyses utilizing Sp1 and CREB binding site oligonucleotides demonstrate that Sp family members are critical components of U1 ( U1A / U1B) and U2 and that ATF / CREB family members are critical components of C1 - C3.	Sp family members,95,112,Gene/Protein	U1,140,142,Gene/Protein	U1A / U1B,145,154,Gene/Protein	U2,160,162,Gene/Protein	ATF / CREB family members,172,197,Gene/Protein	C1 - C3,225,232,Gene/Protein	"[{""token"": ""Sp family members"", ""start_span"": 95, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 160, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""ATF / CREB family members"", ""start_span"": 172, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""C1 - C3"", ""start_span"": 225, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
These data indicated that c - Fos / c - Jun, c - Rel / p65, and Sp1 regulate TF gene expression in human monocytic cells.	c - Fos,26,33,Gene/Protein	/ c - Jun,34,43,Gene/Protein	c - Rel,45,52,Gene/Protein	/ p65,53,58,Gene/Protein	Sp1,64,67,Gene/Protein	TF gene,77,84,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""/ c - Jun"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""/ p65"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""TF gene"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}]"	train
Transcription factor E2F binds to cellular promoters of certain growth - and cell cycle - controlling genes and forms distinct heteromeric complexes with other nuclear proteins.	Transcription factor,0,20,Gene/Protein	E2F,21,24,Gene/Protein	cellular promoters,34,52,Gene/Protein	growth - and cell cycle - controlling genes,64,107,Gene/Protein	heteromeric complexes,127,148,Gene/Protein	nuclear proteins,160,176,Gene/Protein	"[{""token"": ""Transcription factor"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""cellular promoters"", ""start_span"": 34, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""growth - and cell cycle - controlling genes"", ""start_span"": 64, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""heteromeric complexes"", ""start_span"": 127, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 160, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
Notably, no activation of Jak1, Jak2, Tyk2, Stat1, or Stat3 was observed in neutrophils following G - CSF stimulation.	Jak1,26,30,Gene/Protein	Jak2,32,36,Gene/Protein	Tyk2,38,42,Gene/Protein	Stat1,44,49,Gene/Protein	Stat3,54,59,Gene/Protein	G - CSF,98,105,Gene/Protein	"[{""token"": ""Jak1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	train
Although the stimulation of T cells from young subjects resulted in coordinated increases of nuclear protein complexes binding the AP - 1 TRE, c - jun TRE, and c - fos SRE DNA sequence motifs, age - related reductions in the activation of AP - 1 were accompanied by decreased levels of c - jun TRE and c - fos SRE binding complexes.	nuclear protein complexes,93,118,Gene/Protein	AP - 1 TRE,131,141,Gene/Protein	c - jun TRE,143,154,Gene/Protein	c - fos SRE DNA sequence motifs,160,191,Gene/Protein	AP - 1,239,245,Gene/Protein	c - jun TRE and c - fos SRE binding complexes,286,331,Gene/Protein	"[{""token"": ""nuclear protein complexes"", ""start_span"": 93, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 TRE"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""c - jun TRE"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""c - fos SRE DNA sequence motifs"", ""start_span"": 160, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 239, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""c - jun TRE and c - fos SRE binding complexes"", ""start_span"": 286, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	train
Furthermore, the nuclear protein complexes binding the SRE motif induced in activated T cells of young and elderly subjects contained serum response factor and Elk - 1 pointing toward age - related defects in the activation of transcriptional regulatory proteins distinct from c - jun / AP - 1.	nuclear protein complexes,17,42,Gene/Protein	SRE motif,55,64,Gene/Protein	serum response factor,134,155,Gene/Protein	Elk - 1,160,167,Gene/Protein	transcriptional regulatory proteins,227,262,Gene/Protein	c - jun / AP - 1,277,293,Gene/Protein	"[{""token"": ""nuclear protein complexes"", ""start_span"": 17, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""SRE motif"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""serum response factor"", ""start_span"": 134, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Elk - 1"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory proteins"", ""start_span"": 227, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""c - jun / AP - 1"", ""start_span"": 277, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
Because binding sites for B - cell - specific activator protein ( BSAP) are located upstream of several switch regions in the immunoglobulin heavy chain gene cluster, BSAP might play a role in the regulation of germline transcription and isotype switching.	binding sites,8,21,Gene/Protein	B - cell - specific activator protein,26,63,Gene/Protein	BSAP,66,70,Gene/Protein	immunoglobulin heavy chain gene cluster,126,165,Gene/Protein	BSAP,167,171,Gene/Protein	germline,211,219,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 8, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific activator protein"", ""start_span"": 26, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy chain gene cluster"", ""start_span"": 126, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
We found that although IL - 4 stimulation of X - SCID B cells did not result in Janus tyrosine kinase - 3 ( JAK3) phosphorylation, other IL - 4 substrates including JAK1 and IRS - 1 were phosphorylated.	IL - 4,23,29,Gene/Protein	Janus tyrosine kinase - 3,80,105,Gene/Protein	JAK3,108,112,Gene/Protein	IL - 4 substrates,137,154,Gene/Protein	JAK1,165,169,Gene/Protein	IRS - 1,174,181,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Janus tyrosine kinase - 3"", ""start_span"": 80, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 substrates"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IRS - 1"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
We report here that the signaling cascade triggered by interleukin - 4 ( IL - 4) or anti - CD40 monoclonal antibody ( mAb) participates in NF - kappa B activation responsible for germline C epsilon transcription in a human Burkitt lymphoma B cell line, DND39.	interleukin - 4,55,70,Gene/Protein	IL - 4,73,79,Gene/Protein	anti - CD40 monoclonal antibody,84,115,Gene/Protein	mAb,118,121,Gene/Protein	NF - kappa B,139,151,Gene/Protein	germline,179,187,Gene/Protein	"[{""token"": ""interleukin - 4"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40 monoclonal antibody"", ""start_span"": 84, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Both IL - 4 and anti - CD40 mAb induced activation of phosphatidylinositol 3 - kinase ( PI3 - kinase), translocation of a zeta isoform of protein kinase C, and nuclear expression of NF - kappa B.	IL - 4,5,11,Gene/Protein	CD40 mAb,23,31,Gene/Protein	phosphatidylinositol 3 - kinase,54,85,Gene/Protein	PI3 - kinase,88,100,Gene/Protein	protein kinase C,138,154,Gene/Protein	NF - kappa B,182,194,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""CD40 mAb"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 54, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
These results indicate that IL - 4 and ligation of CD40 induce NF - kappa B expression via at least a mechanism dependent on the PI3 - kinase pathway and suggest that NF - kappa B sensitive to NAC may play a role in regulating germline C epsilon transcription.	IL - 4,28,34,Gene/Protein	CD40,51,55,Gene/Protein	NF - kappa B,63,75,Gene/Protein	PI3 - kinase,129,141,Gene/Protein	NF - kappa B,167,179,Gene/Protein	germline,227,235,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 227, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Human IL - 5 promoter / enhancer - luciferase gene construct transfected to T - cell clones was transcribed on either TCR or IL - 2R stimulation and was clearly downregulated by dexamethasone, indicating that the approximately 500 - bp human IL - 5 gene segment located 5 ' upstream of the coding region contains activation - inducible enhancer elements responsible for the regulation by GC.	IL - 5,6,12,Gene/Protein	TCR,118,121,Gene/Protein	IL - 2R,125,132,Gene/Protein	500 - bp human IL - 5 gene segment,227,261,Gene/Protein	5 ' upstream,270,282,Gene/Protein	activation - inducible enhancer elements,313,353,Gene/Protein	"[{""token"": ""IL - 5"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""500 - bp human IL - 5 gene segment"", ""start_span"": 227, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""activation - inducible enhancer elements"", ""start_span"": 313, ""end_span"": 353, ""type"": ""Gene/Protein""}]"	train
Interleukin - 2 ( IL - 2) promoter activity stimulated by cross - linking of CD2, TCR / CD3, and CD28 with antibodies was significantly reduced by transient expression of an Itk mutant lacking the kinase activity.	IL - 2,18,24,Gene/Protein	CD2,77,80,Gene/Protein	TCR,82,85,Gene/Protein	CD28,97,101,Gene/Protein	antibodies,107,117,Gene/Protein	Itk mutant,174,184,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Itk mutant"", ""start_span"": 174, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
These results demonstrate that Itk plays a role in IL - 2 production, indicating a critical involvement of Itk in the initial stage of T cell activation by mediating signals from the TCR / CD3 complex, CD2, and CD28.	Itk,31,34,Gene/Protein	IL - 2,51,57,Gene/Protein	Itk,107,110,Gene/Protein	TCR / CD3 complex,183,200,Gene/Protein	CD2,202,205,Gene/Protein	CD28,211,215,Gene/Protein	"[{""token"": ""Itk"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Itk"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""TCR / CD3 complex"", ""start_span"": 183, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Analysis of the sequence immediately upstream from the transcription initiation site ( TIS) showed no canonical TATA or CAAT elements, however an initiator element commonly found in TATA - less promoters encompassed the TIS.	transcription initiation site,55,84,Gene/Protein	TIS,87,90,Gene/Protein	TATA,112,116,Gene/Protein	CAAT elements,120,133,Gene/Protein	TATA - less promoters,182,203,Gene/Protein	TIS,220,223,Gene/Protein	"[{""token"": ""transcription initiation site"", ""start_span"": 55, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""TIS"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TATA"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""CAAT elements"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""TATA - less promoters"", ""start_span"": 182, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""TIS"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Homology between nucleolin and histone H1 suggests that nucleolin may alter DNA organization in response to cell cycle controls, and the nucleolin component of LR1 may therefore function to organize switch regions before, during, or after switch recombination.	nucleolin,17,26,Gene/Protein	histone H1,31,41,Gene/Protein	nucleolin,56,65,Gene/Protein	nucleolin,137,146,Gene/Protein	LR1,160,163,Gene/Protein	switch regions,199,213,Gene/Protein	"[{""token"": ""nucleolin"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""histone H1"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 56, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""LR1"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""switch regions"", ""start_span"": 199, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
IL - 2 superinduction by Tat occurred at the transcriptional level, was mediated by the CD28 - responsive element in the IL - 2 promoter, and was exclusively dependent on the 29 amino acids encoded by the second exon of Tat.	IL - 2,0,6,Gene/Protein	Tat,25,28,Gene/Protein	CD28 - responsive element,88,113,Gene/Protein	IL - 2 promoter,121,136,Gene/Protein	29 amino acids,175,189,Gene/Protein	second exon of Tat,205,223,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive element"", ""start_span"": 88, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""29 amino acids"", ""start_span"": 175, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""second exon of Tat"", ""start_span"": 205, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Assembly of terminal complement complexes ( TCC) C5b - 7, C5b - 8, and C5b - 9 on target cells during acute and chronic inflammation induces hydrolysis of plasma membrane phospholipids and heterotrimeric G protein activation.	terminal complement complexes,12,41,Gene/Protein	TCC,44,47,Gene/Protein	C5b - 7,49,56,Gene/Protein	C5b - 8,58,65,Gene/Protein	C5b - 9,71,78,Gene/Protein	G protein,204,213,Gene/Protein	"[{""token"": ""terminal complement complexes"", ""start_span"": 12, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""TCC"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""C5b - 7"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""C5b - 8"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""C5b - 9"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""G protein"", ""start_span"": 204, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Involvement of G protein in the activation of MAPK pathway by TCC was indicated by inhibition of Raf - 1 and ERK1 kinase activity, as well as the DNA synthesis by pretreatment of cells with pertussis toxin.	G protein,15,24,Gene/Protein	MAPK,46,50,Gene/Protein	TCC,62,65,Gene/Protein	Raf - 1,97,104,Gene/Protein	ERK1,109,113,Gene/Protein	pertussis toxin,190,205,Gene/Protein	"[{""token"": ""G protein"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""TCC"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""pertussis toxin"", ""start_span"": 190, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Transcriptional factors of the NFAT family play an important role in regulating the expression of several cytokine genes during the immune response, such as the genes for interleukin 2 ( IL - 2) and IL - 4, among others.	Transcriptional factors,0,23,Gene/Protein	NFAT family,31,42,Gene/Protein	cytokine genes,106,120,Gene/Protein	interleukin 2,171,184,Gene/Protein	IL - 2,187,193,Gene/Protein	IL - 4,199,205,Gene/Protein	"[{""token"": ""Transcriptional factors"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""NFAT family"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 171, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Mobility shift assays showed that in vitro translated Pax - 5a and Pax - 5d, but not Pax - 5b or Pax - 5e, could interact with a B - cell - specific activator protein - binding site on the blk promoter.	Pax - 5a,54,62,Gene/Protein	Pax - 5d,67,75,Gene/Protein	Pax - 5b,85,93,Gene/Protein	Pax - 5e,97,105,Gene/Protein	B - cell - specific activator protein - binding site,129,181,Gene/Protein	blk promoter,189,201,Gene/Protein	"[{""token"": ""Pax - 5a"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5d"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5b"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5e"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific activator protein - binding site"", ""start_span"": 129, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""blk promoter"", ""start_span"": 189, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
The capacity of Syk to reconstitute the MAPK response required the catalytic activity of Syk, an intact autophosphorylation site ( Y518 and Y519), both Src homology 2 domains and it was blocked by the inhibitory N17 - mutated dominant - negative Ras construct.	Syk,16,19,Gene/Protein	MAPK,40,44,Gene/Protein	Syk,89,92,Gene/Protein	autophosphorylation site,104,128,Gene/Protein	Src homology 2 domains,152,174,Gene/Protein	inhibitory N17 - mutated dominant - negative Ras construct,201,259,Gene/Protein	"[{""token"": ""Syk"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""autophosphorylation site"", ""start_span"": 104, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Src homology 2 domains"", ""start_span"": 152, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory N17 - mutated dominant - negative Ras construct"", ""start_span"": 201, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
In this manuscript we have investigated the molecular mechanisms by which T cell lines stimulated with phorbol 12 - myristate 13 - acetate ( PMA) and phytohemagglutin ( PHA) display significantly higher levels of NF - kappa B1 encoding transcripts than cells stimulated with tumor necrosis factor - alpha, despite the fact that both stimuli activate NF - kappa B.	phytohemagglutin,150,166,Gene/Protein	PHA,169,172,Gene/Protein	NF - kappa B1,213,226,Gene/Protein	transcripts,236,247,Gene/Protein	tumor necrosis factor - alpha,275,304,Gene/Protein	NF - kappa B,350,362,Gene/Protein	"[{""token"": ""phytohemagglutin"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 213, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""transcripts"", ""start_span"": 236, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 275, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 350, ""end_span"": 362, ""type"": ""Gene/Protein""}]"	train
The nuclear factor of activated T cells ( NFAT) regulates cytokine gene expression in T cells through cis - acting elements located in the promoters of several cytokine genes.	nuclear factor of activated T cells,4,39,Gene/Protein	NFAT,42,46,Gene/Protein	cytokine gene,58,71,Gene/Protein	cis - acting elements,102,123,Gene/Protein	promoters,139,148,Gene/Protein	cytokine genes,160,174,Gene/Protein	"[{""token"": ""nuclear factor of activated T cells"", ""start_span"": 4, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""cytokine gene"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting elements"", ""start_span"": 102, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 160, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
Western blot and immunoprecipitation studies using rabbit anti - C / EBP - epsilon antibodies raised against the N - terminal portion of C / EBP - epsilon ( amino acids 1 to 115) showed that C / EBP - epsilon is a 32 - kDa nuclear phosphoprotein.	rabbit anti - C / EBP - epsilon antibodies,51,93,Gene/Protein	N - terminal portion,113,133,Gene/Protein	C / EBP - epsilon,137,154,Gene/Protein	amino acids 1 to 115,157,177,Gene/Protein	C / EBP - epsilon,191,208,Gene/Protein	32 - kDa nuclear phosphoprotein,214,245,Gene/Protein	"[{""token"": ""rabbit anti - C / EBP - epsilon antibodies"", ""start_span"": 51, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal portion"", ""start_span"": 113, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 1 to 115"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 191, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""32 - kDa nuclear phosphoprotein"", ""start_span"": 214, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Cotransfection of the C / EBP - epsilon sense and antisense expression constructs together with chloramphenicol acetyltransferase reporter vectors containing myeloid - cell - specific c - mim and human myeloperoxidase promoters suggested a role for C / EBP - epsilon transcription factor in the regulation of a subset of myeloid - cell - specific genes.	C / EBP - epsilon,22,39,Gene/Protein	chloramphenicol acetyltransferase reporter vectors,96,146,Gene/Protein	myeloid - cell - specific c - mim and human myeloperoxidase promoters,158,227,Gene/Protein	C / EBP - epsilon,249,266,Gene/Protein	transcription factor,267,287,Gene/Protein	myeloid - cell - specific genes,321,352,Gene/Protein	"[{""token"": ""C / EBP - epsilon"", ""start_span"": 22, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter vectors"", ""start_span"": 96, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""myeloid - cell - specific c - mim and human myeloperoxidase promoters"", ""start_span"": 158, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 249, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 267, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""myeloid - cell - specific genes"", ""start_span"": 321, ""end_span"": 352, ""type"": ""Gene/Protein""}]"	train
In addition to Zap - 70, the 3BP2 SH2 domain associated in vitro with LAT, Grb2, PLCgamma1, and Cbl from activated T cell lysates.	Zap - 70,15,23,Gene/Protein	3BP2 SH2 domain,29,44,Gene/Protein	LAT,70,73,Gene/Protein	Grb2,75,79,Gene/Protein	PLCgamma1,81,90,Gene/Protein	Cbl,96,99,Gene/Protein	"[{""token"": ""Zap - 70"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""3BP2 SH2 domain"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""LAT"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PLCgamma1"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}]"	train
This activity was dependent on the SH2 and pleckstrin - homology domains of 3BP2, and required functional Syk kinases, Ras, and calcineurin.	SH2,35,38,Gene/Protein	pleckstrin - homology domains,43,72,Gene/Protein	3BP2,76,80,Gene/Protein	Syk kinases,106,117,Gene/Protein	Ras,119,122,Gene/Protein	calcineurin,128,139,Gene/Protein	"[{""token"": ""SH2"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""pleckstrin - homology domains"", ""start_span"": 43, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""3BP2"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""Syk kinases"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
This chimera transduced IL - 4 - specific signals in response to IL - 2 binding and dramatically enhanced type 2 responses ( IL - 4, IL - 5, and immunoglobulin E production) upon in vitro TCR stimulation or in vivo antigen challenge.	IL - 4,24,30,Gene/Protein	IL - 2,65,71,Gene/Protein	IL - 4,125,131,Gene/Protein	IL - 5,133,139,Gene/Protein	immunoglobulin E,145,161,Gene/Protein	TCR,188,191,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin E"", ""start_span"": 145, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Regulation of NF - kappa B, AP - 1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF - kappa B p50.	NF - kappa B,14,26,Gene/Protein	AP - 1,28,34,Gene/Protein	NFAT,36,40,Gene/Protein	STAT1,46,51,Gene/Protein	nuclear localization sequence,132,161,Gene/Protein	NF - kappa B p50,165,181,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""nuclear localization sequence"", ""start_span"": 132, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p50"", ""start_span"": 165, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
The NLSs of NF - kappa B, AP - 1, and NFAT differ and the NLS of STAT1 has not yet been identified.	NLSs,4,8,Gene/Protein	NF - kappa B,12,24,Gene/Protein	AP - 1,26,32,Gene/Protein	NFAT,38,42,Gene/Protein	NLS,58,61,Gene/Protein	STAT1,65,70,Gene/Protein	"[{""token"": ""NLSs"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 12, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""NLS"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}]"	train
Herein we demonstrate that the inducible nuclear import of NF - kappa B, AP - 1, NFAT, and STAT1 in Jurkat T lymphocytes is significantly inhibited by a cell - permeable peptide carrying the NLS of the NF - kappa B p50 subunit.	NF - kappa B,59,71,Gene/Protein	AP - 1,73,79,Gene/Protein	NFAT,81,85,Gene/Protein	STAT1,91,96,Gene/Protein	NLS,191,194,Gene/Protein	NF - kappa B p50 subunit,202,226,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NLS"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p50 subunit"", ""start_span"": 202, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Taken together, these data indicate that the inducible nuclear import of NF - kappa B, AP - 1, NFAT, and STAT1 in Jurkat T cells can be regulated by NLS peptide delivered noninvasively to the cytoplasm of Jurkat T cells to target members of the importin ( karyopherin) - alpha beta NLS receptor complex.	NF - kappa B,73,85,Gene/Protein	AP - 1,87,93,Gene/Protein	NFAT,95,99,Gene/Protein	STAT1,105,110,Gene/Protein	NLS,149,152,Gene/Protein	NLS receptor complex,282,302,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""NLS"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""NLS receptor complex"", ""start_span"": 282, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	train
Although cadmium caused an early, transient stimulation of c - jun and c - fos expression and AP - 1 binding activity, heat - shock failed to alter both protooncogene expression and transcription factor binding, indicating that the stress - induced vimentin increase was not the result of AP - 1 - mediated transcriptional activation.	c - jun,59,66,Gene/Protein	c - fos,71,78,Gene/Protein	AP - 1,94,100,Gene/Protein	protooncogene,153,166,Gene/Protein	vimentin,249,257,Gene/Protein	AP - 1,289,295,Gene/Protein	"[{""token"": ""c - jun"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""protooncogene"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""vimentin"", ""start_span"": 249, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 289, ""end_span"": 295, ""type"": ""Gene/Protein""}]"	train
Since the activation of NFAT is MAPK - dependent these findings suggested that the activation of MAPK by Tpl - 2 is either independent or only partially dependent on MEK1 and MEK2.	NFAT,24,28,Gene/Protein	MAPK,32,36,Gene/Protein	MAPK,97,101,Gene/Protein	Tpl - 2,105,112,Gene/Protein	MEK1,166,170,Gene/Protein	MEK2,175,179,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Tpl - 2"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""MEK2"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Depending on the type of lymphocytes, the mechanism of apoptosis induced by glucocorticoids fall roughly in two categories: induction of ` ` death genes ' ' by the activated GR ( I kappa B, c - jun) or repression of survival factors ( AP - 1, c - Myc).	GR,174,176,Gene/Protein	I kappa B,179,188,Gene/Protein	c - jun,190,197,Gene/Protein	survival factors,216,232,Gene/Protein	AP - 1,235,241,Gene/Protein	c - Myc,243,250,Gene/Protein	"[{""token"": ""GR"", ""start_span"": 174, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 179, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""survival factors"", ""start_span"": 216, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 243, ""end_span"": 250, ""type"": ""Gene/Protein""}]"	train
Likewise, the level of expression of the erythroid transcription factors GATA - 1, GATA - 2, NF - E2, SCL and RBTN2, all expressed in untreated K562 cells, did not increase during sodium phenylacetate induced erythroid differentiation.	erythroid transcription factors,41,72,Gene/Protein	GATA - 1,73,81,Gene/Protein	GATA - 2,83,91,Gene/Protein	NF - E2,93,100,Gene/Protein	SCL,102,105,Gene/Protein	RBTN2,110,115,Gene/Protein	"[{""token"": ""erythroid transcription factors"", ""start_span"": 41, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""RBTN2"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	train
Much attention has focused on the series of sequence elements upstream of the transcriptional initiation site in the U3 region of the LTR including the Sp1 and NF - kappaB binding sites.	transcriptional initiation site,78,109,Gene/Protein	U3 region,117,126,Gene/Protein	LTR,134,137,Gene/Protein	Sp1,152,155,Gene/Protein	NF - kappaB,160,171,Gene/Protein	binding sites,172,185,Gene/Protein	"[{""token"": ""transcriptional initiation site"", ""start_span"": 78, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
We demonstrate here that the SLP - 76 linker protein interacts with both nck, an adaptor protein, and Vav, a guanine nucleotide exchange factor for Rho - family GTPases.	SLP - 76,29,37,Gene/Protein	nck,73,76,Gene/Protein	adaptor protein,81,96,Gene/Protein	Vav,102,105,Gene/Protein	guanine nucleotide exchange factor,109,143,Gene/Protein	Rho - family GTPases,148,168,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""nck"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""adaptor protein"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""guanine nucleotide exchange factor"", ""start_span"": 109, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Rho - family GTPases"", ""start_span"": 148, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
This region contains binding sites for several transcription factors, including the STAT family and NF - IL6, and the expression of LOX - 1 was upregulated by several cytokines.	binding sites,21,34,Gene/Protein	transcription factors,47,68,Gene/Protein	STAT family,84,95,Gene/Protein	NF - IL6,100,108,Gene/Protein	LOX - 1,132,139,Gene/Protein	cytokines,167,176,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""STAT family"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""LOX - 1"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL - 2 - induced activation of the promoter containing the minimal beta - casein STAT5 element as well as the promoters of CIS and OSM.	Ras,69,72,Gene/Protein	RasN17,74,80,Gene/Protein	IL - 2,97,103,Gene/Protein	beta - casein STAT5 element,164,191,Gene/Protein	CIS,220,223,Gene/Protein	OSM,228,231,Gene/Protein	"[{""token"": ""Ras"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""RasN17"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein STAT5 element"", ""start_span"": 164, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""OSM"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Unlike ligation of CD3, stimulation with anti - CD28 mAb or CHO cells expressing the CD28 ligands CD80 or CD86 did not lead to tyrosine phosphorylation of HS1 in Jurkat T cells.	CD3,19,22,Gene/Protein	anti - CD28 mAb,41,56,Gene/Protein	CD28 ligands,85,97,Gene/Protein	CD80,98,102,Gene/Protein	CD86,106,110,Gene/Protein	HS1,155,158,Gene/Protein	"[{""token"": ""CD3"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 41, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CD28 ligands"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""HS1"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Adult lymphocytes showed an equivalent increase in mRNA expression of c - fos and c - jun ( 140 + / - 25 and 155 + / - 31%) at 30 min post - PHA stimulation, while cord lymphocyte maximum c - fos and c - jun expression ( 82 + / - 6 and 142 + / - 12%) occurred at 15 min post - PHA stimulation ( c - fos, p = 0. 0354; c - jun, p = 0. 0112).	c - fos,70,77,Gene/Protein	c - jun,82,89,Gene/Protein	PHA,141,144,Gene/Protein	PHA,277,280,Gene/Protein	c - fos,295,302,Gene/Protein	c - jun,317,324,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 277, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 295, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 317, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
The chimeric oncoprotein E2A - HLF, generated by the t ( 17; 19) chromosomal translocation in pro - B - cell acute lymphoblastic leukemia, incorporates the transactivation domains of E2A and the basic leucine zipper ( bZIP) DNA - binding and protein dimerization domain of HLF ( hepatic leukemic factor).	chimeric oncoprotein,4,24,Gene/Protein	E2A - HLF,25,34,Gene/Protein	transactivation domains,156,179,Gene/Protein	E2A,183,186,Gene/Protein	HLF,273,276,Gene/Protein	hepatic leukemic factor,279,302,Gene/Protein	"[{""token"": ""chimeric oncoprotein"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domains"", ""start_span"": 156, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""hepatic leukemic factor"", ""start_span"": 279, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	train
Endotoxin selectively induces monocyte Mn superoxide dismutase ( SOD) without affecting levels of Cu, Zn SOD, catalase, or glutathione peroxidase.	Endotoxin,0,9,Gene/Protein	monocyte Mn superoxide dismutase,30,62,Gene/Protein	SOD,65,68,Gene/Protein	Zn SOD,102,108,Gene/Protein	catalase,110,118,Gene/Protein	glutathione peroxidase,123,145,Gene/Protein	"[{""token"": ""Endotoxin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""monocyte Mn superoxide dismutase"", ""start_span"": 30, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""SOD"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Zn SOD"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""catalase"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""glutathione peroxidase"", ""start_span"": 123, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
We further demonstrated that IL - 2, - 7, and - 15 induce multiple STAT proteins, including STAT5a, STAT5b, STAT1 alpha, STAT3, and another unidentified Fc gamma RI GAS DNA - binding protein.	multiple STAT proteins,58,80,Gene/Protein	STAT5a,92,98,Gene/Protein	STAT5b,100,106,Gene/Protein	STAT1 alpha,108,119,Gene/Protein	STAT3,121,126,Gene/Protein	Fc gamma RI GAS DNA - binding protein,153,190,Gene/Protein	"[{""token"": ""multiple STAT proteins"", ""start_span"": 58, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RI GAS DNA - binding protein"", ""start_span"": 153, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
In this study, we discovered a novel regulatory element located at - 120 of the CD95L promoter which contains DNA binding sites for SP - 1 and a yet unknown inducible factor.	regulatory element,37,55,Gene/Protein	- 120,67,72,Gene/Protein	CD95L promoter,80,94,Gene/Protein	DNA binding sites,110,127,Gene/Protein	SP - 1,132,138,Gene/Protein	inducible factor,157,173,Gene/Protein	"[{""token"": ""regulatory element"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""- 120"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""CD95L promoter"", ""start_span"": 80, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding sites"", ""start_span"": 110, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""SP - 1"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""inducible factor"", ""start_span"": 157, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Sequence analysis of DD products revealed two cDNAs with identity to known gene products: the catalytic sub - unit of DNA - protein kinase ( DNA - PK ( CS)), and the peroxisomal enzyme 17beta - hydroxysteroid dehydrogenase type IV ( 17beta - HSD IV).	DD products,21,32,Gene/Protein	cDNAs,46,51,Gene/Protein	known gene products,69,88,Gene/Protein	catalytic sub - unit of DNA - protein kinase,94,138,Gene/Protein	peroxisomal enzyme 17beta - hydroxysteroid dehydrogenase type IV,166,230,Gene/Protein	17beta - HSD IV,233,248,Gene/Protein	"[{""token"": ""DD products"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""cDNAs"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""known gene products"", ""start_span"": 69, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""catalytic sub - unit of DNA - protein kinase"", ""start_span"": 94, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""peroxisomal enzyme 17beta - hydroxysteroid dehydrogenase type IV"", ""start_span"": 166, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""17beta - HSD IV"", ""start_span"": 233, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
The data presented here indicate that ( 1) the 12 - lipoxygenase activity of murine macrophages is upregulated in vitro and in vivo by IL - 4 and / or IL - 13, ( 2) this upregulation requires expression of the transcription factor STAT6, and ( 3) the constitutive expression of the enzyme appears to be STAT6 independent.	12 - lipoxygenase,47,64,Gene/Protein	IL - 4,135,141,Gene/Protein	IL - 13,151,158,Gene/Protein	transcription factor,210,230,Gene/Protein	STAT6,231,236,Gene/Protein	STAT6,303,308,Gene/Protein	"[{""token"": ""12 - lipoxygenase"", ""start_span"": 47, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 210, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 303, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	train
Our data indicate an important role for NF - AT in the faithful expression of high affinity IL - 2 receptors and a close link between the TCR - mediated induction of IL - 2 and IL - 2 receptor alpha chain promoters, both of which are regulated by NF - AT factors.	NF - AT,40,47,Gene/Protein	high affinity IL - 2 receptors,78,108,Gene/Protein	TCR,138,141,Gene/Protein	IL - 2,166,172,Gene/Protein	IL - 2 receptor alpha chain promoters,177,214,Gene/Protein	NF - AT factors,247,262,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""high affinity IL - 2 receptors"", ""start_span"": 78, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain promoters"", ""start_span"": 177, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT factors"", ""start_span"": 247, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
Conversely, classic HD ( CHD) is heterogeneous because the tumor cells of a fraction of CHD display the BCL - 6 ( -) / syn - 1 ( +) phenotype of post - GC B - cells, whereas another fraction of CHD is constituted by a mixture of tumor cells reflecting the GC ( BCL - 6 ( +) / syn - 1 ( -)) or post - GC ( BCL - 6 ( -) / syn - 1 ( +)) phenotypes.	BCL - 6,104,111,Gene/Protein	syn - 1,119,126,Gene/Protein	BCL - 6,261,268,Gene/Protein	syn - 1,276,283,Gene/Protein	BCL - 6,305,312,Gene/Protein	syn - 1,320,327,Gene/Protein	"[{""token"": ""BCL - 6"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""syn - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 6"", ""start_span"": 261, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""syn - 1"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 6"", ""start_span"": 305, ""end_span"": 312, ""type"": ""Gene/Protein""}, {""token"": ""syn - 1"", ""start_span"": 320, ""end_span"": 327, ""type"": ""Gene/Protein""}]"	train
DNase I footprinting of the upstream delta - globin region revealed protected sequences corresponding to consensus binding sites for GATA - 1 and BP2.	DNase I,0,7,Gene/Protein	upstream delta - globin region,28,58,Gene/Protein	protected sequences,68,87,Gene/Protein	consensus binding sites,105,128,Gene/Protein	GATA - 1,133,141,Gene/Protein	BP2,146,149,Gene/Protein	"[{""token"": ""DNase I"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""upstream delta - globin region"", ""start_span"": 28, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""protected sequences"", ""start_span"": 68, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sites"", ""start_span"": 105, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""BP2"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
CONCLUSION: These results indicate that ( 1) IgE production in asthma and HIE usually is associated with elevated levels of IL - 4, but not IL - 13, in the peripheral blood; ( 2) the increased sera IL - 4 levels in asthma and HIE are not sufficient to induce Stat6 activation in PBMCs; and ( 3) evidence of switch recombination to epsilon may be detected in isolated cases of elevated IgE.	IgE,45,48,Gene/Protein	IL - 4,124,130,Gene/Protein	IL - 13,140,147,Gene/Protein	IL - 4,198,204,Gene/Protein	Stat6,259,264,Gene/Protein	IgE,385,388,Gene/Protein	"[{""token"": ""IgE"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 259, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 385, ""end_span"": 388, ""type"": ""Gene/Protein""}]"	train
Overexpression of hIRAK enhanced IL - 1 - stimulated activation of the transcription factor NFkappaB, whereas a truncated form ( N - IRAK) specifically inhibited IL - 1 - dependent NFkappaB activity.	hIRAK,18,23,Gene/Protein	IL - 1,33,39,Gene/Protein	transcription factor NFkappaB,71,100,Gene/Protein	N - IRAK,129,137,Gene/Protein	IL - 1,162,168,Gene/Protein	NFkappaB,181,189,Gene/Protein	"[{""token"": ""hIRAK"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NFkappaB"", ""start_span"": 71, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""N - IRAK"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Western analysis performed on cellular fractions of resting cells and of TPA - activated cells revealed abundant expression of classical PKC - alpha ( cPKC - alpha), cPKC - betaII, and atypical PKC - zeta isoforms and identified a sustained translocation of cPKC - alpha and cPKC - betaII from the cytosolic compartment to membranes.	classical PKC - alpha,127,148,Gene/Protein	cPKC - alpha,151,163,Gene/Protein	cPKC - betaII,166,179,Gene/Protein	atypical PKC - zeta isoforms,185,213,Gene/Protein	cPKC - alpha,258,270,Gene/Protein	cPKC - betaII,275,288,Gene/Protein	"[{""token"": ""classical PKC - alpha"", ""start_span"": 127, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - alpha"", ""start_span"": 151, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - betaII"", ""start_span"": 166, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""atypical PKC - zeta isoforms"", ""start_span"": 185, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - alpha"", ""start_span"": 258, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - betaII"", ""start_span"": 275, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	train
Human T - cell leukemia virus type 1 Tax induction of NF - kappaB involves activation of the IkappaB kinase alpha ( IKKalpha) and IKKbeta cellular kinases.	Tax,37,40,Gene/Protein	NF - kappaB,54,65,Gene/Protein	IkappaB kinase alpha,93,113,Gene/Protein	IKKalpha,116,124,Gene/Protein	IKKbeta,130,137,Gene/Protein	cellular kinases,138,154,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB kinase alpha"", ""start_span"": 93, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""cellular kinases"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
Previous studies have shown constitutive activation of IL - 4 and IL - 7 signaling pathways, as measured by activation of Janus protein kinase ( JAK) 1, JAK3, STAT5, and STAT6, in pre - B cells transformed by v - Abl.	IL - 4,55,61,Gene/Protein	IL - 7,66,72,Gene/Protein	JAK3,153,157,Gene/Protein	STAT5,159,164,Gene/Protein	STAT6,170,175,Gene/Protein	v - Abl,209,216,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
p53 and p21 / Cip1, respectively, inhibit the expression and activation of PCNA, whereas p130 and pRb, respectively, inhibit the expression and activation of E2F1.	p53,0,3,Gene/Protein	p21 / Cip1,8,18,Gene/Protein	PCNA,75,79,Gene/Protein	p130,89,93,Gene/Protein	pRb,98,101,Gene/Protein	E2F1,158,162,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""p21 / Cip1"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""PCNA"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""E2F1"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
Evidence for a role for PKCalpha as an effector of Rho was obtained by the observation that coexpression of the N - terminal domain of PKCalpha blocked the effects of activated Rho plus PMA on AP - 1 transcriptional activity.	PKCalpha,24,32,Gene/Protein	Rho,51,54,Gene/Protein	N - terminal domain,112,131,Gene/Protein	PKCalpha,135,143,Gene/Protein	Rho,177,180,Gene/Protein	AP - 1,193,199,Gene/Protein	"[{""token"": ""PKCalpha"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal domain"", ""start_span"": 112, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""PKCalpha"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Activation of Janus tyrosine kinases ( Jak) and Signal transducers and activators of transcription ( Stat) after ligation of major histocompatibility complex class I ( MHC - I) was explored in Jurkat T cells.	Janus tyrosine kinases,14,36,Gene/Protein	Jak,39,42,Gene/Protein	Signal transducers and activators of transcription,48,98,Gene/Protein	Stat,101,105,Gene/Protein	major histocompatibility complex class I,125,165,Gene/Protein	MHC - I,168,175,Gene/Protein	"[{""token"": ""Janus tyrosine kinases"", ""start_span"": 14, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""Jak"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Signal transducers and activators of transcription"", ""start_span"": 48, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Stat"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""major histocompatibility complex class I"", ""start_span"": 125, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""MHC - I"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
An association between hSIE and Stat - 3 after MHC - I ligation was directly demonstrated by precipitating Stat - 3 from nuclear extracts with biotinylated hSIE probe and avidin - coupled agarose.	hSIE,23,27,Gene/Protein	Stat - 3,32,40,Gene/Protein	MHC - I,47,54,Gene/Protein	Stat - 3,107,115,Gene/Protein	hSIE probe,156,166,Gene/Protein	avidin,171,177,Gene/Protein	"[{""token"": ""hSIE"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Stat - 3"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""MHC - I"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Stat - 3"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""hSIE probe"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""avidin"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility - shift assays revealed that recombinant IL - 2 increased NF - kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL - 2 increased the abundance of mRNAs encoding the NF - kappaB components c - Rel and KBF1 in these cells.	IL - 2,66,72,Gene/Protein	NF - kappaB,83,94,Gene/Protein	IL - 2,194,200,Gene/Protein	NF - kappaB,247,258,Gene/Protein	c - Rel,270,277,Gene/Protein	KBF1,282,286,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 247, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 270, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""KBF1"", ""start_span"": 282, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
Interphase fluorescence in situ hybridization ( FISH) was performed with 2 YACs flanking the CALM region, a YAC contig of the MLL region, and a YAC spanning the AF10 breakpoint.	YACs,75,79,Gene/Protein	CALM region,93,104,Gene/Protein	YAC contig,108,118,Gene/Protein	MLL region,126,136,Gene/Protein	YAC,144,147,Gene/Protein	AF10,161,165,Gene/Protein	"[{""token"": ""YACs"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""CALM region"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""YAC contig"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""MLL region"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""YAC"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""AF10"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
In this report, we show that NF - kappaB activation by LMP1 or by each of its effector sites is mediated by a pathway that includes NIK, IKKalpha, and IKKbeta.	NF - kappaB,29,40,Gene/Protein	LMP1,55,59,Gene/Protein	effector sites,78,92,Gene/Protein	NIK,132,135,Gene/Protein	IKKalpha,137,145,Gene/Protein	IKKbeta,151,158,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""effector sites"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Furthermore, we demonstrate that IL - 13, like IL - 4, induces distinct STAT6 - DNA binding complexes and tyrosine phosphorylation of STAT6 and Janus kinase 3 ( JAK3) in NK and T cells.	IL - 13,33,40,Gene/Protein	IL - 4,47,53,Gene/Protein	STAT6 - DNA binding complexes,72,101,Gene/Protein	STAT6,134,139,Gene/Protein	Janus kinase 3,144,158,Gene/Protein	JAK3,161,165,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""STAT6 - DNA binding complexes"", ""start_span"": 72, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Death - inducing ligands ( DILs) such as tumor necrosis factor alpha ( TNFalpha) or the cytotoxic drug doxorubicin have been shown to activate a nuclear factor kappaB ( NFkappaB) - dependent program that may rescue cells from apoptosis induction.	Death - inducing ligands,0,24,Gene/Protein	DILs,27,31,Gene/Protein	tumor necrosis factor alpha,41,68,Gene/Protein	TNFalpha,71,79,Gene/Protein	nuclear factor kappaB,145,166,Gene/Protein	NFkappaB,169,177,Gene/Protein	"[{""token"": ""Death - inducing ligands"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""DILs"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 41, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 145, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
These results establish EKLF as a tissue - specific transcription factor that undergoes post - translational acetylation and suggest a mechanism by which EKLF is able to alter chromatin structure and induce beta - globin expression within the beta - like globin cluster.	EKLF,24,28,Gene/Protein	tissue - specific transcription factor,34,72,Gene/Protein	EKLF,154,158,Gene/Protein	chromatin,176,185,Gene/Protein	beta - globin,207,220,Gene/Protein	beta - like globin cluster,243,269,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""tissue - specific transcription factor"", ""start_span"": 34, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""chromatin"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin"", ""start_span"": 207, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""beta - like globin cluster"", ""start_span"": 243, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
The lymphoid - specific transcription complex, NF - AT, is involved in early gene activation in T cells and is assembled from a pre - existing, T cell restricted cytoplasmic factor and an inducible ubiquitous nuclear component within 30 min after activation through the antigen receptor.	lymphoid - specific transcription complex,4,45,Gene/Protein	NF - AT,47,54,Gene/Protein	T cell restricted cytoplasmic factor,144,180,Gene/Protein	ubiquitous,198,208,Gene/Protein	nuclear component,209,226,Gene/Protein	antigen receptor,270,286,Gene/Protein	"[{""token"": ""lymphoid - specific transcription complex"", ""start_span"": 4, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""T cell restricted cytoplasmic factor"", ""start_span"": 144, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous"", ""start_span"": 198, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""nuclear component"", ""start_span"": 209, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""antigen receptor"", ""start_span"": 270, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
The proximal element contains the sequence 5 ' - GGCCAATGGG - 3 ', which closely resembles the consensus binding motif for the CCAAT - binding factor NF - Y ( CBF, CP1, alpha CP1).	proximal element,4,20,Gene/Protein	CCAAT - binding factor,127,149,Gene/Protein	NF - Y,150,156,Gene/Protein	CBF,159,162,Gene/Protein	CP1,164,167,Gene/Protein	alpha CP1,169,178,Gene/Protein	"[{""token"": ""proximal element"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT - binding factor"", ""start_span"": 127, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""CBF"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""CP1"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""alpha CP1"", ""start_span"": 169, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Methylation interference analysis of the - 65 region identified a pattern of contacts with nuclear factors resembling that for NF - Y, and an NF - Y - binding site and the proximal TSP 1 element cross - competed in gel - shift assays, whereas their binding mutants did not.	- 65 region,41,52,Gene/Protein	nuclear factors,91,106,Gene/Protein	NF - Y,127,133,Gene/Protein	NF - Y - binding site,142,163,Gene/Protein	proximal TSP 1 element,172,194,Gene/Protein	binding mutants,249,264,Gene/Protein	"[{""token"": ""- 65 region"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 91, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y - binding site"", ""start_span"": 142, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""proximal TSP 1 element"", ""start_span"": 172, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""binding mutants"", ""start_span"": 249, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
However, activation of the T cell lines leading to enhanced HIV - 1 replication can be induced by antigens, mitogens, and cytokines ( tumor necrosis factor alpha [ TNF - alpha], interleukin 1, and interleukin - 2).	antigens,98,106,Gene/Protein	cytokines,122,131,Gene/Protein	tumor necrosis factor alpha,134,161,Gene/Protein	TNF - alpha,164,175,Gene/Protein	interleukin 1,178,191,Gene/Protein	interleukin - 2,197,212,Gene/Protein	"[{""token"": ""antigens"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 134, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 1"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Using magnetic beads with attached DNA containing the Escherichia coli lac operator, fusion proteins comprising the DNA - binding lac repressor could be affinity - purified and recovered by gentle elution conditions, such as with a lactose analogue or by enzymatic means using either deoxyribonuclease ( DNase) or restriction endonucleases.	Escherichia coli lac operator,54,83,Gene/Protein	fusion proteins,85,100,Gene/Protein	DNA - binding lac repressor,116,143,Gene/Protein	deoxyribonuclease,284,301,Gene/Protein	DNase,304,309,Gene/Protein	restriction endonucleases,314,339,Gene/Protein	"[{""token"": ""Escherichia coli lac operator"", ""start_span"": 54, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""fusion proteins"", ""start_span"": 85, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding lac repressor"", ""start_span"": 116, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""deoxyribonuclease"", ""start_span"": 284, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""DNase"", ""start_span"": 304, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""restriction endonucleases"", ""start_span"": 314, ""end_span"": 339, ""type"": ""Gene/Protein""}]"	train
However, X failed to react with a variety of antibodies against Rb or p107, implicating the involvement of an E1A - binding protein other than Rb or p107.	X,9,10,Gene/Protein	Rb,64,66,Gene/Protein	p107,70,74,Gene/Protein	E1A - binding protein,110,131,Gene/Protein	Rb,143,145,Gene/Protein	p107,149,153,Gene/Protein	"[{""token"": ""X"", ""start_span"": 9, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""p107"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""E1A - binding protein"", ""start_span"": 110, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""p107"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Hence, Ca2 + binds to calmodulin, leading to the binding of calmodulin to calcineurin; the activated calcineurin, in turn, may dephosphorylate the cytoplasmic subunit of NF - AT, resulting in its translocation from the cytoplasm into the nucleus to form a competent transcriptional activator.	calmodulin,22,32,Gene/Protein	calmodulin,60,70,Gene/Protein	calcineurin,74,85,Gene/Protein	calcineurin,101,112,Gene/Protein	cytoplasmic subunit of NF - AT,147,177,Gene/Protein	competent transcriptional activator,256,291,Gene/Protein	"[{""token"": ""calmodulin"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic subunit of NF - AT"", ""start_span"": 147, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""competent transcriptional activator"", ""start_span"": 256, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Both overexpressed p65 and coexpressed p50 are cytoplasmic, whereas p65 delta is partly nuclear, indicating that the I kappa B induced by p65 can maintain NF - kappa B in the cytoplasm.	p65,19,22,Gene/Protein	p50,39,42,Gene/Protein	p65 delta,68,77,Gene/Protein	I kappa B,117,126,Gene/Protein	p65,138,141,Gene/Protein	NF - kappa B,155,167,Gene/Protein	"[{""token"": ""p65"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""p65 delta"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
The transactivator HTLV - I Tax activates the promoter of the gene coding for the interleukin 2 alpha - chain receptor ( IL - 2R alpha) via a kappa B site that can bind several protein species of the rel family.	HTLV - I Tax,19,31,Gene/Protein	promoter,46,54,Gene/Protein	interleukin 2 alpha - chain receptor,82,118,Gene/Protein	IL - 2R alpha,121,134,Gene/Protein	kappa B site,142,154,Gene/Protein	rel family,200,210,Gene/Protein	"[{""token"": ""HTLV - I Tax"", ""start_span"": 19, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 alpha - chain receptor"", ""start_span"": 82, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 121, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""rel family"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Recombinant I kappa B - alpha ( MAD - 3) inhibited the DNA binding activity of p65, p49 / p65, and p50 / p65 but stimulated the binding of NFKB2 ( p49) or NFKB1 ( p50).	MAD - 3,32,39,Gene/Protein	p65,79,82,Gene/Protein	p49 / p65,84,93,Gene/Protein	p50 / p65,99,108,Gene/Protein	NFKB2,139,144,Gene/Protein	p49,147,150,Gene/Protein	"[{""token"": ""MAD - 3"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""p49 / p65"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""p49"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
The long terminal repeat ( LTR) of the type 1 human immunodeficiency virus ( HIV - 1) and the 5 ' regulatory region of the gene encoding the interleukin 2 receptor alpha subunit ( IL - 2R alpha) share functional kappa B enhancer elements involved in the regulation of these inducible transcription units during T - cell activation.	long terminal repeat,4,24,Gene/Protein	LTR,27,30,Gene/Protein	5 ' regulatory region,94,115,Gene/Protein	interleukin 2 receptor alpha subunit,141,177,Gene/Protein	IL - 2R alpha,180,193,Gene/Protein	kappa B enhancer elements,212,237,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""5 ' regulatory region"", ""start_span"": 94, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 receptor alpha subunit"", ""start_span"": 141, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 180, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""kappa B enhancer elements"", ""start_span"": 212, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
This was evidenced by the ability of the AP - 1 site to compete with the NF - AT site for binding to NF - AT and by the capacity of immobilized anti - Jun and anti - Fos antibodies to deplete NF - AT - binding activity from nuclear extracts of activated T cells.	AP - 1 site,41,52,Gene/Protein	NF - AT,73,80,Gene/Protein	NF - AT,101,108,Gene/Protein	immobilized anti - Jun,132,154,Gene/Protein	anti - Fos,159,169,Gene/Protein	NF - AT,192,199,Gene/Protein	"[{""token"": ""AP - 1 site"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""immobilized anti - Jun"", ""start_span"": 132, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fos"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
There was no detectable binding of in vitro translated Jun / Fos heterodimer ( AP - 1) to the NF - AT sequence, and the NF - AT sequence was unable to inhibit the binding of Jun / Fos to the AP - 1 sequence.	Jun / Fos heterodimer,55,76,Gene/Protein	AP - 1,79,85,Gene/Protein	NF - AT,94,101,Gene/Protein	NF - AT sequence,120,136,Gene/Protein	Jun / Fos,174,183,Gene/Protein	AP - 1 sequence,191,206,Gene/Protein	"[{""token"": ""Jun / Fos heterodimer"", ""start_span"": 55, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT sequence"", ""start_span"": 120, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Jun / Fos"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sequence"", ""start_span"": 191, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
How does GATA - 1 regulate red cell genes like globin or the Epo receptor? Once we identify the functional domains of the GATA - binding proteins, we hope to learn what proteins GATA - 1 binds to in the basic transcription machinery or in chromatin.	GATA - 1,9,17,Gene/Protein	red cell genes,27,41,Gene/Protein	globin,47,53,Gene/Protein	Epo receptor,61,73,Gene/Protein	GATA - binding proteins,122,145,Gene/Protein	GATA - 1,178,186,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""red cell genes"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""globin"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Epo receptor"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding proteins"", ""start_span"": 122, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
These data suggest that transcriptional activation of human embryonic zeta 2 globin gene and the fetal / adult alpha globin genes is mediated by erythroid cell - specific and developmental stage - specific nuclear factor - DNA complexes which form at the enhancer ( HS - 40) and the globin promoters.	human embryonic zeta 2 globin gene,54,88,Gene/Protein	fetal / adult alpha globin genes,97,129,Gene/Protein	developmental stage - specific nuclear factor - DNA complexes,175,236,Gene/Protein	enhancer,255,263,Gene/Protein	HS - 40,266,273,Gene/Protein	globin promoters,283,299,Gene/Protein	"[{""token"": ""human embryonic zeta 2 globin gene"", ""start_span"": 54, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""fetal / adult alpha globin genes"", ""start_span"": 97, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""developmental stage - specific nuclear factor - DNA complexes"", ""start_span"": 175, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 255, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""HS - 40"", ""start_span"": 266, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""globin promoters"", ""start_span"": 283, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
We detected an association between the reduced mitogenic response and low expression of both interleukin - 2 ( IL - 2) and the alpha chain ( CD25) of the IL - 2 receptor ( IL - 2R).	interleukin - 2,93,108,Gene/Protein	IL - 2,111,117,Gene/Protein	alpha chain,127,138,Gene/Protein	CD25,141,145,Gene/Protein	IL - 2 receptor,154,169,Gene/Protein	IL - 2R,172,179,Gene/Protein	"[{""token"": ""interleukin - 2"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""alpha chain"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""CD25"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 154, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
The presence of c - fos had a negative influence on GR function and correlated with the cell - specific synergistic or antagonistic activity of Jun with respect to GR; high basal expression of c - fos as well as AP - 1 DNA binding and transcriptional activity were observed in HeLa cells, but not in T cells.	c - fos,16,23,Gene/Protein	GR,52,54,Gene/Protein	Jun,144,147,Gene/Protein	GR,164,166,Gene/Protein	c - fos,193,200,Gene/Protein	AP - 1,212,218,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 164, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 212, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
The affinity of the BAT box binding proteins for the BAT box was approximately 25 - fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10 - fold more rapidly than from the octamer sequence.	BAT box binding proteins,20,44,Gene/Protein	BAT box,53,60,Gene/Protein	octamer sequence,107,123,Gene/Protein	BAT box binding proteins,132,156,Gene/Protein	BAT box,178,185,Gene/Protein	octamer sequence,223,239,Gene/Protein	"[{""token"": ""BAT box binding proteins"", ""start_span"": 20, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""BAT box"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""octamer sequence"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""BAT box binding proteins"", ""start_span"": 132, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""BAT box"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""octamer sequence"", ""start_span"": 223, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
However, Nef does not affect the DNA - binding activity of other transcription factors implicated in HIV - 1 regulation, including SP - 1, USF, URS, and NF - AT.	Nef,9,12,Gene/Protein	transcription factors,65,86,Gene/Protein	SP - 1,131,137,Gene/Protein	USF,139,142,Gene/Protein	URS,144,147,Gene/Protein	NF - AT,153,160,Gene/Protein	"[{""token"": ""Nef"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 65, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""SP - 1"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""USF"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""URS"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
For the study of the changes in plasma interleukin - 1 ( IL - 1) and their possible relationship with the changes in glucocorticoid receptor ( GR), plasma IL - 1 and GR in peripheral blood leukocytes in aged long - distance runner were measured simultaneously.	plasma interleukin - 1,32,54,Gene/Protein	IL - 1,57,63,Gene/Protein	glucocorticoid receptor,117,140,Gene/Protein	GR,143,145,Gene/Protein	plasma IL - 1,148,161,Gene/Protein	GR,166,168,Gene/Protein	"[{""token"": ""plasma interleukin - 1"", ""start_span"": 32, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptor"", ""start_span"": 117, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""plasma IL - 1"", ""start_span"": 148, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Here we demonstrate that the c - myb proto - oncogene product, which is itself a DNA - binding protein and transcriptional transactivator, can interact synergistically with Z in activating the BMRF1 promoter in Jurkat cells ( a T - cell line) or Raji cells ( an EBV - positive B - cell), whereas the c - myb gene product by itself has little effect.	c - myb proto - oncogene product,29,61,Gene/Protein	DNA - binding protein,81,102,Gene/Protein	transcriptional transactivator,107,137,Gene/Protein	Z,173,174,Gene/Protein	BMRF1 promoter,193,207,Gene/Protein	c - myb gene product,300,320,Gene/Protein	"[{""token"": ""c - myb proto - oncogene product"", ""start_span"": 29, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding protein"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional transactivator"", ""start_span"": 107, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 173, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1 promoter"", ""start_span"": 193, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""c - myb gene product"", ""start_span"": 300, ""end_span"": 320, ""type"": ""Gene/Protein""}]"	train
A 30 - bp sequence in the BMRF1 promoter which contains a Z binding site ( a consensus AP - 1 site) is sufficient to transfer high - level lymphoid - specific responsiveness to the Z / c - myb combination to a heterologous promoter.	30 - bp sequence,2,18,Gene/Protein	BMRF1 promoter,26,40,Gene/Protein	Z binding site,58,72,Gene/Protein	consensus AP - 1 site,77,98,Gene/Protein	Z / c - myb combination,181,204,Gene/Protein	heterologous promoter,210,231,Gene/Protein	"[{""token"": ""30 - bp sequence"", ""start_span"": 2, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1 promoter"", ""start_span"": 26, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Z binding site"", ""start_span"": 58, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""consensus AP - 1 site"", ""start_span"": 77, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Z / c - myb combination"", ""start_span"": 181, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""heterologous promoter"", ""start_span"": 210, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Enhanced NF - kappa B binding activity is followed by functional activation in that inducibility of the IL - 2 receptor alpha chain is mediated by enhanced NF - kappa B binding and that a heterologous promoter containing the NF - kappa B consensus sequence ( - 291 to - 245) of the IL - 2 receptor alpha chain gene is activated.	NF - kappa B,9,21,Gene/Protein	IL - 2 receptor alpha chain,104,131,Gene/Protein	NF - kappa B,156,168,Gene/Protein	NF - kappa B consensus sequence,225,256,Gene/Protein	- 291 to - 245,259,273,Gene/Protein	IL - 2 receptor alpha chain gene,282,314,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 9, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain"", ""start_span"": 104, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 156, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B consensus sequence"", ""start_span"": 225, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""- 291 to - 245"", ""start_span"": 259, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain gene"", ""start_span"": 282, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	train
In addition, IL - 2 is capable of increasing transcript levels of the p50 gene coding for the p50 subunit of the NF - kappa B transcription factor, whereas mRNA levels of the p65 NF - kappa B gene remained unchanged.	IL - 2,13,19,Gene/Protein	p50,70,73,Gene/Protein	p50 subunit,94,105,Gene/Protein	NF - kappa B,113,125,Gene/Protein	p65,175,178,Gene/Protein	NF - kappa B gene,179,196,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B gene"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
p50B is able to form heteromeric kappa B - binding complexes with RelB, as well as with p65 and p50, the two subunits of NF - kappa B.	p50B,0,4,Gene/Protein	heteromeric kappa B - binding complexes,21,60,Gene/Protein	RelB,66,70,Gene/Protein	p65,88,91,Gene/Protein	p50,96,99,Gene/Protein	NF - kappa B,121,133,Gene/Protein	"[{""token"": ""p50B"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""heteromeric kappa B - binding complexes"", ""start_span"": 21, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
Viral trans - activators such as Tax ( human T cell leukemia virus - 1, HTLV - 1) and E2 ( bovine papilloma virus, BPV) proteins are other agents which activate lymphokine gene expression by bypassing T cell receptor ( TCR) mediated signaling.	Viral trans - activators,0,24,Gene/Protein	Tax,33,36,Gene/Protein	E2,86,88,Gene/Protein	lymphokine gene,161,176,Gene/Protein	T cell receptor,201,216,Gene/Protein	TCR,219,222,Gene/Protein	"[{""token"": ""Viral trans - activators"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""E2"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine gene"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
To investigate the molecular basis for the critical regulatory interaction between NF - kappa B and I kappa B / MAD - 3, a series of human NF - kappa B p65 mutants was identified that functionally segregated DNA binding, I kappa B - mediated inhibition, and I kappa B - induced nuclear exclusion of this transcription factor.	NF - kappa B,83,95,Gene/Protein	I kappa B / MAD - 3,100,119,Gene/Protein	human NF - kappa B p65 mutants,133,163,Gene/Protein	I kappa B,221,230,Gene/Protein	I kappa B,258,267,Gene/Protein	transcription factor,304,324,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B / MAD - 3"", ""start_span"": 100, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""human NF - kappa B p65 mutants"", ""start_span"": 133, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 221, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 258, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 304, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
Similar repeat motifs are found in a number of diverse regulatory proteins but the motifs of Bcl - 3 are most closely related to those found in I kappa B proteins in which the ankyrin repeat domain is thought to be directly involved in inhibition of NF - kappa B activity.	repeat motifs,8,21,Gene/Protein	diverse regulatory proteins,47,74,Gene/Protein	Bcl - 3,93,100,Gene/Protein	I kappa B proteins,144,162,Gene/Protein	ankyrin repeat,176,190,Gene/Protein	NF - kappa B,250,262,Gene/Protein	"[{""token"": ""repeat motifs"", ""start_span"": 8, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""diverse regulatory proteins"", ""start_span"": 47, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 3"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B proteins"", ""start_span"": 144, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin repeat"", ""start_span"": 176, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 250, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The rules of assembly of the cognate ligands of TF, namely the zymogen plasma factors VII and the serine protease factor VIIa, with the soluble surface domain of TF in free solution, in the presence of phospholipid surfaces and cell surface and of the anchored TF molecule have been described.	TF,48,50,Gene/Protein	zymogen plasma factors VII,63,89,Gene/Protein	serine protease factor VIIa,98,125,Gene/Protein	soluble surface domain,136,158,Gene/Protein	TF,162,164,Gene/Protein	anchored TF molecule,252,272,Gene/Protein	"[{""token"": ""TF"", ""start_span"": 48, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""zymogen plasma factors VII"", ""start_span"": 63, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""serine protease factor VIIa"", ""start_span"": 98, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""soluble surface domain"", ""start_span"": 136, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 162, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""anchored TF molecule"", ""start_span"": 252, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
Elf - 1 contains a DNA binding domain that is nearly identical to that of E74, the ecdysone - inducible Drosophila transcription factor required for metamorphosis ( hence the name Elf - 1, for E74 - like factor 1).	Elf - 1,0,7,Gene/Protein	DNA binding domain,19,37,Gene/Protein	E74,74,77,Gene/Protein	ecdysone - inducible Drosophila transcription factor,83,135,Gene/Protein	Elf - 1,180,187,Gene/Protein	E74 - like factor 1,193,212,Gene/Protein	"[{""token"": ""Elf - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""E74"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""ecdysone - inducible Drosophila transcription factor"", ""start_span"": 83, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""E74 - like factor 1"", ""start_span"": 193, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Deletion mapping and hybrid promoter constructs demonstrate that the newly identified Tat - responsive element corresponds to a sequence within the viral long terminal repeat ( LTR) previously identified as the HIV - 1 enhancer, or NF - kappa B domain.	hybrid promoter constructs,21,47,Gene/Protein	Tat - responsive element,86,110,Gene/Protein	viral long terminal repeat,148,174,Gene/Protein	LTR,177,180,Gene/Protein	HIV - 1 enhancer,211,227,Gene/Protein	NF - kappa B domain,232,251,Gene/Protein	"[{""token"": ""hybrid promoter constructs"", ""start_span"": 21, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Tat - responsive element"", ""start_span"": 86, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""viral long terminal repeat"", ""start_span"": 148, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 enhancer"", ""start_span"": 211, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B domain"", ""start_span"": 232, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
The GM2 sequence ( GGTAGTTCCC) is recognized by an inducible factor NF - GM2; the other ( CCGCCC) by constitutive factors A1, A2, and B.	GM2 sequence,4,16,Gene/Protein	inducible factor NF - GM2,51,76,Gene/Protein	constitutive factors,101,121,Gene/Protein	A1,122,124,Gene/Protein	A2,126,128,Gene/Protein	B,134,135,Gene/Protein	"[{""token"": ""GM2 sequence"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""inducible factor NF - GM2"", ""start_span"": 51, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""constitutive factors"", ""start_span"": 101, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""A1"", ""start_span"": 122, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""A2"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 134, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
Here, we show that v - erbA and c - erbA bind directly to sequences within the promoter of the erythrocyte - specific carbonic anhydrase II ( CAII), a gene whose transcription is efficiently suppressed by v - erbA.	v - erbA,19,27,Gene/Protein	c - erbA,32,40,Gene/Protein	promoter,79,87,Gene/Protein	erythrocyte - specific carbonic anhydrase II,95,139,Gene/Protein	CAII,142,146,Gene/Protein	v - erbA,205,213,Gene/Protein	"[{""token"": ""v - erbA"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""c - erbA"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""erythrocyte - specific carbonic anhydrase II"", ""start_span"": 95, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CAII"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""v - erbA"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
The results also revealed a similar functional cooperation between the transcription factors which bind to the Oct and the adjacent Sp 1 - binding site in BJA - B cells, as has been observed in HeLa cells, since a template which contains a weak binding site for OTFs expresses wild - type levels of U2 snRNA in both cell types when the weak octamer - binding site is combined with a Sp 1 - binding site.	Oct,111,114,Gene/Protein	Sp 1 - binding site,132,151,Gene/Protein	OTFs,262,266,Gene/Protein	U2 snRNA,299,307,Gene/Protein	octamer - binding site,341,363,Gene/Protein	Sp 1 - binding site,383,402,Gene/Protein	"[{""token"": ""Oct"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Sp 1 - binding site"", ""start_span"": 132, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""OTFs"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""U2 snRNA"", ""start_span"": 299, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding site"", ""start_span"": 341, ""end_span"": 363, ""type"": ""Gene/Protein""}, {""token"": ""Sp 1 - binding site"", ""start_span"": 383, ""end_span"": 402, ""type"": ""Gene/Protein""}]"	train
By using the human T - cell line ( JPX - 9), in which expression of the Tax1 is inducible, we showed that expression of mRNAs for Fra - 1, c - Jun, and JunD was also transactivated by Tax1.	Tax1,72,76,Gene/Protein	mRNAs,120,125,Gene/Protein	Fra - 1,130,137,Gene/Protein	c - Jun,139,146,Gene/Protein	JunD,152,156,Gene/Protein	Tax1,184,188,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""mRNAs"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Tax1"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
These findings demonstrate that TGF - beta decreases B lymphocyte Ig secretion by inhibiting the synthesis of Ig mRNA and inhibiting the switch from the membrane form to the secreted forms of mu and gamma mRNA.	TGF - beta,32,42,Gene/Protein	Ig,66,68,Gene/Protein	Ig mRNA,110,117,Gene/Protein	membrane form,153,166,Gene/Protein	secreted forms,174,188,Gene/Protein	mu and gamma mRNA,192,209,Gene/Protein	"[{""token"": ""TGF - beta"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Ig"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Ig mRNA"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""membrane form"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""secreted forms"", ""start_span"": 174, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""mu and gamma mRNA"", ""start_span"": 192, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
These two DNA - protein complexes are composed of at least four host proteins ( p50, p55, p75, p85), each of which shares structural similarity with the v - rel oncogene product.	DNA - protein complexes,10,33,Gene/Protein	p50,80,83,Gene/Protein	p55,85,88,Gene/Protein	p75,90,93,Gene/Protein	p85,95,98,Gene/Protein	v - rel oncogene product,153,177,Gene/Protein	"[{""token"": ""DNA - protein complexes"", ""start_span"": 10, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""p75"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""p85"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""v - rel oncogene product"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
In striking contrast to the mouse Ig heavy - chain enhancer, in which the octamer motif acts as a B - cell - specific enhancer element, the human enhancer contains an octamerlike sequence with one base substitution which bound octamer - binding proteins with only very low affinity and showed no enhancer activity of its own.	mouse Ig heavy - chain enhancer,28,59,Gene/Protein	octamer motif,74,87,Gene/Protein	B - cell - specific enhancer element,98,134,Gene/Protein	human enhancer,140,154,Gene/Protein	octamerlike sequence,167,187,Gene/Protein	octamer - binding proteins,227,253,Gene/Protein	"[{""token"": ""mouse Ig heavy - chain enhancer"", ""start_span"": 28, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific enhancer element"", ""start_span"": 98, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""human enhancer"", ""start_span"": 140, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""octamerlike sequence"", ""start_span"": 167, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding proteins"", ""start_span"": 227, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
From HeLa cells, two major proteins of 52 and 45 kilodaltons ( kD) copurified with DNA binding activity, whereas from T - cells, four proteins - - a major protein of 52 kD and three minor proteins of 82, 67, and 43 - 47 kD - - were purified.	major protein,21,34,Gene/Protein	52 kD,166,171,Gene/Protein	minor proteins,182,196,Gene/Protein	82,200,202,Gene/Protein	67,204,206,Gene/Protein	43 - 47 kD,212,222,Gene/Protein	"[{""token"": ""major protein"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""52 kD"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""minor proteins"", ""start_span"": 182, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""82"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""67"", ""start_span"": 204, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""43 - 47 kD"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
One of these, designated Rhom - 2, is located on human chromosome 11 at band 11p13, where a cluster of T - cell leukemia - specific translocations occur; all translocation breakpoints at 11p13 are upstream of the Rhom - 2 gene.	Rhom - 2,25,33,Gene/Protein	human chromosome 11,49,68,Gene/Protein	band 11p13,72,82,Gene/Protein	T - cell leukemia - specific translocations,103,146,Gene/Protein	11p13,187,192,Gene/Protein	Rhom - 2 gene,213,226,Gene/Protein	"[{""token"": ""Rhom - 2"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 11"", ""start_span"": 49, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""band 11p13"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""T - cell leukemia - specific translocations"", ""start_span"": 103, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""11p13"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Rhom - 2 gene"", ""start_span"": 213, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Thus, TNF alpha - induced NF - kappa B activation was found to be mediated by none of the major signal - mediating kinases such as protein kinase C ( PKC), protein kinase A, or Ca ( 2 +) - regulated kinases.	TNF alpha,6,15,Gene/Protein	NF - kappa B,26,38,Gene/Protein	signal - mediating kinases,96,122,Gene/Protein	protein kinase C,131,147,Gene/Protein	PKC,150,153,Gene/Protein	protein kinase A,156,172,Gene/Protein	"[{""token"": ""TNF alpha"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""signal - mediating kinases"", ""start_span"": 96, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 131, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 156, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Furthermore, we found that cytoplasmic acidification facilitated NF - kappa B activation by both TNF alpha and PKC, by a mechanism that increases NF - kappa B / I kappa B dissociation without affecting the NF - kappa B translocation step.	NF - kappa B,65,77,Gene/Protein	TNF alpha,97,106,Gene/Protein	PKC,111,114,Gene/Protein	NF - kappa B,146,158,Gene/Protein	/ I kappa B,159,170,Gene/Protein	NF - kappa B,206,218,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 146, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""/ I kappa B"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
The Thy - 1 gene promoter resembles a ` ` housekeeping ' ' promoter in that it is located within a methylation - free island, lacks a canonical TATA box, and displays heterogeneity in the 5 ' - end termini of the mRNA.	Thy - 1 gene promoter,4,25,Gene/Protein	` ` housekeeping ' ' promoter,38,67,Gene/Protein	methylation - free island,99,124,Gene/Protein	canonical TATA box,134,152,Gene/Protein	5 ' - end termini,188,205,Gene/Protein	mRNA,213,217,Gene/Protein	"[{""token"": ""Thy - 1 gene promoter"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""` ` housekeeping ' ' promoter"", ""start_span"": 38, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""methylation - free island"", ""start_span"": 99, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""canonical TATA box"", ""start_span"": 134, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - end termini"", ""start_span"": 188, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
The effects of TNF - alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR) and the beta interferon promoter.	TNF - alpha,15,26,Gene/Protein	reporter chloramphenicol acetyltransferase plasmids,97,148,Gene/Protein	regulatory elements,159,178,Gene/Protein	HIV long terminal repeat,188,212,Gene/Protein	LTR,215,218,Gene/Protein	beta interferon promoter,228,252,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""reporter chloramphenicol acetyltransferase plasmids"", ""start_span"": 97, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 159, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 188, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""beta interferon promoter"", ""start_span"": 228, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
A complementary DNA encoding a DNA - binding protein ( human X box binding protein, hXBP - 1) whose target is the human DR alpha X box and the 3 ' flanking region has now been cloned.	complementary DNA,2,19,Gene/Protein	DNA - binding protein,31,52,Gene/Protein	human X box binding protein,55,82,Gene/Protein	hXBP - 1,84,92,Gene/Protein	human DR alpha X box,114,134,Gene/Protein	3 ' flanking region,143,162,Gene/Protein	"[{""token"": ""complementary DNA"", ""start_span"": 2, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding protein"", ""start_span"": 31, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""human X box binding protein"", ""start_span"": 55, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""hXBP - 1"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""human DR alpha X box"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""3 ' flanking region"", ""start_span"": 143, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
Domain B has been described as a B - cell - specific EB1 - responsive element ( P. M. Lieberman, J. M. Hardwick, and S. D. Hayward, J. Virol. 63: 3040 - 3050, 1989) activated synergistically by EB1 and R, an EBV early product encoded by the open reading frame BRLF1 ( M. A. Cox, J. Leahy, and J. M. Hardwick, J. Virol. 64: 313 - 321, 1990).	Domain B,0,8,Gene/Protein	B - cell - specific EB1 - responsive element,33,77,Gene/Protein	EB1,194,197,Gene/Protein	R,202,203,Gene/Protein	EBV early product,208,225,Gene/Protein	open reading frame BRLF1,241,265,Gene/Protein	"[{""token"": ""Domain B"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific EB1 - responsive element"", ""start_span"": 33, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""EB1"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""R"", ""start_span"": 202, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""EBV early product"", ""start_span"": 208, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""open reading frame BRLF1"", ""start_span"": 241, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
Moreover, there is no cooperation or synergy between R and EB1 when activating the B domain ( ZRE - B plus the R - responsive element) positioned as an enhancer.	R,53,54,Gene/Protein	EB1,59,62,Gene/Protein	B domain,83,91,Gene/Protein	ZRE - B,94,101,Gene/Protein	R - responsive element,111,133,Gene/Protein	enhancer,152,160,Gene/Protein	"[{""token"": ""R"", ""start_span"": 53, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""EB1"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""B domain"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""ZRE - B"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""R - responsive element"", ""start_span"": 111, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Strains with mutations in either gene of the regulatory pair ( phoP [ transcriptional activator] or phoQ [ membrane sensor kinase]) had increased sensitivities to defensin.	regulatory pair,45,60,Gene/Protein	phoP,63,67,Gene/Protein	transcriptional activator,70,95,Gene/Protein	phoQ,100,104,Gene/Protein	membrane sensor kinase,107,129,Gene/Protein	defensin,163,171,Gene/Protein	"[{""token"": ""regulatory pair"", ""start_span"": 45, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""phoP"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 70, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""phoQ"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""membrane sensor kinase"", ""start_span"": 107, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""defensin"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Defensin resistance is not the only virulence characteristic controlled by the PhoP - PhoQ regulon because mutations in pagC, as well as ones in the phoP locus that resulted in constitutive pag activation ( phenotype PhoPc), had no effect on defensin resistance, even though they rendered the organism avirulent and deficient in survival within macrophages.	PhoP - PhoQ regulon,79,98,Gene/Protein	pagC,120,124,Gene/Protein	phoP locus,149,159,Gene/Protein	pag,190,193,Gene/Protein	PhoPc,217,222,Gene/Protein	defensin,242,250,Gene/Protein	"[{""token"": ""PhoP - PhoQ regulon"", ""start_span"": 79, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""pagC"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""phoP locus"", ""start_span"": 149, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""pag"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""PhoPc"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""defensin"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Gene/Protein""}]"	train
Thus, the transcriptional activity of TCF - 1 alpha appears to depend on the TCF - 2 alpha and T alpha 1 ( CREB) transcription factors and the context of its binding site within the TCR alpha enhancer.	TCF - 1 alpha,38,51,Gene/Protein	TCF - 2 alpha,77,90,Gene/Protein	T alpha 1,95,104,Gene/Protein	CREB,107,111,Gene/Protein	transcription factors,113,134,Gene/Protein	TCR alpha enhancer,182,200,Gene/Protein	"[{""token"": ""TCF - 1 alpha"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 2 alpha"", ""start_span"": 77, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""T alpha 1"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""TCR alpha enhancer"", ""start_span"": 182, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Although anti - CD3 alone or fibronectin alone can not induce IL - 2 message by CD4 cells, the combination of anti - CD3 plus fibronectin induced IL - 2 message by CD4 cells.	anti - CD3,9,19,Gene/Protein	fibronectin,29,40,Gene/Protein	IL - 2,62,68,Gene/Protein	anti - CD3,110,120,Gene/Protein	fibronectin,126,137,Gene/Protein	IL - 2,146,152,Gene/Protein	"[{""token"": ""anti - CD3"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 110, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Using a combination of transfection, protein - DNA binding, and in vitro transcription methods, we have discovered the novel T - cell - specific transcriptional activator TCF - 1 ( for T - Cell Factor - 1), which recognizes a T - cell - specific response element ( TCE) located within the IL - 2 promoter.	novel T - cell - specific transcriptional activator,119,170,Gene/Protein	TCF - 1,171,178,Gene/Protein	T - Cell Factor - 1,185,204,Gene/Protein	T - cell - specific response element,226,262,Gene/Protein	TCE,265,268,Gene/Protein	IL - 2 promoter,289,304,Gene/Protein	"[{""token"": ""novel T - cell - specific transcriptional activator"", ""start_span"": 119, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""T - Cell Factor - 1"", ""start_span"": 185, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific response element"", ""start_span"": 226, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""TCE"", ""start_span"": 265, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 289, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	train
Using constructs in which mRNA production controlled by a specific transcription factor could be readily measured we found that both cyclosporin A and FK506 completely inhibited transcription activated by NF - AT, NFIL2 A, NFIL2 B and partially inhibited transcription activated by NF kappa B.	mRNA,26,30,Gene/Protein	transcription factor,67,87,Gene/Protein	NF - AT,205,212,Gene/Protein	NFIL2 A,214,221,Gene/Protein	NFIL2 B,223,230,Gene/Protein	NF kappa B,282,292,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 67, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""NFIL2 A"", ""start_span"": 214, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""NFIL2 B"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 282, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
( iv) No other EBV genes were required for EBNA - 2 transactivation of LMP1 since cotransfection of recombinant EBNA - 2 expression vectors and genomic LMP1 DNA fragments enhanced LMP1 expression in the EBV - negative B - lymphoma cell lines BJAB, Louckes, and BL30.	EBV genes,15,24,Gene/Protein	EBNA - 2,43,51,Gene/Protein	LMP1,71,75,Gene/Protein	recombinant EBNA - 2 expression vectors,100,139,Gene/Protein	LMP1 DNA fragments,152,170,Gene/Protein	LMP1,180,184,Gene/Protein	"[{""token"": ""EBV genes"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""EBNA - 2"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""recombinant EBNA - 2 expression vectors"", ""start_span"": 100, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""LMP1 DNA fragments"", ""start_span"": 152, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
In HIV - 1, the sequences that respond to these signaling events are found in the long terminal repeat ( LTR) and comprise the transcriptional enhancer, which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B).	long terminal repeat,82,102,Gene/Protein	LTR,105,108,Gene/Protein	transcriptional enhancer,127,151,Gene/Protein	conserved binding sites,172,195,Gene/Protein	nuclear factor kappa B,204,226,Gene/Protein	NF kappa B,229,239,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional enhancer"", ""start_span"": 127, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""conserved binding sites"", ""start_span"": 172, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 204, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Acquisition of HSF3 DNA - binding activity in HD6 cells is accompanied by oligomerization from a non - DNA - binding dimer to a DNA - binding trimer, whereas the effect of heat shock on HSF1 is oligomerization of an inert monomer to a DNA - binding trimer.	HSF3,15,19,Gene/Protein	non - DNA - binding dimer,97,122,Gene/Protein	DNA - binding trimer,128,148,Gene/Protein	HSF1,186,190,Gene/Protein	inert monomer,216,229,Gene/Protein	DNA - binding trimer,235,255,Gene/Protein	"[{""token"": ""HSF3"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""non - DNA - binding dimer"", ""start_span"": 97, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding trimer"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""HSF1"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""inert monomer"", ""start_span"": 216, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding trimer"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand - induced tyrosine phosphorylation of the Janus protein - tyrosine kinase 3 ( Jak3) and signal transducers and activators of transcription ( Stat proteins).	Staphylococcal enterotoxins,0,27,Gene/Protein	interleukin 2 receptor,37,59,Gene/Protein	Janus protein - tyrosine kinase 3,124,157,Gene/Protein	Jak3,160,164,Gene/Protein	signal transducers and activators of transcription,170,220,Gene/Protein	Stat proteins,223,236,Gene/Protein	"[{""token"": ""Staphylococcal enterotoxins"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 receptor"", ""start_span"": 37, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Janus protein - tyrosine kinase 3"", ""start_span"": 124, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 170, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 223, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
After 16 hr of exposure to SE, the expression of IL - 2R beta remained low, while that of IL2R alpha and IL2R gamma was further up - regulated, and ligand - induced tyrosine phosphorylation of Jak3 and Stat proteins was partly normalized.	SE,27,29,Gene/Protein	IL - 2R beta,49,61,Gene/Protein	IL2R alpha,90,100,Gene/Protein	IL2R gamma,105,115,Gene/Protein	Jak3,193,197,Gene/Protein	Stat proteins,202,215,Gene/Protein	"[{""token"": ""SE"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL2R alpha"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL2R gamma"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 202, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Activation of JAK3, but not JAK1, is critical for IL - 2 - induced proliferation and STAT5 recruitment by a COOH - terminal region of the IL - 2 receptor beta - chain.	JAK3,14,18,Gene/Protein	JAK1,28,32,Gene/Protein	IL - 2,50,56,Gene/Protein	STAT5,85,90,Gene/Protein	COOH - terminal region,108,130,Gene/Protein	IL - 2 receptor beta - chain,138,166,Gene/Protein	"[{""token"": ""JAK3"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal region"", ""start_span"": 108, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor beta - chain"", ""start_span"": 138, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
While homodimerizing cytokine receptors may transmit signal via a single form of JAK ( i. e. growth hormone receptors), several multicomponent cytokine receptors have been shown to require simultaneous activation of pairs of different JAK kinases ( i. e. interferon receptors).	homodimerizing cytokine receptors,6,39,Gene/Protein	JAK,81,84,Gene/Protein	growth hormone receptors,93,117,Gene/Protein	multicomponent cytokine receptors,128,161,Gene/Protein	JAK kinases,235,246,Gene/Protein	interferon receptors,255,275,Gene/Protein	"[{""token"": ""homodimerizing cytokine receptors"", ""start_span"": 6, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""growth hormone receptors"", ""start_span"": 93, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""multicomponent cytokine receptors"", ""start_span"": 128, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""interferon receptors"", ""start_span"": 255, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	train
Furthermore, when human IL - 2R beta was stably expressed in murine BA / F3 cells, robust IL - 2 - induced proliferation and JAK3 activation occurred without detectable involvement of either JAK1, JAK2 or TYK2.	human IL - 2R beta,18,36,Gene/Protein	IL - 2,90,96,Gene/Protein	JAK3,125,129,Gene/Protein	JAK1,191,195,Gene/Protein	JAK2,197,201,Gene/Protein	TYK2,205,209,Gene/Protein	"[{""token"": ""human IL - 2R beta"", ""start_span"": 18, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""TYK2"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
We therefore propose that IL - 2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL - 2 - induced heterodimerization of IL - 2R beta and IL - 2R gamma.	IL - 2 receptor,26,41,Gene/Protein	JAK1,113,117,Gene/Protein	JAK3,122,126,Gene/Protein	IL - 2,137,143,Gene/Protein	IL - 2R beta,176,188,Gene/Protein	IL - 2R gamma,193,206,Gene/Protein	"[{""token"": ""IL - 2 receptor"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 176, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 193, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Lastly, the different mobilities of osteoblast nuclear extract - DNA complexes compared with T - cell nuclear extract - DNA complexes, along with the inability of OSF2 to be upregulated by retinoic acid, unlike the other PEBP2 alpha factors, suggest that OSF2 is a new member of this family of transcription factors.	osteoblast nuclear extract - DNA complexes,36,78,Gene/Protein	T - cell nuclear extract - DNA complexes,93,133,Gene/Protein	OSF2,163,167,Gene/Protein	PEBP2 alpha factors,221,240,Gene/Protein	OSF2,255,259,Gene/Protein	transcription factors,294,315,Gene/Protein	"[{""token"": ""osteoblast nuclear extract - DNA complexes"", ""start_span"": 36, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""T - cell nuclear extract - DNA complexes"", ""start_span"": 93, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""OSF2"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha factors"", ""start_span"": 221, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""OSF2"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 294, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
Thus, this study demonstrates that AML - 1B can increase gene expression of an osteoblast - specific gene through its binding to an osteoblast - specific cis - acting element and presents evidence that OSF2 is a member of the PEBP2 alpha / AML - 1 family of transcription factors.	AML - 1B,35,43,Gene/Protein	osteoblast - specific gene,79,105,Gene/Protein	osteoblast - specific cis - acting element,132,174,Gene/Protein	OSF2,202,206,Gene/Protein	PEBP2 alpha / AML - 1 family,226,254,Gene/Protein	transcription factors,258,279,Gene/Protein	"[{""token"": ""AML - 1B"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""osteoblast - specific gene"", ""start_span"": 79, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""osteoblast - specific cis - acting element"", ""start_span"": 132, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""OSF2"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha / AML - 1 family"", ""start_span"": 226, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 258, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
The three regions concerned are: 1) a region between - 73 and - 36, which is the minimal element inducible by LPS or TNF - alpha; 2) an element located between - 181 and - 73, which appeared to regulate the response to IFN - gamma and TNF - alpha negatively; and 3) a distal element upstream of - 224, which was inducible by IFN - gamma alone.	minimal element,81,96,Gene/Protein	TNF - alpha,117,128,Gene/Protein	IFN - gamma,219,230,Gene/Protein	TNF - alpha,235,246,Gene/Protein	distal element upstream,268,291,Gene/Protein	IFN - gamma,325,336,Gene/Protein	"[{""token"": ""minimal element"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""distal element upstream"", ""start_span"": 268, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 325, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	train
Males with X - linked severe combined immunodeficiency ( XSCID) have defects in the common cytokine receptor gamma chain ( gamma c) gene that encodes a shared, essential component of the receptors of interleukin - 2 ( IL - 2), IL - 4, IL - 7, IL - 9, and IL - 15.	interleukin - 2,200,215,Gene/Protein	IL - 2,218,224,Gene/Protein	IL - 4,227,233,Gene/Protein	IL - 7,235,241,Gene/Protein	IL - 9,243,249,Gene/Protein	IL - 15,255,262,Gene/Protein	"[{""token"": ""interleukin - 2"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 218, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 255, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The only exception is represented by the P3HR1 cells, in which, however, the infection by the variant B does not determine induction of EBV antigens; ( 2) the presence of the EBV genome contributes to the susceptibility of the B cell lines to HHV - 6 infection, increasing the binding sites and the percentage of infectable cells, as detected by immunoelectron microscopy; and ( 3) HHV - 6 infected T cells, transfected with plasmids bearing the promoter regions of the EBV early genes BZLF1 and BMRF1, show a strong transactivation of these promoters.	EBV antigens,136,148,Gene/Protein	EBV genome,175,185,Gene/Protein	plasmids,425,433,Gene/Protein	promoter regions,446,462,Gene/Protein	BMRF1,496,501,Gene/Protein	promoters,542,551,Gene/Protein	"[{""token"": ""EBV antigens"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""EBV genome"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""plasmids"", ""start_span"": 425, ""end_span"": 433, ""type"": ""Gene/Protein""}, {""token"": ""promoter regions"", ""start_span"": 446, ""end_span"": 462, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 496, ""end_span"": 501, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 542, ""end_span"": 551, ""type"": ""Gene/Protein""}]"	train
To identify transcription factors binding to PRE - I, we screened a cDNA expression library from Jurkat T cells and isolated a cDNA encoding nuclear factor ( NF) - IL6 ( also known as C / EBP beta).	transcription factors,12,33,Gene/Protein	PRE - I,45,52,Gene/Protein	cDNA expression library,68,91,Gene/Protein	cDNA,127,131,Gene/Protein	nuclear factor,141,155,Gene/Protein	C / EBP beta,184,196,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 12, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""PRE - I"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""cDNA expression library"", ""start_span"": 68, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""cDNA"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP beta"", ""start_span"": 184, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Complex 2 corresponds to binding of transcription factor ( upstream stimulatory factor) to an E - box motif in the 5 ' portion of the NIP region.	Complex 2,0,9,Gene/Protein	transcription factor,36,56,Gene/Protein	upstream stimulatory factor,59,86,Gene/Protein	E - box motif,94,107,Gene/Protein	5 ' portion,115,126,Gene/Protein	NIP region,134,144,Gene/Protein	"[{""token"": ""Complex 2"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 36, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""upstream stimulatory factor"", ""start_span"": 59, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""E - box motif"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""5 ' portion"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""NIP region"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
CsA also suppressed E - selectin, but not vascular cell adhesion molecule - 1 ( VCAM - 1) expression in endothelial cells, even though the E - selectin promoter is activated by NF - kappa B rather than NFAT.	E - selectin,20,32,Gene/Protein	vascular cell adhesion molecule - 1,42,77,Gene/Protein	VCAM - 1,80,88,Gene/Protein	E - selectin promoter,139,160,Gene/Protein	NF - kappa B,177,189,Gene/Protein	NFAT,202,206,Gene/Protein	"[{""token"": ""E - selectin"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 42, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin promoter"", ""start_span"": 139, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
The changes in gene expression brought about by gamma interferon are thought to involve transient increases in the activities of cellular protein tyrosine kinases, including the Janus kinases Jak1 and Jak2, leading to tyrosine phosphorylation of the transcription factor Stat1.	gamma interferon,48,64,Gene/Protein	cellular protein tyrosine kinases,129,162,Gene/Protein	Janus kinases,178,191,Gene/Protein	Jak1,192,196,Gene/Protein	Jak2,201,205,Gene/Protein	transcription factor Stat1,250,276,Gene/Protein	"[{""token"": ""gamma interferon"", ""start_span"": 48, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""cellular protein tyrosine kinases"", ""start_span"": 129, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor Stat1"", ""start_span"": 250, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
We delineated an element conferring both DNA binding by the receptor in vitro and 1, 25 ( OH) 2D3 - mediated repression in vivo to a short 40 - bp region encompassing an important positive regulatory element, NF - AT - 1, which is bound by a T - cell - specific transcription factor, NFATp, as well as by AP - 1.	40 - bp region,139,153,Gene/Protein	positive regulatory element,180,207,Gene/Protein	NF - AT - 1,209,220,Gene/Protein	T - cell - specific transcription factor,242,282,Gene/Protein	NFATp,284,289,Gene/Protein	AP - 1,305,311,Gene/Protein	"[{""token"": ""40 - bp region"", ""start_span"": 139, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""positive regulatory element"", ""start_span"": 180, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - 1"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific transcription factor"", ""start_span"": 242, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 284, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 305, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
Dephosphorylation by in vitro treatment with calcineurin or alkaline phosphatase restores NFATp DNA binding activity and its ability to reconstitute an NFAT complex with Fos and Jun proteins.	calcineurin,45,56,Gene/Protein	alkaline phosphatase,60,80,Gene/Protein	NFATp,90,95,Gene/Protein	NFAT complex,152,164,Gene/Protein	Fos,170,173,Gene/Protein	Jun,178,181,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""alkaline phosphatase"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NFAT complex"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR - 1.	regulatory element,2,20,Gene/Protein	human interleukin 2 gene promoter,28,61,Gene/Protein	binding site,67,79,Gene/Protein	zinc finger proteins,88,108,Gene/Protein	Sp1,109,112,Gene/Protein	EGR - 1,117,124,Gene/Protein	"[{""token"": ""regulatory element"", ""start_span"": 2, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""human interleukin 2 gene promoter"", ""start_span"": 28, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger proteins"", ""start_span"": 88, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
ER - mediated repression of GATA - 1 activity occurs on an artificial promoter containing a single GATA - binding site, as well as in the context of an intact promoter which is normally regulated by GATA - 1.	ER,0,2,Gene/Protein	GATA - 1,28,36,Gene/Protein	artificial promoter,59,78,Gene/Protein	GATA - binding site,99,118,Gene/Protein	intact promoter,152,167,Gene/Protein	GATA - 1,199,207,Gene/Protein	"[{""token"": ""ER"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""artificial promoter"", ""start_span"": 59, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding site"", ""start_span"": 99, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""intact promoter"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	valid
In addition, IL - 2 but not IL - 12 induced nuclear factors NF - kappa B and AP1, and regulation of the nuclear levels of these two DNA binding protein complexes is correlated with IFN - gamma and GM - CSF gene expression.	IL - 2,13,19,Gene/Protein	IL - 12,28,35,Gene/Protein	nuclear factors,44,59,Gene/Protein	NF - kappa B,60,72,Gene/Protein	AP1,77,80,Gene/Protein	DNA binding protein complexes,132,161,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 44, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding protein complexes"", ""start_span"": 132, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	valid
We examined alpha A1 ( an alpha A - gene product) and alpha B1 and alpha B2 ( two alpha B - encoded isomers) for their effects on the GM - CSF promoter.	alpha A1,12,20,Gene/Protein	alpha A - gene product,26,48,Gene/Protein	alpha B1,54,62,Gene/Protein	alpha B2,67,75,Gene/Protein	alpha B - encoded isomers,82,107,Gene/Protein	GM - CSF promoter,134,151,Gene/Protein	"[{""token"": ""alpha A1"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""alpha A - gene product"", ""start_span"": 26, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""alpha B1"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""alpha B2"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""alpha B - encoded isomers"", ""start_span"": 82, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	valid
The Fc gamma RIC GIRE is homologous to the IFN - gamma activation sequence ( GAS) of the guanylate binding protein and to X box elements of class II MHC genes.	Fc gamma RIC GIRE,4,21,Gene/Protein	IFN - gamma activation sequence,43,74,Gene/Protein	GAS,77,80,Gene/Protein	guanylate binding protein,89,114,Gene/Protein	X box elements,122,136,Gene/Protein	class II MHC genes,140,158,Gene/Protein	"[{""token"": ""Fc gamma RIC GIRE"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma activation sequence"", ""start_span"": 43, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""GAS"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""guanylate binding protein"", ""start_span"": 89, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""X box elements"", ""start_span"": 122, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""class II MHC genes"", ""start_span"": 140, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	valid
We have recently demonstrated that stimulation of human T and natural killer cells with IL - 12 induces tyrosine phosphorylation of the Janus family tyrosine kinase JAK2 and Tyk2, implicating these kinases in the immediate biochemical response to IL - 12.	IL - 12,88,95,Gene/Protein	Janus family tyrosine kinase,136,164,Gene/Protein	JAK2,165,169,Gene/Protein	Tyk2,174,178,Gene/Protein	kinases,198,205,Gene/Protein	IL - 12,247,254,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Janus family tyrosine kinase"", ""start_span"": 136, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 247, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	valid
Finally, we show by both footprint analysis and functional assays that the ability of the G + C - rich region to increase alpha - globin promoter activity from a stably integrated alpha - globin gene is mediated by its multiple binding sites for the transcription factor Sp1.	G + C - rich region,90,109,Gene/Protein	alpha - globin promoter,122,145,Gene/Protein	alpha - globin gene,180,199,Gene/Protein	multiple binding sites,219,241,Gene/Protein	transcription factor,250,270,Gene/Protein	Sp1,271,274,Gene/Protein	"[{""token"": ""G + C - rich region"", ""start_span"": 90, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin promoter"", ""start_span"": 122, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin gene"", ""start_span"": 180, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""multiple binding sites"", ""start_span"": 219, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 250, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 271, ""end_span"": 274, ""type"": ""Gene/Protein""}]"	valid
LFA - 3 induced moderate levels of AP - 1, but did not influence the levels of NF - kappa B, while B7 costimulation strongly induced both AP - 1 and substantially enhanced NF - kappa B binding proteins.	LFA - 3,0,7,Gene/Protein	AP - 1,35,41,Gene/Protein	NF - kappa B,79,91,Gene/Protein	B7,99,101,Gene/Protein	AP - 1,138,144,Gene/Protein	NF - kappa B binding proteins,172,201,Gene/Protein	"[{""token"": ""LFA - 3"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""B7"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding proteins"", ""start_span"": 172, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	valid
In this report, we show that in monocytes and T cells IL - 10 stimulates tyrosine phosphorylation of the signal transducers and activators of transcription, STAT1 alpha and STAT3, in a differential manner such that the relative formation of homo - and heterodimers varies between the two cell types.	IL - 10,54,61,Gene/Protein	signal transducers,105,123,Gene/Protein	activators of transcription,128,155,Gene/Protein	STAT1 alpha,157,168,Gene/Protein	STAT3,173,178,Gene/Protein	homo - and heterodimers,241,264,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""activators of transcription"", ""start_span"": 128, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""homo - and heterodimers"", ""start_span"": 241, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	valid
Because these are the characteristics of a signal transducer and activator of transcription ( Stat) protein, we determined whether antibodies to Stat proteins will interfere with gel mobility shift and found that antibodies to IL - 4 Stat, also known as Stat6, but not antibodies to other Stat proteins, interfere with the formation of the IL - 4 NAF complex.	antibodies to Stat proteins,131,158,Gene/Protein	antibodies to IL - 4 Stat,213,238,Gene/Protein	Stat6,254,259,Gene/Protein	antibodies,269,279,Gene/Protein	Stat proteins,289,302,Gene/Protein	IL - 4 NAF complex,340,358,Gene/Protein	"[{""token"": ""antibodies to Stat proteins"", ""start_span"": 131, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""antibodies to IL - 4 Stat"", ""start_span"": 213, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 269, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 289, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 NAF complex"", ""start_span"": 340, ""end_span"": 358, ""type"": ""Gene/Protein""}]"	valid
Data is presented, using the potent and selective PKC inhibitor Ro 31 - 8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras in the induction of NF - AT and AP - 1 transcriptional activity and in the expression of IL - 2 in human Jurkat T cells.	PKC,50,53,Gene/Protein	PKC,166,169,Gene/Protein	p21ras,191,197,Gene/Protein	NF - AT,218,225,Gene/Protein	AP - 1,230,236,Gene/Protein	IL - 2,287,293,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 230, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	valid
Human T - cell leukemia virus type I Tax activation of NF - kappa B / Rel involves phosphorylation and degradation of I kappa B alpha and RelA ( p65) - mediated induction of the c - rel gene.	Tax,37,40,Gene/Protein	NF - kappa B / Rel,55,73,Gene/Protein	I kappa B alpha,118,133,Gene/Protein	RelA,138,142,Gene/Protein	p65,145,148,Gene/Protein	c - rel gene,178,190,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 118, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""c - rel gene"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	valid
Erythropoietin ( Epo), granulocyte / macrophage colony stimulating factor ( GM - CSF), and interleukin 3 ( IL - 3) promoted the growth of NS - Meg cells.	Erythropoietin,0,14,Gene/Protein	Epo,17,20,Gene/Protein	granulocyte / macrophage colony stimulating factor,23,73,Gene/Protein	GM - CSF,76,84,Gene/Protein	interleukin 3,91,104,Gene/Protein	IL - 3,107,113,Gene/Protein	"[{""token"": ""Erythropoietin"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte / macrophage colony stimulating factor"", ""start_span"": 23, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 3"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	valid
We have used mutants of these kinases and phosphatases ( gamma B * CaM - K and delta CaM - AI, respectively) to explore their relative role in cytokine gene transcription and their interactions with PKC - dependent signaling systems.	kinases,30,37,Gene/Protein	phosphatases,42,54,Gene/Protein	gamma B * CaM - K,57,74,Gene/Protein	delta CaM - AI,79,93,Gene/Protein	cytokine gene,143,156,Gene/Protein	PKC,199,202,Gene/Protein	"[{""token"": ""kinases"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""phosphatases"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""gamma B * CaM - K"", ""start_span"": 57, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""delta CaM - AI"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""cytokine gene"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	valid
Elf - 1 physically associated with HMG - I and with NF - kappa B p50 and c - Rel in vitro, suggesting that protein - protein interactions might functionally coordinate the actions of the upstream and downstream positive regulatory elements.	Elf - 1,0,7,Gene/Protein	HMG - I,35,42,Gene/Protein	NF - kappa B,52,64,Gene/Protein	p50,65,68,Gene/Protein	c - Rel,73,80,Gene/Protein	upstream and downstream positive regulatory elements,187,239,Gene/Protein	"[{""token"": ""Elf - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""HMG - I"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""upstream and downstream positive regulatory elements"", ""start_span"": 187, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	valid
The increase in IL - 2 gene expression triggered by CD28 involves a kappa B - like sequence in the 5 ' - regulatory region of the IL - 2 promoter, called CD28 - responsive element.	IL - 2,16,22,Gene/Protein	CD28,52,56,Gene/Protein	kappa B - like sequence,68,91,Gene/Protein	5 ' - regulatory region,99,122,Gene/Protein	IL - 2 promoter,130,145,Gene/Protein	CD28 - responsive element,154,179,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - like sequence"", ""start_span"": 68, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - regulatory region"", ""start_span"": 99, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 130, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive element"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	valid
Antiandrogens result in protection of both the hinge region and C - terminus of the androgen receptor agonist proteolytic attack, whereas other studies showed that antiestrogens and antiprogestagens expose the C - terminal end of the ligand binding domain of their respective receptors to protease.	hinge region,47,59,Gene/Protein	C - terminus,64,76,Gene/Protein	androgen receptor,84,101,Gene/Protein	C - terminal end,210,226,Gene/Protein	ligand binding domain,234,255,Gene/Protein	protease,289,297,Gene/Protein	"[{""token"": ""hinge region"", ""start_span"": 47, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""androgen receptor"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal end"", ""start_span"": 210, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""ligand binding domain"", ""start_span"": 234, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""protease"", ""start_span"": 289, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	valid
Full activation of the MAP kinases that phosphorylate the Jun activation domain, JNK1 and JNK2, required costimulation of T cells with either TPA and Ca2 + ionophore or antibodies to TCR and CD28.	MAP kinases,23,34,Gene/Protein	Jun activation domain,58,79,Gene/Protein	JNK1,81,85,Gene/Protein	JNK2,90,94,Gene/Protein	TCR,183,186,Gene/Protein	CD28,191,195,Gene/Protein	"[{""token"": ""MAP kinases"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Jun activation domain"", ""start_span"": 58, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""JNK1"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""JNK2"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	valid
Again, in vitro supershift studies indicate that the presence of p50, p52, p65, and cRel correlates with positive function whereas the presence of only p50 and p52 correlates with negative function.	p50,65,68,Gene/Protein	p52,70,73,Gene/Protein	p65,75,78,Gene/Protein	cRel,84,88,Gene/Protein	p50,152,155,Gene/Protein	p52,160,163,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""cRel"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	valid
By employing a derivative E box that binds ZEB but not E2A, we have shown that the repressor is active in B cells and the IgH enhancer is silenced in the absence of binding competition by bHLH proteins.	E box,26,31,Gene/Protein	ZEB,43,46,Gene/Protein	E2A,55,58,Gene/Protein	repressor,83,92,Gene/Protein	IgH enhancer,122,134,Gene/Protein	bHLH proteins,188,201,Gene/Protein	"[{""token"": ""E box"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ZEB"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""repressor"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""bHLH proteins"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	valid
The magnitude and time kinetics of the LIF effects were similar to interleukin 1 ( IL - 1), IL - 6, and tumor necrosis factor ( TNF), other cytokines known to induce HIV replication in this cell line.	LIF,39,42,Gene/Protein	interleukin 1,67,80,Gene/Protein	IL - 1,83,89,Gene/Protein	IL - 6,92,98,Gene/Protein	tumor necrosis factor,104,125,Gene/Protein	TNF,128,131,Gene/Protein	"[{""token"": ""LIF"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 1"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 104, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	valid
We therefore reexamined this issue by using two different experimental approaches that allowed LMP1 - induced effects to be monitored immediately following expression of the viral protein and in the absence of selective pressures; activation of the NF - kappa B transcription factor and upregulation of the cell adhesion molecule ICAM - 1 were used as early indices of LMP1 function.	LMP1,95,99,Gene/Protein	NF - kappa B,249,261,Gene/Protein	transcription factor,262,282,Gene/Protein	cell adhesion molecule,307,329,Gene/Protein	ICAM - 1,330,338,Gene/Protein	LMP1,369,373,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 249, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 262, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""cell adhesion molecule"", ""start_span"": 307, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 330, ""end_span"": 338, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 369, ""end_span"": 373, ""type"": ""Gene/Protein""}]"	valid
We have observed that the R24 mAb stimulates GD3 + T cell proliferation, cytotoxicity, and surface marker expression of IL - 2R alpha - chain, IL - 2R beta - chain, HLA - DR, CD11a, and CD11c.	R24 mAb,26,33,Gene/Protein	IL - 2R alpha - chain,120,141,Gene/Protein	IL - 2R beta - chain,143,163,Gene/Protein	HLA - DR,165,173,Gene/Protein	CD11a,175,180,Gene/Protein	CD11c,186,191,Gene/Protein	"[{""token"": ""R24 mAb"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha - chain"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta - chain"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DR"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""CD11a"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""CD11c"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	valid
Furthermore, the physical interaction of Tax with p100 leads to the inhibition of Tax - induced activation of the HTLV - I and human immunodeficiency virus type 1 long terminal repeats, reflecting p100 - mediated cytoplasmic sequestration of the normally nuclearly expressed Tax protein.	Tax,41,44,Gene/Protein	p100,50,54,Gene/Protein	Tax,82,85,Gene/Protein	human immunodeficiency virus type 1 long terminal repeats,127,184,Gene/Protein	p100,197,201,Gene/Protein	Tax protein,275,286,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""human immunodeficiency virus type 1 long terminal repeats"", ""start_span"": 127, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""Tax protein"", ""start_span"": 275, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	valid
The Epstein - Barr virus ( EBV) transforming protein LMP1 appears to be a constitutively activated tumor necrosis factor receptor ( TNFR) on the basis of an intrinsic ability to aggregate in the plasma membrane and an association of its cytoplasmic carboxyl terminus ( CT) with TNFR - associated factors ( TRAFs).	constitutively activated tumor necrosis factor receptor,74,129,Gene/Protein	TNFR,132,136,Gene/Protein	cytoplasmic carboxyl terminus,237,266,Gene/Protein	CT,269,271,Gene/Protein	TNFR - associated factors,278,303,Gene/Protein	TRAFs,306,311,Gene/Protein	"[{""token"": ""constitutively activated tumor necrosis factor receptor"", ""start_span"": 74, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNFR"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic carboxyl terminus"", ""start_span"": 237, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""CT"", ""start_span"": 269, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""TNFR - associated factors"", ""start_span"": 278, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""TRAFs"", ""start_span"": 306, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	valid
The IRF - 2 promoter region contains a CpG island, with several GC boxes, a putative NF - kappa B - binding site, and a CAAT box, but no TATA box.	IRF - 2,4,11,Gene/Protein	promoter region,12,27,Gene/Protein	GC boxes,64,72,Gene/Protein	NF - kappa B - binding site,85,112,Gene/Protein	CAAT box,120,128,Gene/Protein	TATA box,137,145,Gene/Protein	"[{""token"": ""IRF - 2"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 12, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""GC boxes"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - binding site"", ""start_span"": 85, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""CAAT box"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	valid
When the promoter region was linked with a heterologous reporter gene, we found that the promoter region is inducible by both interferons ( interferon - alpha and - gamma) and interferon regulatory factor 1.	promoter region,9,24,Gene/Protein	heterologous reporter gene,43,69,Gene/Protein	promoter region,89,104,Gene/Protein	interferons,126,137,Gene/Protein	interferon - alpha and - gamma,140,170,Gene/Protein	interferon regulatory factor 1,176,206,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""heterologous reporter gene"", ""start_span"": 43, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 89, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""interferons"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""interferon - alpha and - gamma"", ""start_span"": 140, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""interferon regulatory factor 1"", ""start_span"": 176, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	valid
Whereas AP - 1, NF - kappa B, Oct, CREB and SP1 displayed normal binding activities in nuclear extracts, the binding of NF - AT to its IL - 2 promoter response element was barely detectable both before and after T cell stimulation.	AP - 1,8,14,Gene/Protein	Oct,30,33,Gene/Protein	CREB,35,39,Gene/Protein	SP1,44,47,Gene/Protein	NF - AT,120,127,Gene/Protein	IL - 2,135,141,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""Oct"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""SP1"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	valid
Expression of interleukin 1beta and other cytokines, such as interleukin 6 and tumor necrosis factor alpha, has been shown to be dependent on the activation of the transcription factor, NFkappaB.	interleukin 1beta,14,31,Gene/Protein	cytokines,42,51,Gene/Protein	interleukin 6,61,74,Gene/Protein	tumor necrosis factor alpha,79,106,Gene/Protein	transcription factor,164,184,Gene/Protein	NFkappaB,186,194,Gene/Protein	"[{""token"": ""interleukin 1beta"", ""start_span"": 14, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 6"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 79, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 164, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	valid
Although CD40 ligand ( CD40L) triggers a shift from dephosphorylated to phosphorylated pRB and proliferation of B cells, the addition of exogenous IL - 6 to CD40L - treated B cells does not alter either pRB or proliferation, as observed in MM cells.	CD40 ligand,9,20,Gene/Protein	CD40L,23,28,Gene/Protein	pRB,87,90,Gene/Protein	IL - 6,147,153,Gene/Protein	CD40L,157,162,Gene/Protein	pRB,203,206,Gene/Protein	"[{""token"": ""CD40 ligand"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""pRB"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""pRB"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	valid
In spite of this similar downstream signalling, IL4 and IL13 used a different set of Janus kinases: IL13 is unable to activate JAK1 and JAK3.	IL4,48,51,Gene/Protein	IL13,56,60,Gene/Protein	Janus kinases,85,98,Gene/Protein	IL13,100,104,Gene/Protein	JAK1,127,131,Gene/Protein	JAK3,136,140,Gene/Protein	"[{""token"": ""IL4"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL13"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL13"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	valid
Consistent with these results, quantitative DNase footprinting of the TNF - alpha promoter using increasing amounts of recombinant NFATp demonstrated that the - 76 site binds to NFATp with a higher affinity than the kappa 3 site.	DNase,44,49,Gene/Protein	TNF - alpha promoter,70,90,Gene/Protein	NFATp,131,136,Gene/Protein	- 76 site,159,168,Gene/Protein	NFATp,178,183,Gene/Protein	kappa 3 site,216,228,Gene/Protein	"[{""token"": ""DNase"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha promoter"", ""start_span"": 70, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""- 76 site"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""kappa 3 site"", ""start_span"": 216, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	valid
Nuclear factor of activated T cells - family proteins ( NFAT1 / NFATp, NFATc, NFAT3, and NFAT4 / NFATx / NFATc3) play a key role in the transcription of cytokine genes and other genes during the immune response.	Nuclear factor of activated T cells - family proteins,0,53,Gene/Protein	NFAT1 / NFATp,56,69,Gene/Protein	NFATc,71,76,Gene/Protein	NFAT3,78,83,Gene/Protein	NFAT4 / NFATx / NFATc3,89,111,Gene/Protein	cytokine genes,153,167,Gene/Protein	"[{""token"": ""Nuclear factor of activated T cells - family proteins"", ""start_span"": 0, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1 / NFATp"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NFATc"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""NFAT3"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NFAT4 / NFATx / NFATc3"", ""start_span"": 89, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 153, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	valid
There are four putative NF - kappa B binding sites ( kappa B - 1, kappa B - 2, kappa B - 3, kappa B - 4) in human TNF - alpha promoter.	NF - kappa B binding sites,24,50,Gene/Protein	kappa B - 1,53,64,Gene/Protein	kappa B - 2,66,77,Gene/Protein	kappa B - 3,79,90,Gene/Protein	kappa B - 4,92,103,Gene/Protein	human TNF - alpha promoter,108,134,Gene/Protein	"[{""token"": ""NF - kappa B binding sites"", ""start_span"": 24, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 1"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 2"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 3"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 4"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""human TNF - alpha promoter"", ""start_span"": 108, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	valid
Expression of the MAP kinase - specific phosphatase, MKP - 1, which blocks ERK activation, inhibited IL - 2 promoter and NF - AT - driven transcription stimulated by a calcium ionophore and PMA, and in addition, MKP - 1 neutralized the transcriptional enhancement caused by active Raf - 1 and MEK1 expression.	MAP kinase - specific phosphatase,18,51,Gene/Protein	MKP - 1,53,60,Gene/Protein	ERK,75,78,Gene/Protein	IL - 2 promoter,101,116,Gene/Protein	NF - AT,121,128,Gene/Protein	MKP - 1,212,219,Gene/Protein	"[{""token"": ""MAP kinase - specific phosphatase"", ""start_span"": 18, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""MKP - 1"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""MKP - 1"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	valid
Using these T cells as a model of IL - 12 signal transduction, we confirmed that these events involve members of the Janus kinase family of nonreceptor tyrosine kinases JAK2, TYK2, and signal transducer and activator of transcription 4.	IL - 12,34,41,Gene/Protein	Janus kinase family,117,136,Gene/Protein	nonreceptor tyrosine kinases,140,168,Gene/Protein	JAK2,169,173,Gene/Protein	TYK2,175,179,Gene/Protein	signal transducer and activator of transcription 4,185,235,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase family"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""nonreceptor tyrosine kinases"", ""start_span"": 140, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""TYK2"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription 4"", ""start_span"": 185, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	valid
We conclude that the effects of IFN - gamma on the expression of the transcription factors AP - 1 and NF - kappa B may be important for the modulatory effects of IFN - gamma on the cytokine expression in activated human monocytes.	IFN - gamma,32,43,Gene/Protein	transcription factors,69,90,Gene/Protein	AP - 1,91,97,Gene/Protein	NF - kappa B,102,114,Gene/Protein	IFN - gamma,162,173,Gene/Protein	cytokine,181,189,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 69, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	valid
As judged by supershifting the DNA - protein complexes with Abs recognizing specific components of the NF - kappa B / Rel protein family, the p50 / p65 ( Rel A) heterodimeric form of NF - kappa B is primarily affected.	DNA - protein complexes,31,54,Gene/Protein	Abs,60,63,Gene/Protein	NF - kappa B / Rel protein family,103,136,Gene/Protein	p50 / p65,142,151,Gene/Protein	Rel A,154,159,Gene/Protein	NF - kappa B,183,195,Gene/Protein	"[{""token"": ""DNA - protein complexes"", ""start_span"": 31, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Abs"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel protein family"", ""start_span"": 103, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Rel A"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 183, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	valid
Antibodies against CRE - binding ( CREB) protein but not against c - Fos or c - Jun were able to supershift the DNA - protein complex, identifying the nature of the transcription factor which binds to ZII as a member of the CREB family of proteins.	c - Fos,65,72,Gene/Protein	c - Jun,76,83,Gene/Protein	DNA - protein complex,112,133,Gene/Protein	transcription factor,165,185,Gene/Protein	ZII,201,204,Gene/Protein	CREB family of proteins,224,247,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complex"", ""start_span"": 112, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 165, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""ZII"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""CREB family of proteins"", ""start_span"": 224, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	valid
This raises the intriguing possibility that physical association of the HsN3 proteasome subunit with HTLV - I Tax coupled with the independent interaction of Tax with either p100 or p65 - I kappa B alpha targets these cytoplasmic NF - kappa B / Rel complexes to the proteasome for processing.	HsN3 proteasome subunit,72,95,Gene/Protein	HTLV - I Tax,101,113,Gene/Protein	Tax,158,161,Gene/Protein	I kappa B alpha,188,203,Gene/Protein	cytoplasmic NF - kappa B / Rel complexes,218,258,Gene/Protein	proteasome,266,276,Gene/Protein	"[{""token"": ""HsN3 proteasome subunit"", ""start_span"": 72, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I Tax"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic NF - kappa B / Rel complexes"", ""start_span"": 218, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""proteasome"", ""start_span"": 266, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	valid
We provide evidence that Zta up - regulation of p53 leads to p53 - mediated interference with JAK / STAT activation of Qp.	Zta,25,28,Gene/Protein	p53,48,51,Gene/Protein	p53,61,64,Gene/Protein	JAK,94,97,Gene/Protein	/ STAT,98,104,Gene/Protein	Qp,119,121,Gene/Protein	"[{""token"": ""Zta"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Qp"", ""start_span"": 119, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	valid
We find that recruitment of EKLF to 5 ' HS2 requires the TATA box, but recruitment to 5 ' HS3 depends on the CACCC and TATA boxes of the beta - globin promoter.	EKLF,28,32,Gene/Protein	5 ' HS2,36,43,Gene/Protein	TATA box,57,65,Gene/Protein	5 ' HS3,86,93,Gene/Protein	TATA boxes,119,129,Gene/Protein	beta - globin promoter,137,159,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS2"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS3"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""TATA boxes"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin promoter"", ""start_span"": 137, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	valid
We conclude that glucocorticoids differentially modulate TNFalpha and IL - 10 secretion by human monocytes in a LPS dose - dependent fashion and that the sensitivity of these cells to glucocorticoids is altered by TNFalpha or IL - 10 pretreatment; TNFalpha blocks their effects, whereas IL - 10 acts synergistically with glucocorticoids.	TNFalpha,57,65,Gene/Protein	IL - 10,70,77,Gene/Protein	TNFalpha,214,222,Gene/Protein	IL - 10,226,233,Gene/Protein	TNFalpha,248,256,Gene/Protein	IL - 10,287,294,Gene/Protein	"[{""token"": ""TNFalpha"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 248, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 287, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	valid
Further, CTLA - 4 engagement inhibited progression through the cell cycle by inhibiting the production of cyclin D3, cyclin - dependent kinase ( cdk) 4, and cdk6 when the T cells were stimulated with anti - CD3 / CD28 and with anti - CD3 alone.	CTLA - 4,9,17,Gene/Protein	cyclin D3,106,115,Gene/Protein	cyclin - dependent kinase,117,142,Gene/Protein	cdk6,157,161,Gene/Protein	anti - CD3 / CD28,200,217,Gene/Protein	anti - CD3,227,237,Gene/Protein	"[{""token"": ""CTLA - 4"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D3"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinase"", ""start_span"": 117, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cdk6"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 / CD28"", ""start_span"": 200, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 227, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	valid
In T lymphocytes, the hematopoietic cytokine interleukin - 2 ( IL - 2) uses phosphatidylinositol 3 - kinase ( PI 3 - kinase) - induced signaling pathways to regulate E2F transcriptional activity, a critical cell cycle checkpoint.	hematopoietic cytokine,22,44,Gene/Protein	interleukin - 2,45,60,Gene/Protein	IL - 2,63,69,Gene/Protein	phosphatidylinositol 3 - kinase,76,107,Gene/Protein	PI 3 - kinase,110,123,Gene/Protein	E2F,166,169,Gene/Protein	"[{""token"": ""hematopoietic cytokine"", ""start_span"": 22, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 45, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 76, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	valid
A PMA responsive element was localized to a region between - 319 and - 219 bp upstream of the initiation codon and co - transfections with transcription factor expression plasmids for AP - 2 and Sp1 resulted in augmented ASM promoter activity, which was abolished when the binding sites for these two factors were deleted.	PMA responsive element,2,24,Gene/Protein	- 319 and - 219 bp upstream,59,86,Gene/Protein	transcription factor expression plasmids,139,179,Gene/Protein	AP - 2,184,190,Gene/Protein	Sp1,195,198,Gene/Protein	binding sites,273,286,Gene/Protein	"[{""token"": ""PMA responsive element"", ""start_span"": 2, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""- 319 and - 219 bp upstream"", ""start_span"": 59, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor expression plasmids"", ""start_span"": 139, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 273, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	valid
Although MKK3, MKK4, and MKK6 all activated p38 MAPk in experimental models, only MKK3 was found to activate recombinant p38 MAPk in LPS - treated neutrophils.	MKK3,9,13,Gene/Protein	MKK4,15,19,Gene/Protein	MKK6,25,29,Gene/Protein	p38 MAPk,44,52,Gene/Protein	MKK3,82,86,Gene/Protein	p38 MAPk,121,129,Gene/Protein	"[{""token"": ""MKK3"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""MKK4"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""MKK6"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""MKK3"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	valid
The I gamma 3 ECS lies upstream of the major I gamma 3 transcription initiation site and displays more than 90% identity with the corresponding human I gamma 1, I gamma 2, and I gamma 4 regions.	I gamma 3,4,13,Gene/Protein	ECS,14,17,Gene/Protein	major I gamma 3 transcription initiation site,39,84,Gene/Protein	human I gamma 1,144,159,Gene/Protein	I gamma 2,161,170,Gene/Protein	I gamma 4,176,185,Gene/Protein	"[{""token"": ""I gamma 3"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""ECS"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""major I gamma 3 transcription initiation site"", ""start_span"": 39, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""human I gamma 1"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""I gamma 2"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""I gamma 4"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	valid
Electrophoretic mobility shift assays showed that p50 / p65 / c - Rel and STAT - 6 are effectively induced by CD40L and IL - 4, respectively, and bind to specific DNA motifs within the ECS.	p50 / p65 / c - Rel,50,69,Gene/Protein	STAT - 6,74,82,Gene/Protein	CD40L,110,115,Gene/Protein	IL - 4,120,126,Gene/Protein	DNA motifs,163,173,Gene/Protein	ECS,185,188,Gene/Protein	"[{""token"": ""p50 / p65 / c - Rel"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 6"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""DNA motifs"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""ECS"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	valid
SH2 domain - containing protein 76 ( SLP - 76) interacts with the guanine nucleotide exchange factor Vav to activate the nuclear factor of activated cells ( NF - AT), and its expression is required for normal T cell development.	SH2 domain - containing protein 76,0,34,Gene/Protein	SLP - 76,37,45,Gene/Protein	guanine nucleotide exchange factor,66,100,Gene/Protein	Vav,101,104,Gene/Protein	nuclear factor of activated cells,121,154,Gene/Protein	NF - AT,157,164,Gene/Protein	"[{""token"": ""SH2 domain - containing protein 76"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""guanine nucleotide exchange factor"", ""start_span"": 66, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated cells"", ""start_span"": 121, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	valid
Several intracellular signaling proteins, such as CBL and VAV, were phosphorylated on tyrosine in response to CD80, CD86, and anti - CD28 mAb.	signaling proteins,22,40,Gene/Protein	CBL,50,53,Gene/Protein	VAV,58,61,Gene/Protein	CD80,110,114,Gene/Protein	CD86,116,120,Gene/Protein	anti - CD28 mAb,126,141,Gene/Protein	"[{""token"": ""signaling proteins"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CBL"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""VAV"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 126, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	valid
Apart from clear - cut defects in the synthesis of mRNAs for Th2 - type lymphokines, such as IL - 4, IL - 5, IL - 10 and IL - 13, in primary and secondary stimulations of spleen cells in vitro, of a distinct impaired deletion of V beta 11 + / CD4 + T lymphocytes from these mice was detected after superantigen injection.	mRNAs,51,56,Gene/Protein	Th2 - type lymphokines,61,83,Gene/Protein	IL - 4,93,99,Gene/Protein	IL - 5,101,107,Gene/Protein	IL - 10,109,116,Gene/Protein	IL - 13,121,128,Gene/Protein	"[{""token"": ""mRNAs"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Th2 - type lymphokines"", ""start_span"": 61, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	valid
The aberrant CD4 ( -) CD8 ( -) T cells from lpr / lpr and gld / gld mice, which have mutations in the genes encoding Fas and FasL, respectively, have an activated phenotype and constitutively express high levels of fasL mRNA, prompting us to ask what role if any the FLRE and Egr family proteins have in this aberrant expression of fasL.	Fas,117,120,Gene/Protein	FasL,125,129,Gene/Protein	fasL mRNA,215,224,Gene/Protein	FLRE,267,271,Gene/Protein	Egr family proteins,276,295,Gene/Protein	fasL,332,336,Gene/Protein	"[{""token"": ""Fas"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""fasL mRNA"", ""start_span"": 215, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""FLRE"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""Egr family proteins"", ""start_span"": 276, ""end_span"": 295, ""type"": ""Gene/Protein""}, {""token"": ""fasL"", ""start_span"": 332, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	valid
Stimulation of lymphoid cells with interleukin - 1beta ( IL - 1beta) led to ROI production and NF - kappaB activation, which could both be blocked by antioxidants or FLAP inhibitors, confirming that 5 - LOX was the source of ROIs and was required for NF - kappaB activation in these cells.	interleukin - 1beta,35,54,Gene/Protein	IL - 1beta,57,67,Gene/Protein	NF - kappaB,95,106,Gene/Protein	FLAP,166,170,Gene/Protein	5 - LOX,199,206,Gene/Protein	NF - kappaB,251,262,Gene/Protein	"[{""token"": ""interleukin - 1beta"", ""start_span"": 35, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""FLAP"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""5 - LOX"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 251, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	valid
Evidence for suppressed activity of the transcription factor NFAT1 at its proximal binding element P0 in the IL - 4 promoter associated with enhanced IL - 4 gene transcription in T cells of atopic patients.	transcription factor,40,60,Gene/Protein	NFAT1,61,66,Gene/Protein	proximal binding element,74,98,Gene/Protein	P0,99,101,Gene/Protein	IL - 4 promoter,109,124,Gene/Protein	IL - 4 gene,150,161,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 40, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""proximal binding element"", ""start_span"": 74, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""P0"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 promoter"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	valid
A Taq I polymorphism was identified which enabled chicken IL2 to be mapped to chromosome 4, linked to ANX5, with synteny with mouse chromosome 3 and human chromosome 4.	Taq I polymorphism,2,20,Gene/Protein	IL2,58,61,Gene/Protein	chromosome 4,78,90,Gene/Protein	ANX5,102,106,Gene/Protein	mouse chromosome 3,126,144,Gene/Protein	human chromosome 4,149,167,Gene/Protein	"[{""token"": ""Taq I polymorphism"", ""start_span"": 2, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""chromosome 4"", ""start_span"": 78, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""ANX5"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""mouse chromosome 3"", ""start_span"": 126, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 4"", ""start_span"": 149, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	valid
LSF ( also known as LBP - 1, UBP, and CP - 2) has been shown to repress LTR transcription in vitro, but transient expression of LSF has no effect on LTR activity in vivo.	LSF,0,3,Gene/Protein	LBP - 1,20,27,Gene/Protein	UBP,29,32,Gene/Protein	CP - 2,38,44,Gene/Protein	LSF,128,131,Gene/Protein	LTR,149,152,Gene/Protein	"[{""token"": ""LSF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""LBP - 1"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""UBP"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CP - 2"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""LSF"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	valid
The visualization of heavy and light chain genes in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes: the kappa genes were found to be preferentially confined to an outer nuclear volume, whereas the gamma and lambda genes consistently occupied more central positions within the nucleus, the lambda genes being more interior when compared with the gamma genes.	heavy and light chain genes,21,48,Gene/Protein	Ig genes,93,101,Gene/Protein	kappa genes,186,197,Gene/Protein	gamma and lambda genes,279,301,Gene/Protein	lambda genes,371,383,Gene/Protein	gamma genes,427,438,Gene/Protein	"[{""token"": ""heavy and light chain genes"", ""start_span"": 21, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Ig genes"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""kappa genes"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""gamma and lambda genes"", ""start_span"": 279, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""lambda genes"", ""start_span"": 371, ""end_span"": 383, ""type"": ""Gene/Protein""}, {""token"": ""gamma genes"", ""start_span"": 427, ""end_span"": 438, ""type"": ""Gene/Protein""}]"	valid
NF - kappa B activation was independent of the transmembrane domain of CD40, suggesting that it is independent of p23, a molecule that associates with CD40 in a region other than the cytoplasmic domain.	NF - kappa B,0,12,Gene/Protein	transmembrane domain,47,67,Gene/Protein	CD40,71,75,Gene/Protein	p23,114,117,Gene/Protein	CD40,151,155,Gene/Protein	cytoplasmic domain,183,201,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane domain"", ""start_span"": 47, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""p23"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 183, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	valid
IL - 2 and IL - 7 were equivalent in their ability to induce tyrosine phosphorylation of STAT5A and STAT5B and to facilitate binding of these STATs to an immobilized GAS element.	IL - 2,0,6,Gene/Protein	IL - 7,11,17,Gene/Protein	STAT5A,89,95,Gene/Protein	STAT5B,100,106,Gene/Protein	STATs,142,147,Gene/Protein	immobilized GAS element,154,177,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""STAT5A"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""immobilized GAS element"", ""start_span"": 154, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	valid
Interestingly, co - immunoprecipitation analysis also revealed that Tax mutant IEXC29S is unable to interact with NGFI - A / Egr - 1, whereas Tax mutant IEXL320G is able to interact with NGFI - A / Egr - 1.	Tax,68,71,Gene/Protein	IEXC29S,79,86,Gene/Protein	NGFI - A / Egr - 1,114,132,Gene/Protein	Tax,142,145,Gene/Protein	IEXL320G,153,161,Gene/Protein	NGFI - A / Egr - 1,187,205,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IEXC29S"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 114, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""IEXL320G"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 187, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	valid
However, NF - YB did interact with the C - terminal Tax1 mutants M22 ( 130TL - AS) and M47 ( 319LL - RS).	NF - YB,9,16,Gene/Protein	C - terminal Tax1 mutants,39,64,Gene/Protein	M22,65,68,Gene/Protein	130TL - AS,71,81,Gene/Protein	M47,87,90,Gene/Protein	319LL - RS,93,103,Gene/Protein	"[{""token"": ""NF - YB"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal Tax1 mutants"", ""start_span"": 39, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""M22"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""130TL - AS"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""M47"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""319LL - RS"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	valid
In murine Ba / F3 cells transfected with the human G - CSFR and NFS - 60 cells constitutively expressing the murine G - CSFR, G - CSF induced tyrosine phosphorylation and activation of Jak1, Jak2, and Tyk2.	human G - CSFR,45,59,Gene/Protein	murine G - CSFR,109,124,Gene/Protein	G - CSF,126,133,Gene/Protein	Jak1,185,189,Gene/Protein	Jak2,191,195,Gene/Protein	Tyk2,201,205,Gene/Protein	"[{""token"": ""human G - CSFR"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""murine G - CSFR"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	valid
Following neutrophil stimulation with proinflammatory agonists ( such as lipopolysaccharide [ LPS], tumor necrosis factor - alpha [ TNF - alpha], and fMet - Leu - Phe) that induce the production of cytokines and chemokines in these cells, NF - kappaB / Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF - kappaB DNA binding activity, as determined in gel mobility shift assays.	tumor necrosis factor - alpha,100,129,Gene/Protein	TNF - alpha,132,143,Gene/Protein	cytokines,198,207,Gene/Protein	chemokines,212,222,Gene/Protein	NF - kappaB / Rel proteins,239,265,Gene/Protein	NF - kappaB,339,350,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 100, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 132, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 198, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB / Rel proteins"", ""start_span"": 239, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 339, ""end_span"": 350, ""type"": ""Gene/Protein""}]"	valid
Stimulation of CD2 or TCR / CD3 induced activation of the nuclear factor of activated T cells ( NFAT), the binding site of which is included in the IL - 2 gene promoter.	CD2,15,18,Gene/Protein	TCR / CD3,22,31,Gene/Protein	nuclear factor of activated T cells,58,93,Gene/Protein	NFAT,96,100,Gene/Protein	binding site,107,119,Gene/Protein	IL - 2 gene promoter,148,168,Gene/Protein	"[{""token"": ""CD2"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""TCR / CD3"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 58, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene promoter"", ""start_span"": 148, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	valid
Interaction of transcription factors RFX1 and MIBP1 with the gamma motif of the negative regulatory element of the hepatitis B virus core promoter.	transcription factors,15,36,Gene/Protein	RFX1,37,41,Gene/Protein	MIBP1,46,51,Gene/Protein	gamma motif,61,72,Gene/Protein	negative regulatory element,80,107,Gene/Protein	hepatitis B virus core promoter,115,146,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 15, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""RFX1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""MIBP1"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""gamma motif"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""negative regulatory element"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""hepatitis B virus core promoter"", ""start_span"": 115, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	valid
However, V3 - BH10 enhanced IL - 2 - induced mRNA expression of c - fos but not c - myc or junB.	V3 - BH10,9,18,Gene/Protein	IL - 2,28,34,Gene/Protein	- induced mRNA,35,49,Gene/Protein	c - fos,64,71,Gene/Protein	c - myc,80,87,Gene/Protein	junB,91,95,Gene/Protein	"[{""token"": ""V3 - BH10"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""- induced mRNA"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	valid
One of the latter elements, the IgH 3 ' enhancer, is of particular interest: ( 1) it is B cell - specific and active only in late B cell development; ( 2) in rodent plasmacytomas and in some human Burkitt ' s lymphomas it is part of a locus control region ( LCR) that is involved in deregulation of the c - myc oncogene as a result of translocation into the IgH locus; and ( 3) it has been implicated in the mechanisms that control Ig gene class switch recombination.	IgH 3 ' enhancer,32,48,Gene/Protein	locus control region,235,255,Gene/Protein	LCR,258,261,Gene/Protein	c - myc oncogene,303,319,Gene/Protein	IgH locus,358,367,Gene/Protein	Ig gene class,432,445,Gene/Protein	"[{""token"": ""IgH 3 ' enhancer"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""locus control region"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""c - myc oncogene"", ""start_span"": 303, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""IgH locus"", ""start_span"": 358, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""Ig gene class"", ""start_span"": 432, ""end_span"": 445, ""type"": ""Gene/Protein""}]"	valid
The expression and binding activity of the Nfil3 protein ( also called E4bp4), but not of Hlf, Dbp, or Tef, was found to be regulated by IL - 3 in mouse pro - B cell lines ( Baf - 3 and FL5. 12).	Nfil3 protein,43,56,Gene/Protein	E4bp4,71,76,Gene/Protein	Hlf,90,93,Gene/Protein	Dbp,95,98,Gene/Protein	Tef,103,106,Gene/Protein	IL - 3,137,143,Gene/Protein	"[{""token"": ""Nfil3 protein"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""E4bp4"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""Hlf"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Dbp"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Tef"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	valid
Co - ligation of the A6H antigen and the CD3 complex induced expression of the transcription factor AP - 1 in CD4 + T cells, whereas no increase in NF - kappa B and octamer - binding ( Oct) proteins was seen compared to T cells stimulated with anti - CD3 alone.	A6H,21,24,Gene/Protein	CD3 complex,41,52,Gene/Protein	transcription factor,79,99,Gene/Protein	AP - 1,100,106,Gene/Protein	NF - kappa B,148,160,Gene/Protein	anti - CD3,244,254,Gene/Protein	"[{""token"": ""A6H"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CD3 complex"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 79, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 244, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	valid
In mobility shift assays, a nuclear factor from THP - 1 and U - 937 cells was identified that binds to several AP - 2 response elements within the B2 promoter, but does not react with AP - 2 antibodies, and has a DNA sequence binding affinity profile that differs from AP - 2.	nuclear factor,28,42,Gene/Protein	AP - 2 response elements,111,135,Gene/Protein	B2 promoter,147,158,Gene/Protein	AP - 2 antibodies,184,201,Gene/Protein	DNA sequence,213,225,Gene/Protein	AP - 2,269,275,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 response elements"", ""start_span"": 111, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""B2 promoter"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 antibodies"", ""start_span"": 184, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""DNA sequence"", ""start_span"": 213, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 269, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	valid
The upstream regions UAS3 ( - 1168 to - 440) and UAS2 ( - 352 to - 264) both functioned in a cell lineage - independent manner and were together responsible for the bulk of Wp activity in non - B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.	UAS3,21,25,Gene/Protein	- 1168 to - 440,28,43,Gene/Protein	UAS2,49,53,Gene/Protein	- 352 to - 264,56,70,Gene/Protein	YY1 binding site,253,269,Gene/Protein	UAS2,273,277,Gene/Protein	"[{""token"": ""UAS3"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""- 1168 to - 440"", ""start_span"": 28, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""UAS2"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""- 352 to - 264"", ""start_span"": 56, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""YY1 binding site"", ""start_span"": 253, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""UAS2"", ""start_span"": 273, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	valid
NLS peptide - mediated disruption of the nuclear import of these transcription factors results in inhibition of I kappa B alpha and IL - 2 gene expression, processes dependent on NF - kappa B or the combination of NF - kappa B, AP - 1, and NFAT.	NLS,0,3,Gene/Protein	transcription factors,65,86,Gene/Protein	NF - kappa B,179,191,Gene/Protein	NF - kappa B,214,226,Gene/Protein	AP - 1,228,234,Gene/Protein	NFAT,240,244,Gene/Protein	"[{""token"": ""NLS"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 65, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 214, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	valid
Restoration of the CCAAT box at - 70 bp, or insertion of an EKLF binding site at - 85 bp or - 95 bp in the promoter significantly increased delta globin gene expression in hAEC.	CCAAT box,19,28,Gene/Protein	- 70 bp,32,39,Gene/Protein	EKLF binding site,60,77,Gene/Protein	- 85 bp,81,88,Gene/Protein	- 95 bp,92,99,Gene/Protein	promoter,107,115,Gene/Protein	"[{""token"": ""CCAAT box"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""- 70 bp"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""EKLF binding site"", ""start_span"": 60, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""- 85 bp"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""- 95 bp"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	valid
At the same time there was no change in the level of expression of the cell surface antigenes CD33, CD34, CD45, CD71 and glycophorin A.	cell surface antigenes,71,93,Gene/Protein	CD33,94,98,Gene/Protein	CD34,100,104,Gene/Protein	CD45,106,110,Gene/Protein	CD71,112,116,Gene/Protein	glycophorin A,121,134,Gene/Protein	"[{""token"": ""cell surface antigenes"", ""start_span"": 71, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD33"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""CD71"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""glycophorin A"", ""start_span"": 121, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	valid
In addition, Ras ( G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the beta - casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5 - mediated gene expression.	erythropoietin receptor mutant,54,84,Gene/Protein	Ras,98,101,Gene/Protein	beta - casein promoter,149,171,Gene/Protein	mutant erythropoietin receptor,179,209,Gene/Protein	Ras,251,254,Gene/Protein	Stat5,258,263,Gene/Protein	"[{""token"": ""erythropoietin receptor mutant"", ""start_span"": 54, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein promoter"", ""start_span"": 149, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""mutant erythropoietin receptor"", ""start_span"": 179, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 258, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	valid
We have determined how the phosphorylation of the retinoblastoma family ( pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B - cells during cell cycle exit triggered by alpha - interferon ( alpha - IFN).	retinoblastoma family,50,71,Gene/Protein	pRb,74,77,Gene/Protein	p107,79,83,Gene/Protein	p130,89,93,Gene/Protein	alpha - interferon,194,212,Gene/Protein	alpha - IFN,215,226,Gene/Protein	"[{""token"": ""retinoblastoma family"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""p107"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""alpha - interferon"", ""start_span"": 194, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""alpha - IFN"", ""start_span"": 215, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	valid
Fusion of the upstream portion of the delta promoter to the truncated beta globin promoter yielded a modest increase in promoter strength relative to the truncated beta gene promoter, indicating the presence of a positive transcriptional element ( s) in the upstream delta globin regulatory region.	upstream portion,14,30,Gene/Protein	delta promoter,38,52,Gene/Protein	beta globin promoter,70,90,Gene/Protein	truncated beta gene promoter,154,182,Gene/Protein	positive transcriptional element,213,245,Gene/Protein	upstream delta globin regulatory region,258,297,Gene/Protein	"[{""token"": ""upstream portion"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""delta promoter"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""beta globin promoter"", ""start_span"": 70, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""truncated beta gene promoter"", ""start_span"": 154, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""positive transcriptional element"", ""start_span"": 213, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""upstream delta globin regulatory region"", ""start_span"": 258, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	valid
Together, these results show that activated HLA - DRA expression in response to TPA treatment is strictly dependent on PKC activation acting on the X2 box of the DRA promoter and that selective inhibition of PKC enzymatic activity does not influence subcellular localization of expressed PKC isoenzymes.	HLA - DRA,44,53,Gene/Protein	PKC,119,122,Gene/Protein	X2 box,148,154,Gene/Protein	DRA promoter,162,174,Gene/Protein	PKC,208,211,Gene/Protein	PKC isoenzymes,288,302,Gene/Protein	"[{""token"": ""HLA - DRA"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""X2 box"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 162, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""PKC isoenzymes"", ""start_span"": 288, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	valid
To study the influence of NFkappaB activity on apoptosis mediated by TRAIL, CD95, TNFalpha, or doxorubicin, NFkappaB activation was inhibited using the proteasome inhibitor N - acetyl - L - leucinyl - L - leucinyl - L - norleucinal or transient overexpression of mutant IkappaBalpha.	NFkappaB,26,34,Gene/Protein	TRAIL,69,74,Gene/Protein	TNFalpha,82,90,Gene/Protein	NFkappaB,108,116,Gene/Protein	proteasome,152,162,Gene/Protein	mutant IkappaBalpha,263,282,Gene/Protein	"[{""token"": ""NFkappaB"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""TRAIL"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""proteasome"", ""start_span"": 152, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""mutant IkappaBalpha"", ""start_span"": 263, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	valid
However, its interactions with these histone acetyltransferases are not equivalent, as CBP and p300, but not P / CAF, utilize EKLF as a substrate for in vitro acetylation within its trans - activation region.	histone acetyltransferases,37,63,Gene/Protein	CBP,87,90,Gene/Protein	p300,95,99,Gene/Protein	P / CAF,109,116,Gene/Protein	EKLF,126,130,Gene/Protein	activation region,190,207,Gene/Protein	"[{""token"": ""histone acetyltransferases"", ""start_span"": 37, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""activation region"", ""start_span"": 190, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	valid
Other bacterial toxins, tumor necrosis factor - alpha ( TNF), interleukin - 1 ( IL - 1), T cell mitogens, UV light, gamma rays and oxidative stress were reported to induce NF - kappa B.	tumor necrosis factor - alpha,24,53,Gene/Protein	TNF,56,59,Gene/Protein	interleukin - 1,62,77,Gene/Protein	IL - 1,80,86,Gene/Protein	T cell mitogens,89,104,Gene/Protein	NF - kappa B,172,184,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 24, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""T cell mitogens"", ""start_span"": 89, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	valid
In previous transfection analyses using the chloramphenicol acetyltransferase reporter gene system, we determined that linker substitution ( LS) mutations between - 201 and - 130 ( relative to the transcription start site) of the human immunodeficiency virus type 1 long terminal repeat ( LTR) caused moderate decreases in LTR transcriptional activity in a T - cell line ( S. L. Zeichner, J. Y. H. Kim, and J. C. Alwine, J. Virol. 65: 2436 - 2444, 1991).	chloramphenicol acetyltransferase,44,77,Gene/Protein	reporter gene,78,91,Gene/Protein	- 201 and - 130,163,178,Gene/Protein	long terminal repeat,266,286,Gene/Protein	LTR,289,292,Gene/Protein	LTR,323,326,Gene/Protein	"[{""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 44, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""- 201 and - 130"", ""start_span"": 163, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 266, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 289, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 323, ""end_span"": 326, ""type"": ""Gene/Protein""}]"	valid
Cross competition experiments with an octamer sequence from the Ig heavy chain promoter, the BAT box, and a TA - rich sequence present in the CD21 promoter revealed that all three sequences bound the same nuclear proteins suggesting that the BAT box binding proteins were Oct - 1 and Oct - 2.	BAT box,93,100,Gene/Protein	CD21 promoter,142,155,Gene/Protein	nuclear proteins,205,221,Gene/Protein	BAT box binding proteins,242,266,Gene/Protein	Oct - 1,272,279,Gene/Protein	Oct - 2,284,291,Gene/Protein	"[{""token"": ""BAT box"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CD21 promoter"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 205, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""BAT box binding proteins"", ""start_span"": 242, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 272, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 284, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	valid
Cotransfection of an hGATA - 3 expression plasmid with a reporter plasmid whose transcription is directed by the HIV - 1 LTR resulted in 6 - to 10 - fold stimulation of LTR - mediated transcription, whereas site specific mutation of these GATA sites resulted in virtual abrogation of the activation by hGATA - 3.	hGATA - 3 expression plasmid,21,49,Gene/Protein	reporter plasmid,57,73,Gene/Protein	HIV - 1 LTR,113,124,Gene/Protein	LTR,169,172,Gene/Protein	GATA sites,239,249,Gene/Protein	hGATA - 3,302,311,Gene/Protein	"[{""token"": ""hGATA - 3 expression plasmid"", ""start_span"": 21, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""reporter plasmid"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""GATA sites"", ""start_span"": 239, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 3"", ""start_span"": 302, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	valid
A T cell - specific protein Neg - 1 and a ubiquitous protein Neg - 2 binding to NRE - I and NRE - II, respectively, were identified.	T cell - specific protein,2,27,Gene/Protein	Neg - 1,28,35,Gene/Protein	ubiquitous protein,42,60,Gene/Protein	Neg - 2,61,68,Gene/Protein	NRE - I,80,87,Gene/Protein	NRE - II,92,100,Gene/Protein	"[{""token"": ""T cell - specific protein"", ""start_span"": 2, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Neg - 1"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous protein"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Neg - 2"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NRE - I"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NRE - II"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene/Protein""}]"	valid
We furthermore demonstrate that this process involves activation of the transcription factor NF - chi B and, to a lesser extent, of NF - IL6, while the activity of the transcription factor AP - 1, shown to otherwise confer IL - 6 inducibility, appeared to be unaffected by LTB4.	transcription factor,72,92,Gene/Protein	NF - chi B,93,103,Gene/Protein	NF - IL6,132,140,Gene/Protein	transcription factor,168,188,Gene/Protein	AP - 1,189,195,Gene/Protein	IL - 6,223,229,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 72, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""NF - chi B"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 168, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	valid
After the DNA fragment containing the CAG repeats is amplified by the polymerase chain reaction, a primer extension is carried out; the extension of the end - labelled reverse primer adjacent to 3 ' end of CAG repeats stops at the first T after CAG repeats with the incorporation of dideoxy ATP in the reaction mixture.	DNA fragment,10,22,Gene/Protein	CAG repeats,38,49,Gene/Protein	end - labelled reverse primer,153,182,Gene/Protein	3 ' end,195,202,Gene/Protein	CAG repeats,206,217,Gene/Protein	CAG repeats,245,256,Gene/Protein	"[{""token"": ""DNA fragment"", ""start_span"": 10, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CAG repeats"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""end - labelled reverse primer"", ""start_span"": 153, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""3 ' end"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""CAG repeats"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""CAG repeats"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	valid
It is evident that assembly of the surface domain of TF with VIIa to form the binary TF. VIIa complex induces a significant increase in the Kcat of the catalytic domain of VIIa for small peptidyl substrates and more profoundly for protein substrate.	surface domain,35,49,Gene/Protein	TF,53,55,Gene/Protein	VIIa,61,65,Gene/Protein	catalytic domain,152,168,Gene/Protein	VIIa,172,176,Gene/Protein	protein substrate,231,248,Gene/Protein	"[{""token"": ""surface domain"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""VIIa"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""catalytic domain"", ""start_span"": 152, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""VIIa"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""protein substrate"", ""start_span"": 231, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	valid
A DNA probe that spanned a domain conserved among the proto - oncogene c - rel, the Drosophila morphogen dorsal, and the p50 DNA binding subunit of NF - kappa B was generated from Jurkat T cell complementary DNA with the polymerase chain reaction ( PCR) and degenerate oligonucleotides.	DNA probe,2,11,Gene/Protein	proto - oncogene c - rel,54,78,Gene/Protein	Drosophila morphogen dorsal,84,111,Gene/Protein	p50 DNA binding subunit,121,144,Gene/Protein	NF - kappa B,148,160,Gene/Protein	Jurkat T cell complementary DNA,180,211,Gene/Protein	"[{""token"": ""DNA probe"", ""start_span"": 2, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene c - rel"", ""start_span"": 54, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila morphogen dorsal"", ""start_span"": 84, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""p50 DNA binding subunit"", ""start_span"": 121, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Jurkat T cell complementary DNA"", ""start_span"": 180, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	valid
The human T cell - specific transcription factor TCF - 1 alpha plays a key role in the tissue - specific activation of the T cell receptor ( TCR) C alpha enhancer and binds to pyrimidine - rich elements ( 5 ' - PyCTTTG - 3 ') present in a variety of other T cell - specific control regions.	human T cell - specific transcription factor,4,48,Gene/Protein	TCF - 1 alpha,49,62,Gene/Protein	T cell receptor,123,138,Gene/Protein	TCR,141,144,Gene/Protein	pyrimidine - rich elements,176,202,Gene/Protein	T cell - specific control regions,256,289,Gene/Protein	"[{""token"": ""human T cell - specific transcription factor"", ""start_span"": 4, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1 alpha"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""pyrimidine - rich elements"", ""start_span"": 176, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific control regions"", ""start_span"": 256, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	valid
The induction of AP1 by okadaic acid suggests that protein phosphatases 1 and 2A ( PP1 and PP2A) may be involved in T cell activation as important negative regulators of the transcription factor AP1.	AP1,17,20,Gene/Protein	protein phosphatases 1 and 2A,51,80,Gene/Protein	PP1,83,86,Gene/Protein	PP2A,91,95,Gene/Protein	transcription factor,174,194,Gene/Protein	AP1,195,198,Gene/Protein	"[{""token"": ""AP1"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""protein phosphatases 1 and 2A"", ""start_span"": 51, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 174, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	valid
The fusion cDNA results from an interstitial deletion between a previously unknown locus, SIL ( SCL interrupting locus), and the 5 ' untranslated region of SCL.	fusion cDNA,4,15,Gene/Protein	unknown locus,75,88,Gene/Protein	SIL,90,93,Gene/Protein	SCL interrupting locus,96,118,Gene/Protein	5 ' untranslated region,129,152,Gene/Protein	SCL,156,159,Gene/Protein	"[{""token"": ""fusion cDNA"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""unknown locus"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""SIL"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""SCL interrupting locus"", ""start_span"": 96, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""5 ' untranslated region"", ""start_span"": 129, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	valid
Further, 1, 25 ( OH) 2D3 inhibited the transcriptional activity of NF - kappa B in Jurkat cells transiently transfected with a construct containing four tandem repeats of the NF - kappa B binding sequence of the immunoglobulin kappa light chain gene linked to the chloramphenicol acetyltransferase reporter gene.	NF - kappa B,67,79,Gene/Protein	construct,127,136,Gene/Protein	tandem repeats,153,167,Gene/Protein	NF - kappa B binding sequence,175,204,Gene/Protein	immunoglobulin kappa light chain gene,212,249,Gene/Protein	chloramphenicol acetyltransferase reporter gene,264,311,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""construct"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""tandem repeats"", ""start_span"": 153, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding sequence"", ""start_span"": 175, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin kappa light chain gene"", ""start_span"": 212, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter gene"", ""start_span"": 264, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	valid
Exposure of activated human T lymphocytes or of a natural killer cell line ( NKL) to IL - 2 leads to the phosphorylation of Stat1 alpha, Stat1 beta, and Stat3, as well as of two Stat - related proteins, p94 and p95.	IL - 2,85,91,Gene/Protein	Stat1 alpha,124,135,Gene/Protein	Stat3,153,158,Gene/Protein	Stat - related proteins,178,201,Gene/Protein	p94,203,206,Gene/Protein	p95,211,214,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Stat1 alpha"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""Stat - related proteins"", ""start_span"": 178, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""p94"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""p95"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	valid
The present study verified the ability of IL - 2 to cause tyrosine phosphorylation and activation of JAK1 and JAK3, but demonstrated that IL - 2 stimulated JAK3 to a significantly larger extent than JAK1 in human T lymphocytes and the YT cell line.	IL - 2,42,48,Gene/Protein	JAK1,101,105,Gene/Protein	JAK3,110,114,Gene/Protein	IL - 2,138,144,Gene/Protein	JAK3,156,160,Gene/Protein	JAK1,199,203,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	valid
In most cases, the transcriptional factor NF - kappa B is a heterodimer consisting of two subunits, p50 and p65, which are encoded by two distinct genes of the Rel family.	transcriptional factor,19,41,Gene/Protein	NF - kappa B,42,54,Gene/Protein	heterodimer,60,71,Gene/Protein	p50,100,103,Gene/Protein	p65,108,111,Gene/Protein	Rel family,160,170,Gene/Protein	"[{""token"": ""transcriptional factor"", ""start_span"": 19, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""heterodimer"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Rel family"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	valid
The lack of Jak3 expression correlated with impaired B cell signaling, as demonstrated by the inability of IL - 4 to activate Stat6 in the EBV - transformed cell line from the patient. These observations indicate that the functions of gamma c are dependent on Jak3 and that Jak3 is essential for lymphoid development and signaling.	Jak3,12,16,Gene/Protein	IL - 4,107,113,Gene/Protein	Stat6,126,131,Gene/Protein	gamma c,235,242,Gene/Protein	Jak3,260,264,Gene/Protein	Jak3,274,278,Gene/Protein	"[{""token"": ""Jak3"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""gamma c"", ""start_span"": 235, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 260, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 274, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	valid
Integration of the signals generated by TCR and CD28 engagement occurs along this pathway, which then bifurcates to induce I kappa B phosphorylation and NF - kappa B activation on the one hand, and JNK activation and c - Jun phosphorylation on the other.	TCR,40,43,Gene/Protein	CD28,48,52,Gene/Protein	I kappa B,123,132,Gene/Protein	NF - kappa B,153,165,Gene/Protein	JNK,198,201,Gene/Protein	c - Jun,217,224,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	valid
To understand the role of MARs in IgH enhancer regulation, we have identified a novel MAR - binding protein, MAR - BP1, from soluble nuclear matrix preparations based on its ability to bind to the MARs associated with the IgH enhancer.	MARs,26,30,Gene/Protein	IgH enhancer,34,46,Gene/Protein	MAR - binding protein,86,107,Gene/Protein	MAR - BP1,109,118,Gene/Protein	MARs,197,201,Gene/Protein	IgH enhancer,222,234,Gene/Protein	"[{""token"": ""MARs"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""MAR - binding protein"", ""start_span"": 86, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""MAR - BP1"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""MARs"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	valid
As neutralizing anti - IL - 6 Abs effectively down - regulated the early induction of STAT proteins and as exogenously added IL - 6 rapidly activated DNA binding similar to TCR - mediated bindings, it can be concluded that IL - 6 is the factor responsible for the activation of STAT proteins in a primary T cell response.	neutralizing anti - IL - 6 Abs,3,33,Gene/Protein	STAT proteins,86,99,Gene/Protein	IL - 6,125,131,Gene/Protein	TCR,173,176,Gene/Protein	IL - 6,223,229,Gene/Protein	STAT proteins,278,291,Gene/Protein	"[{""token"": ""neutralizing anti - IL - 6 Abs"", ""start_span"": 3, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 278, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	valid
NF - A1 is present in a variety of cell types, whereas the presence of NF - A2 is essentially confined to B cells, leading to the hypothesis that NF - A2 activates cell - type - specific transcription of the Ig promoter and NF - A1 mediates the other responses of the OCTA element.	NF - A1,0,7,Gene/Protein	NF - A2,71,78,Gene/Protein	NF - A2,146,153,Gene/Protein	Ig promoter,208,219,Gene/Protein	NF - A1,224,231,Gene/Protein	OCTA element,268,280,Gene/Protein	"[{""token"": ""NF - A1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""NF - A2"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""NF - A2"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Ig promoter"", ""start_span"": 208, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""NF - A1"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""OCTA element"", ""start_span"": 268, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	test
Because NF - A1 can stimulate Ig transcription, the inability of this factor to activate in vivo the Ig promoter to the same degree as the snRNA promoters probably reflects a difference in the context of the OCTA element in these two types of promoters.	NF - A1,8,15,Gene/Protein	Ig,30,32,Gene/Protein	Ig promoter,101,112,Gene/Protein	snRNA promoters,139,154,Gene/Protein	OCTA element,208,220,Gene/Protein	promoters,243,252,Gene/Protein	"[{""token"": ""NF - A1"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Ig"", ""start_span"": 30, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""Ig promoter"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""snRNA promoters"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""OCTA element"", ""start_span"": 208, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 243, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	test
The promoters of the adenovirus 2 major late gene, the mouse beta - globin gene, the mouse immunoglobulin VH gene and the LTR of the human T - lymphotropic retrovirus type I were tested for their transcription activities in cell - free extracts of four cell lines; HeLa, CESS ( Epstein - Barr virus - transformed human B cell line), MT - 1 ( HTLV - I - infected human T cell line without viral protein synthesis), and MT - 2 ( HTLV - I - infected human T cell line producing viral proteins).	promoters,4,13,Gene/Protein	adenovirus 2 major late gene,21,49,Gene/Protein	mouse beta - globin gene,55,79,Gene/Protein	mouse immunoglobulin VH gene,85,113,Gene/Protein	LTR,122,125,Gene/Protein	viral proteins,475,489,Gene/Protein	"[{""token"": ""promoters"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""adenovirus 2 major late gene"", ""start_span"": 21, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""mouse beta - globin gene"", ""start_span"": 55, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""mouse immunoglobulin VH gene"", ""start_span"": 85, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""viral proteins"", ""start_span"": 475, ""end_span"": 489, ""type"": ""Gene/Protein""}]"	test
We report here the identification of a human B - cell nuclear factor ( IgNF - A) that binds to DNA sequences in the upstream regions of both the mouse heavy and kappa light - chain gene promoters and also to the mouse heavy - chain gene enhancer.	human B - cell nuclear factor,39,68,Gene/Protein	IgNF - A,71,79,Gene/Protein	DNA sequences,95,108,Gene/Protein	upstream regions,116,132,Gene/Protein	mouse heavy and kappa light - chain gene promoters,145,195,Gene/Protein	mouse heavy - chain gene enhancer,212,245,Gene/Protein	"[{""token"": ""human B - cell nuclear factor"", ""start_span"": 39, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IgNF - A"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""DNA sequences"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""upstream regions"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""mouse heavy and kappa light - chain gene promoters"", ""start_span"": 145, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""mouse heavy - chain gene enhancer"", ""start_span"": 212, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	test
The NF - Y complex derived from class II + mature B - cells bound with high affinity to anion exchangers, and eluted as an intact trimeric complex, whereas, NF - Y derived from class II - plasma B - cells, and from bare lymphocyte syndrome group II cell lines, RJ2. 2. 5 and RM3, dissociated into discrete NF - YA and NF - YB: C subunit fractions.	NF - Y complex,4,18,Gene/Protein	anion exchangers,88,104,Gene/Protein	trimeric complex,130,146,Gene/Protein	NF - Y,157,163,Gene/Protein	NF - YA,306,313,Gene/Protein	subunit fractions,329,346,Gene/Protein	"[{""token"": ""NF - Y complex"", ""start_span"": 4, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""anion exchangers"", ""start_span"": 88, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""trimeric complex"", ""start_span"": 130, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""NF - YA"", ""start_span"": 306, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""subunit fractions"", ""start_span"": 329, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	test
Recombination of the native NF - YA: B: C complex with the transcriptional cofactor, PC4, likewise conferred high affinity NF - Y binding to anion exchangers, and stabilized NF - Y interaction with CCAAT - box DNA motifs in vitro.	transcriptional cofactor,59,83,Gene/Protein	PC4,85,88,Gene/Protein	high affinity NF - Y,109,129,Gene/Protein	anion exchangers,141,157,Gene/Protein	NF - Y,174,180,Gene/Protein	CCAAT - box DNA motifs,198,220,Gene/Protein	"[{""token"": ""transcriptional cofactor"", ""start_span"": 59, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PC4"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""high affinity NF - Y"", ""start_span"": 109, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""anion exchangers"", ""start_span"": 141, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT - box DNA motifs"", ""start_span"": 198, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	test
Inactivation of the NF - kappaB and 3 ' NF - IL - 6 DNA binding sites decreased IL - 8 gene transcriptional activation in response to TNF while inactivation of the 5 ' NF - IL - 6 binding site increased IL - 8 gene transcriptional activity in response to TNF.	NF - kappaB and 3 ' NF - IL - 6 DNA binding sites,20,69,Gene/Protein	IL - 8 gene,80,91,Gene/Protein	TNF,134,137,Gene/Protein	5 ' NF - IL - 6 binding site,164,192,Gene/Protein	IL - 8 gene,203,214,Gene/Protein	TNF,255,258,Gene/Protein	"[{""token"": ""NF - kappaB and 3 ' NF - IL - 6 DNA binding sites"", ""start_span"": 20, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 gene"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""5 ' NF - IL - 6 binding site"", ""start_span"": 164, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8 gene"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	test
Anti - CD3 - restimulated T cells ( mainly CD8 +) produced IL - 2, interferon - gamma ( IFN - gamma) and tumour necrosis factor - alpha ( TNF - alpha) and low levels of IL - 4 and IL - 10 transcripts and proteins.	IL - 2,59,65,Gene/Protein	interferon - gamma,67,85,Gene/Protein	IFN - gamma,88,99,Gene/Protein	tumour necrosis factor - alpha,105,135,Gene/Protein	TNF - alpha,138,149,Gene/Protein	IL - 4 and IL - 10 transcripts,169,199,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 67, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""tumour necrosis factor - alpha"", ""start_span"": 105, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 and IL - 10 transcripts"", ""start_span"": 169, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	test
Cotransfection assays with the TR3 / nur77 promoter sequence or the NBRE binding motif together with a series of Tax mutants have shown that Tax - induced TR3 / nur77 expression is mediated by CREB / ATF - related transcription factors.	TR3 / nur77 promoter sequence,31,60,Gene/Protein	NBRE,68,72,Gene/Protein	Tax,113,116,Gene/Protein	Tax,141,144,Gene/Protein	TR3 / nur77,155,166,Gene/Protein	CREB / ATF - related transcription factors,193,235,Gene/Protein	"[{""token"": ""TR3 / nur77 promoter sequence"", ""start_span"": 31, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""NBRE"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""TR3 / nur77"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF - related transcription factors"", ""start_span"": 193, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	test
A stable and stoichiometric complex of CaMKIV with protein serine - threonine phosphatase 2A ( PP2A) was identified in which PP2A dephosphorylates CaMKIV and functions as a negative regulator of CaMKIV signaling.	CaMKIV,39,45,Gene/Protein	protein serine - threonine phosphatase 2A,51,92,Gene/Protein	PP2A,95,99,Gene/Protein	PP2A,125,129,Gene/Protein	CaMKIV,147,153,Gene/Protein	CaMKIV,195,201,Gene/Protein	"[{""token"": ""CaMKIV"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""protein serine - threonine phosphatase 2A"", ""start_span"": 51, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""CaMKIV"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CaMKIV"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	test
Wortmannin only inhibits MAPK activation induced by EPO but not that by SCF, suggesting that SCF and EPO may activate MAPK through different pathways, which would facilitate synergy.	MAPK,25,29,Gene/Protein	EPO,52,55,Gene/Protein	SCF,72,75,Gene/Protein	SCF,93,96,Gene/Protein	EPO,101,104,Gene/Protein	MAPK,118,122,Gene/Protein	"[{""token"": ""MAPK"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	test
In the present study, we demonstrate that HIV - 1 envelope glycoproteins of both T - cell - tropic and macrophagetropic strains rapidly activate the ERK / mitogen - activated protein ( MAP) kinase pathway and the binding of nuclear transcription factors ( AP - 1, NF - kappaB, and C / EBP) and stimulate expression of cytokine and chemokine genes.	HIV - 1 envelope glycoproteins,42,72,Gene/Protein	nuclear transcription factors,224,253,Gene/Protein	AP - 1,256,262,Gene/Protein	NF - kappaB,264,275,Gene/Protein	C / EBP,281,288,Gene/Protein	cytokine and chemokine genes,318,346,Gene/Protein	"[{""token"": ""HIV - 1 envelope glycoproteins"", ""start_span"": 42, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcription factors"", ""start_span"": 224, ""end_span"": 253, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 256, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 264, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 281, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""cytokine and chemokine genes"", ""start_span"": 318, ""end_span"": 346, ""type"": ""Gene/Protein""}]"	test
Concentrations of cytosol and nuclear estrogen receptors ( ERC and ERN, respectively) and progestin receptors ( PRC and PRN) were also measured from endometrial biopsies taken on the 24th day of the control and treatment cycle.	cytosol and nuclear estrogen receptors,18,56,Gene/Protein	ERC,59,62,Gene/Protein	ERN,67,70,Gene/Protein	progestin receptors,90,109,Gene/Protein	PRC,112,115,Gene/Protein	PRN,120,123,Gene/Protein	"[{""token"": ""cytosol and nuclear estrogen receptors"", ""start_span"": 18, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""ERC"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""ERN"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""progestin receptors"", ""start_span"": 90, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""PRC"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""PRN"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	test
TNFalpha plus NAC treatment resulted in a marked decrease in Bcl - 2 protein levels in HIV - 1 - infected cells, coupled with an increase in Bax protein compared to uninfected cells, suggesting that the difference in susceptibility to TNFalpha - induced apoptosis may relate to the differences in relative levels of Bcl - 2 and Bax.	TNFalpha,0,8,Gene/Protein	Bcl - 2 protein,61,76,Gene/Protein	Bax protein,141,152,Gene/Protein	TNFalpha,235,243,Gene/Protein	Bcl - 2,316,323,Gene/Protein	Bax,328,331,Gene/Protein	"[{""token"": ""TNFalpha"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2 protein"", ""start_span"": 61, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""Bax protein"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 235, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 316, ""end_span"": 323, ""type"": ""Gene/Protein""}, {""token"": ""Bax"", ""start_span"": 328, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	test
Activated CD4 ( +) T cells that expressed low levels of IL - 18Ralpha could produce IFN - gamma when stimulated with the combination of IL - 12 and IL - 18, while CD4 ( +) cells which expressed high levels of IL - 18Ralpha could respond to IL - 18 alone.	IL - 18Ralpha,56,69,Gene/Protein	IFN - gamma,84,95,Gene/Protein	IL - 12,136,143,Gene/Protein	IL - 18,148,155,Gene/Protein	IL - 18Ralpha,209,222,Gene/Protein	IL - 18,240,247,Gene/Protein	"[{""token"": ""IL - 18Ralpha"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IL - 18"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 18Ralpha"", ""start_span"": 209, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""IL - 18"", ""start_span"": 240, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	test
Whereas B cell Ag receptor ( BCR) cross - linking alone stimulated increased expression of CD86, up - regulation of CD80 required dual stimulation with anti - IgM and anti - CD54.	B cell Ag receptor,8,26,Gene/Protein	BCR,29,32,Gene/Protein	CD86,91,95,Gene/Protein	CD80,116,120,Gene/Protein	anti - IgM,152,162,Gene/Protein	anti - CD54,167,178,Gene/Protein	"[{""token"": ""B cell Ag receptor"", ""start_span"": 8, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""BCR"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""anti - IgM"", ""start_span"": 152, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD54"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	test
In the present study, we demonstrated that BMP - 2 activated the mouse p21 ( CIP1 / WAF1) promoter in HS - 72 cells, and that a 29 - base pair ( b) region of the promoter ( - 1928 / - 1900 relative to the TATA box), conserved between mice and humans, was responsive to BMP - 2 as well as expression of Smad1, Smad4, and constitutively active mutants of BMP type I receptors.	BMP - 2,43,50,Gene/Protein	TATA box,205,213,Gene/Protein	BMP - 2,269,276,Gene/Protein	Smad1,302,307,Gene/Protein	Smad4,309,314,Gene/Protein	BMP type I receptors,353,373,Gene/Protein	"[{""token"": ""BMP - 2"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""BMP - 2"", ""start_span"": 269, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""Smad1"", ""start_span"": 302, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""Smad4"", ""start_span"": 309, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""BMP type I receptors"", ""start_span"": 353, ""end_span"": 373, ""type"": ""Gene/Protein""}]"	test
We also examined whether signaling by muramyl peptides involves the use of cell surface receptors, including CD14 and Toll - like receptor 2 ( TLR2) or TLR4 that are known to be signal - transducing receptors for other bacterial cell wall components.	cell surface receptors,75,97,Gene/Protein	CD14,109,113,Gene/Protein	Toll - like receptor 2,118,140,Gene/Protein	TLR2,143,147,Gene/Protein	TLR4,152,156,Gene/Protein	signal - transducing receptors,178,208,Gene/Protein	"[{""token"": ""cell surface receptors"", ""start_span"": 75, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""Toll - like receptor 2"", ""start_span"": 118, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""signal - transducing receptors"", ""start_span"": 178, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	test
When Ush, FOG - 1, FOG - 2, or mutant FOG - 2 is coexpressed with Pnr during these developmental processes, severe eye and heart phenotypes result, consistent with a conserved negative regulation of Pnr function.	Ush,5,8,Gene/Protein	FOG - 1,10,17,Gene/Protein	FOG - 2,19,26,Gene/Protein	mutant FOG - 2,31,45,Gene/Protein	Pnr,66,69,Gene/Protein	Pnr,199,202,Gene/Protein	"[{""token"": ""Ush"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""FOG - 1"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""FOG - 2"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""mutant FOG - 2"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Pnr"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Pnr"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	test
However, after inhibition of the PI3K / Akt - 1 pathway, a marked decrease in the expression of the antiapoptotic molecule Mcl - 1, but not other Bcl - 2 family members was observed, and Mcl - 1 rescued macrophages from LY294002 - induced cell death.	PI3K,33,37,Gene/Protein	Akt - 1,40,47,Gene/Protein	antiapoptotic molecule,100,122,Gene/Protein	Mcl - 1,123,130,Gene/Protein	Bcl - 2 family members,146,168,Gene/Protein	Mcl - 1,187,194,Gene/Protein	"[{""token"": ""PI3K"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Akt - 1"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""antiapoptotic molecule"", ""start_span"": 100, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Mcl - 1"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2 family members"", ""start_span"": 146, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""Mcl - 1"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	test
To test these properties in humans, we investigated the effect of troglitazone on the proinflammatory transcription factor nuclear factor - kappaB and its inhibitory protein IkappaB in mononuclear cells ( MNC) and plasma soluble intracellular adhesion molecule - 1, monocyte chemoattractant protein - 1, plasminogen activator inhibitor - 1, and C - reactive protein.	proinflammatory transcription factor nuclear factor - kappaB,86,146,Gene/Protein	inhibitory protein IkappaB,155,181,Gene/Protein	plasma soluble intracellular adhesion molecule - 1,214,264,Gene/Protein	monocyte chemoattractant protein - 1,266,302,Gene/Protein	plasminogen activator inhibitor - 1,304,339,Gene/Protein	C - reactive protein,345,365,Gene/Protein	"[{""token"": ""proinflammatory transcription factor nuclear factor - kappaB"", ""start_span"": 86, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory protein IkappaB"", ""start_span"": 155, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""plasma soluble intracellular adhesion molecule - 1"", ""start_span"": 214, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemoattractant protein - 1"", ""start_span"": 266, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""plasminogen activator inhibitor - 1"", ""start_span"": 304, ""end_span"": 339, ""type"": ""Gene/Protein""}, {""token"": ""C - reactive protein"", ""start_span"": 345, ""end_span"": 365, ""type"": ""Gene/Protein""}]"	test
Recently, invariant chain ( Ii), a major histocompatibility complex class II chaperone, as well as the transcription factors c - Rel and p65 / RelA, were found to play a role in the final antigen - independent differentiation stage of B cells in the spleen.	invariant chain,10,25,Gene/Protein	Ii,28,30,Gene/Protein	major histocompatibility complex class II chaperone,35,86,Gene/Protein	transcription factors,103,124,Gene/Protein	c - Rel,125,132,Gene/Protein	p65 / RelA,137,147,Gene/Protein	"[{""token"": ""invariant chain"", ""start_span"": 10, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Ii"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""major histocompatibility complex class II chaperone"", ""start_span"": 35, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 103, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""p65 / RelA"", ""start_span"": 137, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	test
GILZ also potently inhibited AP - 1 - driven and IL - 2 promoter - driven reporter constructs, and recombinant GILZ specifically interacted with c - Fos and c - Jun in vitro and inhibited the binding of active AP - 1 to its target DNA.	GILZ,0,4,Gene/Protein	AP - 1 - driven and IL - 2 promoter - driven reporter constructs,29,93,Gene/Protein	GILZ,111,115,Gene/Protein	c - Fos,145,152,Gene/Protein	c - Jun,157,164,Gene/Protein	active AP - 1,203,216,Gene/Protein	"[{""token"": ""GILZ"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 - driven and IL - 2 promoter - driven reporter constructs"", ""start_span"": 29, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""GILZ"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""active AP - 1"", ""start_span"": 203, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	test
Transforming growth factor ( TGF) - beta1 is well established as a critical IgA isotype switching factor and Smad molecules have been reported to act as transducers and transcriptional factors in the expression of TGF - beta1 - targeted genes.	IgA isotype switching factor,76,104,Gene/Protein	Smad molecules,109,123,Gene/Protein	transducers,153,164,Gene/Protein	transcriptional factors,169,192,Gene/Protein	TGF - beta1,214,225,Gene/Protein	genes,237,242,Gene/Protein	"[{""token"": ""IgA isotype switching factor"", ""start_span"": 76, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Smad molecules"", ""start_span"": 109, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""transducers"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional factors"", ""start_span"": 169, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""TGF - beta1"", ""start_span"": 214, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	test
Introduction of Tax into resting Kit 225 cells induced activation of the G1 / S transition regulation cascade consisting of activation of cyclin dependent kinase 2 ( CDK2) and CDK4, phosphorylation of the Rb family proteins and an increase in free E2F.	Tax,16,19,Gene/Protein	cyclin dependent kinase 2,138,163,Gene/Protein	CDK2,166,170,Gene/Protein	CDK4,176,180,Gene/Protein	Rb family proteins,205,223,Gene/Protein	E2F,248,251,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""cyclin dependent kinase 2"", ""start_span"": 138, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""CDK2"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""CDK4"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""Rb family proteins"", ""start_span"": 205, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 248, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	test
Even more, coexpression of a dominant negative version of NFAT inhibited Cot kinase - mediated COX - 2 promoter activation, whereas cotransfection of a constitutively active version of the calcium - dependent phosphatase calcineurin synergizes with Cot kinase in the up - regulation of COX - 2 promoter - driven transcription.	NFAT,58,62,Gene/Protein	Cot kinase,73,83,Gene/Protein	COX - 2 promoter,95,111,Gene/Protein	calcium - dependent phosphatase calcineurin,189,232,Gene/Protein	Cot kinase,249,259,Gene/Protein	COX - 2 promoter,286,302,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Cot kinase"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""COX - 2 promoter"", ""start_span"": 95, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""calcium - dependent phosphatase calcineurin"", ""start_span"": 189, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""Cot kinase"", ""start_span"": 249, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""COX - 2 promoter"", ""start_span"": 286, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	test
We found that ligation of CD11b or CD11c but not CD11a alpha chains of beta ( 2) integrins by antibodies or soluble CD23 ( sCD23) fusion proteins rapidly induced transcription and secretion of interleukin 8, macrophage inflammatory protein ( MIP) 1alpha, and MIP - 1beta.	CD11b,26,31,Gene/Protein	CD11c,35,40,Gene/Protein	CD11a alpha chains,49,67,Gene/Protein	antibodies,94,104,Gene/Protein	interleukin 8,193,206,Gene/Protein	MIP - 1beta,259,270,Gene/Protein	"[{""token"": ""CD11b"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""CD11c"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD11a alpha chains"", ""start_span"": 49, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 8"", ""start_span"": 193, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1beta"", ""start_span"": 259, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	test
Electrophoretic mobility shift assays indicated plasmin - induced activation of NF - kappaB; DNA - binding complexes were composed of p50, p65, and c - Rel, as shown by supershift experiments.	plasmin,48,55,Gene/Protein	NF - kappaB,80,91,Gene/Protein	DNA - binding complexes,93,116,Gene/Protein	p50,134,137,Gene/Protein	p65,139,142,Gene/Protein	c - Rel,148,155,Gene/Protein	"[{""token"": ""plasmin"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding complexes"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	test
Gads is distinguished from Grb2 and the closely related Grap protein by the presence of a 120 amino acid unique region between the SH2 domain and the carboxy terminal SH3 domain.	Gads,0,4,Gene/Protein	Grb2,27,31,Gene/Protein	Grap protein,56,68,Gene/Protein	120 amino acid unique region,90,118,Gene/Protein	SH2 domain,131,141,Gene/Protein	carboxy terminal SH3 domain,150,177,Gene/Protein	"[{""token"": ""Gads"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Grap protein"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""120 amino acid unique region"", ""start_span"": 90, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""carboxy terminal SH3 domain"", ""start_span"": 150, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	test
The intrinsic histone acetyltransferase activity of p300 is dispensable for activation of the IL - 2 promoter, and the N - terminal 743 residues contain the minimal structural requirements for synergistic transactivation of the CD28RE - TRE, the IL - 2 promoter, and endogenous IL - 2 gene expression.	p300,52,56,Gene/Protein	IL - 2 promoter,94,109,Gene/Protein	N - terminal 743 residues,119,144,Gene/Protein	CD28RE - TRE,228,240,Gene/Protein	IL - 2 promoter,246,261,Gene/Protein	IL - 2 gene,278,289,Gene/Protein	"[{""token"": ""p300"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 94, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal 743 residues"", ""start_span"": 119, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE - TRE"", ""start_span"": 228, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 246, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 278, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	test
Hypoxia inducible factor - 1 ( HIF - 1) is a constitutively expressed basic helix - loop - helix transcription factor, formed by the assembly of HIF - 1alpha and HIF - 1beta ( Arnt), that is stablized in response to hypoxia, and rapidly degraded under normoxic conditions.	Hypoxia inducible factor - 1,0,28,Gene/Protein	HIF - 1,31,38,Gene/Protein	helix - loop - helix transcription factor,76,117,Gene/Protein	HIF - 1alpha,145,157,Gene/Protein	HIF - 1beta,162,173,Gene/Protein	Arnt,176,180,Gene/Protein	"[{""token"": ""Hypoxia inducible factor - 1"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HIF - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""helix - loop - helix transcription factor"", ""start_span"": 76, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""HIF - 1alpha"", ""start_span"": 145, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""HIF - 1beta"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Arnt"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	test
Analysis of known Moloney MLV target genes in these lymphomas showed a high frequency of rearrangement at c - Myc or N - Myc ( 82%), and a significant number at Pim1 or Pim2 ( 23%), and at Pal1 / Gfi1 ( 18%).	Moloney MLV target genes,18,42,Gene/Protein	c - Myc,106,113,Gene/Protein	N - Myc,117,124,Gene/Protein	Pim1,161,165,Gene/Protein	Pim2,169,173,Gene/Protein	Pal1 / Gfi1,189,200,Gene/Protein	"[{""token"": ""Moloney MLV target genes"", ""start_span"": 18, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""N - Myc"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Pim1"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Pim2"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Pal1 / Gfi1"", ""start_span"": 189, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	test
Regulation of the helix - loop - helix proteins, E2A and Id3, by the Ras - ERK MAPK cascade.	helix - loop - helix proteins,18,47,Gene/Protein	E2A,49,52,Gene/Protein	Id3,57,60,Gene/Protein	Ras,69,72,Gene/Protein	ERK,75,78,Gene/Protein	MAPK,79,83,Gene/Protein	"[{""token"": ""helix - loop - helix proteins"", ""start_span"": 18, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""Id3"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}]"	test
Similar to transmembrane PTP, CD45, the membrane - associated populations of SHP - 1 and SHP - 2 are essentially excluded from lipid rafts, where other signaling molecules such as Lck, linker for activation of T cells, and CD3 zeta are enriched.	transmembrane PTP,11,28,Gene/Protein	CD45,30,34,Gene/Protein	SHP - 1,77,84,Gene/Protein	SHP - 2,89,96,Gene/Protein	signaling molecules,152,171,Gene/Protein	CD3 zeta,223,231,Gene/Protein	"[{""token"": ""transmembrane PTP"", ""start_span"": 11, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""SHP - 1"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""SHP - 2"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""signaling molecules"", ""start_span"": 152, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""CD3 zeta"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	test
Using triple transgenic mice expressing a TCR transgene, dominant negative ras / Mek proteins and a reporter gene construct with AP - 1 or NF - kappa B binding sites, we showed a complete lack of transcriptional activity of NF - kappa B but not AP - 1 in DP thymocytes, whereas both were transcriptionally active in mature T cells after antigenic stimulation.	TCR transgene,42,55,Gene/Protein	dominant negative ras / Mek proteins,57,93,Gene/Protein	reporter gene construct,100,123,Gene/Protein	AP - 1 or NF - kappa B binding sites,129,165,Gene/Protein	NF - kappa B,224,236,Gene/Protein	AP - 1,245,251,Gene/Protein	"[{""token"": ""TCR transgene"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative ras / Mek proteins"", ""start_span"": 57, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene construct"", ""start_span"": 100, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 or NF - kappa B binding sites"", ""start_span"": 129, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 224, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 245, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	test
Plasma tumor necrosis factor ( TNF) - alpha, soluble intercellular adhesion molecule - 1 ( sICAM - 1), monocyte chemoattractant protein - 1 ( MCP - 1), plasminogen activator inhibitor type 1 ( PAI - 1), C - reactive protein ( CRP), and interleukin ( IL) - 10 ( antiinflammatory cytokine) concentrations were also measured as mediators of inflammatory activity that are regulated by the proinflammatory transcription factor NFkappaB.	soluble intercellular adhesion molecule - 1,45,88,Gene/Protein	sICAM - 1,91,100,Gene/Protein	plasminogen activator inhibitor type 1,152,190,Gene/Protein	PAI - 1,193,200,Gene/Protein	antiinflammatory cytokine,261,286,Gene/Protein	proinflammatory transcription factor NFkappaB,386,431,Gene/Protein	"[{""token"": ""soluble intercellular adhesion molecule - 1"", ""start_span"": 45, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""sICAM - 1"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""plasminogen activator inhibitor type 1"", ""start_span"": 152, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""PAI - 1"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""antiinflammatory cytokine"", ""start_span"": 261, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""proinflammatory transcription factor NFkappaB"", ""start_span"": 386, ""end_span"": 431, ""type"": ""Gene/Protein""}]"	test
Plasma was used to measure insulin glucose, TNFalpha, sICAM, MCP - 1, PAI - 1, CRP, and IL - 10.	TNFalpha,44,52,Gene/Protein	sICAM,54,59,Gene/Protein	MCP - 1,61,68,Gene/Protein	PAI - 1,70,77,Gene/Protein	CRP,79,82,Gene/Protein	IL - 10,88,95,Gene/Protein	"[{""token"": ""TNFalpha"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""sICAM"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""PAI - 1"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	test
Given that C / EBP proteins have been shown to interact with many other transcription factors including members of the ATF / CREB family, we proceeded to determine whether an adjacent ATF / CREB binding site could affect C / EBP protein binding to C / EBP site I.	C / EBP proteins,11,27,Gene/Protein	transcription factors,72,93,Gene/Protein	ATF / CREB family,119,136,Gene/Protein	ATF / CREB binding site,184,207,Gene/Protein	C / EBP protein,221,236,Gene/Protein	C / EBP site I,248,262,Gene/Protein	"[{""token"": ""C / EBP proteins"", ""start_span"": 11, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 72, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""ATF / CREB family"", ""start_span"": 119, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""ATF / CREB binding site"", ""start_span"": 184, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP protein"", ""start_span"": 221, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP site I"", ""start_span"": 248, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	test
We show in this study that inhibition of NF - kappaB through the expression of an IkappaBalpha ( inhibitory protein that dissociates from NF - kappaB) mutant refractory to signal - induced degradation ( IkappaBalpha ( DeltaN)) interfered with the acquisition of competence to proliferate in response to IL - 4 as well as IL - 2.	NF - kappaB,41,52,Gene/Protein	IkappaBalpha,82,94,Gene/Protein	inhibitory protein,97,115,Gene/Protein	NF - kappaB,138,149,Gene/Protein	IL - 4,303,309,Gene/Protein	IL - 2,321,327,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory protein"", ""start_span"": 97, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 303, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 321, ""end_span"": 327, ""type"": ""Gene/Protein""}]"	test
CONCLUSION / INTERPRETATION: These results suggest that high glucose can upregulate intercellular adhesion molecule - 1 protein and mRNA expression but not vascular adhesion molecule - 1 expression in mesangial cells and promote leukocyte adhesion through up - regulation of intercellular adhesion molecule - 1 through osmotic effect, possibly depending on the protein kinase C nuclear factor - kappa B ( PKC - NF - kappa B) pathway.	intercellular adhesion molecule - 1,84,119,Gene/Protein	intercellular adhesion molecule - 1,275,310,Gene/Protein	protein kinase C,361,377,Gene/Protein	nuclear factor - kappa B,378,402,Gene/Protein	PKC,405,408,Gene/Protein	NF - kappa B,411,423,Gene/Protein	"[{""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 84, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 275, ""end_span"": 310, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 361, ""end_span"": 377, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 378, ""end_span"": 402, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 405, ""end_span"": 408, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 411, ""end_span"": 423, ""type"": ""Gene/Protein""}]"	test
Transcripts to RAR - alpha, RAR - beta and RXR - alpha increased after incubation with 9 - cRA whereas RXR - gamma was inhibited, suggesting a major role for RARs and RXRs in 9 - cRA - anti - inflammatory effects.	RAR - alpha,15,26,Gene/Protein	RAR - beta,28,38,Gene/Protein	RXR - alpha,43,54,Gene/Protein	RXR - gamma,103,114,Gene/Protein	RARs,158,162,Gene/Protein	RXRs,167,171,Gene/Protein	"[{""token"": ""RAR - alpha"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""RAR - beta"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""RXR - alpha"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""RXR - gamma"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	test
Notably, CD28 ligation activated p38 MAPK and CaMKIV, the kinases stimulated by CD3 engagement, suggesting that CD28 acts by increasing the activation extent of p38 MAPK and CaMKIV.	p38 MAPK,33,41,Gene/Protein	CaMKIV,46,52,Gene/Protein	kinases,58,65,Gene/Protein	CD28,112,116,Gene/Protein	p38 MAPK,161,169,Gene/Protein	CaMKIV,174,180,Gene/Protein	"[{""token"": ""p38 MAPK"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""CaMKIV"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPK"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""CaMKIV"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	test
To monitor changes in the subcellular distribution of Syk in B cells responding to BCR cross - linking, we expressed in Syk - deficient DT40 B cells a fusion protein consisting of Syk coupled to green fluorescent protein.	Syk,54,57,Gene/Protein	BCR,83,86,Gene/Protein	Syk,120,123,Gene/Protein	fusion protein,151,165,Gene/Protein	Syk,180,183,Gene/Protein	green fluorescent protein,195,220,Gene/Protein	"[{""token"": ""Syk"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""BCR"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""fusion protein"", ""start_span"": 151, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""green fluorescent protein"", ""start_span"": 195, ""end_span"": 220, ""type"": ""Gene/Protein""}]"	test
Human T - cell leukemia virus type 1 ( HTLV - 1) Tax protein induces the expression of various family members of the transcription factor AP - 1, such as c - Jun, JunD, c - Fos, and Fra - 1, at the level of RNA expression in T cells.	Tax protein,49,60,Gene/Protein	transcription factor AP - 1,117,144,Gene/Protein	c - Jun,154,161,Gene/Protein	JunD,163,167,Gene/Protein	c - Fos,169,176,Gene/Protein	Fra - 1,182,189,Gene/Protein	"[{""token"": ""Tax protein"", ""start_span"": 49, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor AP - 1"", ""start_span"": 117, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	test
The slowly migrating complex could not be supershifted with antibodies against NF - kappaB, Jun, or the transcriptional coactivators p300 or CBP.	migrating complex,11,28,Gene/Protein	antibodies,60,70,Gene/Protein	NF - kappaB,79,90,Gene/Protein	Jun,92,95,Gene/Protein	p300,133,137,Gene/Protein	CBP,141,144,Gene/Protein	"[{""token"": ""migrating complex"", ""start_span"": 11, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	test
In addition we report that BLyS binding to B cells results in the activation of NF - kappaB and the Ets family transcription factor, ELF - 1, and in the induction of mRNA for Polo - like kinase ( PLK).	BLyS,27,31,Gene/Protein	NF - kappaB,80,91,Gene/Protein	Ets family transcription factor,100,131,Gene/Protein	ELF - 1,133,140,Gene/Protein	Polo - like kinase,175,193,Gene/Protein	PLK,196,199,Gene/Protein	"[{""token"": ""BLyS"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Ets family transcription factor"", ""start_span"": 100, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""ELF - 1"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Polo - like kinase"", ""start_span"": 175, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""PLK"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	test
The promotor region contains consensus binding sites for transcription factor nuclear factor kappaB ( NF - kappaB) and activator protein - 1 ( AP - 1).	promotor region,4,19,Gene/Protein	consensus binding sites,29,52,Gene/Protein	transcription factor nuclear factor kappaB,57,99,Gene/Protein	NF - kappaB,102,113,Gene/Protein	activator protein - 1,119,140,Gene/Protein	AP - 1,143,149,Gene/Protein	"[{""token"": ""promotor region"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sites"", ""start_span"": 29, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor nuclear factor kappaB"", ""start_span"": 57, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 119, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	test
Using purified proteins, we have prepared a five - protein heterocomplex assembly system consisting of two proteins essential for heterocomplex assembly - hsp90 and hsp70 - and three proteins that act as co - chaperones to enhance assembly - Hop, hsp40, p23 [ Morishima, Y., Kanelakis, K. C., Silverstein, A. M., Dittmar, K. D., Estrada, L., and Pratt, W. B. ( 2000) J. Biol. Chem. 275, 6894 - 6900].	purified proteins,6,23,Gene/Protein	hsp90,155,160,Gene/Protein	hsp70,165,170,Gene/Protein	Hop,242,245,Gene/Protein	hsp40,247,252,Gene/Protein	p23,254,257,Gene/Protein	"[{""token"": ""purified proteins"", ""start_span"": 6, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""hsp90"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""hsp70"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""Hop"", ""start_span"": 242, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""hsp40"", ""start_span"": 247, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""p23"", ""start_span"": 254, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	test
We previously showed that Tax induces the expression of various family members of the transcription factor AP - 1 such as c - Jun, JunD, c - Fos, and Fra - 1 at the mRNA level in T cells.	Tax,26,29,Gene/Protein	transcription factor AP - 1,86,113,Gene/Protein	c - Jun,122,129,Gene/Protein	JunD,131,135,Gene/Protein	c - Fos,137,144,Gene/Protein	Fra - 1,150,157,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor AP - 1"", ""start_span"": 86, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	test
The conditionally active Raf proteins were regulated by beta - estradiol as cDNAs containing the Raf catalytic, but lacking negative - regulatory domains, were ligated to the hormone binding domain of the estrogen receptor ( deltaRaf: ER).	Raf proteins,25,37,Gene/Protein	cDNAs,76,81,Gene/Protein	Raf catalytic,97,110,Gene/Protein	negative - regulatory domains,124,153,Gene/Protein	hormone binding domain,175,197,Gene/Protein	estrogen receptor,205,222,Gene/Protein	"[{""token"": ""Raf proteins"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""cDNAs"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Raf catalytic"", ""start_span"": 97, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""negative - regulatory domains"", ""start_span"": 124, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""hormone binding domain"", ""start_span"": 175, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""estrogen receptor"", ""start_span"": 205, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	test
These results suggest that STAT3 activation is involved with IL - 4 and IL - 13 signals in human B cells along with the activation of STAT6, and that there is a unique sequence in IL - 13R alpha 1 to activate STAT3.	STAT3,27,32,Gene/Protein	IL - 4,61,67,Gene/Protein	IL - 13,72,79,Gene/Protein	STAT6,134,139,Gene/Protein	IL - 13R alpha 1,180,196,Gene/Protein	STAT3,209,214,Gene/Protein	"[{""token"": ""STAT3"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13R alpha 1"", ""start_span"": 180, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	test
Disruption of constitutive Jak3 / Stat5 activation by AG - 490 was demonstrated by inhibition of 1) tyrosine phosphorylation of Jak3, Stat5a ( Tyr ( 694)), and Stat5b ( Tyr ( 699)); 2) serine phosphorylation of Stat5a ( Ser ( 726)) as determined by a novel phosphospecific Ab; and 3) Stat5a / b DNA binding to the Stat5 - responsive beta - casein promoter.	Jak3,27,31,Gene/Protein	Stat5a,134,140,Gene/Protein	Stat5b,160,166,Gene/Protein	Stat5a,211,217,Gene/Protein	phosphospecific Ab,257,275,Gene/Protein	Stat5 - responsive beta - casein promoter,314,355,Gene/Protein	"[{""token"": ""Jak3"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Stat5a"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""Stat5b"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""Stat5a"", ""start_span"": 211, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""phosphospecific Ab"", ""start_span"": 257, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""Stat5 - responsive beta - casein promoter"", ""start_span"": 314, ""end_span"": 355, ""type"": ""Gene/Protein""}]"	test
Transient expression of actively mutated Fyn, having Phe - 528 instead of Tyr - 528 or Thr - 338 instead of Ile - 338, in Jurkat T - cells stimulated the serum response element ( SRE), 12 - O - tetradecanoyl - phorbol - 13 - acetate response element, cyclic AMP response element, and c - fos promoter.	Fyn,41,44,Gene/Protein	stimulated the serum response element,139,176,Gene/Protein	SRE,179,182,Gene/Protein	12 - O - tetradecanoyl - phorbol - 13 - acetate response element,185,249,Gene/Protein	cyclic AMP response element,251,278,Gene/Protein	c - fos promoter,284,300,Gene/Protein	"[{""token"": ""Fyn"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""stimulated the serum response element"", ""start_span"": 139, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""SRE"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""12 - O - tetradecanoyl - phorbol - 13 - acetate response element"", ""start_span"": 185, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""cyclic AMP response element"", ""start_span"": 251, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""c - fos promoter"", ""start_span"": 284, ""end_span"": 300, ""type"": ""Gene/Protein""}]"	test
We conclude that expression of the human IL - 3 gene requires the AP - 1 and Elf - 1 binding sites; however, unlike other previously characterized cytokine genes such as IL - 2, the AP - 1 and Elf - 1 factors can bind independently in the IL - 3 gene.	human IL - 3 gene,35,52,Gene/Protein	AP - 1 and Elf - 1 binding sites,66,98,Gene/Protein	cytokine genes,147,161,Gene/Protein	IL - 2,170,176,Gene/Protein	AP - 1 and Elf - 1 factors,182,208,Gene/Protein	IL - 3 gene,239,250,Gene/Protein	"[{""token"": ""human IL - 3 gene"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 and Elf - 1 binding sites"", ""start_span"": 66, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 147, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 and Elf - 1 factors"", ""start_span"": 182, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 gene"", ""start_span"": 239, ""end_span"": 250, ""type"": ""Gene/Protein""}]"	test
In T lymphocytes, triggering of the T cell receptor ( TCR) induces several signaling cascades which ultimately synergize to induce the activity of the nuclear factor of activated T cells ( NFAT), a DNA binding complex critical to the inducibility and T cell specificity of the T cell growth factor interleukin 2.	T cell receptor,36,51,Gene/Protein	TCR,54,57,Gene/Protein	nuclear factor,151,165,Gene/Protein	DNA binding complex,198,217,Gene/Protein	T cell growth factor,277,297,Gene/Protein	interleukin 2,298,311,Gene/Protein	"[{""token"": ""T cell receptor"", ""start_span"": 36, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 151, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding complex"", ""start_span"": 198, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""T cell growth factor"", ""start_span"": 277, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 298, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	test
Both PTK inhibitors also reduced the LPS activation of nuclear factor - kappa B ( NF - kappa B), which is a transcription factor involved in the expression of cytokine genes such as IL - 6 and TNF - alpha.	nuclear factor - kappa B,55,79,Gene/Protein	NF - kappa B,82,94,Gene/Protein	transcription factor,108,128,Gene/Protein	cytokine genes,159,173,Gene/Protein	IL - 6,182,188,Gene/Protein	TNF - alpha,193,204,Gene/Protein	"[{""token"": ""nuclear factor - kappa B"", ""start_span"": 55, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 108, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 159, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	test
In summary, these findings suggest that protein kinase C and protein kinase A appear to have selective effects in the LPS induction of cytokines, whereas PTK is required for LPS induction of a broad spectrum of cytokines and NF - kappa B activation in monocytes.	protein kinase C,40,56,Gene/Protein	protein kinase A,61,77,Gene/Protein	cytokines,135,144,Gene/Protein	PTK,154,157,Gene/Protein	cytokines,211,220,Gene/Protein	NF - kappa B,225,237,Gene/Protein	"[{""token"": ""protein kinase C"", ""start_span"": 40, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 211, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 225, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	test
Results obtained from the binding competition assay, nevertheless, suggest that NF - P1 and NF - P2 are related to but distinct from Ets proteins, e. g., Ets - 1, Ets - 2, and NF - AT / Elf - 1, known to be expressed in T cells.	NF - P1,80,87,Gene/Protein	NF - P2,92,99,Gene/Protein	Ets proteins,133,145,Gene/Protein	Ets - 1,154,161,Gene/Protein	Ets - 2,163,170,Gene/Protein	NF - AT / Elf - 1,176,193,Gene/Protein	"[{""token"": ""NF - P1"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NF - P2"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Ets proteins"", ""start_span"": 133, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 2"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT / Elf - 1"", ""start_span"": 176, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	test
Double immunostaining with the anti - ER MAb and with specific MAb to detect different macrophage antigens ( Ber - MAC3, MAC387, CD68) and CD8 + T cell subsets ( CD29 +, CD45RO + and CD29 -, CD45RO -) was performed.	anti - ER MAb,31,44,Gene/Protein	specific MAb,54,66,Gene/Protein	macrophage antigens,87,106,Gene/Protein	Ber - MAC3,109,119,Gene/Protein	MAC387,121,127,Gene/Protein	CD68,129,133,Gene/Protein	"[{""token"": ""anti - ER MAb"", ""start_span"": 31, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""specific MAb"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""macrophage antigens"", ""start_span"": 87, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Ber - MAC3"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""MAC387"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	test
To further dissect p95vav involvement in TCR signaling, we analyzed various Jurkat mutants deficient in TCR signaling function or TCR expression and showed that an intact TCR signaling pathway is required for p95vav to function.	p95vav,19,25,Gene/Protein	TCR,41,44,Gene/Protein	TCR,104,107,Gene/Protein	TCR,130,133,Gene/Protein	TCR,171,174,Gene/Protein	p95vav,209,215,Gene/Protein	"[{""token"": ""p95vav"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""p95vav"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
In erythroid cells most of the transcription activity was contained in a 150 bp promoter fragment with binding sites for transcription factors AP2, Sp1 and the erythroid - specific GATA - 1.	150 bp promoter,73,88,Gene/Protein	binding sites,103,116,Gene/Protein	transcription factors,121,142,Gene/Protein	AP2,143,146,Gene/Protein	Sp1,148,151,Gene/Protein	erythroid - specific GATA - 1,160,189,Gene/Protein	"[{""token"": ""150 bp promoter"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 121, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""AP2"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific GATA - 1"", ""start_span"": 160, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
NO also decreased the endothelial expression of other leukocyte adhesion molecules ( E - selectin and to a lesser extent, intercellular adhesion molecule - 1) and secretable cytokines ( IL - 6 and IL - 8).	leukocyte adhesion molecules,54,82,Gene/Protein	E - selectin,85,97,Gene/Protein	intercellular adhesion molecule - 1,122,157,Gene/Protein	cytokines,174,183,Gene/Protein	IL - 6,186,192,Gene/Protein	IL - 8,197,203,Gene/Protein	"[{""token"": ""leukocyte adhesion molecules"", ""start_span"": 54, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 122, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 186, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
However, unlike another tumor suppressor protein, p53, Rb did not have any significant effect on basal levels of transcription, suggesting that Rb specifically interacts with IE2 rather than other cellular factors involved in the general transcription machinery.	tumor suppressor protein,24,48,Gene/Protein	p53,50,53,Gene/Protein	Rb,55,57,Gene/Protein	Rb,144,146,Gene/Protein	IE2,175,178,Gene/Protein	cellular factors,197,213,Gene/Protein	"[{""token"": ""tumor suppressor protein"", ""start_span"": 24, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 55, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""IE2"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""cellular factors"", ""start_span"": 197, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Recently, transcription factors known as STATs ( signal transducers and activators of transcription) have been shown to be tyrosine phosphorylated and activated in response to a number of cytokines that bind hematopoietin receptors and activate JAK kinases.	transcription factors,10,31,Gene/Protein	STATs,41,46,Gene/Protein	signal transducers and activators of transcription,49,99,Gene/Protein	cytokines,188,197,Gene/Protein	hematopoietin receptors,208,231,Gene/Protein	JAK kinases,245,256,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 10, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 49, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""hematopoietin receptors"", ""start_span"": 208, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
The AP - 1 binding proteins contained c - Jun, Jun - D, and Fra - 1, but marginal amounts of Jun - B and c - Fos.	AP - 1 binding proteins,4,27,Gene/Protein	c - Jun,38,45,Gene/Protein	Jun - D,47,54,Gene/Protein	Fra - 1,60,67,Gene/Protein	Jun - B,93,100,Gene/Protein	c - Fos,105,112,Gene/Protein	"[{""token"": ""AP - 1 binding proteins"", ""start_span"": 4, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Jun - D"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""Jun - B"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
The CK - 1 / CD28RE of GM - CSF shows a high degree of similarity to the IL - 2 CD28RE and the IL - 3 gene also contains a related region.	CK - 1,4,10,Gene/Protein	/ CD28RE,11,19,Gene/Protein	GM - CSF,23,31,Gene/Protein	IL - 2,73,79,Gene/Protein	CD28RE,80,86,Gene/Protein	IL - 3 gene,95,106,Gene/Protein	"[{""token"": ""CK - 1"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""/ CD28RE"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3 gene"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}]"	train
To test these hypotheses, we studied several tat mutants, including two stop codon mutants and one deletion mutant using replication - competent HIV - 1 constructs carrying wild - type or mutant LTRs with modifications in the NF - kappa B and / or Sp1 binding sites.	tat mutants,45,56,Gene/Protein	stop codon mutants,72,90,Gene/Protein	deletion mutant,99,114,Gene/Protein	replication - competent HIV - 1 constructs,121,163,Gene/Protein	wild - type or mutant LTRs,173,199,Gene/Protein	NF - kappa B and / or Sp1 binding sites,226,265,Gene/Protein	"[{""token"": ""tat mutants"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""stop codon mutants"", ""start_span"": 72, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""deletion mutant"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""replication - competent HIV - 1 constructs"", ""start_span"": 121, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""wild - type or mutant LTRs"", ""start_span"": 173, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B and / or Sp1 binding sites"", ""start_span"": 226, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
Core binding factor ( CBF), also known as polyomavirus enhancer - binding protein 2 and SL3 enhancer factor 1, is a mammalian transcription factor that binds to an element termed the core within the enhancers of the murine leukemia virus family of retroviruses.	Core binding factor,0,19,Gene/Protein	CBF,22,25,Gene/Protein	polyomavirus enhancer - binding protein 2,42,83,Gene/Protein	SL3 enhancer factor 1,88,109,Gene/Protein	mammalian transcription factor,116,146,Gene/Protein	enhancers,199,208,Gene/Protein	"[{""token"": ""Core binding factor"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""CBF"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""polyomavirus enhancer - binding protein 2"", ""start_span"": 42, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""SL3 enhancer factor 1"", ""start_span"": 88, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""mammalian transcription factor"", ""start_span"": 116, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""enhancers"", ""start_span"": 199, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
A truncated Tat protein ( Tat1 - 72), known to transactivate the HIV - 1 long terminal repeat ( LTR), no longer affected Mn - SOD expression, the cellular redox state or TNF - mediated cytotoxicity.	Tat protein,12,23,Gene/Protein	Tat1 - 72,26,35,Gene/Protein	HIV - 1 long terminal repeat,65,93,Gene/Protein	LTR,96,99,Gene/Protein	Mn - SOD,121,129,Gene/Protein	TNF,170,173,Gene/Protein	"[{""token"": ""Tat protein"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""Tat1 - 72"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 long terminal repeat"", ""start_span"": 65, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Mn - SOD"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
We cultured M - TAT cells long term ( > 1 year) in the continuous presence of erythropoietin ( EPO), granulocyte - macrophage colony - stimulating factor ( GM - CSF), or stem cell factor ( SCF).	erythropoietin,78,92,Gene/Protein	EPO,95,98,Gene/Protein	granulocyte - macrophage colony - stimulating factor,101,153,Gene/Protein	GM - CSF,156,164,Gene/Protein	stem cell factor,170,186,Gene/Protein	SCF,189,192,Gene/Protein	"[{""token"": ""erythropoietin"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 101, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""stem cell factor"", ""start_span"": 170, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
These redox - regulated enzymes trigger signal cascades for NF kappa B activation and transduce signals from the T cell antigen receptor, from CD4 and CD8 molecules, and from the IL - 2 receptor beta - chain.	redox - regulated enzymes,6,31,Gene/Protein	NF kappa B,60,70,Gene/Protein	T cell antigen receptor,113,136,Gene/Protein	CD4,143,146,Gene/Protein	CD8 molecules,151,164,Gene/Protein	IL - 2 receptor beta - chain,179,207,Gene/Protein	"[{""token"": ""redox - regulated enzymes"", ""start_span"": 6, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 113, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""CD8 molecules"", ""start_span"": 151, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor beta - chain"", ""start_span"": 179, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
Although we detected no IL - 2 mRNA in ALD - treated cells, the nuclei of these cells contain proteins capable of binding to three regulatory sequences in the IL - 2 promoter region: NFAT, NF kappa B, and AP - 1.	IL - 2 mRNA,24,35,Gene/Protein	regulatory sequences,131,151,Gene/Protein	IL - 2 promoter region,159,181,Gene/Protein	NFAT,183,187,Gene/Protein	NF kappa B,189,199,Gene/Protein	AP - 1,205,211,Gene/Protein	"[{""token"": ""IL - 2 mRNA"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""regulatory sequences"", ""start_span"": 131, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter region"", ""start_span"": 159, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Surprisingly, even p65, but not c - rel, was phosphorylated after induction in vivo, suggesting that TNF - alpha selectively activates only specific NF - kappa B heteromers and that modifications regulate not only I kappa B molecules but also NF - kappa B molecules.	p65,19,22,Gene/Protein	c - rel,32,39,Gene/Protein	TNF - alpha,101,112,Gene/Protein	NF - kappa B,149,161,Gene/Protein	I kappa B molecules,214,233,Gene/Protein	NF - kappa B,243,255,Gene/Protein	"[{""token"": ""p65"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""c - rel"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 149, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B molecules"", ""start_span"": 214, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 243, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
The IL - 2 octamer motif is a composite cis - element which binds Oct - 1 and Oct - 2 as well as a TPA / Ca ( 2 +) - inducible nuclear factor, previously termed octamer - associated protein ( OAP40).	IL - 2 octamer motif,4,24,Gene/Protein	cis - element,40,53,Gene/Protein	Oct - 1,66,73,Gene/Protein	Oct - 2,78,85,Gene/Protein	octamer - associated protein,161,189,Gene/Protein	OAP40,192,197,Gene/Protein	"[{""token"": ""IL - 2 octamer motif"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""cis - element"", ""start_span"": 40, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""octamer - associated protein"", ""start_span"": 161, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""OAP40"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Furthermore, retinoic acid receptor ( RAR) alpha is able to inhibit in vitro the formation of the complex between the nuclear AP - 1 / OAP and its specific binding site, resulting in the interference with Oct - 2 - dependent cis - regulatory function of this AP - 1 element.	retinoic acid receptor,13,35,Gene/Protein	RAR,38,41,Gene/Protein	AP - 1,126,132,Gene/Protein	/ OAP,133,138,Gene/Protein	Oct - 2,205,212,Gene/Protein	AP - 1,259,265,Gene/Protein	"[{""token"": ""retinoic acid receptor"", ""start_span"": 13, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""RAR"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""/ OAP"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 259, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
The EBV - encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF - kappa B site but not the intact element, suggesting that the latent membrane protein 1 - driven activation of NF - kappa B / Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.	EBV - encoded latent membrane protein 1,4,43,Gene/Protein	CD48,87,91,Gene/Protein	NF - kappa B site,92,109,Gene/Protein	intact element,122,136,Gene/Protein	latent membrane protein 1,158,183,Gene/Protein	NF - kappa B / Rel,207,225,Gene/Protein	"[{""token"": ""EBV - encoded latent membrane protein 1"", ""start_span"": 4, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD48"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 92, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""intact element"", ""start_span"": 122, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""latent membrane protein 1"", ""start_span"": 158, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 207, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
Southern analysis using a human progesterone receptor ( hPR) cDNA probe identified a germline TaqI restriction fragment length polymorphism ( RFLP) defined by two alleles: T1, represented by a 2. 7 kb fragment; and T2, represented by a 1. 9 kb fragment and characterised by an additional TaqI restriction site with respect to T1.	germline TaqI restriction fragment length polymorphism,85,139,Gene/Protein	RFLP,142,146,Gene/Protein	T1,172,174,Gene/Protein	T2,215,217,Gene/Protein	TaqI restriction site,288,309,Gene/Protein	T1,326,328,Gene/Protein	"[{""token"": ""germline TaqI restriction fragment length polymorphism"", ""start_span"": 85, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""RFLP"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""T1"", ""start_span"": 172, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""T2"", ""start_span"": 215, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""TaqI restriction site"", ""start_span"": 288, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""T1"", ""start_span"": 326, ""end_span"": 328, ""type"": ""Gene/Protein""}]"	train
Biochemical studies demonstrate that OBF - 1 has no intrinsic DNA - binding activity and recognizes the POU domains of Oct - 1 and Oct - 2, but not those of Oct - 4 and Oct - 6.	OBF - 1,37,44,Gene/Protein	POU domains,104,115,Gene/Protein	Oct - 1,119,126,Gene/Protein	Oct - 2,131,138,Gene/Protein	Oct - 4,157,164,Gene/Protein	Oct - 6,169,176,Gene/Protein	"[{""token"": ""OBF - 1"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""POU domains"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 4"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 6"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
Steel factor is one of the growth factors that controls the proliferation and differentiation of hematopoietic cells and SCL, also known as Tcl - 5 or Tal - 1, is a transcription factor involved in erythropoiesis.	Steel factor,0,12,Gene/Protein	growth factors,27,41,Gene/Protein	SCL,121,124,Gene/Protein	Tcl - 5,140,147,Gene/Protein	Tal - 1,151,158,Gene/Protein	transcription factor,165,185,Gene/Protein	"[{""token"": ""Steel factor"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""growth factors"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""Tcl - 5"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Tal - 1"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 165, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
Transactivation of the ICAM - I promoter by TaxI was further shown by co - transfection of a CAT reporter construct with the ICAM - I promoter and a plasmid expressing TaxI.	ICAM - I promoter,23,40,Gene/Protein	TaxI,44,48,Gene/Protein	CAT reporter construct,93,115,Gene/Protein	ICAM - I promoter,125,142,Gene/Protein	plasmid,149,156,Gene/Protein	TaxI,168,172,Gene/Protein	"[{""token"": ""ICAM - I promoter"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""TaxI"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CAT reporter construct"", ""start_span"": 93, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - I promoter"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""plasmid"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TaxI"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Detailed structural analysis of the first 12 cDNAs ( HZF 1 - 10) and a partial characterization of HZF 11 - 42 revealed that a common feature of human Kruppel - related zinc finger proteins is the presence of tandem arrays of zinc fingers ranging in number from 3 to over 20 that are preferentially located in the carboxy - terminal regions of the proteins.	cDNAs,45,50,Gene/Protein	HZF 1 - 10,53,63,Gene/Protein	HZF 11 - 42,99,110,Gene/Protein	human Kruppel - related zinc finger proteins,145,189,Gene/Protein	zinc fingers,226,238,Gene/Protein	carboxy - terminal regions,314,340,Gene/Protein	"[{""token"": ""cDNAs"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""HZF 1 - 10"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""HZF 11 - 42"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""human Kruppel - related zinc finger proteins"", ""start_span"": 145, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""zinc fingers"", ""start_span"": 226, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""carboxy - terminal regions"", ""start_span"": 314, ""end_span"": 340, ""type"": ""Gene/Protein""}]"	train
Three binding sites for the Ets family of transcription factors are found in this region: two adjacent sites at positions - 50 and - 54 bp and a more 5 ' site at position - 67 bp.	binding sites,6,19,Gene/Protein	Ets family,28,38,Gene/Protein	transcription factors,42,63,Gene/Protein	- 50 and - 54 bp,122,138,Gene/Protein	5 ' site,150,158,Gene/Protein	- 67 bp,171,178,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 6, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Ets family"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""- 50 and - 54 bp"", ""start_span"": 122, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""5 ' site"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""- 67 bp"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Gene for a tissue - specific transcriptional activator ( EBF or Olf - 1), expressed in early B lymphocytes, adipocytes, and olfactory neurons, is located on human chromosome 5, band q34, and proximal mouse chromosome 11.	tissue - specific transcriptional activator,11,54,Gene/Protein	EBF,57,60,Gene/Protein	Olf - 1,64,71,Gene/Protein	human chromosome 5,157,175,Gene/Protein	band q34,177,185,Gene/Protein	proximal mouse chromosome 11,191,219,Gene/Protein	"[{""token"": ""tissue - specific transcriptional activator"", ""start_span"": 11, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""EBF"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Olf - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 5"", ""start_span"": 157, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""band q34"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""proximal mouse chromosome 11"", ""start_span"": 191, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
By Southern hybridization analyses of somatic cell hybrid panels with murine cDNA probe, fluorescence chromosomal in situ hybridization ( FISH) of human genomic clones, and analysis of recombinant inbred mouse strains, we have found single sites for EBF homologous sequences on human Chromosome ( Chr) 5, band q34, and on proximal mouse Chr 11, in an evolutionarily conserved region.	murine cDNA probe,70,87,Gene/Protein	human genomic clones,147,167,Gene/Protein	EBF homologous sequences,250,274,Gene/Protein	band q34,305,313,Gene/Protein	proximal mouse Chr 11,322,343,Gene/Protein	evolutionarily conserved region,351,382,Gene/Protein	"[{""token"": ""murine cDNA probe"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""human genomic clones"", ""start_span"": 147, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""EBF homologous sequences"", ""start_span"": 250, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""band q34"", ""start_span"": 305, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""proximal mouse Chr 11"", ""start_span"": 322, ""end_span"": 343, ""type"": ""Gene/Protein""}, {""token"": ""evolutionarily conserved region"", ""start_span"": 351, ""end_span"": 382, ""type"": ""Gene/Protein""}]"	train
In contrast, cotransfection with a combination of NF - kappa B and AP - 1 significantly augmented transcription from the GM - CSF promoter containing the GM - kappa B / GC - box and the CLE0 ( AP - 1 / NF - AT).	NF - kappa B,50,62,Gene/Protein	AP - 1,67,73,Gene/Protein	GM - CSF promoter,121,138,Gene/Protein	GM - kappa B / GC - box,154,177,Gene/Protein	CLE0,186,190,Gene/Protein	AP - 1 / NF - AT,193,209,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 121, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""GM - kappa B / GC - box"", ""start_span"": 154, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""CLE0"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 / NF - AT"", ""start_span"": 193, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
This bipartite motif consists of an N - terminal POU - specific domain ( POUs), a flexible linker, and a C - terminal POU - specific homeodomain ( POUHD).	bipartite motif,5,20,Gene/Protein	N - terminal POU - specific domain,36,70,Gene/Protein	POUs,73,77,Gene/Protein	flexible linker,82,97,Gene/Protein	C - terminal POU - specific homeodomain,105,144,Gene/Protein	POUHD,147,152,Gene/Protein	"[{""token"": ""bipartite motif"", ""start_span"": 5, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal POU - specific domain"", ""start_span"": 36, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""POUs"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""flexible linker"", ""start_span"": 82, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal POU - specific homeodomain"", ""start_span"": 105, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""POUHD"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Fos kinase phosphorylates c - Fos at a site near the C - terminus, as well as a peptide derived from this region ( residues 359 - 370, RKGSSSNEPSSD), and Fos peptide competitively inhibited c - Fos phosphorylation.	Fos kinase,0,10,Gene/Protein	c - Fos,26,33,Gene/Protein	C - terminus,53,65,Gene/Protein	residues 359 - 370,115,133,Gene/Protein	RKGSSSNEPSSD,135,147,Gene/Protein	c - Fos,190,197,Gene/Protein	"[{""token"": ""Fos kinase"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""residues 359 - 370"", ""start_span"": 115, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""RKGSSSNEPSSD"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
The t ( 17; 19) translocation in acute lymphoblastic leukemias results in creation of E2A - hepatic leukemia factor ( HLF) chimeric proteins that contain the DNA - binding and protein dimerization domains of the basic leucine zipper ( bZIP) protein HLF fused to a portion of E2A proteins with transcriptional activation properties.	E2A - hepatic leukemia factor,86,115,Gene/Protein	HLF,118,121,Gene/Protein	chimeric proteins,123,140,Gene/Protein	DNA - binding and protein dimerization domains,158,204,Gene/Protein	HLF,249,252,Gene/Protein	E2A proteins,275,287,Gene/Protein	"[{""token"": ""E2A - hepatic leukemia factor"", ""start_span"": 86, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""chimeric proteins"", ""start_span"": 123, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding and protein dimerization domains"", ""start_span"": 158, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""E2A proteins"", ""start_span"": 275, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Antibodies against the NF - kappa B and Rel proteins and UV cross - linking studies revealed the presence of c - Rel and p65 and the absence of p50 in the TF complex and further showed that c - Rel / p65 heterodimers selectively bound to the TF kappa B - like site.	NF - kappa B,23,35,Gene/Protein	c - Rel,109,116,Gene/Protein	p50,144,147,Gene/Protein	TF complex,155,165,Gene/Protein	c - Rel / p65 heterodimers,190,216,Gene/Protein	TF kappa B - like site,242,264,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 23, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""TF complex"", ""start_span"": 155, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel / p65 heterodimers"", ""start_span"": 190, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""TF kappa B - like site"", ""start_span"": 242, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
On the basis of cross - linking results with 21 different EMCV IRES fragments and cytoplasmic HeLa extract or rabbit reticulocyte lysate as the source of polypeptides, consensus binding sites for p52, p57, p70, and p100 are proposed.	EMCV IRES fragments,58,77,Gene/Protein	consensus binding sites,168,191,Gene/Protein	p52,196,199,Gene/Protein	p57,201,204,Gene/Protein	p70,206,209,Gene/Protein	p100,215,219,Gene/Protein	"[{""token"": ""EMCV IRES fragments"", ""start_span"": 58, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sites"", ""start_span"": 168, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""p57"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""p70"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
The gene encoding the 105 - kDa protein ( p105) precursor of the p50 subunit of transcription factor NF - kappa B also encodes a p70 I kappa B protein, I kappa B gamma, which is identical to the C - terminal 607 amino acids of p105.	p50,65,68,Gene/Protein	NF - kappa B,101,113,Gene/Protein	p70 I kappa B protein,129,150,Gene/Protein	I kappa B gamma,152,167,Gene/Protein	C - terminal 607 amino acids,195,223,Gene/Protein	p105,227,231,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""p70 I kappa B protein"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal 607 amino acids"", ""start_span"": 195, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
One 63 - kDa isoform, termed I kappa B gamma - 1, which lacks 59 amino acids C - terminal to ankyrin repeat 7, has a novel 35 - amino acid C terminus encoded by an alternative reading frame of the p105 gene.	63 - kDa isoform,4,20,Gene/Protein	I kappa B gamma - 1,29,48,Gene/Protein	ankyrin repeat 7,93,109,Gene/Protein	35 - amino acid C terminus,123,149,Gene/Protein	alternative reading frame,164,189,Gene/Protein	p105 gene,197,206,Gene/Protein	"[{""token"": ""63 - kDa isoform"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 1"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin repeat 7"", ""start_span"": 93, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""35 - amino acid C terminus"", ""start_span"": 123, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""alternative reading frame"", ""start_span"": 164, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""p105 gene"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
The absence in I kappa B gamma - 1 and I kappa B gamma - 2 of a protein kinase A site whose phosphorylation modulates p70 I kappa B gamma inhibitory activity suggests that alternative RNA splicing may be used to generate I kappa B gamma isoforms that respond differently to intracellular signals.	I kappa B gamma - 1,15,34,Gene/Protein	I kappa B gamma - 2,39,58,Gene/Protein	protein kinase A site,64,85,Gene/Protein	p70,118,121,Gene/Protein	I kappa B gamma,122,137,Gene/Protein	I kappa B gamma isoforms,221,245,Gene/Protein	"[{""token"": ""I kappa B gamma - 1"", ""start_span"": 15, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma - 2"", ""start_span"": 39, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A site"", ""start_span"": 64, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""p70"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B gamma isoforms"", ""start_span"": 221, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Finally, we show that a DNA fragment containing the human GATA3 transcription unit, 3 kb upstream from the initiation site and 4 kb downstream from the polyadenylation site, displays T - cell specificity.	DNA fragment,24,36,Gene/Protein	human GATA3 transcription unit,52,82,Gene/Protein	3 kb upstream,84,97,Gene/Protein	initiation site,107,122,Gene/Protein	4 kb downstream,127,142,Gene/Protein	polyadenylation site,152,172,Gene/Protein	"[{""token"": ""DNA fragment"", ""start_span"": 24, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""human GATA3 transcription unit"", ""start_span"": 52, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""3 kb upstream"", ""start_span"": 84, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""initiation site"", ""start_span"": 107, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""4 kb downstream"", ""start_span"": 127, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""polyadenylation site"", ""start_span"": 152, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
LBR ' s nucleoplasmic domain is encoded by exons 1 - 4, and its hydrophobic domain, with eight putative transmembrane segments, is encoded by exons 5 - 13.	LBR,0,3,Gene/Protein	nucleoplasmic domain,8,28,Gene/Protein	exons 1 - 4,43,54,Gene/Protein	hydrophobic domain,64,82,Gene/Protein	transmembrane segments,104,126,Gene/Protein	exons 5 - 13,142,154,Gene/Protein	"[{""token"": ""LBR"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""nucleoplasmic domain"", ""start_span"": 8, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""exons 1 - 4"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""hydrophobic domain"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane segments"", ""start_span"": 104, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""exons 5 - 13"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
LIF induces the production of other cytokines in monocytes but its effects on HIV replication were not inhibited by antibodies to IL - 1, TNF, or IL - 6.	LIF,0,3,Gene/Protein	cytokines,36,45,Gene/Protein	antibodies,116,126,Gene/Protein	IL - 1,130,136,Gene/Protein	TNF,138,141,Gene/Protein	IL - 6,146,152,Gene/Protein	"[{""token"": ""LIF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 116, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
In this study we investigated the effect of IL - 4 on the expression of cytokine genes in monocytes evoked by other T - helper cell cytokines: IL - 2, IL - 3, and GM - CSF.	IL - 4,44,50,Gene/Protein	cytokine genes,72,86,Gene/Protein	T - helper cell cytokines,116,141,Gene/Protein	IL - 2,143,149,Gene/Protein	IL - 3,151,157,Gene/Protein	GM - CSF,163,171,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""T - helper cell cytokines"", ""start_span"": 116, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
IL - 4 did not exert significant influence on the induction of expression of IL - 1 - RA or various CSFs by IL - 2, IL - 3, and GM - CSF.	IL - 4,0,6,Gene/Protein	IL - 1 - RA,77,88,Gene/Protein	CSFs,100,104,Gene/Protein	IL - 2,108,114,Gene/Protein	IL - 3,116,122,Gene/Protein	GM - CSF,128,136,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 - RA"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""CSFs"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
Secretion of IL - 2 and TNF - alpha, surface expression of IL - 2R, and DNA - binding activity of NF - kappa B and AP - 1 ( Fos / Jun) complex in response to phorbol myristate acetate, TNF - alpha, or immobilized antibodies to CD3 were monitored.	IL - 2,13,19,Gene/Protein	TNF - alpha,24,35,Gene/Protein	IL - 2R,59,66,Gene/Protein	NF - kappa B,98,110,Gene/Protein	TNF - alpha,185,196,Gene/Protein	CD3,227,230,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 98, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Based on peptide matches covering more than 10% of the TBP7 sequence, and the fact that the migration of S6 on SDS - PAGE is consistent with the estimated molecular mass for TBP7, we conclude that subunit 6 of the 26S protease is TBP7.	TBP7,55,59,Gene/Protein	S6,105,107,Gene/Protein	TBP7,174,178,Gene/Protein	subunit 6,197,206,Gene/Protein	26S protease,214,226,Gene/Protein	TBP7,230,234,Gene/Protein	"[{""token"": ""TBP7"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""S6"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TBP7"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""subunit 6"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""26S protease"", ""start_span"": 214, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""TBP7"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
The Tax protein of HTLV - I, a positive transcriptional activator of HTLV - I gene expression, is a viral oncogene that also increases transcription of cellular genes including GM - CSF, IL - 2R alpha and IL - 2.	Tax protein,4,15,Gene/Protein	positive transcriptional activator,31,65,Gene/Protein	cellular genes,152,166,Gene/Protein	GM - CSF,177,185,Gene/Protein	IL - 2R alpha,187,200,Gene/Protein	IL - 2,205,211,Gene/Protein	"[{""token"": ""Tax protein"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""positive transcriptional activator"", ""start_span"": 31, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""cellular genes"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 187, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Both sIgM - and sIgD - crosslinking with antibodies induced elevation of cAMP levels, phosphatidylinositol turnover, PKC activation and expression of Egr - 1 and c - fos mRNA, although sIgM - crosslinking was more effective than sIgD - crosslinking, presumably due to the higher expression of sIgM than of sIgD.	PKC,117,120,Gene/Protein	Egr - 1 and c - fos mRNA,150,174,Gene/Protein	sIgM,185,189,Gene/Protein	sIgD,229,233,Gene/Protein	sIgM,293,297,Gene/Protein	sIgD,306,310,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Egr - 1 and c - fos mRNA"", ""start_span"": 150, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""sIgM"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""sIgD"", ""start_span"": 229, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""sIgM"", ""start_span"": 293, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""sIgD"", ""start_span"": 306, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes, lymphocytes, and polymorphonucleate cells, but is markedly induced by interferon; that PML and PML / RAR alpha expression is augmented by interferon in the NB4 APL cell line, which carries the t ( 15; 17), and in APL blasts from patients; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA; that interferons alone have minimal maturation effect on NB4 cells; and, finally, that interferon gamma, but not alpha or beta, induces maturation and growth suppression of NB4 cells with de novo retinoid resistance, and partially restores RA response.	PML,20,23,Gene/Protein	interferon,177,187,Gene/Protein	PML,194,197,Gene/Protein	PML / RAR alpha,202,217,Gene/Protein	interferon,245,255,Gene/Protein	interferon,351,361,Gene/Protein	"[{""token"": ""PML"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 177, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""PML"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""PML / RAR alpha"", ""start_span"": 202, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 245, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 351, ""end_span"": 361, ""type"": ""Gene/Protein""}]"	train
Nevertheless, the simian EBV LMP1s retain most functions in common with EBV LMP1, including the ability to induce NF - ( kappa) B activity in human cells, to bind the tumor necrosis factor - associated factor 3 ( TRAF3) in vitro, and to induce expression of tumor necrosis factor - responsive genes, such as ICAM1, in human B lymphocytes.	simian EBV LMP1s,18,34,Gene/Protein	LMP1,76,80,Gene/Protein	tumor necrosis factor - associated factor 3,167,210,Gene/Protein	TRAF3,213,218,Gene/Protein	tumor necrosis factor - responsive genes,258,298,Gene/Protein	ICAM1,308,313,Gene/Protein	"[{""token"": ""simian EBV LMP1s"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - associated factor 3"", ""start_span"": 167, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""TRAF3"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - responsive genes"", ""start_span"": 258, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""ICAM1"", ""start_span"": 308, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
Rather, IFN - gamma antagonized the effect of IL - 4 and suppressed the DC and MGC formation induced by GM - CSF + IL - 4 and M - CSF + IL - 4, respectively.	IFN - gamma,8,19,Gene/Protein	IL - 4,46,52,Gene/Protein	GM - CSF,104,112,Gene/Protein	IL - 4,115,121,Gene/Protein	M - CSF,126,133,Gene/Protein	IL - 4,136,142,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 8, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
The SCMV SNE sites contain potential overlapping core recognition binding motifs for SRF, Rel / NFkappaB, ETS, and YY1 class transcription factors but fail to respond to either serum or tumor necrosis factor alpha.	SCMV SNE sites,4,18,Gene/Protein	SRF,85,88,Gene/Protein	Rel / NFkappaB,90,104,Gene/Protein	ETS,106,109,Gene/Protein	YY1 class transcription factors,115,146,Gene/Protein	serum or tumor necrosis factor alpha,177,213,Gene/Protein	"[{""token"": ""SCMV SNE sites"", ""start_span"": 4, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""Rel / NFkappaB"", ""start_span"": 90, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""ETS"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""YY1 class transcription factors"", ""start_span"": 115, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""serum or tumor necrosis factor alpha"", ""start_span"": 177, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
However, the TPA responsiveness of both CMV elements proved to involve synergistic interactions between the core SRF binding site ( CCATATATGG) and the adjacent inverted ETS binding motifs ( TTCC), which correlated directly with formation of a bound tripartite complex containing both the cellular SRF and ELK - 1 proteins.	CMV elements,40,52,Gene/Protein	SRF binding site,113,129,Gene/Protein	ETS binding motifs,170,188,Gene/Protein	tripartite complex,250,268,Gene/Protein	SRF,298,301,Gene/Protein	ELK - 1 proteins,306,322,Gene/Protein	"[{""token"": ""CMV elements"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""SRF binding site"", ""start_span"": 113, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""ETS binding motifs"", ""start_span"": 170, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""tripartite complex"", ""start_span"": 250, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 298, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""ELK - 1 proteins"", ""start_span"": 306, ""end_span"": 322, ""type"": ""Gene/Protein""}]"	train
In exerting their antiproliferative effects, GCS diffuse into target cells where they bind their cytoplasmic receptor, which in turn translocates to the nucleus where it inhibits transcription of cytokine genes through direct binding to the glucocorticoid response elements ( GRE), which are located in the promoter region of cytokine genes or, alternatively, through antagonism of the action of transcription factors required for optimal transcriptional activation.	cytoplasmic receptor,97,117,Gene/Protein	cytokine genes,196,210,Gene/Protein	glucocorticoid response elements,241,273,Gene/Protein	GRE,276,279,Gene/Protein	cytokine genes,326,340,Gene/Protein	transcription factors,396,417,Gene/Protein	"[{""token"": ""cytoplasmic receptor"", ""start_span"": 97, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 196, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid response elements"", ""start_span"": 241, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""GRE"", ""start_span"": 276, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 326, ""end_span"": 340, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 396, ""end_span"": 417, ""type"": ""Gene/Protein""}]"	train
A highly conserved 19 - bp element located immediately 5 ' of the human GM - CSF TATA box ( bp - 34 to - 52), herein called purine box 1 ( PB1), has been shown to bind a T - cell nuclear protein complex and to be required for transcriptional induction of the GM - CSF gene following T - cell activation.	human GM - CSF TATA box,66,89,Gene/Protein	bp - 34 to - 52,92,107,Gene/Protein	purine box 1,124,136,Gene/Protein	PB1,139,142,Gene/Protein	T - cell nuclear protein complex,170,202,Gene/Protein	GM - CSF gene,259,272,Gene/Protein	"[{""token"": ""human GM - CSF TATA box"", ""start_span"": 66, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""bp - 34 to - 52"", ""start_span"": 92, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""purine box 1"", ""start_span"": 124, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""PB1"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""T - cell nuclear protein complex"", ""start_span"": 170, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 259, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
The constitutive association of TRAFs with LMP1 through the aa 187 to 231 domain which is important in NF - kappaB activation and primary B - lymphocyte growth transformation implicates TRAF aggregation in LMP1 signaling.	TRAFs,32,37,Gene/Protein	LMP1,43,47,Gene/Protein	aa 187 to 231 domain,60,80,Gene/Protein	NF - kappaB,103,114,Gene/Protein	TRAF,186,190,Gene/Protein	LMP1,206,210,Gene/Protein	"[{""token"": ""TRAFs"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""aa 187 to 231 domain"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""TRAF"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
The IL - 12 nonresponsiveness of the Th2 clones was further evident by the total lack of IL - 12 - induced phosphorylation of STAT4 ( signal transducer and activator of transcription - 4), a transcription factor that is typically involved in IL - 12 signaling.	IL - 12,4,11,Gene/Protein	IL - 12,89,96,Gene/Protein	STAT4,126,131,Gene/Protein	signal transducer and activator of transcription - 4,134,186,Gene/Protein	transcription factor,191,211,Gene/Protein	IL - 12,242,249,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription - 4"", ""start_span"": 134, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 191, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
In fact, while the NH2 regulatory domain is sufficient to mediate CD4 accessory function, we show here that the catalytic domain of pp56 ( lck) is sufficient for induction of IL - 2 production, mimicking TCR ligation.	NH2,19,22,Gene/Protein	regulatory domain,23,40,Gene/Protein	CD4,66,69,Gene/Protein	catalytic domain,112,128,Gene/Protein	IL - 2,175,181,Gene/Protein	TCR,204,207,Gene/Protein	"[{""token"": ""NH2"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""regulatory domain"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""catalytic domain"", ""start_span"": 112, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.	DR3,0,3,Gene/Protein	intracellular signaling molecules,52,85,Gene/Protein	TRADD,96,101,Gene/Protein	TRAF2,103,108,Gene/Protein	FADD,110,114,Gene/Protein	FLICE,120,125,Gene/Protein	"[{""token"": ""DR3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""intracellular signaling molecules"", ""start_span"": 52, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TRADD"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""FADD"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""FLICE"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
SLP - 76 ( SH2 domain leukocyte protein of 76 kDa) is a recently identified substrate of the TCR - stimulated protein tyrosine kinases that functions in the signal transduction cascade linking the TCR with IL - 2 gene expression.	SLP - 76,0,8,Gene/Protein	SH2 domain leukocyte protein,11,39,Gene/Protein	TCR - stimulated protein,93,117,Gene/Protein	tyrosine kinases,118,134,Gene/Protein	TCR,197,200,Gene/Protein	IL - 2,206,212,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain leukocyte protein"", ""start_span"": 11, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""TCR - stimulated protein"", ""start_span"": 93, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinases"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
We previously identified and analyzed a 45 - nucleotide sequence ( downstream regulatory element 1 [ DRE 1]), + 195 to + 240, at the boundary of the R / U5 region of the long terminal repeat which is required for HTLV - I basal transcription.	45 - nucleotide sequence,40,64,Gene/Protein	downstream regulatory element 1,67,98,Gene/Protein	DRE 1,101,106,Gene/Protein	+ 195 to + 240,110,124,Gene/Protein	R / U5 region,149,162,Gene/Protein	long terminal repeat,170,190,Gene/Protein	"[{""token"": ""45 - nucleotide sequence"", ""start_span"": 40, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""downstream regulatory element 1"", ""start_span"": 67, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""DRE 1"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""+ 195 to + 240"", ""start_span"": 110, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""R / U5 region"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 170, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Using monospecific antibodies, the 80 - kDa tyrosine - phosphorylated protein has been shown to be p80c - rel, a proto - oncogene belonging to a family of transcriptional regulators which include NF - kB.	monospecific antibodies,6,29,Gene/Protein	tyrosine - phosphorylated protein,44,77,Gene/Protein	p80c - rel,99,109,Gene/Protein	proto - oncogene,113,129,Gene/Protein	transcriptional regulators,155,181,Gene/Protein	NF - kB,196,203,Gene/Protein	"[{""token"": ""monospecific antibodies"", ""start_span"": 6, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine - phosphorylated protein"", ""start_span"": 44, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""p80c - rel"", ""start_span"": 99, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene"", ""start_span"": 113, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 155, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
The findings presented here link an atheogenic lipoprotein, LDL, with the induction of an adhesion molecule important in atherogenesis Human LDL induces the vascular cell adhesion molecule - 1 ( VCAM - 1) transcriptionally with an increase in mRNA levels through activation of the VCAM promoter.	atheogenic lipoprotein,36,58,Gene/Protein	LDL,60,63,Gene/Protein	LDL,141,144,Gene/Protein	vascular cell adhesion molecule - 1,157,192,Gene/Protein	VCAM - 1,195,203,Gene/Protein	VCAM promoter,281,294,Gene/Protein	"[{""token"": ""atheogenic lipoprotein"", ""start_span"": 36, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""LDL"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""LDL"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 157, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""VCAM promoter"", ""start_span"": 281, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
RelA ( p65) functions as the critical transactivating component of the heterodimeric p50 - p65 NF - kappa B complex and contains a high - affinity binding site for its cytoplasmic inhibitor, I kappa B alpha.	RelA,0,4,Gene/Protein	p65,7,10,Gene/Protein	heterodimeric p50 - p65 NF - kappa B complex,71,115,Gene/Protein	high - affinity binding site,131,159,Gene/Protein	cytoplasmic inhibitor,168,189,Gene/Protein	I kappa B alpha,191,206,Gene/Protein	"[{""token"": ""RelA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""heterodimeric p50 - p65 NF - kappa B complex"", ""start_span"": 71, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity binding site"", ""start_span"": 131, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic inhibitor"", ""start_span"": 168, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 191, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Earlier studies on the IL - 2 gene expression showed that overexpression of calcineurin ( CN), a Ca2 + / calmodulin - dependent protein phosphatase, can stimulate transcription from the IL - 2 promoter through the NF - AT - binding site.	IL - 2,23,29,Gene/Protein	calcineurin,76,87,Gene/Protein	CN,90,92,Gene/Protein	Ca2 + / calmodulin - dependent protein phosphatase,97,147,Gene/Protein	IL - 2 promoter,186,201,Gene/Protein	NF - AT - binding site,214,236,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CN"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + / calmodulin - dependent protein phosphatase"", ""start_span"": 97, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 186, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - binding site"", ""start_span"": 214, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
By multimerizing the regulatory elements of the GM - CSF promoter, we found that one of the target sites for the CN action is the conserved lymphokine element 0 ( CLE0), located at positions between - 54 and - 40.	regulatory elements,21,40,Gene/Protein	GM - CSF promoter,48,65,Gene/Protein	target sites,92,104,Gene/Protein	CN,113,115,Gene/Protein	conserved lymphokine element 0,130,160,Gene/Protein	CLE0,163,167,Gene/Protein	"[{""token"": ""regulatory elements"", ""start_span"": 21, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""target sites"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CN"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""conserved lymphokine element 0"", ""start_span"": 130, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""CLE0"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
These results suggest that CN is involved in the coordinated induction of the GM - CSF and IL - 2 genes and that the CLE0 sequence of the GM - CSF gene is a functional analogue of the NF - AT - binding site in the IL - 2 promoter, which mediates signals downstream of T cell activation.	CN,27,29,Gene/Protein	GM - CSF and IL - 2 genes,78,103,Gene/Protein	CLE0 sequence,117,130,Gene/Protein	GM - CSF gene,138,151,Gene/Protein	NF - AT - binding site,184,206,Gene/Protein	IL - 2 promoter,214,229,Gene/Protein	"[{""token"": ""CN"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF and IL - 2 genes"", ""start_span"": 78, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CLE0 sequence"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF gene"", ""start_span"": 138, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - binding site"", ""start_span"": 184, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 214, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Predicted peptide sequence of ORF2 contained a zinc finger domain which showed significant homology to GC box binding proteins BTEB2 and SP1.	Predicted peptide sequence,0,26,Gene/Protein	ORF2,30,34,Gene/Protein	zinc finger domain,47,65,Gene/Protein	GC box binding proteins,103,126,Gene/Protein	BTEB2,127,132,Gene/Protein	SP1,137,140,Gene/Protein	"[{""token"": ""Predicted peptide sequence"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""ORF2"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger domain"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""GC box binding proteins"", ""start_span"": 103, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""BTEB2"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""SP1"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
These blast cells express lineage - specific transcription factors such as GATA - 1 common to these lineages and frequently express erythroid - specific mRNAs such as gamma - globin and erythroid delta - aminolevulinate synthase ( ALAS - E), indicating that most of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes.	lineage - specific transcription factors,26,66,Gene/Protein	GATA - 1,75,83,Gene/Protein	erythroid - specific mRNAs,132,158,Gene/Protein	gamma - globin,167,181,Gene/Protein	erythroid delta - aminolevulinate synthase,186,228,Gene/Protein	ALAS - E,231,239,Gene/Protein	"[{""token"": ""lineage - specific transcription factors"", ""start_span"": 26, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""erythroid - specific mRNAs"", ""start_span"": 132, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 167, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""erythroid delta - aminolevulinate synthase"", ""start_span"": 186, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""ALAS - E"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Previously we and others showed by targeted gene disruption that the zinc finger gene, erythroid Kruppel - like factor ( EKLF), is required for expression of the beta - globin gene in mice, presumably through interaction with a high - affinity binding site in the proximal promoter.	zinc finger gene,69,85,Gene/Protein	erythroid Kruppel - like factor,87,118,Gene/Protein	EKLF,121,125,Gene/Protein	beta - globin gene,162,180,Gene/Protein	high - affinity binding site,228,256,Gene/Protein	proximal promoter,264,281,Gene/Protein	"[{""token"": ""zinc finger gene"", ""start_span"": 69, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""erythroid Kruppel - like factor"", ""start_span"": 87, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin gene"", ""start_span"": 162, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""high - affinity binding site"", ""start_span"": 228, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""proximal promoter"", ""start_span"": 264, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	train
This loss of activity was shown to correlate with deletion of two CCAAT boxes, a proximal CCAAT box located at bp - 61 to - 65 and a distal CCAAT box located at bp - 253 to - 257, upstream of Cp.	CCAAT boxes,66,77,Gene/Protein	proximal CCAAT box,81,99,Gene/Protein	bp - 61 to - 65,111,126,Gene/Protein	CCAAT box,140,149,Gene/Protein	- 253 to - 257,164,178,Gene/Protein	Cp,192,194,Gene/Protein	"[{""token"": ""CCAAT boxes"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""proximal CCAAT box"", ""start_span"": 81, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""bp - 61 to - 65"", ""start_span"": 111, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT box"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""- 253 to - 257"", ""start_span"": 164, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 192, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Recombinant NFAT1 can mediate transcription of the interleukin - 2, interleukin - 4, tumor necrosis factor alpha, and granulocyte - macrophage colony - stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA - sensitive transcription of these genes during the immune response.	NFAT1,12,17,Gene/Protein	interleukin - 2,51,66,Gene/Protein	tumor necrosis factor alpha,85,112,Gene/Protein	granulocyte - macrophage colony - stimulating factor promoters,118,180,Gene/Protein	NFAT1,209,214,Gene/Protein	genes,273,278,Gene/Protein	"[{""token"": ""NFAT1"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 51, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 85, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte - macrophage colony - stimulating factor promoters"", ""start_span"": 118, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""genes"", ""start_span"": 273, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
The cDNA encoding hTAFII105 reveals a highly conserved C - terminal domain shared by hTAFII130 and oTAFII110, while the N - terminal coactivator domain has diverged significantly.	cDNA,4,8,Gene/Protein	hTAFII105,18,27,Gene/Protein	C - terminal domain,55,74,Gene/Protein	hTAFII130,85,94,Gene/Protein	oTAFII110,99,108,Gene/Protein	N - terminal coactivator domain,120,151,Gene/Protein	"[{""token"": ""cDNA"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""hTAFII105"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal domain"", ""start_span"": 55, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hTAFII130"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""oTAFII110"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal coactivator domain"", ""start_span"": 120, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
The close homology of the basic region / leucine zipper ( bZIP) DNA - binding and dimerization domain of HLF to that of the CES - 2 cell - death specification protein of Caenorhabditis elegans suggests a model of leukaemogenesis in which E2A - HLF blocks an early step within an evolutionarily conserved cell - death pathway.	basic region / leucine zipper,26,55,Gene/Protein	bZIP,58,62,Gene/Protein	dimerization domain,82,101,Gene/Protein	HLF,105,108,Gene/Protein	CES - 2 cell - death specification protein,124,166,Gene/Protein	E2A - HLF,238,247,Gene/Protein	"[{""token"": ""basic region / leucine zipper"", ""start_span"": 26, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""bZIP"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""dimerization domain"", ""start_span"": 82, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""CES - 2 cell - death specification protein"", ""start_span"": 124, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 238, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
The EBNA transcription was initiated from one of three EBNA promoters, Qp: by contrast, both Cp and Wp were silent, thus resulting in the lack of EBNA2 mRNA.	EBNA,4,8,Gene/Protein	EBNA promoters,55,69,Gene/Protein	Qp,71,73,Gene/Protein	Cp,93,95,Gene/Protein	Wp,100,102,Gene/Protein	EBNA2 mRNA,146,156,Gene/Protein	"[{""token"": ""EBNA"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""EBNA promoters"", ""start_span"": 55, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Qp"", ""start_span"": 71, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Cp"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Wp"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""EBNA2 mRNA"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
An IL - 2 response element in the human IL - 2 receptor alpha chain promoter is a composite element that binds Stat5, Elf - 1, HMG - I ( Y) and a GATA family protein.	IL - 2 response element,3,26,Gene/Protein	human IL - 2 receptor alpha chain promoter,34,76,Gene/Protein	composite element,82,99,Gene/Protein	Stat5,111,116,Gene/Protein	Elf - 1,118,125,Gene/Protein	GATA family protein,146,165,Gene/Protein	"[{""token"": ""IL - 2 response element"", ""start_span"": 3, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 2 receptor alpha chain promoter"", ""start_span"": 34, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""composite element"", ""start_span"": 82, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""GATA family protein"", ""start_span"": 146, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
A construct termed PFP5a containing - 795 bp exhibited the highest CAT activity, and PFP9a20 containing only - 73 bp also produced significantly high CAT activity in CTLL - R8 cells.	PFP5a,19,24,Gene/Protein	- 795 bp,36,44,Gene/Protein	CAT,67,70,Gene/Protein	PFP9a20,85,92,Gene/Protein	- 73 bp,109,116,Gene/Protein	CAT,150,153,Gene/Protein	"[{""token"": ""PFP5a"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""- 795 bp"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""PFP9a20"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""- 73 bp"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
To confirm the importance of the three cis - acting elements in the perforin gene expression, point mutation was introduced again to each proximal GC box, EBS, and GT box of PFP5a.	cis - acting elements,39,60,Gene/Protein	perforin gene,68,81,Gene/Protein	proximal GC box,138,153,Gene/Protein	EBS,155,158,Gene/Protein	GT box,164,170,Gene/Protein	PFP5a,174,179,Gene/Protein	"[{""token"": ""cis - acting elements"", ""start_span"": 39, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""perforin gene"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""proximal GC box"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""EBS"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""GT box"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""PFP5a"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
In this work, we report that these anergic T cells are defective in their ability to up - regulate protein binding and transactivation at two critical IL - 2 DNA enhancer elements: NF - AT ( nuclear factor of activated T cells; a sequence that binds a heterotrimeric NFATp, Fos, and Jun protein complex) and Activator Protein - 1 ( AP - 1) ( that binds Fos and Jun heterodimers).	IL - 2 DNA enhancer elements,151,179,Gene/Protein	NF - AT,181,188,Gene/Protein	nuclear factor of activated T cells,191,226,Gene/Protein	Activator Protein - 1,308,329,Gene/Protein	AP - 1,332,338,Gene/Protein	Fos and Jun heterodimers,353,377,Gene/Protein	"[{""token"": ""IL - 2 DNA enhancer elements"", ""start_span"": 151, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 191, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""Activator Protein - 1"", ""start_span"": 308, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 332, ""end_span"": 338, ""type"": ""Gene/Protein""}, {""token"": ""Fos and Jun heterodimers"", ""start_span"": 353, ""end_span"": 377, ""type"": ""Gene/Protein""}]"	train
The recognition of both the POU domain and the octamer sequence by OCA - B provides a mechanism for differential regulation of octamer sites containing genes by the ubiquitous factor Oct - 1.	POU domain,28,38,Gene/Protein	octamer sequence,47,63,Gene/Protein	OCA - B,67,74,Gene/Protein	octamer sites,127,140,Gene/Protein	ubiquitous factor,165,182,Gene/Protein	Oct - 1,183,190,Gene/Protein	"[{""token"": ""POU domain"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""octamer sequence"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""octamer sites"", ""start_span"": 127, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous factor"", ""start_span"": 165, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
The cytokines IFN - beta, IFN - gamma, IL - 4, and LPS, although unable to induce sialoadhesin expression by themselves, were able to enhance GC - mediated induction of sialoadhesin.	cytokines,4,13,Gene/Protein	IFN - beta,14,24,Gene/Protein	IFN - gamma,26,37,Gene/Protein	IL - 4,39,45,Gene/Protein	sialoadhesin,82,94,Gene/Protein	sialoadhesin,169,181,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IFN - beta"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""sialoadhesin"", ""start_span"": 169, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
The requirements for induction of transcription factors reflected the requirements for the secretion of multiple cytokines, including IL - 2, TNF - alpha, IFN - gamma, and granulocyte macrophage - CSF.	transcription factors,34,55,Gene/Protein	cytokines,113,122,Gene/Protein	IL - 2,134,140,Gene/Protein	TNF - alpha,142,153,Gene/Protein	IFN - gamma,155,166,Gene/Protein	granulocyte macrophage - CSF,172,200,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 34, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte macrophage - CSF"", ""start_span"": 172, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
By using run - on assays, ACLA was shown to induce an enhancement of the transcription of erythroid genes, including gamma - globin, PBGD, erythropoietin receptor, and GATA - 1 transcription factor.	erythroid genes,90,105,Gene/Protein	gamma - globin,117,131,Gene/Protein	PBGD,133,137,Gene/Protein	erythropoietin receptor,139,162,Gene/Protein	GATA - 1,168,176,Gene/Protein	transcription factor,177,197,Gene/Protein	"[{""token"": ""erythroid genes"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""gamma - globin"", ""start_span"": 117, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""PBGD"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin receptor"", ""start_span"": 139, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 177, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
IL - 7 also induced STAT / DNA binding in BCP - ALL cases that failed to proliferate in response to IL - 7, suggesting that the ability of IL - 7R to activate the JAK / STAT pathway per se is not sufficient for proliferation induction.	IL - 7,0,6,Gene/Protein	STAT,20,24,Gene/Protein	IL - 7,100,106,Gene/Protein	IL - 7R,139,146,Gene/Protein	JAK,163,166,Gene/Protein	/ STAT,167,173,Gene/Protein	"[{""token"": ""IL - 7"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7R"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
InterleUkin 2 expression requires several transcription factors of which nuclear translocation of NFAT ( nuclear factor of activated T cells) and NFAT - mediated transactivation were impaired by BCL - 2.	InterleUkin 2,0,13,Gene/Protein	transcription factors,42,63,Gene/Protein	NFAT,98,102,Gene/Protein	nuclear factor of activated T cells,105,140,Gene/Protein	NFAT,146,150,Gene/Protein	BCL - 2,195,202,Gene/Protein	"[{""token"": ""InterleUkin 2"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 105, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 2"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Importantly, two previously characterized mutants with point mutations in Tax, M32 ( Y196A, K197S) and M41 ( H287A, P288S), which were shown to be defective in Tax - activated transcription were unable to interact with TFIIA in this assay.	mutants,42,49,Gene/Protein	Tax,74,77,Gene/Protein	M32,79,82,Gene/Protein	M41,103,106,Gene/Protein	Tax,160,163,Gene/Protein	TFIIA,219,224,Gene/Protein	"[{""token"": ""mutants"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""M32"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""M41"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""TFIIA"", ""start_span"": 219, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Pb - induced activation of NF - kappa B is blocked by antibodies for p65 and p50 subunits but not cRel, indicating that the p65: p50 heterodimer ( NF - kappa B) is involved.	NF - kappa B,27,39,Gene/Protein	antibodies,54,64,Gene/Protein	p65,69,72,Gene/Protein	p50,77,80,Gene/Protein	cRel,98,102,Gene/Protein	NF - kappa B,147,159,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""cRel"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 147, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Finally, IL - 2 induced tyrosine phosphorylation of JAK1 and JAK3, while IL - 12 induced phosphorylation of JAK2 and TYK2 in both preactivated primary NK and NK3. 3 cells.	IL - 2,9,15,Gene/Protein	JAK1,52,56,Gene/Protein	JAK3,61,65,Gene/Protein	IL - 12,73,80,Gene/Protein	JAK2,108,112,Gene/Protein	TYK2,117,121,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""TYK2"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
Granulocyte - macrophage colony - stimulating factor ( GM - CSF) induces immediate effects in monocytes by activation of the Janus kinase ( JAK2) and STAT transcription factor ( STAT5) pathway.	Granulocyte - macrophage colony - stimulating factor,0,52,Gene/Protein	GM - CSF,55,63,Gene/Protein	Janus kinase,125,137,Gene/Protein	JAK2,140,144,Gene/Protein	STAT transcription factor,150,175,Gene/Protein	STAT5,178,183,Gene/Protein	"[{""token"": ""Granulocyte - macrophage colony - stimulating factor"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""STAT transcription factor"", ""start_span"": 150, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
The translocation found in acute promyelocytic leukemia rearranges the promyelocytic leukemia gene ( PML) on chromosome 15 with the retinoic acid receptor alpha ( RARalpha) on chromosome 17.	promyelocytic leukemia gene,71,98,Gene/Protein	PML,101,104,Gene/Protein	chromosome 15,109,122,Gene/Protein	retinoic acid receptor alpha,132,160,Gene/Protein	RARalpha,163,171,Gene/Protein	chromosome 17,176,189,Gene/Protein	"[{""token"": ""promyelocytic leukemia gene"", ""start_span"": 71, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""PML"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""chromosome 15"", ""start_span"": 109, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid receptor alpha"", ""start_span"": 132, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""RARalpha"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""chromosome 17"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Although transcriptional factors AP - 1 and nuclear factor of activated T cells ( NF - AT) are important for the normal induction of IL - 2, it is unknown if the age - related decline in IL - 2 production by activated human T cells may be associated with aberrancies in transcriptional regulatory proteins.	transcriptional factors,9,32,Gene/Protein	AP - 1,33,39,Gene/Protein	NF - AT,82,89,Gene/Protein	IL - 2,133,139,Gene/Protein	IL - 2,187,193,Gene/Protein	transcriptional regulatory proteins,270,305,Gene/Protein	"[{""token"": ""transcriptional factors"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory proteins"", ""start_span"": 270, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
Thus, these results show that age - related impairments in the activation of AP - 1 and NF - AT are closely associated with decreased expression of IL - 2 and further suggest that aberrancies in the signaling pathways important for the induction of transcriptionally active c - Fos / c - Jun AP - 1 may contribute to the impaired activation of NF - AT.	AP - 1,77,83,Gene/Protein	NF - AT,88,95,Gene/Protein	IL - 2,148,154,Gene/Protein	c - Fos / c - Jun,274,291,Gene/Protein	AP - 1,292,298,Gene/Protein	NF - AT,344,351,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 77, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos / c - Jun"", ""start_span"": 274, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 292, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 344, ""end_span"": 351, ""type"": ""Gene/Protein""}]"	train
In addition, IL - 13 phosphorylated insulin response substrate - 1, IL - 4R p140, JAK1, and Tyk2, but not JAK3 kinase.	IL - 13,13,20,Gene/Protein	insulin response substrate - 1,36,66,Gene/Protein	IL - 4R p140,68,80,Gene/Protein	JAK1,82,86,Gene/Protein	Tyk2,92,96,Gene/Protein	JAK3 kinase,106,117,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""insulin response substrate - 1"", ""start_span"": 36, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R p140"", ""start_span"": 68, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""JAK3 kinase"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift assays showed that IL - 4, but not IL - 10, inhibited nuclear NF - kappaB activity, and that IL - 4 and IL - 10 did not affect NF - IL - 6 activity.	IL - 4,50,56,Gene/Protein	IL - 10,66,73,Gene/Protein	NF - kappaB,93,104,Gene/Protein	IL - 4,124,130,Gene/Protein	IL - 10,135,142,Gene/Protein	IL - 6,163,169,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Transient expression experiments of 5 ' - deletion fragments of the CD36 promoter coupled to luciferase demonstrated that as few as 158 base pairs upstream from the transcription initiation site were sufficient to direct the monocyte - specific transcription of the reporter gene.	5 ' - deletion fragments,36,60,Gene/Protein	CD36 promoter,68,81,Gene/Protein	luciferase,93,103,Gene/Protein	158 base pairs upstream,132,155,Gene/Protein	transcription initiation site,165,194,Gene/Protein	reporter gene,266,279,Gene/Protein	"[{""token"": ""5 ' - deletion fragments"", ""start_span"": 36, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""CD36 promoter"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""158 base pairs upstream"", ""start_span"": 132, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 165, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 266, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
We conclude that the MAP kinase signal transduction pathway consisting of Raf - 1, MEK1, and ERK1 and ERK2 functions in the stimulation IL - 2 gene transcription in activated T lymphocytes.	MAP kinase,21,31,Gene/Protein	Raf - 1,74,81,Gene/Protein	MEK1,83,87,Gene/Protein	ERK1,93,97,Gene/Protein	ERK2,102,106,Gene/Protein	IL - 2 gene,136,147,Gene/Protein	"[{""token"": ""MAP kinase"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Costimulation of cells with LPS plus GM - CSF induced the production of proinflammatory cytokines, IL - 8, IL - 1 beta and IL - 6, but not TNF - alpha.	GM - CSF,37,45,Gene/Protein	proinflammatory cytokines,72,97,Gene/Protein	IL - 8,99,105,Gene/Protein	IL - 1 beta,107,118,Gene/Protein	IL - 6,123,129,Gene/Protein	TNF - alpha,139,150,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""proinflammatory cytokines"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 beta"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Interestingly, the processing rate of p105 is markedly inhibited in cells co - transfected with p50 or other NF - kappaB subunits, including RelA and c - Rel, that physically interact with p105.	p105,38,42,Gene/Protein	p50,96,99,Gene/Protein	NF - kappaB subunits,109,129,Gene/Protein	RelA,141,145,Gene/Protein	c - Rel,150,157,Gene/Protein	p105,189,193,Gene/Protein	"[{""token"": ""p105"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB subunits"", ""start_span"": 109, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
We found that two IL - 1alpha kappaB - like sites ( positions - 1, 065 to - 1, 056 and + 646 to + 655) specifically formed a complex with NF - kappaB - containing nuclear extract from MT - 2 cells and that NF - kappaB bound with higher affinity to the 3 ' NF - kappaB binding site than to the 5 ' NF - kappaB site.	IL - 1alpha kappaB - like sites,18,49,Gene/Protein	+ 646 to + 655,87,101,Gene/Protein	NF - kappaB,138,149,Gene/Protein	NF - kappaB,206,217,Gene/Protein	3 ' NF - kappaB binding site,252,280,Gene/Protein	5 ' NF - kappaB site,293,313,Gene/Protein	"[{""token"": ""IL - 1alpha kappaB - like sites"", ""start_span"": 18, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""+ 646 to + 655"", ""start_span"": 87, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""3 ' NF - kappaB binding site"", ""start_span"": 252, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""5 ' NF - kappaB site"", ""start_span"": 293, ""end_span"": 313, ""type"": ""Gene/Protein""}]"	train
On the other hand, the up - regulation of CD80 Ag, found on monocytes obtained from PBMC incubated with OKT3, is not detected after addition of IL - 10, and the anti - CD28 mAb CLB - CD28 / 1 restores the NF - kappa B / Rel nuclear activity in IL - 10 - inhibited lymphocytes.	CD80 Ag,42,49,Gene/Protein	OKT3,104,108,Gene/Protein	IL - 10,144,151,Gene/Protein	anti - CD28 mAb,161,176,Gene/Protein	CLB - CD28 / 1,177,191,Gene/Protein	NF - kappa B / Rel,205,223,Gene/Protein	"[{""token"": ""CD80 Ag"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""OKT3"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""CLB - CD28 / 1"", ""start_span"": 177, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 205, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
In the present study we demonstrate that also the signal transducers and activators of transcription ( STAT) family members STAT1 p91 and STAT3 p92 and the product of the c - fps / fes protooncogene become tyrosine - phosphorylated upon GM - CSF stimulation and physically associated with both GM - CSF receptor beta common subunit and JAK2.	STAT1 p91,124,133,Gene/Protein	STAT3 p92,138,147,Gene/Protein	c - fps / fes protooncogene,171,198,Gene/Protein	GM - CSF,237,245,Gene/Protein	GM - CSF,294,302,Gene/Protein	JAK2,336,340,Gene/Protein	"[{""token"": ""STAT1 p91"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""STAT3 p92"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""c - fps / fes protooncogene"", ""start_span"": 171, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 237, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 294, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 336, ""end_span"": 340, ""type"": ""Gene/Protein""}]"	train
The gammac chain is a subunit of multiple cytokine receptors ( interleukin ( IL) - 2, IL - 4, IL - 7, IL - 9, and IL - 15), the expression of which is restricted to hematopoietic lineages.	gammac chain,4,16,Gene/Protein	cytokine receptors,42,60,Gene/Protein	IL - 4,86,92,Gene/Protein	IL - 7,94,100,Gene/Protein	IL - 9,102,108,Gene/Protein	IL - 15,114,121,Gene/Protein	"[{""token"": ""gammac chain"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""cytokine receptors"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
The functional Ets binding site was found to bind Ets family proteins, principally GA - binding protein and Elf - 1 and could be transactivated by GABPalpha and - beta synergistically.	Ets binding site,15,31,Gene/Protein	Ets family proteins,50,69,Gene/Protein	GA - binding protein,83,103,Gene/Protein	Elf - 1,108,115,Gene/Protein	GABPalpha,147,156,Gene/Protein	- beta,161,167,Gene/Protein	"[{""token"": ""Ets binding site"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""Ets family proteins"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GA - binding protein"", ""start_span"": 83, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""GABPalpha"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""- beta"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Expression of either the cyclic AMP response element - binding protein ( CREB) or CREB fused to the GAL4 activation domain ( GAD) in this strain did not modify the expression of the reporter gene.	cyclic AMP response element - binding protein,25,70,Gene/Protein	CREB,73,77,Gene/Protein	CREB,82,86,Gene/Protein	GAL4 activation domain,100,122,Gene/Protein	GAD,125,128,Gene/Protein	reporter gene,182,195,Gene/Protein	"[{""token"": ""cyclic AMP response element - binding protein"", ""start_span"": 25, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""GAL4 activation domain"", ""start_span"": 100, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""GAD"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Using synthetic ligands to retinoic acid receptors ( RARs) and retinoid X receptors ( RXRs) that selectively bind and activate RAR - RXR or RXR - RXR dimers, respectively, we dissected the involvement of the two retinoid response pathways in the regulation of normal myeloid and erythroid progenitor cell growth.	retinoic acid receptors,27,50,Gene/Protein	RARs,53,57,Gene/Protein	retinoid X receptors,63,83,Gene/Protein	RXRs,86,90,Gene/Protein	RAR - RXR,127,136,Gene/Protein	RXR - RXR,140,149,Gene/Protein	"[{""token"": ""retinoic acid receptors"", ""start_span"": 27, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""RARs"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""retinoid X receptors"", ""start_span"": 63, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""RXRs"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""RAR - RXR"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RXR"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
We hypothesized that an intracellular vitamin D binding protein ( IDBP), present in both nuclear and cytoplasmic fractions of NWP cells, or another protein ( s) may cause or contribute to the steroid hormone - resistant state in NWP by disruption of the receptor dimerization process and / or by interference of receptor complex binding to the consensus response elements present in the enhancer regions of steroid - responsive genes.	intracellular vitamin D binding protein,24,63,Gene/Protein	IDBP,66,70,Gene/Protein	receptor complex,312,328,Gene/Protein	consensus response elements,344,371,Gene/Protein	enhancer regions,387,403,Gene/Protein	steroid - responsive genes,407,433,Gene/Protein	"[{""token"": ""intracellular vitamin D binding protein"", ""start_span"": 24, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IDBP"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""receptor complex"", ""start_span"": 312, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""consensus response elements"", ""start_span"": 344, ""end_span"": 371, ""type"": ""Gene/Protein""}, {""token"": ""enhancer regions"", ""start_span"": 387, ""end_span"": 403, ""type"": ""Gene/Protein""}, {""token"": ""steroid - responsive genes"", ""start_span"": 407, ""end_span"": 433, ""type"": ""Gene/Protein""}]"	train
Despite the dual specificity of HTLV - 1 Tax for IkappaBalpha and IkappaBbeta at the protein level, Tax selectively stimulates NF - kappaB - directed transcription of the IkappaBalpha gene.	Tax,41,44,Gene/Protein	IkappaBalpha,49,61,Gene/Protein	IkappaBbeta,66,77,Gene/Protein	Tax,100,103,Gene/Protein	NF - kappaB,127,138,Gene/Protein	IkappaBalpha gene,171,188,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBbeta"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha gene"", ""start_span"": 171, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Phosphorylation of the retinoblastoma protein by cyclin - dependent kinases 4 and 6 prevents its interaction with the transcription factor E2F, which subsequently promotes the expression of S phase regulated genes, such as thymidine kinase.	retinoblastoma protein,23,45,Gene/Protein	cyclin - dependent kinases 4 and 6,49,83,Gene/Protein	transcription factor,118,138,Gene/Protein	E2F,139,142,Gene/Protein	S phase regulated genes,190,213,Gene/Protein	thymidine kinase,223,239,Gene/Protein	"[{""token"": ""retinoblastoma protein"", ""start_span"": 23, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinases 4 and 6"", ""start_span"": 49, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 118, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""S phase regulated genes"", ""start_span"": 190, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""thymidine kinase"", ""start_span"": 223, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Analysis of long terminal repeat - driven secreted alkaline phosphatase activity in transient assays showed that, unlike human immunodeficiency virus type 1, the SIV long terminal repeat possesses an enhancer region just upstream of the NF - kappaB element which maintains significant levels of basal transcription in the absence of NF - kappaB and Sp1 sites.	long terminal repeat,12,32,Gene/Protein	alkaline phosphatase,51,71,Gene/Protein	SIV long terminal repeat,162,186,Gene/Protein	enhancer region,200,215,Gene/Protein	NF - kappaB element,237,256,Gene/Protein	NF - kappaB and Sp1 sites,333,358,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 12, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""alkaline phosphatase"", ""start_span"": 51, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""SIV long terminal repeat"", ""start_span"": 162, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""enhancer region"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB element"", ""start_span"": 237, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB and Sp1 sites"", ""start_span"": 333, ""end_span"": 358, ""type"": ""Gene/Protein""}]"	train
In Rel - / - splenic T cell cultures stimulated with phorbol 12 - myristate 13 - acetate and ionomycin, the levels of IL - 3, IL - 5, granulocyte - macrophage colony - stimulating factor ( GM - CSF), tumor necrosis factor alpha ( TNF - alpha), and gamma interferon ( IFN - gamma) were only 2 - to 3 - fold lower compared with normal T cells.	granulocyte - macrophage colony - stimulating factor,134,186,Gene/Protein	GM - CSF,189,197,Gene/Protein	tumor necrosis factor alpha,200,227,Gene/Protein	TNF - alpha,230,241,Gene/Protein	gamma interferon,248,264,Gene/Protein	IFN - gamma,267,278,Gene/Protein	"[{""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 134, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 200, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 230, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""gamma interferon"", ""start_span"": 248, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 267, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
Deletion constructs containing as little as 72 bp of 5 ' - flanking sequence of the collagenase promoter were sufficient for LPS - or zymosan - mediated transcriptional induction, whereas phorbol inducibility exhibited an absolute requirement for upstream elements including the polyoma enhancer A - binding protein - 3 site ( - 83 to - 91) and TTCA sequence ( - 102 to - 105) in both monocytic cells and fibroblasts.	5 ' - flanking sequence,53,76,Gene/Protein	collagenase promoter,84,104,Gene/Protein	polyoma enhancer A - binding protein - 3 site,279,324,Gene/Protein	- 83 to - 91,327,339,Gene/Protein	TTCA sequence,345,358,Gene/Protein	- 102 to - 105,361,375,Gene/Protein	"[{""token"": ""5 ' - flanking sequence"", ""start_span"": 53, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""collagenase promoter"", ""start_span"": 84, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""polyoma enhancer A - binding protein - 3 site"", ""start_span"": 279, ""end_span"": 324, ""type"": ""Gene/Protein""}, {""token"": ""- 83 to - 91"", ""start_span"": 327, ""end_span"": 339, ""type"": ""Gene/Protein""}, {""token"": ""TTCA sequence"", ""start_span"": 345, ""end_span"": 358, ""type"": ""Gene/Protein""}, {""token"": ""- 102 to - 105"", ""start_span"": 361, ""end_span"": 375, ""type"": ""Gene/Protein""}]"	train
Specifically, we examined nuclear factor - kappa B ( NF - kappa B) activation because it is crucial in transcriptional regulation of many inflammatory cytokine genes including TNF, IL - 1, and IL - 6.	nuclear factor - kappa B,26,50,Gene/Protein	NF - kappa B,53,65,Gene/Protein	inflammatory cytokine genes,138,165,Gene/Protein	TNF,176,179,Gene/Protein	IL - 1,181,187,Gene/Protein	IL - 6,193,199,Gene/Protein	"[{""token"": ""nuclear factor - kappa B"", ""start_span"": 26, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory cytokine genes"", ""start_span"": 138, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Truncated c - Jun and c - Fos mutant proteins including wbJun and wbFos were also ubiquitinylated under the same conditions, suggesting the sites of ubiquitinylation are located within the dimerization and DNA binding domains of c - Jun and c - Fos.	Truncated c - Jun and c - Fos mutant proteins,0,45,Gene/Protein	wbJun,56,61,Gene/Protein	wbFos,66,71,Gene/Protein	dimerization and DNA binding domains,189,225,Gene/Protein	c - Jun,229,236,Gene/Protein	c - Fos,241,248,Gene/Protein	"[{""token"": ""Truncated c - Jun and c - Fos mutant proteins"", ""start_span"": 0, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""wbJun"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""wbFos"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""dimerization and DNA binding domains"", ""start_span"": 189, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
In this study, we investigated the ability of the major envelope glycoprotein of HIV, glycoprotein 120 ( gp120), to regulate intercellular adhesion molecule - 1 ( ICAM - 1) expression in glial cells, because ICAM - 1 is important in mediating immune responsiveness in the CNS, facilitating entry of HIV - infected cells into the CNS, and promoting syncytia formation.	major envelope glycoprotein,50,77,Gene/Protein	glycoprotein 120,86,102,Gene/Protein	gp120,105,110,Gene/Protein	intercellular adhesion molecule - 1,125,160,Gene/Protein	ICAM - 1,163,171,Gene/Protein	ICAM - 1,208,216,Gene/Protein	"[{""token"": ""major envelope glycoprotein"", ""start_span"": 50, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""glycoprotein 120"", ""start_span"": 86, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 125, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
The effects of the two cytokines were distinguishable functionally since pretreatment with TNF - alpha attenuated the cytokine cooperativity, while pretreatment with IL - 10 potentiated their cooperativity, suggesting that IL - 10 and TNF - alpha play different roles in the activation of virus.	cytokines,23,32,Gene/Protein	TNF - alpha,91,102,Gene/Protein	cytokine,118,126,Gene/Protein	IL - 10,166,173,Gene/Protein	IL - 10,223,230,Gene/Protein	TNF - alpha,235,246,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
Pretreatment with the broad serine / threonine kinase inhibitor staurosporine partly blocked the calyculin A - induced STAT3 phosphorylation, whereas inhibitors of serine / threonine kinases, such as mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase, mitogen - activated protein p38 kinase, and phosphatidylinositol 3 - kinase, did not.	calyculin A,97,108,Gene/Protein	STAT3,119,124,Gene/Protein	serine / threonine kinases,164,190,Gene/Protein	mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase,200,280,Gene/Protein	mitogen - activated protein p38 kinase,282,320,Gene/Protein	phosphatidylinositol 3 - kinase,326,357,Gene/Protein	"[{""token"": ""calyculin A"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""serine / threonine kinases"", ""start_span"": 164, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase - 1 extracellular - regulated kinase - kinase"", ""start_span"": 200, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein p38 kinase"", ""start_span"": 282, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 326, ""end_span"": 357, ""type"": ""Gene/Protein""}]"	train
The mechanism of this effect is that Bcl - 2 prevents the nuclear translocation of NFAT ( nuclear factor of activated T lymphocytes, a transcription factor activated by microtubule damage) by binding and sequestering calcineurin, a calcium - dependent phosphatase that must dephosphorylate NFAT to move to the nucleus.	Bcl - 2,37,44,Gene/Protein	NFAT,83,87,Gene/Protein	nuclear factor of activated T lymphocytes,90,131,Gene/Protein	transcription factor,135,155,Gene/Protein	microtubule,169,180,Gene/Protein	NFAT,290,294,Gene/Protein	"[{""token"": ""Bcl - 2"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T lymphocytes"", ""start_span"": 90, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 135, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""microtubule"", ""start_span"": 169, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 290, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
In electrophoretic mobility shift assays using the E1 oligonucleotide as probe, nuclear extracts from unstimulated T and B cell lines formed a constitutive complex termed complex I, while nuclear extracts from stimulated SCM - 1 - producer T cell lines formed a higher mobility complex termed complex II with a concomitant decrease in complex I.	E1,51,53,Gene/Protein	constitutive complex,143,163,Gene/Protein	complex I,171,180,Gene/Protein	higher mobility complex,262,285,Gene/Protein	complex II,293,303,Gene/Protein	complex I,335,344,Gene/Protein	"[{""token"": ""E1"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""constitutive complex"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""complex I"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""higher mobility complex"", ""start_span"": 262, ""end_span"": 285, ""type"": ""Gene/Protein""}, {""token"": ""complex II"", ""start_span"": 293, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""complex I"", ""start_span"": 335, ""end_span"": 344, ""type"": ""Gene/Protein""}]"	train
However, in contrast with TNF - alpha, dopamine treatment did not affect NF - kappaB DNA binding activity nor the concentrations of p50, p65 and IkappaB - alpha proteins, which suggests a distinct NF - kappaB activation mechanism.	TNF - alpha,26,37,Gene/Protein	NF - kappaB,73,84,Gene/Protein	p50,132,135,Gene/Protein	p65,137,140,Gene/Protein	IkappaB - alpha proteins,145,169,Gene/Protein	NF - kappaB,197,208,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha proteins"", ""start_span"": 145, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus latency BamHI - Q promoter is positively regulated by STATs and Zta interference with JAK / STAT activation leads to loss of BamHI - Q promoter activity.	Epstein - Barr virus latency BamHI - Q promoter,4,51,Gene/Protein	STATs,79,84,Gene/Protein	Zta,89,92,Gene/Protein	JAK,111,114,Gene/Protein	/ STAT,115,121,Gene/Protein	BamHI - Q promoter,150,168,Gene/Protein	"[{""token"": ""Epstein - Barr virus latency BamHI - Q promoter"", ""start_span"": 4, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Zta"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""BamHI - Q promoter"", ""start_span"": 150, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
CD3 - mediated activation of Stat3 is almost completely inhibited by a Src kinase inhibitor ( PP1), whereas IL - 2 - induced Stat3 activation is unaffected.	CD3,0,3,Gene/Protein	Stat3,29,34,Gene/Protein	Src kinase inhibitor,71,91,Gene/Protein	PP1,94,97,Gene/Protein	IL - 2,108,114,Gene/Protein	Stat3,125,130,Gene/Protein	"[{""token"": ""CD3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Src kinase inhibitor"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
While CD40 ligation strongly activates the SAPKs ( up to 25 - fold), it does not affect members of the mitogen - activated protein kinase family ( MAPK; ERK1 and ERK2).	CD40,6,10,Gene/Protein	SAPKs,43,48,Gene/Protein	mitogen - activated protein kinase family,103,144,Gene/Protein	MAPK,147,151,Gene/Protein	ERK1,153,157,Gene/Protein	ERK2,162,166,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""SAPKs"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase family"", ""start_span"": 103, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""ERK2"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
Tumor necrosis factor ( TNF) and interleukin - 7 ( IL - 7), secreted during this interaction, are critical cytokines for HIV long terminal repeat transactivation through NF - kappaB - dependent activation.	Tumor necrosis factor,0,21,Gene/Protein	TNF,24,27,Gene/Protein	interleukin - 7,33,48,Gene/Protein	IL - 7,51,57,Gene/Protein	HIV long terminal repeat,121,145,Gene/Protein	NF - kappaB,170,181,Gene/Protein	"[{""token"": ""Tumor necrosis factor"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 7"", ""start_span"": 33, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 121, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
This peptide potently inhibited NFAT activation and NFAT - dependent expression of endogenous cytokine genes in T cells, without affecting the expression of other cytokines that require calcineurin but not NFAT.	NFAT,32,36,Gene/Protein	NFAT,52,56,Gene/Protein	endogenous cytokine genes,83,108,Gene/Protein	cytokines,163,172,Gene/Protein	calcineurin,186,197,Gene/Protein	NFAT,206,210,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""endogenous cytokine genes"", ""start_span"": 83, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Other peroxisome proliferator activated receptor ( PPAR) ligands, 15d - PGJ ( 2) and troglitazone ( PPARgamma), Wy14, 643 ( PPARalpha), and PD195599 ( PPARbeta) inhibited the induction of MCP - 1 by RA.	peroxisome proliferator activated receptor,6,48,Gene/Protein	PPAR,51,55,Gene/Protein	PPARgamma,100,109,Gene/Protein	PPARalpha,124,133,Gene/Protein	PPARbeta,151,159,Gene/Protein	MCP - 1,188,195,Gene/Protein	"[{""token"": ""peroxisome proliferator activated receptor"", ""start_span"": 6, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""PPAR"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""PPARgamma"", ""start_span"": 100, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""PPARalpha"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""PPARbeta"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 188, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
A dominant - negative version of STAT5b, but not of STAT5a, interfered with IL - 4 - induced DNA synthesis in Ba / F3 cells, suggesting an involvement of STAT5b in the control of cell proliferation through IL - 4R.	dominant - negative version,2,29,Gene/Protein	STAT5b,33,39,Gene/Protein	STAT5a,52,58,Gene/Protein	IL - 4,76,82,Gene/Protein	STAT5b,154,160,Gene/Protein	IL - 4R,206,213,Gene/Protein	"[{""token"": ""dominant - negative version"", ""start_span"": 2, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4R"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
SHP1 - DeltaSH2 also inhibited events downstream of ZAP - 70 and Syk, such as activation of the mitogen - activated protein kinase Erk2 and the transcriptional activation of the interleukin - 2 gene.	SHP1 - DeltaSH2,0,15,Gene/Protein	ZAP - 70,52,60,Gene/Protein	Syk,65,68,Gene/Protein	mitogen - activated protein kinase,96,130,Gene/Protein	Erk2,131,135,Gene/Protein	interleukin - 2 gene,178,198,Gene/Protein	"[{""token"": ""SHP1 - DeltaSH2"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 96, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 gene"", ""start_span"": 178, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
Expression of FOG ( riend ATA), which binds to GATA - 1 and acts as a cofactor for GATA - binding proteins, decreased transactivation activity of GATA - 1 for the MBP promoter in a dose - dependent manner.	FOG,14,17,Gene/Protein	riend ATA,20,29,Gene/Protein	GATA - 1,47,55,Gene/Protein	GATA - binding proteins,83,106,Gene/Protein	GATA - 1,146,154,Gene/Protein	MBP promoter,163,175,Gene/Protein	"[{""token"": ""FOG"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""riend ATA"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding proteins"", ""start_span"": 83, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""MBP promoter"", ""start_span"": 163, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
These results indicate that within the TCR / CD3 signal transduction pathway both PKC and calcineurin are required for the effective activation of the IKK complex and NF - kappaB in T lymphocytes.	TCR,39,42,Gene/Protein	/ CD3,43,48,Gene/Protein	PKC,82,85,Gene/Protein	calcineurin,90,101,Gene/Protein	IKK complex,151,162,Gene/Protein	NF - kappaB,167,178,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""/ CD3"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IKK complex"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
The product of the B - cell - specific B29 gene ( B29, Ig beta, CD79b) is essential for Ig - mediated B - cell activation via the B - cell antigen receptor complex ( BCR) on human and murine B lymphocytes.	B - cell - specific B29 gene,19,47,Gene/Protein	B29,50,53,Gene/Protein	Ig beta,55,62,Gene/Protein	CD79b,64,69,Gene/Protein	B - cell antigen receptor complex,130,163,Gene/Protein	BCR,166,169,Gene/Protein	"[{""token"": ""B - cell - specific B29 gene"", ""start_span"": 19, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""B29"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Ig beta"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD79b"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""B - cell antigen receptor complex"", ""start_span"": 130, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""BCR"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
Activation of the CDC42 effector N - WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2 / 3 complex and bacterial actin - based motility.	CDC42 effector,18,32,Gene/Protein	N - WASP,33,41,Gene/Protein	Shigella flexneri IcsA protein,49,79,Gene/Protein	actin,89,94,Gene/Protein	Arp2 / 3 complex,109,125,Gene/Protein	actin,140,145,Gene/Protein	"[{""token"": ""CDC42 effector"", ""start_span"": 18, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""N - WASP"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Shigella flexneri IcsA protein"", ""start_span"": 49, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Arp2 / 3 complex"", ""start_span"": 109, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
The isolated COOH - terminal domain of N - WASP containing a verprolin - homology region, a cofilin - homology sequence, and an acidic terminal segment ( VCA) interacts with G - actin in a unique profilin - like functional fashion.	COOH - terminal domain,13,35,Gene/Protein	N - WASP,39,47,Gene/Protein	verprolin - homology region,61,88,Gene/Protein	acidic terminal segment,128,151,Gene/Protein	VCA,154,157,Gene/Protein	G - actin,174,183,Gene/Protein	"[{""token"": ""COOH - terminal domain"", ""start_span"": 13, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""N - WASP"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""verprolin - homology region"", ""start_span"": 61, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""acidic terminal segment"", ""start_span"": 128, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""VCA"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""G - actin"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
We have studied the effects of prednisone ( PDN), deflazacort ( DFC), and dexamethasone ( DXM) on the production of cytokines ( IL - 2, IL - 6, TNF - alpha, IL - 10) by peripheral T lymphocytes, and the effects on the inhibition of NF - kB DNA binding activity by activated Jurkat cell line.	cytokines,116,125,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 6,136,142,Gene/Protein	TNF - alpha,144,155,Gene/Protein	IL - 10,157,164,Gene/Protein	NF - kB,232,239,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Forty - one HD samples ( 19 NLPHD, 12 nodular sclerosis, and 10 mixed cellularity) were immunostained with the monoclonal antibodies PG - B6 and PG - B6p that react with a fixative - sensitive and a formalin - resistant epitope on the aminoterminal region of the BCL - 6 gene product, respectively.	monoclonal antibodies,111,132,Gene/Protein	PG - B6,133,140,Gene/Protein	PG - B6p,145,153,Gene/Protein	formalin - resistant epitope,199,227,Gene/Protein	aminoterminal region,235,255,Gene/Protein	BCL - 6 gene product,263,283,Gene/Protein	"[{""token"": ""monoclonal antibodies"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""PG - B6"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""PG - B6p"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""formalin - resistant epitope"", ""start_span"": 199, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""aminoterminal region"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 6 gene product"", ""start_span"": 263, ""end_span"": 283, ""type"": ""Gene/Protein""}]"	train
Exposure to LPS or TNF led to differential patterns of IkappaB - alpha and IkappaB - epsilon disappearance from and reassembly with the signalsome, whereas IKK - alpha, IKK - beta, and NIK remained complex - associated.	TNF,19,22,Gene/Protein	IkappaB - alpha,55,70,Gene/Protein	IkappaB - epsilon,75,92,Gene/Protein	IKK - alpha,156,167,Gene/Protein	IKK - beta,169,179,Gene/Protein	NIK,185,188,Gene/Protein	"[{""token"": ""TNF"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - epsilon"", ""start_span"": 75, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IKK - alpha"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""IKK - beta"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
NIK can not phosphorylate IkappaB - alpha directly, but it appears to be a functionally important subunit, because mutated NIK inhibited stimulus - induced kappaB - dependent transcription more effectively than mutated IKK - alpha or - beta.	NIK,0,3,Gene/Protein	IkappaB - alpha,26,41,Gene/Protein	NIK,123,126,Gene/Protein	kappaB,156,162,Gene/Protein	IKK - alpha,219,230,Gene/Protein	- beta,234,240,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""kappaB"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""IKK - alpha"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""- beta"", ""start_span"": 234, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
We show here that in addition to the strong N - terminal trans - activation domain, TAD - A, which is common to all three NF - ATc isoforms, NF - ATc / C contains a second trans - activation domain, TAD - B, in its C - terminal peptide.	strong N - terminal trans - activation domain,37,82,Gene/Protein	TAD - A,84,91,Gene/Protein	NF - ATc isoforms,122,139,Gene/Protein	NF - ATc / C,141,153,Gene/Protein	trans - activation domain,172,197,Gene/Protein	TAD - B,199,206,Gene/Protein	"[{""token"": ""strong N - terminal trans - activation domain"", ""start_span"": 37, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""TAD - A"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc isoforms"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NF - ATc / C"", ""start_span"": 141, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""trans - activation domain"", ""start_span"": 172, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""TAD - B"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
We have introduced a small deletion within beta - catenin ( Delta19) that disrupts binding to LEF - 1, E - cadherin, and APC but not axin.	beta - catenin,43,57,Gene/Protein	Delta19,60,67,Gene/Protein	LEF - 1,94,101,Gene/Protein	E - cadherin,103,115,Gene/Protein	APC,121,124,Gene/Protein	axin,133,137,Gene/Protein	"[{""token"": ""beta - catenin"", ""start_span"": 43, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Delta19"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""LEF - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""E - cadherin"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""axin"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	train
We show that the BR3 sequence contains a novel negative regulatory element located at positions - 90 to - 79 of the hIL - 5 promoter, which binds Oct1, octamer - like, and YY1 nuclear factors.	BR3,17,20,Gene/Protein	negative regulatory element,47,74,Gene/Protein	hIL - 5 promoter,116,132,Gene/Protein	Oct1,146,150,Gene/Protein	octamer - like,152,166,Gene/Protein	YY1 nuclear factors,172,191,Gene/Protein	"[{""token"": ""BR3"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""negative regulatory element"", ""start_span"": 47, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""hIL - 5 promoter"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Oct1"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""octamer - like"", ""start_span"": 152, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""YY1 nuclear factors"", ""start_span"": 172, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
CONCLUSION: We suggest that Oct1, YY1, and octamer - like factors binding to the - 90 / - 79 sequence within the proximal IL - 5 promoter are involved in suppression of IL - 5 transcription in T cells.	Oct1,28,32,Gene/Protein	YY1,34,37,Gene/Protein	octamer - like factors,43,65,Gene/Protein	- 90 / - 79 sequence,81,101,Gene/Protein	proximal IL - 5 promoter,113,137,Gene/Protein	IL - 5,169,175,Gene/Protein	"[{""token"": ""Oct1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""YY1"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""octamer - like factors"", ""start_span"": 43, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""- 90 / - 79 sequence"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""proximal IL - 5 promoter"", ""start_span"": 113, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Binding of NF - AT, NF - kappaB, and AP - 1 was induced by T - cell receptor ( TcR) stimulation, although there was no significant upregulation of binding by IL - 2 stimulation.	NF - AT,11,18,Gene/Protein	NF - kappaB,20,31,Gene/Protein	AP - 1,37,43,Gene/Protein	T - cell receptor,59,76,Gene/Protein	TcR,79,82,Gene/Protein	IL - 2,158,164,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""T - cell receptor"", ""start_span"": 59, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""TcR"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
We found that the spontaneous production of tumor necrosis factor alpha and other pro - inflammatory cytokines is NF - kappaB - dependent in rheumatoid synovial tissue, in contrast to the main anti - inflammatory mediators, like IL - 10 and - 11, and the IL - 1 receptor antagonist.	tumor necrosis factor alpha,44,71,Gene/Protein	pro - inflammatory cytokines,82,110,Gene/Protein	NF - kappaB,114,125,Gene/Protein	anti - inflammatory mediators,193,222,Gene/Protein	IL - 10 and - 11,229,245,Gene/Protein	IL - 1 receptor antagonist,255,281,Gene/Protein	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 44, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""pro - inflammatory cytokines"", ""start_span"": 82, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""anti - inflammatory mediators"", ""start_span"": 193, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 and - 11"", ""start_span"": 229, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor antagonist"", ""start_span"": 255, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	train
We have previously shown that the membrane - proximal portion in the cytoplasmic domain of the human IL - 4R alpha ( hIL - 4R alpha) is critical for proliferation, generation of germline epsilon transcript, and activation of STAT6, based on analyses of truncated hIL - 4R alphas.	membrane - proximal portion,34,61,Gene/Protein	cytoplasmic domain,69,87,Gene/Protein	human IL - 4R alpha,95,114,Gene/Protein	hIL - 4R alpha,117,131,Gene/Protein	STAT6,225,230,Gene/Protein	truncated hIL - 4R alphas,253,278,Gene/Protein	"[{""token"": ""membrane - proximal portion"", ""start_span"": 34, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 69, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 4R alpha"", ""start_span"": 95, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""hIL - 4R alpha"", ""start_span"": 117, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""truncated hIL - 4R alphas"", ""start_span"": 253, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
Protein kinase B ( c - Akt), phosphatidylinositol 3 - kinase, and STAT5 are activated by erythropoietin ( EPO) in HCD57 erythroid cells but are constitutively active in an EPO - independent, apoptosis - resistant subclone ( HCD57 - SREI cells).	Protein kinase B,0,16,Gene/Protein	c - Akt,19,26,Gene/Protein	phosphatidylinositol 3 - kinase,29,60,Gene/Protein	STAT5,66,71,Gene/Protein	erythropoietin,89,103,Gene/Protein	EPO,106,109,Gene/Protein	"[{""token"": ""Protein kinase B"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""c - Akt"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 29, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""erythropoietin"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
We found that erythropoietin ( EPO) and stem cell factor ( SCF) activated protein kinase B ( PKB / Akt) in EPO - dependent HCD57 erythroid cells.	erythropoietin,14,28,Gene/Protein	EPO,31,34,Gene/Protein	stem cell factor,40,56,Gene/Protein	SCF,59,62,Gene/Protein	activated protein kinase B,64,90,Gene/Protein	PKB / Akt,93,102,Gene/Protein	"[{""token"": ""erythropoietin"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""stem cell factor"", ""start_span"": 40, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""activated protein kinase B"", ""start_span"": 64, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""PKB / Akt"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	train
All three steps progressively helpX? ed to discriminate T - cell - specific promoter sequences against other functional regions ( coding and intronic sequences) of the same genes, against promoters of muscle - specific genes or against random sequences.	T - cell - specific promoter sequences,56,94,Gene/Protein	functional regions,109,127,Gene/Protein	coding and intronic sequences,130,159,Gene/Protein	promoters,188,197,Gene/Protein	muscle - specific genes,201,224,Gene/Protein	random sequences,236,252,Gene/Protein	"[{""token"": ""T - cell - specific promoter sequences"", ""start_span"": 56, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""functional regions"", ""start_span"": 109, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""coding and intronic sequences"", ""start_span"": 130, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""muscle - specific genes"", ""start_span"": 201, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""random sequences"", ""start_span"": 236, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
Using this approach, we identified potential NFAT composite elements in promoters of cytokine genes and their receptors as well as in promoters of genes for AP - 1 family members, Ca2 + - binding proteins and some other components of the regulatory network operating in activated T - cells and other immune cells.	NFAT composite elements,45,68,Gene/Protein	promoters,72,81,Gene/Protein	cytokine genes,85,99,Gene/Protein	promoters,134,143,Gene/Protein	AP - 1 family members,157,178,Gene/Protein	Ca2 + - binding proteins,180,204,Gene/Protein	"[{""token"": ""NFAT composite elements"", ""start_span"": 45, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 72, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 85, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 family members"", ""start_span"": 157, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Ca2 + - binding proteins"", ""start_span"": 180, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
The composite motif binds a multi - protein hematopoietic - specific transcription factor complex which includes GATA - 1, SCL / tal - 1, E2A, Lmo2 and Ldb - 1.	composite motif,4,19,Gene/Protein	multi - protein hematopoietic - specific transcription factor complex,28,97,Gene/Protein	GATA - 1,113,121,Gene/Protein	E2A,138,141,Gene/Protein	Lmo2,143,147,Gene/Protein	Ldb - 1,152,159,Gene/Protein	"[{""token"": ""composite motif"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""multi - protein hematopoietic - specific transcription factor complex"", ""start_span"": 28, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Lmo2"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""Ldb - 1"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
In addition to activating transcription from the viral long terminal repeat ( LTR) through the cyclic AMP response element binding protein / activating transcription factor ( CREB / ATF) family of transcription factors, Tax activates the expression of multiple cellular promoters through the NF - kappaB pathway of transcriptional activation.	viral long terminal repeat,49,75,Gene/Protein	LTR,78,81,Gene/Protein	transcription factors,197,218,Gene/Protein	Tax,220,223,Gene/Protein	multiple cellular promoters,252,279,Gene/Protein	NF - kappaB,292,303,Gene/Protein	"[{""token"": ""viral long terminal repeat"", ""start_span"": 49, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 197, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""multiple cellular promoters"", ""start_span"": 252, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 292, ""end_span"": 303, ""type"": ""Gene/Protein""}]"	train
RanBP1 as well as Ran - binding domains of the cytoplasmic nucleoporin RanBP2 promote the release of CRM1 from the NPC.	RanBP1,0,6,Gene/Protein	Ran - binding domains,18,39,Gene/Protein	cytoplasmic nucleoporin,47,70,Gene/Protein	RanBP2,71,77,Gene/Protein	CRM1,101,105,Gene/Protein	NPC,115,118,Gene/Protein	"[{""token"": ""RanBP1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""Ran - binding domains"", ""start_span"": 18, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic nucleoporin"", ""start_span"": 47, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""RanBP2"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""CRM1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	train
Taken together, our results indicate that Ran GTP is important for the targeting of export complexes to the cytoplasmic side of the NPC and that RanBP1 and probably RanBP2 are involved in the dissociation of nuclear export complexes from the NPC in a terminal step of transport.	Ran,42,45,Gene/Protein	NPC,132,135,Gene/Protein	RanBP1,145,151,Gene/Protein	RanBP2,165,171,Gene/Protein	nuclear export complexes,208,232,Gene/Protein	NPC,242,245,Gene/Protein	"[{""token"": ""Ran"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""RanBP1"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""RanBP2"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""nuclear export complexes"", ""start_span"": 208, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""NPC"", ""start_span"": 242, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
In early to intermediate stages of erythroid differentiation we monitored the induction of CD36, Tal1, EKLF, NF - E2, and GATA - 1 that preceeded expression of EpoR.	CD36,91,95,Gene/Protein	Tal1,97,101,Gene/Protein	EKLF,103,107,Gene/Protein	NF - E2,109,116,Gene/Protein	GATA - 1,122,130,Gene/Protein	EpoR,160,164,Gene/Protein	"[{""token"": ""CD36"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Tal1"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""EpoR"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Previous studies have implicated activation of both protein kinase C ( PKC) and protein tyrosine kinases ( PTK) in LPS - induced NF - kappaB activation and TNF - alpha production.	protein kinase C,52,68,Gene/Protein	PKC,71,74,Gene/Protein	protein tyrosine kinases,80,104,Gene/Protein	PTK,107,110,Gene/Protein	NF - kappaB,129,140,Gene/Protein	TNF - alpha,156,167,Gene/Protein	"[{""token"": ""protein kinase C"", ""start_span"": 52, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine kinases"", ""start_span"": 80, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Nonspecific protein kinase inhibition inhibited NF - kappaB activation and TNF - alpha release, while specific PKC inhibition with Bis had no effect on LPS - induced NF - kappaB DNA binding or TNF - alpha release.	protein kinase,12,26,Gene/Protein	NF - kappaB,48,59,Gene/Protein	TNF - alpha,75,86,Gene/Protein	PKC,111,114,Gene/Protein	NF - kappaB,166,177,Gene/Protein	TNF - alpha,193,204,Gene/Protein	"[{""token"": ""protein kinase"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 75, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Gene/Protein""}]"	train
Binding of interferon - gamma ( IFN - gamma) to its heterodimeric receptor induces activation of the tyrosine kinases JAK1 and JAK2 followed by tyrosine phosphorylation of STAT1alpha.	interferon - gamma,11,29,Gene/Protein	IFN - gamma,32,43,Gene/Protein	tyrosine kinases,101,117,Gene/Protein	JAK1,118,122,Gene/Protein	JAK2,127,131,Gene/Protein	STAT1alpha,172,182,Gene/Protein	"[{""token"": ""interferon - gamma"", ""start_span"": 11, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine kinases"", ""start_span"": 101, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""STAT1alpha"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
Overexpression of hematopoietic protein - tyrosine phosphatase ( HePTP) results in suppression of T lymphocyte activation as measured by T cell antigen receptor - induced activation of transcription factors binding to the 5 ' promoter of the interleukin - 2 gene.	hematopoietic protein - tyrosine phosphatase,18,62,Gene/Protein	HePTP,65,70,Gene/Protein	T cell antigen receptor,137,160,Gene/Protein	transcription factors,185,206,Gene/Protein	5 ' promoter,222,234,Gene/Protein	interleukin - 2 gene,242,262,Gene/Protein	"[{""token"": ""hematopoietic protein - tyrosine phosphatase"", ""start_span"": 18, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""HePTP"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 137, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 185, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""5 ' promoter"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 gene"", ""start_span"": 242, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The specificity of HePTP correlated with its physical association through its noncatalytic N terminus with Erk and another MAP kinase, p38, but not Jnk or other proteins.	HePTP,19,24,Gene/Protein	N terminus,91,101,Gene/Protein	Erk,107,110,Gene/Protein	MAP kinase,123,133,Gene/Protein	p38,135,138,Gene/Protein	Jnk,148,151,Gene/Protein	"[{""token"": ""HePTP"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""N terminus"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Jnk"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
However, we found that RA opposed anti - apoptotic effects of G - CSF and GM - CSF on CD34 + cells ( G - CSF: 8% dead cells at day 6; G - CSF + RA: 20%; GM - CSF: 12%; GM - CSF + RA: 27%).	G - CSF,62,69,Gene/Protein	GM - CSF,74,82,Gene/Protein	G - CSF,101,108,Gene/Protein	G - CSF,134,141,Gene/Protein	GM - CSF,153,161,Gene/Protein	GM - CSF,168,176,Gene/Protein	"[{""token"": ""G - CSF"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
PHA stimulates IL - 2R alpha -, beta -, and gamma - chain expression and their signaling pathway molecules Jak1, Jak3, Stat1, Stat3, and Stat5.	PHA,0,3,Gene/Protein	signaling pathway molecules,79,106,Gene/Protein	Jak1,107,111,Gene/Protein	Jak3,113,117,Gene/Protein	Stat3,126,131,Gene/Protein	Stat5,137,142,Gene/Protein	"[{""token"": ""PHA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""signaling pathway molecules"", ""start_span"": 79, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
We propose a model in which stimulation of monocytes by IFN activates de novo synthesis of an inhibitory factor, possibly one or more members of the SOCS / SSI / CIS gene family, capable of suppressing activation of STAT6 by IL - 4 and IL - 13.	IFN,56,59,Gene/Protein	inhibitory factor,94,111,Gene/Protein	SOCS / SSI / CIS gene family,149,177,Gene/Protein	STAT6,216,221,Gene/Protein	IL - 4,225,231,Gene/Protein	IL - 13,236,243,Gene/Protein	"[{""token"": ""IFN"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory factor"", ""start_span"": 94, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""SOCS / SSI / CIS gene family"", ""start_span"": 149, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
HLA class I - mediated inactivation of Rb can be inhibited specifically by neutralizing Abs to basic fibroblast growth factor ( bFGF), suggesting a role for FGF receptors in the signaling process.	HLA class I,0,11,Gene/Protein	Rb,39,41,Gene/Protein	neutralizing Abs,75,91,Gene/Protein	basic fibroblast growth factor,95,125,Gene/Protein	bFGF,128,132,Gene/Protein	FGF receptors,157,170,Gene/Protein	"[{""token"": ""HLA class I"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""neutralizing Abs"", ""start_span"": 75, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 95, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""bFGF"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""FGF receptors"", ""start_span"": 157, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL - 4 via cooperative NF - kappa B and STAT - 6 binding sites.	evolutionarily conserved sequence,4,37,Gene/Protein	human Ig heavy chain S gamma 3 region,54,91,Gene/Protein	inducible promoter,98,116,Gene/Protein	CD40 ligand,144,155,Gene/Protein	IL - 4,160,166,Gene/Protein	NF - kappa B and STAT - 6 binding sites,183,222,Gene/Protein	"[{""token"": ""evolutionarily conserved sequence"", ""start_span"": 4, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""human Ig heavy chain S gamma 3 region"", ""start_span"": 54, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""inducible promoter"", ""start_span"": 98, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""CD40 ligand"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B and STAT - 6 binding sites"", ""start_span"": 183, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Reporter luciferase gene vectors containing the human gamma 3 ECS were used to transfect CL - 01 cells, which have been shown to undergo Smu - - > S gamma 3 DNA recombination, upon engagement of CD40 by CD40 ligand ( CD40L) and exposure to IL - 4.	Reporter luciferase gene vectors,0,32,Gene/Protein	human gamma 3 ECS,48,65,Gene/Protein	CD40,195,199,Gene/Protein	CD40 ligand,203,214,Gene/Protein	CD40L,217,222,Gene/Protein	IL - 4,240,246,Gene/Protein	"[{""token"": ""Reporter luciferase gene vectors"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""human gamma 3 ECS"", ""start_span"": 48, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""CD40 ligand"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 240, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
Targeted mutational analysis demonstrated that a tandem NF - kappa B / Rel binding motif is critical for the gamma 3 ECS responsiveness to both CD40L and IL - 4, while a STAT - 6 - binding site is additionally required for IL - 4 inducibility.	NF - kappa B / Rel binding motif,56,88,Gene/Protein	gamma 3 ECS,109,120,Gene/Protein	CD40L,144,149,Gene/Protein	IL - 4,154,160,Gene/Protein	STAT - 6 - binding site,170,193,Gene/Protein	IL - 4,223,229,Gene/Protein	"[{""token"": ""NF - kappa B / Rel binding motif"", ""start_span"": 56, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""gamma 3 ECS"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 6 - binding site"", ""start_span"": 170, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
Increased expression of IFNgamma - induced IP - 10 mRNA following the differentiation of U937 cells was mediated largely by augmented transcriptional activity of the gene and was related to differentiation - dependent changes of the proteins bound to IFN stimulus response element ( ISRE) and kB sites, suggesting that these nuclear proteins may determine the IP - 10 mRNA inducibility by IFNgamma.	IFNgamma,24,32,Gene/Protein	IP - 10 mRNA,43,55,Gene/Protein	kB sites,293,301,Gene/Protein	nuclear proteins,325,341,Gene/Protein	IP - 10 mRNA,360,372,Gene/Protein	IFNgamma,389,397,Gene/Protein	"[{""token"": ""IFNgamma"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IP - 10 mRNA"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""kB sites"", ""start_span"": 293, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 325, ""end_span"": 341, ""type"": ""Gene/Protein""}, {""token"": ""IP - 10 mRNA"", ""start_span"": 360, ""end_span"": 372, ""type"": ""Gene/Protein""}, {""token"": ""IFNgamma"", ""start_span"": 389, ""end_span"": 397, ""type"": ""Gene/Protein""}]"	train
After tyrosine phosphorylation by src and possibly syk protein tyrosine kinases SIT recruits the SH2 domain - containing tyrosine phosphatase SHP2 via an immunoreceptor tyrosine - based inhibition motif.	src,34,37,Gene/Protein	syk,51,54,Gene/Protein	protein tyrosine kinases,55,79,Gene/Protein	SIT,80,83,Gene/Protein	SH2 domain - containing tyrosine phosphatase,97,141,Gene/Protein	SHP2,142,146,Gene/Protein	"[{""token"": ""src"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""syk"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine kinases"", ""start_span"": 55, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""SIT"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""SH2 domain - containing tyrosine phosphatase"", ""start_span"": 97, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""SHP2"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
The multiple biologic activities of retinoic acid ( RA) are mediated through RAR and retinoid X receptor ( RXR) nuclear receptors that interact with specific DNA target sequences as heterodimers ( RXR - RAR) or homodimers ( RXR - RXR).	RAR,77,80,Gene/Protein	DNA target sequences,158,178,Gene/Protein	heterodimers,182,194,Gene/Protein	RXR - RAR,197,206,Gene/Protein	homodimers,211,221,Gene/Protein	RXR - RXR,224,233,Gene/Protein	"[{""token"": ""RAR"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""DNA target sequences"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""heterodimers"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RAR"", ""start_span"": 197, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""homodimers"", ""start_span"": 211, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""RXR - RXR"", ""start_span"": 224, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
The functional synergy between IL - 2 and IL - 12 is also associated with a prominent increase in STAT1 and STAT3 serine phosphorylation over that observed with IL - 12 or IL - 2 alone.	IL - 2,31,37,Gene/Protein	IL - 12,42,49,Gene/Protein	STAT1,98,103,Gene/Protein	STAT3,108,113,Gene/Protein	IL - 12,161,168,Gene/Protein	IL - 2,172,178,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
A specific inhibitor of p38 MAP kinase completely inhibits the serine phosphorylation of STAT1 and STAT3 induced by IL - 12 and IL - 2 and abrogates the functional synergy between IL - 12 and IL - 2 without affecting STAT tyrosine phosphorylation.	STAT1,89,94,Gene/Protein	STAT3,99,104,Gene/Protein	IL - 12,116,123,Gene/Protein	IL - 2,128,134,Gene/Protein	IL - 12,180,187,Gene/Protein	IL - 2,192,198,Gene/Protein	"[{""token"": ""STAT1"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
One of the prominent substrates for these kinases is the adaptor protein Cbl [ 3] and recent studies suggest that Cbl negatively regulates upstream kinases such as Syk and Zap - 70 [ 4] [ 5].	kinases,42,49,Gene/Protein	adaptor protein,57,72,Gene/Protein	Cbl,73,76,Gene/Protein	upstream kinases,139,155,Gene/Protein	Syk,164,167,Gene/Protein	Zap - 70,172,180,Gene/Protein	"[{""token"": ""kinases"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""adaptor protein"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""upstream kinases"", ""start_span"": 139, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""Zap - 70"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
Our data suggest that Grf40 is an adaptor molecule involved in TCR - mediated signaling through a more efficient interaction than Grb2 with SLP - 76 and LAT.	Grf40,22,27,Gene/Protein	adaptor molecule,34,50,Gene/Protein	TCR,63,66,Gene/Protein	Grb2,130,134,Gene/Protein	SLP - 76,140,148,Gene/Protein	LAT,153,156,Gene/Protein	"[{""token"": ""Grf40"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""adaptor molecule"", ""start_span"": 34, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""LAT"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Our previous results show that recombinant gp41 ( aa565 - 647), the extracellular domain of HIV - 1 transmembrane glycoprotein, stimulates interleukin - 10 ( IL - 10) production in human monocytes.	recombinant gp41,31,47,Gene/Protein	aa565 - 647,50,61,Gene/Protein	extracellular domain,68,88,Gene/Protein	HIV - 1 transmembrane glycoprotein,92,126,Gene/Protein	interleukin - 10,139,155,Gene/Protein	IL - 10,158,165,Gene/Protein	"[{""token"": ""recombinant gp41"", ""start_span"": 31, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""aa565 - 647"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 transmembrane glycoprotein"", ""start_span"": 92, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 10"", ""start_span"": 139, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
In contrast, gp41 failed to stimulate NF - kappaB binding activity in as much as no NF - kappaB bound to the main NF - kappaB - binding site 2 of the IL - 10 promoter after addition of gp41.	gp41,13,17,Gene/Protein	NF - kappaB,38,49,Gene/Protein	NF - kappaB,84,95,Gene/Protein	main NF - kappaB - binding site,109,140,Gene/Protein	IL - 10 promoter,150,166,Gene/Protein	gp41,185,189,Gene/Protein	"[{""token"": ""gp41"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""main NF - kappaB - binding site"", ""start_span"": 109, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10 promoter"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""gp41"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
We show here that in circulating monocytes, NF - Y binding activity is not detected on the CCAAT motif present in the promoters of genes such as major histocompatibility complex ( MHC) class II, gp91 - phox, mig, and fibronectin, whereas during macrophage differentiation, a progressive increase in NF - Y binding activity is observed on these promoters.	NF - Y,44,50,Gene/Protein	CCAAT motif,91,102,Gene/Protein	promoters of genes,118,136,Gene/Protein	gp91 - phox,195,206,Gene/Protein	mig,208,211,Gene/Protein	NF - Y,299,305,Gene/Protein	"[{""token"": ""NF - Y"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT motif"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""promoters of genes"", ""start_span"": 118, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""gp91 - phox"", ""start_span"": 195, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""mig"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 299, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
This is manifested by the ability of Delta to restore induction of calcium fluxes and mitogen - activated protein kinase activation and by the ability of dominant negative Ras and FK506 to block the induction of NF - AT activity mediated by Delta.	Delta,37,42,Gene/Protein	mitogen - activated protein kinase,86,120,Gene/Protein	Ras,172,175,Gene/Protein	FK506,180,185,Gene/Protein	NF - AT,212,219,Gene/Protein	Delta,241,246,Gene/Protein	"[{""token"": ""Delta"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""mitogen - activated protein kinase"", ""start_span"": 86, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""FK506"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""Delta"", ""start_span"": 241, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
In an attempt to find such elusive Oct2 target genes and to understand the molecular function of Oct2 in B cell development, we isolated cDNAs for Oct2 target genes.	Oct2,35,39,Gene/Protein	target genes,40,52,Gene/Protein	Oct2,97,101,Gene/Protein	cDNAs,137,142,Gene/Protein	Oct2,147,151,Gene/Protein	target genes,152,164,Gene/Protein	"[{""token"": ""Oct2"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""Oct2"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""cDNAs"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""Oct2"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""target genes"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift assay revealed that the potential NF - kappaB binding sequence which is located around 120 bp upstream of the transcription initiation site in murine and human p40 genes formed an NF - kappaB complex with nuclear extract from Daudi cells stimulated by CD40 ligation.	NF - kappaB binding sequence,65,93,Gene/Protein	120 bp upstream,118,133,Gene/Protein	transcription initiation site,141,170,Gene/Protein	murine and human p40 genes,174,200,Gene/Protein	NF - kappaB complex,211,230,Gene/Protein	CD40,283,287,Gene/Protein	"[{""token"": ""NF - kappaB binding sequence"", ""start_span"": 65, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""120 bp upstream"", ""start_span"": 118, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 141, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""murine and human p40 genes"", ""start_span"": 174, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB complex"", ""start_span"": 211, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
These results suggest that the NF - kappaB binding site located around 120 bp upstream of the transcription initiation site in murine and human p40 promoter regions could be important for the p40 induction by CD40 ligation via activation of NF - kappaB.	NF - kappaB binding site,31,55,Gene/Protein	transcription initiation site,94,123,Gene/Protein	murine and human p40 promoter regions,127,164,Gene/Protein	p40,192,195,Gene/Protein	CD40,209,213,Gene/Protein	NF - kappaB,241,252,Gene/Protein	"[{""token"": ""NF - kappaB binding site"", ""start_span"": 31, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""transcription initiation site"", ""start_span"": 94, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""murine and human p40 promoter regions"", ""start_span"": 127, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""p40"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
We also showed that tumor necrosis factor ( TNF) and to a lesser extent interleukin - 1 ( IL - 1), secreted within the coculture, induce NF - kappaB activity and a correlative LTR transactivation.	tumor necrosis factor,20,41,Gene/Protein	TNF,44,47,Gene/Protein	interleukin - 1,72,87,Gene/Protein	IL - 1,90,96,Gene/Protein	NF - kappaB,137,148,Gene/Protein	LTR,176,179,Gene/Protein	"[{""token"": ""tumor necrosis factor"", ""start_span"": 20, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 137, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
In concert with the coactivator CREB binding protein / p300, which interacts with GABPalpha, the binding of GABPalpha and - beta to the dyad symmetry element controls the induction of IL - 16 promoter in T cells.	coactivator CREB binding protein / p300,20,59,Gene/Protein	GABPalpha,82,91,Gene/Protein	GABPalpha,108,117,Gene/Protein	- beta,122,128,Gene/Protein	dyad symmetry element,136,157,Gene/Protein	IL - 16 promoter,184,200,Gene/Protein	"[{""token"": ""coactivator CREB binding protein / p300"", ""start_span"": 20, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GABPalpha"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""GABPalpha"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""- beta"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""dyad symmetry element"", ""start_span"": 136, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""IL - 16 promoter"", ""start_span"": 184, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
The mammalian NF - kappaB and octamer binding sites seem to be absent, although there are alternative potential NF - kappaB and octamer - binding elements in the chicken IL2 promoter, in close proximity to their mammalian homologues.	mammalian NF - kappaB,4,25,Gene/Protein	octamer binding sites,30,51,Gene/Protein	NF - kappaB,112,123,Gene/Protein	octamer - binding elements,128,154,Gene/Protein	chicken IL2 promoter,162,182,Gene/Protein	mammalian homologues,212,232,Gene/Protein	"[{""token"": ""mammalian NF - kappaB"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""octamer binding sites"", ""start_span"": 30, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 112, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding elements"", ""start_span"": 128, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""chicken IL2 promoter"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""mammalian homologues"", ""start_span"": 212, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
IL - 12 induced STAT4 and IL - 2 and IL - 15 induced STAT5 binding to the GAS elements.	IL - 12,0,7,Gene/Protein	STAT4,16,21,Gene/Protein	IL - 2,26,32,Gene/Protein	IL - 15,37,44,Gene/Protein	STAT5,53,58,Gene/Protein	GAS elements,74,86,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""STAT4"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""GAS elements"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Gene/Protein""}]"	train
Over the next week, this cell population accumulates phenotypic markers of osteoclasts ( vitronectin receptor [ VR], calcitonin receptor, TRAP, cathepsin K protein, and mRNA) with increased nuclearity, covering the entire surface by 15 days.	vitronectin receptor,89,109,Gene/Protein	VR,112,114,Gene/Protein	calcitonin receptor,117,136,Gene/Protein	TRAP,138,142,Gene/Protein	cathepsin K protein,144,163,Gene/Protein	mRNA,169,173,Gene/Protein	"[{""token"": ""vitronectin receptor"", ""start_span"": 89, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""VR"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""calcitonin receptor"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""TRAP"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cathepsin K protein"", ""start_span"": 144, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
The stability of already formed complexed was somewhat different in the HLA - A3 and HLA - Cw * 0702 system: both were more stable at 26 degrees C than at 37 degrees C but while the beta 2 - m and FCS did not influence the stability of the HLA - A3 / peptide complex, they seemed to cause opposite effects in the HLA - Cw * 0702 system ( beta 2 - m stabilized and FCS destabilized the complex).	HLA - A3,72,80,Gene/Protein	HLA - Cw * 0702,85,100,Gene/Protein	beta 2 - m,182,192,Gene/Protein	HLA - A3 / peptide complex,240,266,Gene/Protein	HLA - Cw * 0702,313,328,Gene/Protein	beta 2 - m,338,348,Gene/Protein	"[{""token"": ""HLA - A3"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""HLA - Cw * 0702"", ""start_span"": 85, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""beta 2 - m"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""HLA - A3 / peptide complex"", ""start_span"": 240, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""HLA - Cw * 0702"", ""start_span"": 313, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""beta 2 - m"", ""start_span"": 338, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
The modulation by anti - LPS mAbs of mCD14 - mediated LPS uptake was associated with inhibition of LPS - induced nuclear factor - kappaB ( NF - kappaB) translocation and TNF - alpha secretion in CHO - CD14 cells and monocytes, respectively, while mAb enhancement of non - mCD14 - mediated LPS uptake stimulated these activities.	anti - LPS mAbs,18,33,Gene/Protein	mCD14,37,42,Gene/Protein	LPS - induced nuclear factor - kappaB,99,136,Gene/Protein	NF - kappaB,139,150,Gene/Protein	TNF - alpha,170,181,Gene/Protein	mCD14,272,277,Gene/Protein	"[{""token"": ""anti - LPS mAbs"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""mCD14"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""LPS - induced nuclear factor - kappaB"", ""start_span"": 99, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""mCD14"", ""start_span"": 272, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
We used reverse transcriptase - polymerase chain reaction to examine both fetal and term neonatal cord bloods for mRNA expression of three transcription factors implicated in T - cell activation: c - jun, c - fos, and NF kappa B ( p50 subunit).	reverse transcriptase,8,29,Gene/Protein	transcription factors,139,160,Gene/Protein	c - jun,196,203,Gene/Protein	c - fos,205,212,Gene/Protein	NF kappa B,218,228,Gene/Protein	p50 subunit,231,242,Gene/Protein	"[{""token"": ""reverse transcriptase"", ""start_span"": 8, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 139, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 218, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 231, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
Since the DSE and TRE sites can not bind CREB / ATF homodimers, we propose a mechanism in which the HIV - 1 DSE bind heterodimers composed of both AP - 1 and CREB / ATF proteins.	DSE,10,13,Gene/Protein	TRE,18,21,Gene/Protein	CREB / ATF homodimers,41,62,Gene/Protein	DSE,108,111,Gene/Protein	heterodimers,117,129,Gene/Protein	AP - 1 and CREB / ATF proteins,147,177,Gene/Protein	"[{""token"": ""DSE"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""TRE"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF homodimers"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""DSE"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""heterodimers"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 and CREB / ATF proteins"", ""start_span"": 147, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
IgE germline promoter reporter gene constructs carrying point mutations in the NF kappa B2 site were largely unresponsive to IL - 4 stimulation in transient transfection experiments, while plasmids with similar mutations in the NF kappa B1 site responded to cytokine stimulation better than the wild - type promoter.	IgE germline promoter reporter gene constructs,0,46,Gene/Protein	NF kappa B2,79,90,Gene/Protein	IL - 4,125,131,Gene/Protein	NF kappa B1,228,239,Gene/Protein	cytokine,258,266,Gene/Protein	wild - type promoter,295,315,Gene/Protein	"[{""token"": ""IgE germline promoter reporter gene constructs"", ""start_span"": 0, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B2"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B1"", ""start_span"": 228, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 258, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""wild - type promoter"", ""start_span"": 295, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
In addition, alpha G2S exhibited increased expression of CD11b and CD54, while alpha B5A cells showed increased expression of CD102, suggesting that RXR - alpha has a role in regulating expression of cell adhesion molecules in U937 cells.	alpha G2S,13,22,Gene/Protein	CD11b,57,62,Gene/Protein	CD54,67,71,Gene/Protein	CD102,126,131,Gene/Protein	RXR - alpha,149,160,Gene/Protein	cell adhesion molecules,200,223,Gene/Protein	"[{""token"": ""alpha G2S"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD54"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD102"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""RXR - alpha"", ""start_span"": 149, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""cell adhesion molecules"", ""start_span"": 200, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
The distinct N - terminal half of MZF - 2 carries two characteristic domains, a leucine - rich domain called LeR and an acidic domain, which suggests a unique function of MZF - 2 in neutrophil development.	N - terminal half,13,30,Gene/Protein	MZF - 2,34,41,Gene/Protein	leucine - rich domain,80,101,Gene/Protein	LeR,109,112,Gene/Protein	acidic domain,120,133,Gene/Protein	MZF - 2,171,178,Gene/Protein	"[{""token"": ""N - terminal half"", ""start_span"": 13, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""MZF - 2"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""leucine - rich domain"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""LeR"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""acidic domain"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""MZF - 2"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Serum ACTH and IgE were measured by immunoradiometric assay, and IL - 2, IL - 4, and IL - 10 cytokines and interferon - gamma were measured by enzyme - linked immunosorbent assay.	IgE,15,18,Gene/Protein	IL - 2,65,71,Gene/Protein	IL - 4,73,79,Gene/Protein	IL - 10,85,92,Gene/Protein	cytokines,93,102,Gene/Protein	interferon - gamma,107,125,Gene/Protein	"[{""token"": ""IgE"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""interferon - gamma"", ""start_span"": 107, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
During CD30 signal transduction, we found that binding of TRAF2 to the cytoplasmic domain of CD30 results in the rapid depletion of TRAF2 and the associated protein TRAF1 by proteolysis.	CD30,7,11,Gene/Protein	TRAF2,58,63,Gene/Protein	cytoplasmic domain,71,89,Gene/Protein	CD30,93,97,Gene/Protein	TRAF2,132,137,Gene/Protein	TRAF1,165,170,Gene/Protein	"[{""token"": ""CD30"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 71, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""CD30"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""TRAF2"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""TRAF1"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
The highly specific granulomonocyte - associated lysosomal proteins myeloperoxidase ( MPO) and lysozyme ( LZ), as well as the transcription factor PU. 1, were already detectable in the most immature CD34 + Thy - 1 + subset.	granulomonocyte - associated lysosomal proteins,20,67,Gene/Protein	myeloperoxidase,68,83,Gene/Protein	MPO,86,89,Gene/Protein	lysozyme,95,103,Gene/Protein	LZ,106,108,Gene/Protein	transcription factor,126,146,Gene/Protein	"[{""token"": ""granulomonocyte - associated lysosomal proteins"", ""start_span"": 20, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""myeloperoxidase"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""MPO"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""lysozyme"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""LZ"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 126, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
The binding site for nuclear factor - kappaB ( NF - kappaB) is present at the promoter region of the germline Cepsilon gene, but there is little information on whether this factor is involved in regulating IgE synthesis by human B cells.	binding site,4,16,Gene/Protein	nuclear factor - kappaB,21,44,Gene/Protein	NF - kappaB,47,58,Gene/Protein	promoter region,78,93,Gene/Protein	germline Cepsilon gene,101,123,Gene/Protein	IgE,206,209,Gene/Protein	"[{""token"": ""binding site"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappaB"", ""start_span"": 21, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""germline Cepsilon gene"", ""start_span"": 101, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Although IL - 4 activated signal transducers and activators of transcription ( STAT) 6 in addition to NF - kappaB, NAC treatment or the transfection of decoy oligodeoxynucleotide for NF - kappaB or STAT6 only partly blocked IL - 4 - induced germline Cepsilon transcription.	IL - 4,9,15,Gene/Protein	NF - kappaB,102,113,Gene/Protein	NF - kappaB,183,194,Gene/Protein	STAT6,198,203,Gene/Protein	IL - 4,224,230,Gene/Protein	germline,241,249,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 241, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
Using protein - DNA interaction assays we show that the H4 promoter contains two ATF / CREB recognition motifs which interact with CREB, ATF1, and ATF2 but not with ATF4 / CREB2.	H4 promoter,56,67,Gene/Protein	CREB,87,91,Gene/Protein	CREB,131,135,Gene/Protein	ATF1,137,141,Gene/Protein	ATF2,147,151,Gene/Protein	ATF4 / CREB2,165,177,Gene/Protein	"[{""token"": ""H4 promoter"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""ATF1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""ATF2"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""ATF4 / CREB2"", ""start_span"": 165, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
LMP - 1 effects on AP - 1 are mediated through activation of the c - Jun N - terminal kinase ( JNK) cascade, but not the extracellular signal - regulated kinase ( Erk) pathway.	LMP - 1,0,7,Gene/Protein	AP - 1,19,25,Gene/Protein	c - Jun,65,72,Gene/Protein	JNK,95,98,Gene/Protein	extracellular signal - regulated kinase,121,160,Gene/Protein	Erk,163,166,Gene/Protein	"[{""token"": ""LMP - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 121, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
To characterize the regulation of NGAL further, we have cloned and sequenced a 5869 - bp region of the NGAL gene including 1695 bp of the 5 ' nontranscribed region and a 3696 - bp coding region encompassing seven exons and six introns.	NGAL,34,38,Gene/Protein	5869 - bp region,79,95,Gene/Protein	NGAL gene,103,112,Gene/Protein	5 ' nontranscribed region,138,163,Gene/Protein	3696 - bp coding region,170,193,Gene/Protein	seven exons and six introns,207,234,Gene/Protein	"[{""token"": ""NGAL"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""5869 - bp region"", ""start_span"": 79, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NGAL gene"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""5 ' nontranscribed region"", ""start_span"": 138, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""3696 - bp coding region"", ""start_span"": 170, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""seven exons and six introns"", ""start_span"": 207, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
Moreover, the mechanism of action of BHRF1 resembled that of Bcl - 2 and Bcl - xL as it inhibited TNF - and anti - Fas - induced activation of two enzymes participating in the apoptosis pathway, cytosolic phospholipase A2 and caspase - 3 / CPP32, but did not interfere with the activation of NF - kappaB - like transcription factors.	BHRF1,37,42,Gene/Protein	Bcl - 2,61,68,Gene/Protein	Bcl - xL,73,81,Gene/Protein	cytosolic phospholipase A2,195,221,Gene/Protein	caspase - 3 / CPP32,226,245,Gene/Protein	NF - kappaB - like transcription factors,292,332,Gene/Protein	"[{""token"": ""BHRF1"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - xL"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""cytosolic phospholipase A2"", ""start_span"": 195, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""caspase - 3 / CPP32"", ""start_span"": 226, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - like transcription factors"", ""start_span"": 292, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	train
To investigate whether the molar ratio of HSF2 - alpha and HSF2 - beta isoforms is crucial for the activation of HSF2 and whether the HSF2 isoforms play functionally distinct roles during the hemin - mediated erythroid differentiation, we generated cell clones expressing different levels of HSF2 - alpha and HSF2 - beta.	HSF2 - alpha,42,54,Gene/Protein	HSF2 - beta,59,70,Gene/Protein	HSF2,113,117,Gene/Protein	HSF2,134,138,Gene/Protein	HSF2 - alpha,292,304,Gene/Protein	HSF2 - beta,309,320,Gene/Protein	"[{""token"": ""HSF2 - alpha"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - beta"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""HSF2"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""HSF2"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - alpha"", ""start_span"": 292, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""HSF2 - beta"", ""start_span"": 309, ""end_span"": 320, ""type"": ""Gene/Protein""}]"	train
These results indicate that Bcl - 2 acts downstream of MAPK kinase - 1 but upstream of MAPK and suggest that, in the signaling pathway of the apoptotic process induced by bufalin, the transcriptional activity of activator protein - 1 may be down - regulated through the inhibition of MAPK activity by Bcl - 2.	Bcl - 2,28,35,Gene/Protein	MAPK kinase - 1,55,70,Gene/Protein	MAPK,87,91,Gene/Protein	activator protein - 1,212,233,Gene/Protein	MAPK,284,288,Gene/Protein	Bcl - 2,301,308,Gene/Protein	"[{""token"": ""Bcl - 2"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""MAPK kinase - 1"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""activator protein - 1"", ""start_span"": 212, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 284, ""end_span"": 288, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 301, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	train
Fab fragment of anti - E. chaffeensis immunoglobulin G complexed with E. chaffeensis did not induce any of these three cytokines, indicating that ehrlichial binding is required for IL - 1beta mRNA expression and that binding of the immune complex to the Fc gamma receptor is required for TNF - alpha and IL - 6 mRNA expression and enhanced IL - 1beta mRNA expression.	IL - 1beta mRNA,181,196,Gene/Protein	immune complex,232,246,Gene/Protein	Fc gamma receptor,254,271,Gene/Protein	TNF - alpha,288,299,Gene/Protein	IL - 6 mRNA,304,315,Gene/Protein	IL - 1beta mRNA,340,355,Gene/Protein	"[{""token"": ""IL - 1beta mRNA"", ""start_span"": 181, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""immune complex"", ""start_span"": 232, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma receptor"", ""start_span"": 254, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 288, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6 mRNA"", ""start_span"": 304, ""end_span"": 315, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta mRNA"", ""start_span"": 340, ""end_span"": 355, ""type"": ""Gene/Protein""}]"	train
This activation domain of CIITA interacts with the 32 kDa subunit of the general transcription complex TFIID, TAFII32.	activation domain,5,22,Gene/Protein	CIITA,26,31,Gene/Protein	32 kDa subunit,51,65,Gene/Protein	general transcription complex,73,102,Gene/Protein	TFIID,103,108,Gene/Protein	TAFII32,110,117,Gene/Protein	"[{""token"": ""activation domain"", ""start_span"": 5, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CIITA"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""32 kDa subunit"", ""start_span"": 51, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""general transcription complex"", ""start_span"": 73, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TFIID"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TAFII32"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
To gain a better understanding of the mechanism of binding to the human mineralocorticoid receptor ( hMR), we developed a new monoclonal antibody ( mAb) raised against the hormone - binding domain ( HBD).	human mineralocorticoid receptor,66,98,Gene/Protein	hMR,101,104,Gene/Protein	monoclonal antibody,126,145,Gene/Protein	mAb,148,151,Gene/Protein	hormone - binding domain,172,196,Gene/Protein	HBD,199,202,Gene/Protein	"[{""token"": ""human mineralocorticoid receptor"", ""start_span"": 66, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""hMR"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""monoclonal antibody"", ""start_span"": 126, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""hormone - binding domain"", ""start_span"": 172, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""HBD"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Interestingly, we find that in contrast to SLP - 76, overexpression of SLAP - 130 diminishes T cell antigen receptor - induced activation of the interleukin - 2 promoter in Jurkat T cells and interferes with the augmentation of interleukin - 2 promoter activity seen when SLP - 76 is overexpressed in these cells.	SLP - 76,43,51,Gene/Protein	SLAP - 130,71,81,Gene/Protein	T cell antigen receptor,93,116,Gene/Protein	interleukin - 2 promoter,145,169,Gene/Protein	interleukin - 2 promoter,228,252,Gene/Protein	SLP - 76,272,280,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""SLAP - 130"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""T cell antigen receptor"", ""start_span"": 93, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 promoter"", ""start_span"": 145, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 promoter"", ""start_span"": 228, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 272, ""end_span"": 280, ""type"": ""Gene/Protein""}]"	train
Emphasis is placed on cytokines that have been studied in periodontitis, principally TNF - alpha, IL - 1, IL - 6, IL - 8 and beta - interferon.	cytokines,22,31,Gene/Protein	TNF - alpha,85,96,Gene/Protein	IL - 1,98,104,Gene/Protein	IL - 6,106,112,Gene/Protein	IL - 8,114,120,Gene/Protein	beta - interferon,125,142,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""beta - interferon"", ""start_span"": 125, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
We show that IFN - alpha and IFN - gamma rapidly and efficiently enhanced STAT1, STAT2, p48, and IRF - 1 gene expression.	IFN - alpha,13,24,Gene/Protein	IFN - gamma,29,40,Gene/Protein	STAT1,74,79,Gene/Protein	STAT2,81,86,Gene/Protein	p48,88,91,Gene/Protein	IRF - 1 gene,97,109,Gene/Protein	"[{""token"": ""IFN - alpha"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""STAT2"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p48"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1 gene"", ""start_span"": 97, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
Overexpression of BXB, a constitutive active version of c - Raf, and of further members of the Ras - Raf - Erk signal cascade exerted an increase of GABP - mediated promoter - enhancer induction.	BXB,18,21,Gene/Protein	c - Raf,56,63,Gene/Protein	Ras,95,98,Gene/Protein	Raf,101,104,Gene/Protein	Erk,107,110,Gene/Protein	GABP,149,153,Gene/Protein	"[{""token"": ""BXB"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""c - Raf"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Raf"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Erk"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""GABP"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Two regions were identified: region I ( - 182 to - 162 bp) contained an overlapping Sp1 / Egr - 1 site, and region II ( - 119 to - 88) contained CRE and NF - kappaB ( designated kappaB3) sites.	region I,29,37,Gene/Protein	- 182 to - 162 bp,40,57,Gene/Protein	Sp1 / Egr - 1 site,84,102,Gene/Protein	region II,108,117,Gene/Protein	- 119 to - 88,120,133,Gene/Protein	CRE,145,148,Gene/Protein	"[{""token"": ""region I"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""- 182 to - 162 bp"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Sp1 / Egr - 1 site"", ""start_span"": 84, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""region II"", ""start_span"": 108, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""- 119 to - 88"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CRE"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
To further explore the involvement of PI3 - K in T cell activation, we created a set of potentially dominant negative PI3 - K constructs comprising individual or tandem domains of the regulatory p85 subunit and tested their effect on downstream signaling events like Erk2 activation and transcription from an NFAT ( nuclear factor of activated T cells) element taken from the interleukin - 2 promoter.	PI3 - K,38,45,Gene/Protein	dominant negative PI3 - K constructs,100,136,Gene/Protein	tandem domains,162,176,Gene/Protein	regulatory p85 subunit,184,206,Gene/Protein	Erk2,267,271,Gene/Protein	interleukin - 2 promoter,376,400,Gene/Protein	"[{""token"": ""PI3 - K"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""dominant negative PI3 - K constructs"", ""start_span"": 100, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""tandem domains"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""regulatory p85 subunit"", ""start_span"": 184, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""Erk2"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2 promoter"", ""start_span"": 376, ""end_span"": 400, ""type"": ""Gene/Protein""}]"	train
We propose a model where basal transcription is maintained by binding of various transcription factors to the IFN - gamma promoter, whereas PMA + PHA - inducible IFN - gamma transcription in CD45R0 T cells is associated with binding of AP - 1 to the C - site.	transcription factors,81,102,Gene/Protein	IFN - gamma promoter,110,130,Gene/Protein	PHA,146,149,Gene/Protein	IFN - gamma,162,173,Gene/Protein	AP - 1,236,242,Gene/Protein	C - site,250,258,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma promoter"", ""start_span"": 110, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 236, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""C - site"", ""start_span"": 250, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
The CHEMR1 gene Scya3r2 is a single - copy gene whose open reading frame may be in a single exon and maps to the distal region of mouse Chr 9 where the mouse macrophage inflammatory protein - 1alpha ( MIP - 1alpha) receptor gene Scya3r and two related C - C chemokine receptor - like genes reside.	CHEMR1 gene,4,15,Gene/Protein	Scya3r2,16,23,Gene/Protein	single - copy gene,29,47,Gene/Protein	mouse Chr 9,130,141,Gene/Protein	Scya3r,229,235,Gene/Protein	C - C chemokine receptor - like genes,252,289,Gene/Protein	"[{""token"": ""CHEMR1 gene"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Scya3r2"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""single - copy gene"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mouse Chr 9"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""Scya3r"", ""start_span"": 229, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""C - C chemokine receptor - like genes"", ""start_span"": 252, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	train
Previous reports have suggested the CD28 stimulation contributes to the activation of the IL - 2 promoter by up - regulating the activity of several transcription factors, including AP - 1 and nuclear factor - kappaB ( NF - kappaB) / Rel family members as well as an uncharacterized transcription factor called CD28 response complex.	CD28,36,40,Gene/Protein	IL - 2 promoter,90,105,Gene/Protein	transcription factors,149,170,Gene/Protein	AP - 1,182,188,Gene/Protein	uncharacterized transcription factor,267,303,Gene/Protein	CD28,311,315,Gene/Protein	"[{""token"": ""CD28"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 90, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 149, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""uncharacterized transcription factor"", ""start_span"": 267, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 311, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
Of the NF - kappaB / Rel family members tested, this CD28RE / AP - 1 - specific complex contains predominantly c - Rel, despite the fact that both p50 and RelA can efficiently bind to the CD28RE.	NF - kappaB / Rel family members,7,39,Gene/Protein	CD28RE / AP - 1 - specific complex,53,87,Gene/Protein	c - Rel,111,118,Gene/Protein	p50,147,150,Gene/Protein	RelA,155,159,Gene/Protein	CD28RE,188,194,Gene/Protein	"[{""token"": ""NF - kappaB / Rel family members"", ""start_span"": 7, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE / AP - 1 - specific complex"", ""start_span"": 53, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""CD28RE"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Tax1, a transcriptional trans - activator of the Human T - cell leukemia virus type I ( HTLV - I), induces the expression of many cellular genes through interaction with at least three distinct cellular transcription factors; CREB / ATF, NF - kappaB, and SRF.	Tax1,0,4,Gene/Protein	transcriptional trans - activator,8,41,Gene/Protein	cellular transcription factors,194,224,Gene/Protein	CREB / ATF,226,236,Gene/Protein	NF - kappaB,238,249,Gene/Protein	SRF,255,258,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional trans - activator"", ""start_span"": 8, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""cellular transcription factors"", ""start_span"": 194, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""CREB / ATF"", ""start_span"": 226, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 238, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""SRF"", ""start_span"": 255, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
Mutations in the AT box or in the BSAP sites did not affect CD19 reporter construct activity, while a mutation of the GC box reduced it modestly, and a PyG box mutation reduced it dramatically.	AT box,17,23,Gene/Protein	BSAP sites,34,44,Gene/Protein	CD19,60,64,Gene/Protein	reporter construct,65,83,Gene/Protein	GC box,118,124,Gene/Protein	PyG box,152,159,Gene/Protein	"[{""token"": ""AT box"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""BSAP sites"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""reporter construct"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""GC box"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""PyG box"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
In combination, EBF and E47 induce efficient expression of the endogenous immunoglobulin surrogate light chain genes, lambda5 and VpreB, whereas other pre - B cell - specific genes remain silent.	EBF,16,19,Gene/Protein	E47,24,27,Gene/Protein	endogenous immunoglobulin surrogate light chain genes,63,116,Gene/Protein	lambda5,118,125,Gene/Protein	VpreB,130,135,Gene/Protein	pre - B cell - specific genes,151,180,Gene/Protein	"[{""token"": ""EBF"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""E47"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""endogenous immunoglobulin surrogate light chain genes"", ""start_span"": 63, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""lambda5"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""VpreB"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""pre - B cell - specific genes"", ""start_span"": 151, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
That the signal transduction pathways used by the cytokines IL - 2 and IL - 15 are identical would suggest that these cytokines have redundant roles in lymphoid development; instead, IL - 2 is the guardian of thymus - derived T - cell homeostasis, while interleukin - 15 promotes extrathymic development of T and NK cells.	cytokines,50,59,Gene/Protein	IL - 2,60,66,Gene/Protein	IL - 15,71,78,Gene/Protein	cytokines,118,127,Gene/Protein	IL - 2,183,189,Gene/Protein	interleukin - 15,254,270,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 15"", ""start_span"": 254, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
Together, these data demonstrate that the IL - 4R alpha cytoplasmic domain is sufficient to activate JAK - 1 and STAT6 and to induce expression of IL - 4 target genes, thus identifying a mechanism by which IL - 4 signaling can proceed in the absence of JAK - 3 and gamma ( c).	IL - 4R alpha cytoplasmic domain,42,74,Gene/Protein	JAK - 1,101,108,Gene/Protein	STAT6,113,118,Gene/Protein	IL - 4 target genes,147,166,Gene/Protein	IL - 4,206,212,Gene/Protein	JAK - 3,253,260,Gene/Protein	"[{""token"": ""IL - 4R alpha cytoplasmic domain"", ""start_span"": 42, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""JAK - 1"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 target genes"", ""start_span"": 147, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""JAK - 3"", ""start_span"": 253, ""end_span"": 260, ""type"": ""Gene/Protein""}]"	train
Reduction of IL - 2 production is secondary to the inability to phosphorylate the cAMP response element binding protein, CREB, and induce expression of the immediate early genes such as Fos B that are required to transactivate the IL - 2 promoter.	IL - 2,13,19,Gene/Protein	cAMP response element binding protein,82,119,Gene/Protein	CREB,121,125,Gene/Protein	immediate early genes,156,177,Gene/Protein	Fos B,186,191,Gene/Protein	IL - 2 promoter,231,246,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""cAMP response element binding protein"", ""start_span"": 82, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""immediate early genes"", ""start_span"": 156, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Fos B"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 231, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
The SRG3 protein contains an acidic NH2 terminus, a myb - like DNA binding domain, a leucine - zipper motif, and a proline - and glutamine - rich region at its COOH terminus.	SRG3 protein,4,16,Gene/Protein	acidic NH2 terminus,29,48,Gene/Protein	myb - like DNA binding domain,52,81,Gene/Protein	leucine - zipper motif,85,107,Gene/Protein	proline - and glutamine - rich region,115,152,Gene/Protein	COOH terminus,160,173,Gene/Protein	"[{""token"": ""SRG3 protein"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""acidic NH2 terminus"", ""start_span"": 29, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""myb - like DNA binding domain"", ""start_span"": 52, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""leucine - zipper motif"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""proline - and glutamine - rich region"", ""start_span"": 115, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""COOH terminus"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Unlike full - sized NOTCH1, two such truncated forms of the protein either lacking a major portion of the extracellular domain ( DeltaE) or consisting only of the intracellular domain ( ICN) were found to activate transcription in cultured cells, presumably through RBP - Jkappa response elements within DNA.	NOTCH1,20,26,Gene/Protein	extracellular domain,106,126,Gene/Protein	DeltaE,129,135,Gene/Protein	intracellular domain,163,183,Gene/Protein	ICN,186,189,Gene/Protein	RBP - Jkappa,266,278,Gene/Protein	"[{""token"": ""NOTCH1"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 106, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""DeltaE"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""intracellular domain"", ""start_span"": 163, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""ICN"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""RBP - Jkappa"", ""start_span"": 266, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
Human T cell lymphotropic virus type I ( HTLV - I) encodes the transactivator protein, Tax, which facilitates viral transcription from three 21 bp repeated elements within the U3 region of the long terminal repeat ( LTR).	transactivator protein,63,85,Gene/Protein	Tax,87,90,Gene/Protein	21 bp repeated elements,141,164,Gene/Protein	U3 region,176,185,Gene/Protein	long terminal repeat,193,213,Gene/Protein	LTR,216,219,Gene/Protein	"[{""token"": ""transactivator protein"", ""start_span"": 63, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""21 bp repeated elements"", ""start_span"": 141, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 193, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Competition EMS analyses utilizing Sp1 and CREB binding site oligonucleotides demonstrate that Sp family members are critical components of U1 ( U1A / U1B) and U2 and that ATF / CREB family members are critical components of C1 - C3.	Sp family members,95,112,Gene/Protein	U1,140,142,Gene/Protein	U1A / U1B,145,154,Gene/Protein	U2,160,162,Gene/Protein	ATF / CREB family members,172,197,Gene/Protein	C1 - C3,225,232,Gene/Protein	"[{""token"": ""Sp family members"", ""start_span"": 95, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""U1"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""U1A / U1B"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""U2"", ""start_span"": 160, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""ATF / CREB family members"", ""start_span"": 172, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""C1 - C3"", ""start_span"": 225, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
These data indicated that c - Fos / c - Jun, c - Rel / p65, and Sp1 regulate TF gene expression in human monocytic cells.	c - Fos,26,33,Gene/Protein	/ c - Jun,34,43,Gene/Protein	c - Rel,45,52,Gene/Protein	/ p65,53,58,Gene/Protein	Sp1,64,67,Gene/Protein	TF gene,77,84,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""/ c - Jun"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""/ p65"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""TF gene"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}]"	train
Transcription factor E2F binds to cellular promoters of certain growth - and cell cycle - controlling genes and forms distinct heteromeric complexes with other nuclear proteins.	Transcription factor,0,20,Gene/Protein	E2F,21,24,Gene/Protein	cellular promoters,34,52,Gene/Protein	growth - and cell cycle - controlling genes,64,107,Gene/Protein	heteromeric complexes,127,148,Gene/Protein	nuclear proteins,160,176,Gene/Protein	"[{""token"": ""Transcription factor"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""cellular promoters"", ""start_span"": 34, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""growth - and cell cycle - controlling genes"", ""start_span"": 64, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""heteromeric complexes"", ""start_span"": 127, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 160, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
Notably, no activation of Jak1, Jak2, Tyk2, Stat1, or Stat3 was observed in neutrophils following G - CSF stimulation.	Jak1,26,30,Gene/Protein	Jak2,32,36,Gene/Protein	Tyk2,38,42,Gene/Protein	Stat1,44,49,Gene/Protein	Stat3,54,59,Gene/Protein	G - CSF,98,105,Gene/Protein	"[{""token"": ""Jak1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 98, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	train
Although the stimulation of T cells from young subjects resulted in coordinated increases of nuclear protein complexes binding the AP - 1 TRE, c - jun TRE, and c - fos SRE DNA sequence motifs, age - related reductions in the activation of AP - 1 were accompanied by decreased levels of c - jun TRE and c - fos SRE binding complexes.	nuclear protein complexes,93,118,Gene/Protein	AP - 1 TRE,131,141,Gene/Protein	c - jun TRE,143,154,Gene/Protein	c - fos SRE DNA sequence motifs,160,191,Gene/Protein	AP - 1,239,245,Gene/Protein	c - jun TRE and c - fos SRE binding complexes,286,331,Gene/Protein	"[{""token"": ""nuclear protein complexes"", ""start_span"": 93, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 TRE"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""c - jun TRE"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""c - fos SRE DNA sequence motifs"", ""start_span"": 160, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 239, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""c - jun TRE and c - fos SRE binding complexes"", ""start_span"": 286, ""end_span"": 331, ""type"": ""Gene/Protein""}]"	train
Furthermore, the nuclear protein complexes binding the SRE motif induced in activated T cells of young and elderly subjects contained serum response factor and Elk - 1 pointing toward age - related defects in the activation of transcriptional regulatory proteins distinct from c - jun / AP - 1.	nuclear protein complexes,17,42,Gene/Protein	SRE motif,55,64,Gene/Protein	serum response factor,134,155,Gene/Protein	Elk - 1,160,167,Gene/Protein	transcriptional regulatory proteins,227,262,Gene/Protein	c - jun / AP - 1,277,293,Gene/Protein	"[{""token"": ""nuclear protein complexes"", ""start_span"": 17, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""SRE motif"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""serum response factor"", ""start_span"": 134, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Elk - 1"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulatory proteins"", ""start_span"": 227, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""c - jun / AP - 1"", ""start_span"": 277, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
Because binding sites for B - cell - specific activator protein ( BSAP) are located upstream of several switch regions in the immunoglobulin heavy chain gene cluster, BSAP might play a role in the regulation of germline transcription and isotype switching.	binding sites,8,21,Gene/Protein	B - cell - specific activator protein,26,63,Gene/Protein	BSAP,66,70,Gene/Protein	immunoglobulin heavy chain gene cluster,126,165,Gene/Protein	BSAP,167,171,Gene/Protein	germline,211,219,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 8, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific activator protein"", ""start_span"": 26, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin heavy chain gene cluster"", ""start_span"": 126, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""BSAP"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 211, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
We found that although IL - 4 stimulation of X - SCID B cells did not result in Janus tyrosine kinase - 3 ( JAK3) phosphorylation, other IL - 4 substrates including JAK1 and IRS - 1 were phosphorylated.	IL - 4,23,29,Gene/Protein	Janus tyrosine kinase - 3,80,105,Gene/Protein	JAK3,108,112,Gene/Protein	IL - 4 substrates,137,154,Gene/Protein	JAK1,165,169,Gene/Protein	IRS - 1,174,181,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Janus tyrosine kinase - 3"", ""start_span"": 80, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 substrates"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IRS - 1"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
We report here that the signaling cascade triggered by interleukin - 4 ( IL - 4) or anti - CD40 monoclonal antibody ( mAb) participates in NF - kappa B activation responsible for germline C epsilon transcription in a human Burkitt lymphoma B cell line, DND39.	interleukin - 4,55,70,Gene/Protein	IL - 4,73,79,Gene/Protein	anti - CD40 monoclonal antibody,84,115,Gene/Protein	mAb,118,121,Gene/Protein	NF - kappa B,139,151,Gene/Protein	germline,179,187,Gene/Protein	"[{""token"": ""interleukin - 4"", ""start_span"": 55, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD40 monoclonal antibody"", ""start_span"": 84, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""mAb"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 139, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Both IL - 4 and anti - CD40 mAb induced activation of phosphatidylinositol 3 - kinase ( PI3 - kinase), translocation of a zeta isoform of protein kinase C, and nuclear expression of NF - kappa B.	IL - 4,5,11,Gene/Protein	CD40 mAb,23,31,Gene/Protein	phosphatidylinositol 3 - kinase,54,85,Gene/Protein	PI3 - kinase,88,100,Gene/Protein	protein kinase C,138,154,Gene/Protein	NF - kappa B,182,194,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""CD40 mAb"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 54, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 182, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
These results indicate that IL - 4 and ligation of CD40 induce NF - kappa B expression via at least a mechanism dependent on the PI3 - kinase pathway and suggest that NF - kappa B sensitive to NAC may play a role in regulating germline C epsilon transcription.	IL - 4,28,34,Gene/Protein	CD40,51,55,Gene/Protein	NF - kappa B,63,75,Gene/Protein	PI3 - kinase,129,141,Gene/Protein	NF - kappa B,167,179,Gene/Protein	germline,227,235,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 63, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - kinase"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""germline"", ""start_span"": 227, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Human IL - 5 promoter / enhancer - luciferase gene construct transfected to T - cell clones was transcribed on either TCR or IL - 2R stimulation and was clearly downregulated by dexamethasone, indicating that the approximately 500 - bp human IL - 5 gene segment located 5 ' upstream of the coding region contains activation - inducible enhancer elements responsible for the regulation by GC.	IL - 5,6,12,Gene/Protein	TCR,118,121,Gene/Protein	IL - 2R,125,132,Gene/Protein	500 - bp human IL - 5 gene segment,227,261,Gene/Protein	5 ' upstream,270,282,Gene/Protein	activation - inducible enhancer elements,313,353,Gene/Protein	"[{""token"": ""IL - 5"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""500 - bp human IL - 5 gene segment"", ""start_span"": 227, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""5 ' upstream"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""activation - inducible enhancer elements"", ""start_span"": 313, ""end_span"": 353, ""type"": ""Gene/Protein""}]"	train
Interleukin - 2 ( IL - 2) promoter activity stimulated by cross - linking of CD2, TCR / CD3, and CD28 with antibodies was significantly reduced by transient expression of an Itk mutant lacking the kinase activity.	IL - 2,18,24,Gene/Protein	CD2,77,80,Gene/Protein	TCR,82,85,Gene/Protein	CD28,97,101,Gene/Protein	antibodies,107,117,Gene/Protein	Itk mutant,174,184,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Itk mutant"", ""start_span"": 174, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
These results demonstrate that Itk plays a role in IL - 2 production, indicating a critical involvement of Itk in the initial stage of T cell activation by mediating signals from the TCR / CD3 complex, CD2, and CD28.	Itk,31,34,Gene/Protein	IL - 2,51,57,Gene/Protein	Itk,107,110,Gene/Protein	TCR / CD3 complex,183,200,Gene/Protein	CD2,202,205,Gene/Protein	CD28,211,215,Gene/Protein	"[{""token"": ""Itk"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Itk"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""TCR / CD3 complex"", ""start_span"": 183, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""CD2"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Analysis of the sequence immediately upstream from the transcription initiation site ( TIS) showed no canonical TATA or CAAT elements, however an initiator element commonly found in TATA - less promoters encompassed the TIS.	transcription initiation site,55,84,Gene/Protein	TIS,87,90,Gene/Protein	TATA,112,116,Gene/Protein	CAAT elements,120,133,Gene/Protein	TATA - less promoters,182,203,Gene/Protein	TIS,220,223,Gene/Protein	"[{""token"": ""transcription initiation site"", ""start_span"": 55, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""TIS"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TATA"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""CAAT elements"", ""start_span"": 120, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""TATA - less promoters"", ""start_span"": 182, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""TIS"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Homology between nucleolin and histone H1 suggests that nucleolin may alter DNA organization in response to cell cycle controls, and the nucleolin component of LR1 may therefore function to organize switch regions before, during, or after switch recombination.	nucleolin,17,26,Gene/Protein	histone H1,31,41,Gene/Protein	nucleolin,56,65,Gene/Protein	nucleolin,137,146,Gene/Protein	LR1,160,163,Gene/Protein	switch regions,199,213,Gene/Protein	"[{""token"": ""nucleolin"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""histone H1"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 56, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""LR1"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""switch regions"", ""start_span"": 199, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
IL - 2 superinduction by Tat occurred at the transcriptional level, was mediated by the CD28 - responsive element in the IL - 2 promoter, and was exclusively dependent on the 29 amino acids encoded by the second exon of Tat.	IL - 2,0,6,Gene/Protein	Tat,25,28,Gene/Protein	CD28 - responsive element,88,113,Gene/Protein	IL - 2 promoter,121,136,Gene/Protein	29 amino acids,175,189,Gene/Protein	second exon of Tat,205,223,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""Tat"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive element"", ""start_span"": 88, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""29 amino acids"", ""start_span"": 175, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""second exon of Tat"", ""start_span"": 205, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
Assembly of terminal complement complexes ( TCC) C5b - 7, C5b - 8, and C5b - 9 on target cells during acute and chronic inflammation induces hydrolysis of plasma membrane phospholipids and heterotrimeric G protein activation.	terminal complement complexes,12,41,Gene/Protein	TCC,44,47,Gene/Protein	C5b - 7,49,56,Gene/Protein	C5b - 8,58,65,Gene/Protein	C5b - 9,71,78,Gene/Protein	G protein,204,213,Gene/Protein	"[{""token"": ""terminal complement complexes"", ""start_span"": 12, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""TCC"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""C5b - 7"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""C5b - 8"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""C5b - 9"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""G protein"", ""start_span"": 204, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Involvement of G protein in the activation of MAPK pathway by TCC was indicated by inhibition of Raf - 1 and ERK1 kinase activity, as well as the DNA synthesis by pretreatment of cells with pertussis toxin.	G protein,15,24,Gene/Protein	MAPK,46,50,Gene/Protein	TCC,62,65,Gene/Protein	Raf - 1,97,104,Gene/Protein	ERK1,109,113,Gene/Protein	pertussis toxin,190,205,Gene/Protein	"[{""token"": ""G protein"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""TCC"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""pertussis toxin"", ""start_span"": 190, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Transcriptional factors of the NFAT family play an important role in regulating the expression of several cytokine genes during the immune response, such as the genes for interleukin 2 ( IL - 2) and IL - 4, among others.	Transcriptional factors,0,23,Gene/Protein	NFAT family,31,42,Gene/Protein	cytokine genes,106,120,Gene/Protein	interleukin 2,171,184,Gene/Protein	IL - 2,187,193,Gene/Protein	IL - 4,199,205,Gene/Protein	"[{""token"": ""Transcriptional factors"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""NFAT family"", ""start_span"": 31, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2"", ""start_span"": 171, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Mobility shift assays showed that in vitro translated Pax - 5a and Pax - 5d, but not Pax - 5b or Pax - 5e, could interact with a B - cell - specific activator protein - binding site on the blk promoter.	Pax - 5a,54,62,Gene/Protein	Pax - 5d,67,75,Gene/Protein	Pax - 5b,85,93,Gene/Protein	Pax - 5e,97,105,Gene/Protein	B - cell - specific activator protein - binding site,129,181,Gene/Protein	blk promoter,189,201,Gene/Protein	"[{""token"": ""Pax - 5a"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5d"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5b"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Pax - 5e"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific activator protein - binding site"", ""start_span"": 129, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""blk promoter"", ""start_span"": 189, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
The capacity of Syk to reconstitute the MAPK response required the catalytic activity of Syk, an intact autophosphorylation site ( Y518 and Y519), both Src homology 2 domains and it was blocked by the inhibitory N17 - mutated dominant - negative Ras construct.	Syk,16,19,Gene/Protein	MAPK,40,44,Gene/Protein	Syk,89,92,Gene/Protein	autophosphorylation site,104,128,Gene/Protein	Src homology 2 domains,152,174,Gene/Protein	inhibitory N17 - mutated dominant - negative Ras construct,201,259,Gene/Protein	"[{""token"": ""Syk"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Syk"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""autophosphorylation site"", ""start_span"": 104, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Src homology 2 domains"", ""start_span"": 152, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""inhibitory N17 - mutated dominant - negative Ras construct"", ""start_span"": 201, ""end_span"": 259, ""type"": ""Gene/Protein""}]"	train
In this manuscript we have investigated the molecular mechanisms by which T cell lines stimulated with phorbol 12 - myristate 13 - acetate ( PMA) and phytohemagglutin ( PHA) display significantly higher levels of NF - kappa B1 encoding transcripts than cells stimulated with tumor necrosis factor - alpha, despite the fact that both stimuli activate NF - kappa B.	phytohemagglutin,150,166,Gene/Protein	PHA,169,172,Gene/Protein	NF - kappa B1,213,226,Gene/Protein	transcripts,236,247,Gene/Protein	tumor necrosis factor - alpha,275,304,Gene/Protein	NF - kappa B,350,362,Gene/Protein	"[{""token"": ""phytohemagglutin"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B1"", ""start_span"": 213, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""transcripts"", ""start_span"": 236, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 275, ""end_span"": 304, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 350, ""end_span"": 362, ""type"": ""Gene/Protein""}]"	train
The nuclear factor of activated T cells ( NFAT) regulates cytokine gene expression in T cells through cis - acting elements located in the promoters of several cytokine genes.	nuclear factor of activated T cells,4,39,Gene/Protein	NFAT,42,46,Gene/Protein	cytokine gene,58,71,Gene/Protein	cis - acting elements,102,123,Gene/Protein	promoters,139,148,Gene/Protein	cytokine genes,160,174,Gene/Protein	"[{""token"": ""nuclear factor of activated T cells"", ""start_span"": 4, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""cytokine gene"", ""start_span"": 58, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""cis - acting elements"", ""start_span"": 102, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 160, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
Western blot and immunoprecipitation studies using rabbit anti - C / EBP - epsilon antibodies raised against the N - terminal portion of C / EBP - epsilon ( amino acids 1 to 115) showed that C / EBP - epsilon is a 32 - kDa nuclear phosphoprotein.	rabbit anti - C / EBP - epsilon antibodies,51,93,Gene/Protein	N - terminal portion,113,133,Gene/Protein	C / EBP - epsilon,137,154,Gene/Protein	amino acids 1 to 115,157,177,Gene/Protein	C / EBP - epsilon,191,208,Gene/Protein	32 - kDa nuclear phosphoprotein,214,245,Gene/Protein	"[{""token"": ""rabbit anti - C / EBP - epsilon antibodies"", ""start_span"": 51, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal portion"", ""start_span"": 113, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""amino acids 1 to 115"", ""start_span"": 157, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 191, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""32 - kDa nuclear phosphoprotein"", ""start_span"": 214, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Cotransfection of the C / EBP - epsilon sense and antisense expression constructs together with chloramphenicol acetyltransferase reporter vectors containing myeloid - cell - specific c - mim and human myeloperoxidase promoters suggested a role for C / EBP - epsilon transcription factor in the regulation of a subset of myeloid - cell - specific genes.	C / EBP - epsilon,22,39,Gene/Protein	chloramphenicol acetyltransferase reporter vectors,96,146,Gene/Protein	myeloid - cell - specific c - mim and human myeloperoxidase promoters,158,227,Gene/Protein	C / EBP - epsilon,249,266,Gene/Protein	transcription factor,267,287,Gene/Protein	myeloid - cell - specific genes,321,352,Gene/Protein	"[{""token"": ""C / EBP - epsilon"", ""start_span"": 22, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter vectors"", ""start_span"": 96, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""myeloid - cell - specific c - mim and human myeloperoxidase promoters"", ""start_span"": 158, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP - epsilon"", ""start_span"": 249, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 267, ""end_span"": 287, ""type"": ""Gene/Protein""}, {""token"": ""myeloid - cell - specific genes"", ""start_span"": 321, ""end_span"": 352, ""type"": ""Gene/Protein""}]"	train
In addition to Zap - 70, the 3BP2 SH2 domain associated in vitro with LAT, Grb2, PLCgamma1, and Cbl from activated T cell lysates.	Zap - 70,15,23,Gene/Protein	3BP2 SH2 domain,29,44,Gene/Protein	LAT,70,73,Gene/Protein	Grb2,75,79,Gene/Protein	PLCgamma1,81,90,Gene/Protein	Cbl,96,99,Gene/Protein	"[{""token"": ""Zap - 70"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""3BP2 SH2 domain"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""LAT"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Grb2"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PLCgamma1"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}]"	train
This activity was dependent on the SH2 and pleckstrin - homology domains of 3BP2, and required functional Syk kinases, Ras, and calcineurin.	SH2,35,38,Gene/Protein	pleckstrin - homology domains,43,72,Gene/Protein	3BP2,76,80,Gene/Protein	Syk kinases,106,117,Gene/Protein	Ras,119,122,Gene/Protein	calcineurin,128,139,Gene/Protein	"[{""token"": ""SH2"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""pleckstrin - homology domains"", ""start_span"": 43, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""3BP2"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""Syk kinases"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
This chimera transduced IL - 4 - specific signals in response to IL - 2 binding and dramatically enhanced type 2 responses ( IL - 4, IL - 5, and immunoglobulin E production) upon in vitro TCR stimulation or in vivo antigen challenge.	IL - 4,24,30,Gene/Protein	IL - 2,65,71,Gene/Protein	IL - 4,125,131,Gene/Protein	IL - 5,133,139,Gene/Protein	immunoglobulin E,145,161,Gene/Protein	TCR,188,191,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 133, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin E"", ""start_span"": 145, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Regulation of NF - kappa B, AP - 1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF - kappa B p50.	NF - kappa B,14,26,Gene/Protein	AP - 1,28,34,Gene/Protein	NFAT,36,40,Gene/Protein	STAT1,46,51,Gene/Protein	nuclear localization sequence,132,161,Gene/Protein	NF - kappa B p50,165,181,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""nuclear localization sequence"", ""start_span"": 132, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p50"", ""start_span"": 165, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
The NLSs of NF - kappa B, AP - 1, and NFAT differ and the NLS of STAT1 has not yet been identified.	NLSs,4,8,Gene/Protein	NF - kappa B,12,24,Gene/Protein	AP - 1,26,32,Gene/Protein	NFAT,38,42,Gene/Protein	NLS,58,61,Gene/Protein	STAT1,65,70,Gene/Protein	"[{""token"": ""NLSs"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 12, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""NLS"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}]"	train
Herein we demonstrate that the inducible nuclear import of NF - kappa B, AP - 1, NFAT, and STAT1 in Jurkat T lymphocytes is significantly inhibited by a cell - permeable peptide carrying the NLS of the NF - kappa B p50 subunit.	NF - kappa B,59,71,Gene/Protein	AP - 1,73,79,Gene/Protein	NFAT,81,85,Gene/Protein	STAT1,91,96,Gene/Protein	NLS,191,194,Gene/Protein	NF - kappa B p50 subunit,202,226,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 59, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 73, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NLS"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B p50 subunit"", ""start_span"": 202, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Taken together, these data indicate that the inducible nuclear import of NF - kappa B, AP - 1, NFAT, and STAT1 in Jurkat T cells can be regulated by NLS peptide delivered noninvasively to the cytoplasm of Jurkat T cells to target members of the importin ( karyopherin) - alpha beta NLS receptor complex.	NF - kappa B,73,85,Gene/Protein	AP - 1,87,93,Gene/Protein	NFAT,95,99,Gene/Protein	STAT1,105,110,Gene/Protein	NLS,149,152,Gene/Protein	NLS receptor complex,282,302,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""STAT1"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""NLS"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""NLS receptor complex"", ""start_span"": 282, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	train
Although cadmium caused an early, transient stimulation of c - jun and c - fos expression and AP - 1 binding activity, heat - shock failed to alter both protooncogene expression and transcription factor binding, indicating that the stress - induced vimentin increase was not the result of AP - 1 - mediated transcriptional activation.	c - jun,59,66,Gene/Protein	c - fos,71,78,Gene/Protein	AP - 1,94,100,Gene/Protein	protooncogene,153,166,Gene/Protein	vimentin,249,257,Gene/Protein	AP - 1,289,295,Gene/Protein	"[{""token"": ""c - jun"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""protooncogene"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""vimentin"", ""start_span"": 249, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 289, ""end_span"": 295, ""type"": ""Gene/Protein""}]"	train
Since the activation of NFAT is MAPK - dependent these findings suggested that the activation of MAPK by Tpl - 2 is either independent or only partially dependent on MEK1 and MEK2.	NFAT,24,28,Gene/Protein	MAPK,32,36,Gene/Protein	MAPK,97,101,Gene/Protein	Tpl - 2,105,112,Gene/Protein	MEK1,166,170,Gene/Protein	MEK2,175,179,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Tpl - 2"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""MEK2"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Depending on the type of lymphocytes, the mechanism of apoptosis induced by glucocorticoids fall roughly in two categories: induction of ` ` death genes ' ' by the activated GR ( I kappa B, c - jun) or repression of survival factors ( AP - 1, c - Myc).	GR,174,176,Gene/Protein	I kappa B,179,188,Gene/Protein	c - jun,190,197,Gene/Protein	survival factors,216,232,Gene/Protein	AP - 1,235,241,Gene/Protein	c - Myc,243,250,Gene/Protein	"[{""token"": ""GR"", ""start_span"": 174, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 179, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""survival factors"", ""start_span"": 216, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""c - Myc"", ""start_span"": 243, ""end_span"": 250, ""type"": ""Gene/Protein""}]"	train
Likewise, the level of expression of the erythroid transcription factors GATA - 1, GATA - 2, NF - E2, SCL and RBTN2, all expressed in untreated K562 cells, did not increase during sodium phenylacetate induced erythroid differentiation.	erythroid transcription factors,41,72,Gene/Protein	GATA - 1,73,81,Gene/Protein	GATA - 2,83,91,Gene/Protein	NF - E2,93,100,Gene/Protein	SCL,102,105,Gene/Protein	RBTN2,110,115,Gene/Protein	"[{""token"": ""erythroid transcription factors"", ""start_span"": 41, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 2"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""NF - E2"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""RBTN2"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	train
Much attention has focused on the series of sequence elements upstream of the transcriptional initiation site in the U3 region of the LTR including the Sp1 and NF - kappaB binding sites.	transcriptional initiation site,78,109,Gene/Protein	U3 region,117,126,Gene/Protein	LTR,134,137,Gene/Protein	Sp1,152,155,Gene/Protein	NF - kappaB,160,171,Gene/Protein	binding sites,172,185,Gene/Protein	"[{""token"": ""transcriptional initiation site"", ""start_span"": 78, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""U3 region"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 160, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
We demonstrate here that the SLP - 76 linker protein interacts with both nck, an adaptor protein, and Vav, a guanine nucleotide exchange factor for Rho - family GTPases.	SLP - 76,29,37,Gene/Protein	nck,73,76,Gene/Protein	adaptor protein,81,96,Gene/Protein	Vav,102,105,Gene/Protein	guanine nucleotide exchange factor,109,143,Gene/Protein	Rho - family GTPases,148,168,Gene/Protein	"[{""token"": ""SLP - 76"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""nck"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""adaptor protein"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""guanine nucleotide exchange factor"", ""start_span"": 109, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Rho - family GTPases"", ""start_span"": 148, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
This region contains binding sites for several transcription factors, including the STAT family and NF - IL6, and the expression of LOX - 1 was upregulated by several cytokines.	binding sites,21,34,Gene/Protein	transcription factors,47,68,Gene/Protein	STAT family,84,95,Gene/Protein	NF - IL6,100,108,Gene/Protein	LOX - 1,132,139,Gene/Protein	cytokines,167,176,Gene/Protein	"[{""token"": ""binding sites"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""STAT family"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""LOX - 1"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	train
In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL - 2 - induced activation of the promoter containing the minimal beta - casein STAT5 element as well as the promoters of CIS and OSM.	Ras,69,72,Gene/Protein	RasN17,74,80,Gene/Protein	IL - 2,97,103,Gene/Protein	beta - casein STAT5 element,164,191,Gene/Protein	CIS,220,223,Gene/Protein	OSM,228,231,Gene/Protein	"[{""token"": ""Ras"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""RasN17"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein STAT5 element"", ""start_span"": 164, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 220, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""OSM"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Unlike ligation of CD3, stimulation with anti - CD28 mAb or CHO cells expressing the CD28 ligands CD80 or CD86 did not lead to tyrosine phosphorylation of HS1 in Jurkat T cells.	CD3,19,22,Gene/Protein	anti - CD28 mAb,41,56,Gene/Protein	CD28 ligands,85,97,Gene/Protein	CD80,98,102,Gene/Protein	CD86,106,110,Gene/Protein	HS1,155,158,Gene/Protein	"[{""token"": ""CD3"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 41, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CD28 ligands"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""HS1"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Adult lymphocytes showed an equivalent increase in mRNA expression of c - fos and c - jun ( 140 + / - 25 and 155 + / - 31%) at 30 min post - PHA stimulation, while cord lymphocyte maximum c - fos and c - jun expression ( 82 + / - 6 and 142 + / - 12%) occurred at 15 min post - PHA stimulation ( c - fos, p = 0. 0354; c - jun, p = 0. 0112).	c - fos,70,77,Gene/Protein	c - jun,82,89,Gene/Protein	PHA,141,144,Gene/Protein	PHA,277,280,Gene/Protein	c - fos,295,302,Gene/Protein	c - jun,317,324,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""PHA"", ""start_span"": 277, ""end_span"": 280, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 295, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""c - jun"", ""start_span"": 317, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
The chimeric oncoprotein E2A - HLF, generated by the t ( 17; 19) chromosomal translocation in pro - B - cell acute lymphoblastic leukemia, incorporates the transactivation domains of E2A and the basic leucine zipper ( bZIP) DNA - binding and protein dimerization domain of HLF ( hepatic leukemic factor).	chimeric oncoprotein,4,24,Gene/Protein	E2A - HLF,25,34,Gene/Protein	transactivation domains,156,179,Gene/Protein	E2A,183,186,Gene/Protein	HLF,273,276,Gene/Protein	hepatic leukemic factor,279,302,Gene/Protein	"[{""token"": ""chimeric oncoprotein"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""E2A - HLF"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domains"", ""start_span"": 156, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""HLF"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""hepatic leukemic factor"", ""start_span"": 279, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	train
Endotoxin selectively induces monocyte Mn superoxide dismutase ( SOD) without affecting levels of Cu, Zn SOD, catalase, or glutathione peroxidase.	Endotoxin,0,9,Gene/Protein	monocyte Mn superoxide dismutase,30,62,Gene/Protein	SOD,65,68,Gene/Protein	Zn SOD,102,108,Gene/Protein	catalase,110,118,Gene/Protein	glutathione peroxidase,123,145,Gene/Protein	"[{""token"": ""Endotoxin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""monocyte Mn superoxide dismutase"", ""start_span"": 30, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""SOD"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Zn SOD"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""catalase"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""glutathione peroxidase"", ""start_span"": 123, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
We further demonstrated that IL - 2, - 7, and - 15 induce multiple STAT proteins, including STAT5a, STAT5b, STAT1 alpha, STAT3, and another unidentified Fc gamma RI GAS DNA - binding protein.	multiple STAT proteins,58,80,Gene/Protein	STAT5a,92,98,Gene/Protein	STAT5b,100,106,Gene/Protein	STAT1 alpha,108,119,Gene/Protein	STAT3,121,126,Gene/Protein	Fc gamma RI GAS DNA - binding protein,153,190,Gene/Protein	"[{""token"": ""multiple STAT proteins"", ""start_span"": 58, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""STAT5a"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""STAT5b"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma RI GAS DNA - binding protein"", ""start_span"": 153, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
In this study, we discovered a novel regulatory element located at - 120 of the CD95L promoter which contains DNA binding sites for SP - 1 and a yet unknown inducible factor.	regulatory element,37,55,Gene/Protein	- 120,67,72,Gene/Protein	CD95L promoter,80,94,Gene/Protein	DNA binding sites,110,127,Gene/Protein	SP - 1,132,138,Gene/Protein	inducible factor,157,173,Gene/Protein	"[{""token"": ""regulatory element"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""- 120"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""CD95L promoter"", ""start_span"": 80, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding sites"", ""start_span"": 110, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""SP - 1"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""inducible factor"", ""start_span"": 157, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Sequence analysis of DD products revealed two cDNAs with identity to known gene products: the catalytic sub - unit of DNA - protein kinase ( DNA - PK ( CS)), and the peroxisomal enzyme 17beta - hydroxysteroid dehydrogenase type IV ( 17beta - HSD IV).	DD products,21,32,Gene/Protein	cDNAs,46,51,Gene/Protein	known gene products,69,88,Gene/Protein	catalytic sub - unit of DNA - protein kinase,94,138,Gene/Protein	peroxisomal enzyme 17beta - hydroxysteroid dehydrogenase type IV,166,230,Gene/Protein	17beta - HSD IV,233,248,Gene/Protein	"[{""token"": ""DD products"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""cDNAs"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""known gene products"", ""start_span"": 69, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""catalytic sub - unit of DNA - protein kinase"", ""start_span"": 94, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""peroxisomal enzyme 17beta - hydroxysteroid dehydrogenase type IV"", ""start_span"": 166, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""17beta - HSD IV"", ""start_span"": 233, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
The data presented here indicate that ( 1) the 12 - lipoxygenase activity of murine macrophages is upregulated in vitro and in vivo by IL - 4 and / or IL - 13, ( 2) this upregulation requires expression of the transcription factor STAT6, and ( 3) the constitutive expression of the enzyme appears to be STAT6 independent.	12 - lipoxygenase,47,64,Gene/Protein	IL - 4,135,141,Gene/Protein	IL - 13,151,158,Gene/Protein	transcription factor,210,230,Gene/Protein	STAT6,231,236,Gene/Protein	STAT6,303,308,Gene/Protein	"[{""token"": ""12 - lipoxygenase"", ""start_span"": 47, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 210, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 303, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	train
Our data indicate an important role for NF - AT in the faithful expression of high affinity IL - 2 receptors and a close link between the TCR - mediated induction of IL - 2 and IL - 2 receptor alpha chain promoters, both of which are regulated by NF - AT factors.	NF - AT,40,47,Gene/Protein	high affinity IL - 2 receptors,78,108,Gene/Protein	TCR,138,141,Gene/Protein	IL - 2,166,172,Gene/Protein	IL - 2 receptor alpha chain promoters,177,214,Gene/Protein	NF - AT factors,247,262,Gene/Protein	"[{""token"": ""NF - AT"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""high affinity IL - 2 receptors"", ""start_span"": 78, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain promoters"", ""start_span"": 177, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT factors"", ""start_span"": 247, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
Conversely, classic HD ( CHD) is heterogeneous because the tumor cells of a fraction of CHD display the BCL - 6 ( -) / syn - 1 ( +) phenotype of post - GC B - cells, whereas another fraction of CHD is constituted by a mixture of tumor cells reflecting the GC ( BCL - 6 ( +) / syn - 1 ( -)) or post - GC ( BCL - 6 ( -) / syn - 1 ( +)) phenotypes.	BCL - 6,104,111,Gene/Protein	syn - 1,119,126,Gene/Protein	BCL - 6,261,268,Gene/Protein	syn - 1,276,283,Gene/Protein	BCL - 6,305,312,Gene/Protein	syn - 1,320,327,Gene/Protein	"[{""token"": ""BCL - 6"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""syn - 1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 6"", ""start_span"": 261, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""syn - 1"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""BCL - 6"", ""start_span"": 305, ""end_span"": 312, ""type"": ""Gene/Protein""}, {""token"": ""syn - 1"", ""start_span"": 320, ""end_span"": 327, ""type"": ""Gene/Protein""}]"	train
DNase I footprinting of the upstream delta - globin region revealed protected sequences corresponding to consensus binding sites for GATA - 1 and BP2.	DNase I,0,7,Gene/Protein	upstream delta - globin region,28,58,Gene/Protein	protected sequences,68,87,Gene/Protein	consensus binding sites,105,128,Gene/Protein	GATA - 1,133,141,Gene/Protein	BP2,146,149,Gene/Protein	"[{""token"": ""DNase I"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""upstream delta - globin region"", ""start_span"": 28, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""protected sequences"", ""start_span"": 68, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""consensus binding sites"", ""start_span"": 105, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""BP2"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
CONCLUSION: These results indicate that ( 1) IgE production in asthma and HIE usually is associated with elevated levels of IL - 4, but not IL - 13, in the peripheral blood; ( 2) the increased sera IL - 4 levels in asthma and HIE are not sufficient to induce Stat6 activation in PBMCs; and ( 3) evidence of switch recombination to epsilon may be detected in isolated cases of elevated IgE.	IgE,45,48,Gene/Protein	IL - 4,124,130,Gene/Protein	IL - 13,140,147,Gene/Protein	IL - 4,198,204,Gene/Protein	Stat6,259,264,Gene/Protein	IgE,385,388,Gene/Protein	"[{""token"": ""IgE"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 259, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 385, ""end_span"": 388, ""type"": ""Gene/Protein""}]"	train
Overexpression of hIRAK enhanced IL - 1 - stimulated activation of the transcription factor NFkappaB, whereas a truncated form ( N - IRAK) specifically inhibited IL - 1 - dependent NFkappaB activity.	hIRAK,18,23,Gene/Protein	IL - 1,33,39,Gene/Protein	transcription factor NFkappaB,71,100,Gene/Protein	N - IRAK,129,137,Gene/Protein	IL - 1,162,168,Gene/Protein	NFkappaB,181,189,Gene/Protein	"[{""token"": ""hIRAK"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor NFkappaB"", ""start_span"": 71, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""N - IRAK"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Western analysis performed on cellular fractions of resting cells and of TPA - activated cells revealed abundant expression of classical PKC - alpha ( cPKC - alpha), cPKC - betaII, and atypical PKC - zeta isoforms and identified a sustained translocation of cPKC - alpha and cPKC - betaII from the cytosolic compartment to membranes.	classical PKC - alpha,127,148,Gene/Protein	cPKC - alpha,151,163,Gene/Protein	cPKC - betaII,166,179,Gene/Protein	atypical PKC - zeta isoforms,185,213,Gene/Protein	cPKC - alpha,258,270,Gene/Protein	cPKC - betaII,275,288,Gene/Protein	"[{""token"": ""classical PKC - alpha"", ""start_span"": 127, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - alpha"", ""start_span"": 151, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - betaII"", ""start_span"": 166, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""atypical PKC - zeta isoforms"", ""start_span"": 185, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - alpha"", ""start_span"": 258, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""cPKC - betaII"", ""start_span"": 275, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	train
Human T - cell leukemia virus type 1 Tax induction of NF - kappaB involves activation of the IkappaB kinase alpha ( IKKalpha) and IKKbeta cellular kinases.	Tax,37,40,Gene/Protein	NF - kappaB,54,65,Gene/Protein	IkappaB kinase alpha,93,113,Gene/Protein	IKKalpha,116,124,Gene/Protein	IKKbeta,130,137,Gene/Protein	cellular kinases,138,154,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB kinase alpha"", ""start_span"": 93, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""cellular kinases"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
Previous studies have shown constitutive activation of IL - 4 and IL - 7 signaling pathways, as measured by activation of Janus protein kinase ( JAK) 1, JAK3, STAT5, and STAT6, in pre - B cells transformed by v - Abl.	IL - 4,55,61,Gene/Protein	IL - 7,66,72,Gene/Protein	JAK3,153,157,Gene/Protein	STAT5,159,164,Gene/Protein	STAT6,170,175,Gene/Protein	v - Abl,209,216,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""v - Abl"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
p53 and p21 / Cip1, respectively, inhibit the expression and activation of PCNA, whereas p130 and pRb, respectively, inhibit the expression and activation of E2F1.	p53,0,3,Gene/Protein	p21 / Cip1,8,18,Gene/Protein	PCNA,75,79,Gene/Protein	p130,89,93,Gene/Protein	pRb,98,101,Gene/Protein	E2F1,158,162,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""p21 / Cip1"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""PCNA"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""E2F1"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
Evidence for a role for PKCalpha as an effector of Rho was obtained by the observation that coexpression of the N - terminal domain of PKCalpha blocked the effects of activated Rho plus PMA on AP - 1 transcriptional activity.	PKCalpha,24,32,Gene/Protein	Rho,51,54,Gene/Protein	N - terminal domain,112,131,Gene/Protein	PKCalpha,135,143,Gene/Protein	Rho,177,180,Gene/Protein	AP - 1,193,199,Gene/Protein	"[{""token"": ""PKCalpha"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""N - terminal domain"", ""start_span"": 112, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""PKCalpha"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Rho"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 193, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Activation of Janus tyrosine kinases ( Jak) and Signal transducers and activators of transcription ( Stat) after ligation of major histocompatibility complex class I ( MHC - I) was explored in Jurkat T cells.	Janus tyrosine kinases,14,36,Gene/Protein	Jak,39,42,Gene/Protein	Signal transducers and activators of transcription,48,98,Gene/Protein	Stat,101,105,Gene/Protein	major histocompatibility complex class I,125,165,Gene/Protein	MHC - I,168,175,Gene/Protein	"[{""token"": ""Janus tyrosine kinases"", ""start_span"": 14, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""Jak"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Signal transducers and activators of transcription"", ""start_span"": 48, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Stat"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""major histocompatibility complex class I"", ""start_span"": 125, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""MHC - I"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
An association between hSIE and Stat - 3 after MHC - I ligation was directly demonstrated by precipitating Stat - 3 from nuclear extracts with biotinylated hSIE probe and avidin - coupled agarose.	hSIE,23,27,Gene/Protein	Stat - 3,32,40,Gene/Protein	MHC - I,47,54,Gene/Protein	Stat - 3,107,115,Gene/Protein	hSIE probe,156,166,Gene/Protein	avidin,171,177,Gene/Protein	"[{""token"": ""hSIE"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Stat - 3"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""MHC - I"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Stat - 3"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""hSIE probe"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""avidin"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility - shift assays revealed that recombinant IL - 2 increased NF - kappaB binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL - 2 increased the abundance of mRNAs encoding the NF - kappaB components c - Rel and KBF1 in these cells.	IL - 2,66,72,Gene/Protein	NF - kappaB,83,94,Gene/Protein	IL - 2,194,200,Gene/Protein	NF - kappaB,247,258,Gene/Protein	c - Rel,270,277,Gene/Protein	KBF1,282,286,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 83, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 247, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 270, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""KBF1"", ""start_span"": 282, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
Interphase fluorescence in situ hybridization ( FISH) was performed with 2 YACs flanking the CALM region, a YAC contig of the MLL region, and a YAC spanning the AF10 breakpoint.	YACs,75,79,Gene/Protein	CALM region,93,104,Gene/Protein	YAC contig,108,118,Gene/Protein	MLL region,126,136,Gene/Protein	YAC,144,147,Gene/Protein	AF10,161,165,Gene/Protein	"[{""token"": ""YACs"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""CALM region"", ""start_span"": 93, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""YAC contig"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""MLL region"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""YAC"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""AF10"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
In this report, we show that NF - kappaB activation by LMP1 or by each of its effector sites is mediated by a pathway that includes NIK, IKKalpha, and IKKbeta.	NF - kappaB,29,40,Gene/Protein	LMP1,55,59,Gene/Protein	effector sites,78,92,Gene/Protein	NIK,132,135,Gene/Protein	IKKalpha,137,145,Gene/Protein	IKKbeta,151,158,Gene/Protein	"[{""token"": ""NF - kappaB"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""effector sites"", ""start_span"": 78, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Furthermore, we demonstrate that IL - 13, like IL - 4, induces distinct STAT6 - DNA binding complexes and tyrosine phosphorylation of STAT6 and Janus kinase 3 ( JAK3) in NK and T cells.	IL - 13,33,40,Gene/Protein	IL - 4,47,53,Gene/Protein	STAT6 - DNA binding complexes,72,101,Gene/Protein	STAT6,134,139,Gene/Protein	Janus kinase 3,144,158,Gene/Protein	JAK3,161,165,Gene/Protein	"[{""token"": ""IL - 13"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""STAT6 - DNA binding complexes"", ""start_span"": 72, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""STAT6"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase 3"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Death - inducing ligands ( DILs) such as tumor necrosis factor alpha ( TNFalpha) or the cytotoxic drug doxorubicin have been shown to activate a nuclear factor kappaB ( NFkappaB) - dependent program that may rescue cells from apoptosis induction.	Death - inducing ligands,0,24,Gene/Protein	DILs,27,31,Gene/Protein	tumor necrosis factor alpha,41,68,Gene/Protein	TNFalpha,71,79,Gene/Protein	nuclear factor kappaB,145,166,Gene/Protein	NFkappaB,169,177,Gene/Protein	"[{""token"": ""Death - inducing ligands"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""DILs"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 41, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 145, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
These results establish EKLF as a tissue - specific transcription factor that undergoes post - translational acetylation and suggest a mechanism by which EKLF is able to alter chromatin structure and induce beta - globin expression within the beta - like globin cluster.	EKLF,24,28,Gene/Protein	tissue - specific transcription factor,34,72,Gene/Protein	EKLF,154,158,Gene/Protein	chromatin,176,185,Gene/Protein	beta - globin,207,220,Gene/Protein	beta - like globin cluster,243,269,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""tissue - specific transcription factor"", ""start_span"": 34, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""chromatin"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin"", ""start_span"": 207, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""beta - like globin cluster"", ""start_span"": 243, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
The lymphoid - specific transcription complex, NF - AT, is involved in early gene activation in T cells and is assembled from a pre - existing, T cell restricted cytoplasmic factor and an inducible ubiquitous nuclear component within 30 min after activation through the antigen receptor.	lymphoid - specific transcription complex,4,45,Gene/Protein	NF - AT,47,54,Gene/Protein	T cell restricted cytoplasmic factor,144,180,Gene/Protein	ubiquitous,198,208,Gene/Protein	nuclear component,209,226,Gene/Protein	antigen receptor,270,286,Gene/Protein	"[{""token"": ""lymphoid - specific transcription complex"", ""start_span"": 4, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""T cell restricted cytoplasmic factor"", ""start_span"": 144, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous"", ""start_span"": 198, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""nuclear component"", ""start_span"": 209, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""antigen receptor"", ""start_span"": 270, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
The proximal element contains the sequence 5 ' - GGCCAATGGG - 3 ', which closely resembles the consensus binding motif for the CCAAT - binding factor NF - Y ( CBF, CP1, alpha CP1).	proximal element,4,20,Gene/Protein	CCAAT - binding factor,127,149,Gene/Protein	NF - Y,150,156,Gene/Protein	CBF,159,162,Gene/Protein	CP1,164,167,Gene/Protein	alpha CP1,169,178,Gene/Protein	"[{""token"": ""proximal element"", ""start_span"": 4, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CCAAT - binding factor"", ""start_span"": 127, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""CBF"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""CP1"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""alpha CP1"", ""start_span"": 169, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Methylation interference analysis of the - 65 region identified a pattern of contacts with nuclear factors resembling that for NF - Y, and an NF - Y - binding site and the proximal TSP 1 element cross - competed in gel - shift assays, whereas their binding mutants did not.	- 65 region,41,52,Gene/Protein	nuclear factors,91,106,Gene/Protein	NF - Y,127,133,Gene/Protein	NF - Y - binding site,142,163,Gene/Protein	proximal TSP 1 element,172,194,Gene/Protein	binding mutants,249,264,Gene/Protein	"[{""token"": ""- 65 region"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 91, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""NF - Y - binding site"", ""start_span"": 142, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""proximal TSP 1 element"", ""start_span"": 172, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""binding mutants"", ""start_span"": 249, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
However, activation of the T cell lines leading to enhanced HIV - 1 replication can be induced by antigens, mitogens, and cytokines ( tumor necrosis factor alpha [ TNF - alpha], interleukin 1, and interleukin - 2).	antigens,98,106,Gene/Protein	cytokines,122,131,Gene/Protein	tumor necrosis factor alpha,134,161,Gene/Protein	TNF - alpha,164,175,Gene/Protein	interleukin 1,178,191,Gene/Protein	interleukin - 2,197,212,Gene/Protein	"[{""token"": ""antigens"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 134, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 1"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 197, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Using magnetic beads with attached DNA containing the Escherichia coli lac operator, fusion proteins comprising the DNA - binding lac repressor could be affinity - purified and recovered by gentle elution conditions, such as with a lactose analogue or by enzymatic means using either deoxyribonuclease ( DNase) or restriction endonucleases.	Escherichia coli lac operator,54,83,Gene/Protein	fusion proteins,85,100,Gene/Protein	DNA - binding lac repressor,116,143,Gene/Protein	deoxyribonuclease,284,301,Gene/Protein	DNase,304,309,Gene/Protein	restriction endonucleases,314,339,Gene/Protein	"[{""token"": ""Escherichia coli lac operator"", ""start_span"": 54, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""fusion proteins"", ""start_span"": 85, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding lac repressor"", ""start_span"": 116, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""deoxyribonuclease"", ""start_span"": 284, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""DNase"", ""start_span"": 304, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""restriction endonucleases"", ""start_span"": 314, ""end_span"": 339, ""type"": ""Gene/Protein""}]"	train
However, X failed to react with a variety of antibodies against Rb or p107, implicating the involvement of an E1A - binding protein other than Rb or p107.	X,9,10,Gene/Protein	Rb,64,66,Gene/Protein	p107,70,74,Gene/Protein	E1A - binding protein,110,131,Gene/Protein	Rb,143,145,Gene/Protein	p107,149,153,Gene/Protein	"[{""token"": ""X"", ""start_span"": 9, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""p107"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""E1A - binding protein"", ""start_span"": 110, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""Rb"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""p107"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
Hence, Ca2 + binds to calmodulin, leading to the binding of calmodulin to calcineurin; the activated calcineurin, in turn, may dephosphorylate the cytoplasmic subunit of NF - AT, resulting in its translocation from the cytoplasm into the nucleus to form a competent transcriptional activator.	calmodulin,22,32,Gene/Protein	calmodulin,60,70,Gene/Protein	calcineurin,74,85,Gene/Protein	calcineurin,101,112,Gene/Protein	cytoplasmic subunit of NF - AT,147,177,Gene/Protein	competent transcriptional activator,256,291,Gene/Protein	"[{""token"": ""calmodulin"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic subunit of NF - AT"", ""start_span"": 147, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""competent transcriptional activator"", ""start_span"": 256, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Both overexpressed p65 and coexpressed p50 are cytoplasmic, whereas p65 delta is partly nuclear, indicating that the I kappa B induced by p65 can maintain NF - kappa B in the cytoplasm.	p65,19,22,Gene/Protein	p50,39,42,Gene/Protein	p65 delta,68,77,Gene/Protein	I kappa B,117,126,Gene/Protein	p65,138,141,Gene/Protein	NF - kappa B,155,167,Gene/Protein	"[{""token"": ""p65"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""p65 delta"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
The transactivator HTLV - I Tax activates the promoter of the gene coding for the interleukin 2 alpha - chain receptor ( IL - 2R alpha) via a kappa B site that can bind several protein species of the rel family.	HTLV - I Tax,19,31,Gene/Protein	promoter,46,54,Gene/Protein	interleukin 2 alpha - chain receptor,82,118,Gene/Protein	IL - 2R alpha,121,134,Gene/Protein	kappa B site,142,154,Gene/Protein	rel family,200,210,Gene/Protein	"[{""token"": ""HTLV - I Tax"", ""start_span"": 19, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 alpha - chain receptor"", ""start_span"": 82, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 121, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""kappa B site"", ""start_span"": 142, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""rel family"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Recombinant I kappa B - alpha ( MAD - 3) inhibited the DNA binding activity of p65, p49 / p65, and p50 / p65 but stimulated the binding of NFKB2 ( p49) or NFKB1 ( p50).	MAD - 3,32,39,Gene/Protein	p65,79,82,Gene/Protein	p49 / p65,84,93,Gene/Protein	p50 / p65,99,108,Gene/Protein	NFKB2,139,144,Gene/Protein	p49,147,150,Gene/Protein	"[{""token"": ""MAD - 3"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""p49 / p65"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NFKB2"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""p49"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
The long terminal repeat ( LTR) of the type 1 human immunodeficiency virus ( HIV - 1) and the 5 ' regulatory region of the gene encoding the interleukin 2 receptor alpha subunit ( IL - 2R alpha) share functional kappa B enhancer elements involved in the regulation of these inducible transcription units during T - cell activation.	long terminal repeat,4,24,Gene/Protein	LTR,27,30,Gene/Protein	5 ' regulatory region,94,115,Gene/Protein	interleukin 2 receptor alpha subunit,141,177,Gene/Protein	IL - 2R alpha,180,193,Gene/Protein	kappa B enhancer elements,212,237,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 4, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""5 ' regulatory region"", ""start_span"": 94, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 receptor alpha subunit"", ""start_span"": 141, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha"", ""start_span"": 180, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""kappa B enhancer elements"", ""start_span"": 212, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
This was evidenced by the ability of the AP - 1 site to compete with the NF - AT site for binding to NF - AT and by the capacity of immobilized anti - Jun and anti - Fos antibodies to deplete NF - AT - binding activity from nuclear extracts of activated T cells.	AP - 1 site,41,52,Gene/Protein	NF - AT,73,80,Gene/Protein	NF - AT,101,108,Gene/Protein	immobilized anti - Jun,132,154,Gene/Protein	anti - Fos,159,169,Gene/Protein	NF - AT,192,199,Gene/Protein	"[{""token"": ""AP - 1 site"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""immobilized anti - Jun"", ""start_span"": 132, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""anti - Fos"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
There was no detectable binding of in vitro translated Jun / Fos heterodimer ( AP - 1) to the NF - AT sequence, and the NF - AT sequence was unable to inhibit the binding of Jun / Fos to the AP - 1 sequence.	Jun / Fos heterodimer,55,76,Gene/Protein	AP - 1,79,85,Gene/Protein	NF - AT,94,101,Gene/Protein	NF - AT sequence,120,136,Gene/Protein	Jun / Fos,174,183,Gene/Protein	AP - 1 sequence,191,206,Gene/Protein	"[{""token"": ""Jun / Fos heterodimer"", ""start_span"": 55, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT sequence"", ""start_span"": 120, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Jun / Fos"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1 sequence"", ""start_span"": 191, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
How does GATA - 1 regulate red cell genes like globin or the Epo receptor? Once we identify the functional domains of the GATA - binding proteins, we hope to learn what proteins GATA - 1 binds to in the basic transcription machinery or in chromatin.	GATA - 1,9,17,Gene/Protein	red cell genes,27,41,Gene/Protein	globin,47,53,Gene/Protein	Epo receptor,61,73,Gene/Protein	GATA - binding proteins,122,145,Gene/Protein	GATA - 1,178,186,Gene/Protein	"[{""token"": ""GATA - 1"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""red cell genes"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""globin"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""Epo receptor"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding proteins"", ""start_span"": 122, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
These data suggest that transcriptional activation of human embryonic zeta 2 globin gene and the fetal / adult alpha globin genes is mediated by erythroid cell - specific and developmental stage - specific nuclear factor - DNA complexes which form at the enhancer ( HS - 40) and the globin promoters.	human embryonic zeta 2 globin gene,54,88,Gene/Protein	fetal / adult alpha globin genes,97,129,Gene/Protein	developmental stage - specific nuclear factor - DNA complexes,175,236,Gene/Protein	enhancer,255,263,Gene/Protein	HS - 40,266,273,Gene/Protein	globin promoters,283,299,Gene/Protein	"[{""token"": ""human embryonic zeta 2 globin gene"", ""start_span"": 54, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""fetal / adult alpha globin genes"", ""start_span"": 97, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""developmental stage - specific nuclear factor - DNA complexes"", ""start_span"": 175, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 255, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""HS - 40"", ""start_span"": 266, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""globin promoters"", ""start_span"": 283, ""end_span"": 299, ""type"": ""Gene/Protein""}]"	train
We detected an association between the reduced mitogenic response and low expression of both interleukin - 2 ( IL - 2) and the alpha chain ( CD25) of the IL - 2 receptor ( IL - 2R).	interleukin - 2,93,108,Gene/Protein	IL - 2,111,117,Gene/Protein	alpha chain,127,138,Gene/Protein	CD25,141,145,Gene/Protein	IL - 2 receptor,154,169,Gene/Protein	IL - 2R,172,179,Gene/Protein	"[{""token"": ""interleukin - 2"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""alpha chain"", ""start_span"": 127, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""CD25"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor"", ""start_span"": 154, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
The presence of c - fos had a negative influence on GR function and correlated with the cell - specific synergistic or antagonistic activity of Jun with respect to GR; high basal expression of c - fos as well as AP - 1 DNA binding and transcriptional activity were observed in HeLa cells, but not in T cells.	c - fos,16,23,Gene/Protein	GR,52,54,Gene/Protein	Jun,144,147,Gene/Protein	GR,164,166,Gene/Protein	c - fos,193,200,Gene/Protein	AP - 1,212,218,Gene/Protein	"[{""token"": ""c - fos"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 164, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 193, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 212, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
The affinity of the BAT box binding proteins for the BAT box was approximately 25 - fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10 - fold more rapidly than from the octamer sequence.	BAT box binding proteins,20,44,Gene/Protein	BAT box,53,60,Gene/Protein	octamer sequence,107,123,Gene/Protein	BAT box binding proteins,132,156,Gene/Protein	BAT box,178,185,Gene/Protein	octamer sequence,223,239,Gene/Protein	"[{""token"": ""BAT box binding proteins"", ""start_span"": 20, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""BAT box"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""octamer sequence"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""BAT box binding proteins"", ""start_span"": 132, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""BAT box"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""octamer sequence"", ""start_span"": 223, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
However, Nef does not affect the DNA - binding activity of other transcription factors implicated in HIV - 1 regulation, including SP - 1, USF, URS, and NF - AT.	Nef,9,12,Gene/Protein	transcription factors,65,86,Gene/Protein	SP - 1,131,137,Gene/Protein	USF,139,142,Gene/Protein	URS,144,147,Gene/Protein	NF - AT,153,160,Gene/Protein	"[{""token"": ""Nef"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 65, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""SP - 1"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""USF"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""URS"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
For the study of the changes in plasma interleukin - 1 ( IL - 1) and their possible relationship with the changes in glucocorticoid receptor ( GR), plasma IL - 1 and GR in peripheral blood leukocytes in aged long - distance runner were measured simultaneously.	plasma interleukin - 1,32,54,Gene/Protein	IL - 1,57,63,Gene/Protein	glucocorticoid receptor,117,140,Gene/Protein	GR,143,145,Gene/Protein	plasma IL - 1,148,161,Gene/Protein	GR,166,168,Gene/Protein	"[{""token"": ""plasma interleukin - 1"", ""start_span"": 32, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptor"", ""start_span"": 117, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""plasma IL - 1"", ""start_span"": 148, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""GR"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Here we demonstrate that the c - myb proto - oncogene product, which is itself a DNA - binding protein and transcriptional transactivator, can interact synergistically with Z in activating the BMRF1 promoter in Jurkat cells ( a T - cell line) or Raji cells ( an EBV - positive B - cell), whereas the c - myb gene product by itself has little effect.	c - myb proto - oncogene product,29,61,Gene/Protein	DNA - binding protein,81,102,Gene/Protein	transcriptional transactivator,107,137,Gene/Protein	Z,173,174,Gene/Protein	BMRF1 promoter,193,207,Gene/Protein	c - myb gene product,300,320,Gene/Protein	"[{""token"": ""c - myb proto - oncogene product"", ""start_span"": 29, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding protein"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional transactivator"", ""start_span"": 107, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""Z"", ""start_span"": 173, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1 promoter"", ""start_span"": 193, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""c - myb gene product"", ""start_span"": 300, ""end_span"": 320, ""type"": ""Gene/Protein""}]"	train
A 30 - bp sequence in the BMRF1 promoter which contains a Z binding site ( a consensus AP - 1 site) is sufficient to transfer high - level lymphoid - specific responsiveness to the Z / c - myb combination to a heterologous promoter.	30 - bp sequence,2,18,Gene/Protein	BMRF1 promoter,26,40,Gene/Protein	Z binding site,58,72,Gene/Protein	consensus AP - 1 site,77,98,Gene/Protein	Z / c - myb combination,181,204,Gene/Protein	heterologous promoter,210,231,Gene/Protein	"[{""token"": ""30 - bp sequence"", ""start_span"": 2, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1 promoter"", ""start_span"": 26, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Z binding site"", ""start_span"": 58, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""consensus AP - 1 site"", ""start_span"": 77, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Z / c - myb combination"", ""start_span"": 181, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""heterologous promoter"", ""start_span"": 210, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Enhanced NF - kappa B binding activity is followed by functional activation in that inducibility of the IL - 2 receptor alpha chain is mediated by enhanced NF - kappa B binding and that a heterologous promoter containing the NF - kappa B consensus sequence ( - 291 to - 245) of the IL - 2 receptor alpha chain gene is activated.	NF - kappa B,9,21,Gene/Protein	IL - 2 receptor alpha chain,104,131,Gene/Protein	NF - kappa B,156,168,Gene/Protein	NF - kappa B consensus sequence,225,256,Gene/Protein	- 291 to - 245,259,273,Gene/Protein	IL - 2 receptor alpha chain gene,282,314,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 9, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain"", ""start_span"": 104, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 156, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B consensus sequence"", ""start_span"": 225, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""- 291 to - 245"", ""start_span"": 259, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor alpha chain gene"", ""start_span"": 282, ""end_span"": 314, ""type"": ""Gene/Protein""}]"	train
In addition, IL - 2 is capable of increasing transcript levels of the p50 gene coding for the p50 subunit of the NF - kappa B transcription factor, whereas mRNA levels of the p65 NF - kappa B gene remained unchanged.	IL - 2,13,19,Gene/Protein	p50,70,73,Gene/Protein	p50 subunit,94,105,Gene/Protein	NF - kappa B,113,125,Gene/Protein	p65,175,178,Gene/Protein	NF - kappa B gene,179,196,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""p50 subunit"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 113, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B gene"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
p50B is able to form heteromeric kappa B - binding complexes with RelB, as well as with p65 and p50, the two subunits of NF - kappa B.	p50B,0,4,Gene/Protein	heteromeric kappa B - binding complexes,21,60,Gene/Protein	RelB,66,70,Gene/Protein	p65,88,91,Gene/Protein	p50,96,99,Gene/Protein	NF - kappa B,121,133,Gene/Protein	"[{""token"": ""p50B"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""heteromeric kappa B - binding complexes"", ""start_span"": 21, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 121, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
Viral trans - activators such as Tax ( human T cell leukemia virus - 1, HTLV - 1) and E2 ( bovine papilloma virus, BPV) proteins are other agents which activate lymphokine gene expression by bypassing T cell receptor ( TCR) mediated signaling.	Viral trans - activators,0,24,Gene/Protein	Tax,33,36,Gene/Protein	E2,86,88,Gene/Protein	lymphokine gene,161,176,Gene/Protein	T cell receptor,201,216,Gene/Protein	TCR,219,222,Gene/Protein	"[{""token"": ""Viral trans - activators"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""E2"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""lymphokine gene"", ""start_span"": 161, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
To investigate the molecular basis for the critical regulatory interaction between NF - kappa B and I kappa B / MAD - 3, a series of human NF - kappa B p65 mutants was identified that functionally segregated DNA binding, I kappa B - mediated inhibition, and I kappa B - induced nuclear exclusion of this transcription factor.	NF - kappa B,83,95,Gene/Protein	I kappa B / MAD - 3,100,119,Gene/Protein	human NF - kappa B p65 mutants,133,163,Gene/Protein	I kappa B,221,230,Gene/Protein	I kappa B,258,267,Gene/Protein	transcription factor,304,324,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B / MAD - 3"", ""start_span"": 100, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""human NF - kappa B p65 mutants"", ""start_span"": 133, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 221, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 258, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 304, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
Similar repeat motifs are found in a number of diverse regulatory proteins but the motifs of Bcl - 3 are most closely related to those found in I kappa B proteins in which the ankyrin repeat domain is thought to be directly involved in inhibition of NF - kappa B activity.	repeat motifs,8,21,Gene/Protein	diverse regulatory proteins,47,74,Gene/Protein	Bcl - 3,93,100,Gene/Protein	I kappa B proteins,144,162,Gene/Protein	ankyrin repeat,176,190,Gene/Protein	NF - kappa B,250,262,Gene/Protein	"[{""token"": ""repeat motifs"", ""start_span"": 8, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""diverse regulatory proteins"", ""start_span"": 47, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 3"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B proteins"", ""start_span"": 144, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin repeat"", ""start_span"": 176, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 250, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The rules of assembly of the cognate ligands of TF, namely the zymogen plasma factors VII and the serine protease factor VIIa, with the soluble surface domain of TF in free solution, in the presence of phospholipid surfaces and cell surface and of the anchored TF molecule have been described.	TF,48,50,Gene/Protein	zymogen plasma factors VII,63,89,Gene/Protein	serine protease factor VIIa,98,125,Gene/Protein	soluble surface domain,136,158,Gene/Protein	TF,162,164,Gene/Protein	anchored TF molecule,252,272,Gene/Protein	"[{""token"": ""TF"", ""start_span"": 48, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""zymogen plasma factors VII"", ""start_span"": 63, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""serine protease factor VIIa"", ""start_span"": 98, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""soluble surface domain"", ""start_span"": 136, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 162, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""anchored TF molecule"", ""start_span"": 252, ""end_span"": 272, ""type"": ""Gene/Protein""}]"	train
Elf - 1 contains a DNA binding domain that is nearly identical to that of E74, the ecdysone - inducible Drosophila transcription factor required for metamorphosis ( hence the name Elf - 1, for E74 - like factor 1).	Elf - 1,0,7,Gene/Protein	DNA binding domain,19,37,Gene/Protein	E74,74,77,Gene/Protein	ecdysone - inducible Drosophila transcription factor,83,135,Gene/Protein	Elf - 1,180,187,Gene/Protein	E74 - like factor 1,193,212,Gene/Protein	"[{""token"": ""Elf - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding domain"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""E74"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""ecdysone - inducible Drosophila transcription factor"", ""start_span"": 83, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Elf - 1"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""E74 - like factor 1"", ""start_span"": 193, ""end_span"": 212, ""type"": ""Gene/Protein""}]"	train
Deletion mapping and hybrid promoter constructs demonstrate that the newly identified Tat - responsive element corresponds to a sequence within the viral long terminal repeat ( LTR) previously identified as the HIV - 1 enhancer, or NF - kappa B domain.	hybrid promoter constructs,21,47,Gene/Protein	Tat - responsive element,86,110,Gene/Protein	viral long terminal repeat,148,174,Gene/Protein	LTR,177,180,Gene/Protein	HIV - 1 enhancer,211,227,Gene/Protein	NF - kappa B domain,232,251,Gene/Protein	"[{""token"": ""hybrid promoter constructs"", ""start_span"": 21, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Tat - responsive element"", ""start_span"": 86, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""viral long terminal repeat"", ""start_span"": 148, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 enhancer"", ""start_span"": 211, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B domain"", ""start_span"": 232, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
The GM2 sequence ( GGTAGTTCCC) is recognized by an inducible factor NF - GM2; the other ( CCGCCC) by constitutive factors A1, A2, and B.	GM2 sequence,4,16,Gene/Protein	inducible factor NF - GM2,51,76,Gene/Protein	constitutive factors,101,121,Gene/Protein	A1,122,124,Gene/Protein	A2,126,128,Gene/Protein	B,134,135,Gene/Protein	"[{""token"": ""GM2 sequence"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""inducible factor NF - GM2"", ""start_span"": 51, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""constitutive factors"", ""start_span"": 101, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""A1"", ""start_span"": 122, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""A2"", ""start_span"": 126, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""B"", ""start_span"": 134, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
Here, we show that v - erbA and c - erbA bind directly to sequences within the promoter of the erythrocyte - specific carbonic anhydrase II ( CAII), a gene whose transcription is efficiently suppressed by v - erbA.	v - erbA,19,27,Gene/Protein	c - erbA,32,40,Gene/Protein	promoter,79,87,Gene/Protein	erythrocyte - specific carbonic anhydrase II,95,139,Gene/Protein	CAII,142,146,Gene/Protein	v - erbA,205,213,Gene/Protein	"[{""token"": ""v - erbA"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""c - erbA"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""erythrocyte - specific carbonic anhydrase II"", ""start_span"": 95, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""CAII"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""v - erbA"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
The results also revealed a similar functional cooperation between the transcription factors which bind to the Oct and the adjacent Sp 1 - binding site in BJA - B cells, as has been observed in HeLa cells, since a template which contains a weak binding site for OTFs expresses wild - type levels of U2 snRNA in both cell types when the weak octamer - binding site is combined with a Sp 1 - binding site.	Oct,111,114,Gene/Protein	Sp 1 - binding site,132,151,Gene/Protein	OTFs,262,266,Gene/Protein	U2 snRNA,299,307,Gene/Protein	octamer - binding site,341,363,Gene/Protein	Sp 1 - binding site,383,402,Gene/Protein	"[{""token"": ""Oct"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Sp 1 - binding site"", ""start_span"": 132, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""OTFs"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""U2 snRNA"", ""start_span"": 299, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding site"", ""start_span"": 341, ""end_span"": 363, ""type"": ""Gene/Protein""}, {""token"": ""Sp 1 - binding site"", ""start_span"": 383, ""end_span"": 402, ""type"": ""Gene/Protein""}]"	train
By using the human T - cell line ( JPX - 9), in which expression of the Tax1 is inducible, we showed that expression of mRNAs for Fra - 1, c - Jun, and JunD was also transactivated by Tax1.	Tax1,72,76,Gene/Protein	mRNAs,120,125,Gene/Protein	Fra - 1,130,137,Gene/Protein	c - Jun,139,146,Gene/Protein	JunD,152,156,Gene/Protein	Tax1,184,188,Gene/Protein	"[{""token"": ""Tax1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""mRNAs"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Fra - 1"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""JunD"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Tax1"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
These findings demonstrate that TGF - beta decreases B lymphocyte Ig secretion by inhibiting the synthesis of Ig mRNA and inhibiting the switch from the membrane form to the secreted forms of mu and gamma mRNA.	TGF - beta,32,42,Gene/Protein	Ig,66,68,Gene/Protein	Ig mRNA,110,117,Gene/Protein	membrane form,153,166,Gene/Protein	secreted forms,174,188,Gene/Protein	mu and gamma mRNA,192,209,Gene/Protein	"[{""token"": ""TGF - beta"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Ig"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Ig mRNA"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""membrane form"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""secreted forms"", ""start_span"": 174, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""mu and gamma mRNA"", ""start_span"": 192, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
These two DNA - protein complexes are composed of at least four host proteins ( p50, p55, p75, p85), each of which shares structural similarity with the v - rel oncogene product.	DNA - protein complexes,10,33,Gene/Protein	p50,80,83,Gene/Protein	p55,85,88,Gene/Protein	p75,90,93,Gene/Protein	p85,95,98,Gene/Protein	v - rel oncogene product,153,177,Gene/Protein	"[{""token"": ""DNA - protein complexes"", ""start_span"": 10, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""p55"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""p75"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""p85"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""v - rel oncogene product"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
In striking contrast to the mouse Ig heavy - chain enhancer, in which the octamer motif acts as a B - cell - specific enhancer element, the human enhancer contains an octamerlike sequence with one base substitution which bound octamer - binding proteins with only very low affinity and showed no enhancer activity of its own.	mouse Ig heavy - chain enhancer,28,59,Gene/Protein	octamer motif,74,87,Gene/Protein	B - cell - specific enhancer element,98,134,Gene/Protein	human enhancer,140,154,Gene/Protein	octamerlike sequence,167,187,Gene/Protein	octamer - binding proteins,227,253,Gene/Protein	"[{""token"": ""mouse Ig heavy - chain enhancer"", ""start_span"": 28, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""octamer motif"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific enhancer element"", ""start_span"": 98, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""human enhancer"", ""start_span"": 140, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""octamerlike sequence"", ""start_span"": 167, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""octamer - binding proteins"", ""start_span"": 227, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
From HeLa cells, two major proteins of 52 and 45 kilodaltons ( kD) copurified with DNA binding activity, whereas from T - cells, four proteins - - a major protein of 52 kD and three minor proteins of 82, 67, and 43 - 47 kD - - were purified.	major protein,21,34,Gene/Protein	52 kD,166,171,Gene/Protein	minor proteins,182,196,Gene/Protein	82,200,202,Gene/Protein	67,204,206,Gene/Protein	43 - 47 kD,212,222,Gene/Protein	"[{""token"": ""major protein"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""52 kD"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""minor proteins"", ""start_span"": 182, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""82"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""67"", ""start_span"": 204, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""43 - 47 kD"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
One of these, designated Rhom - 2, is located on human chromosome 11 at band 11p13, where a cluster of T - cell leukemia - specific translocations occur; all translocation breakpoints at 11p13 are upstream of the Rhom - 2 gene.	Rhom - 2,25,33,Gene/Protein	human chromosome 11,49,68,Gene/Protein	band 11p13,72,82,Gene/Protein	T - cell leukemia - specific translocations,103,146,Gene/Protein	11p13,187,192,Gene/Protein	Rhom - 2 gene,213,226,Gene/Protein	"[{""token"": ""Rhom - 2"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 11"", ""start_span"": 49, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""band 11p13"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""T - cell leukemia - specific translocations"", ""start_span"": 103, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""11p13"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Rhom - 2 gene"", ""start_span"": 213, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Thus, TNF alpha - induced NF - kappa B activation was found to be mediated by none of the major signal - mediating kinases such as protein kinase C ( PKC), protein kinase A, or Ca ( 2 +) - regulated kinases.	TNF alpha,6,15,Gene/Protein	NF - kappa B,26,38,Gene/Protein	signal - mediating kinases,96,122,Gene/Protein	protein kinase C,131,147,Gene/Protein	PKC,150,153,Gene/Protein	protein kinase A,156,172,Gene/Protein	"[{""token"": ""TNF alpha"", ""start_span"": 6, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""signal - mediating kinases"", ""start_span"": 96, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 131, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 156, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Furthermore, we found that cytoplasmic acidification facilitated NF - kappa B activation by both TNF alpha and PKC, by a mechanism that increases NF - kappa B / I kappa B dissociation without affecting the NF - kappa B translocation step.	NF - kappa B,65,77,Gene/Protein	TNF alpha,97,106,Gene/Protein	PKC,111,114,Gene/Protein	NF - kappa B,146,158,Gene/Protein	/ I kappa B,159,170,Gene/Protein	NF - kappa B,206,218,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TNF alpha"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 146, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""/ I kappa B"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
The Thy - 1 gene promoter resembles a ` ` housekeeping ' ' promoter in that it is located within a methylation - free island, lacks a canonical TATA box, and displays heterogeneity in the 5 ' - end termini of the mRNA.	Thy - 1 gene promoter,4,25,Gene/Protein	` ` housekeeping ' ' promoter,38,67,Gene/Protein	methylation - free island,99,124,Gene/Protein	canonical TATA box,134,152,Gene/Protein	5 ' - end termini,188,205,Gene/Protein	mRNA,213,217,Gene/Protein	"[{""token"": ""Thy - 1 gene promoter"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""` ` housekeeping ' ' promoter"", ""start_span"": 38, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""methylation - free island"", ""start_span"": 99, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""canonical TATA box"", ""start_span"": 134, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - end termini"", ""start_span"": 188, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""mRNA"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
The effects of TNF - alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR) and the beta interferon promoter.	TNF - alpha,15,26,Gene/Protein	reporter chloramphenicol acetyltransferase plasmids,97,148,Gene/Protein	regulatory elements,159,178,Gene/Protein	HIV long terminal repeat,188,212,Gene/Protein	LTR,215,218,Gene/Protein	beta interferon promoter,228,252,Gene/Protein	"[{""token"": ""TNF - alpha"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""reporter chloramphenicol acetyltransferase plasmids"", ""start_span"": 97, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""regulatory elements"", ""start_span"": 159, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""HIV long terminal repeat"", ""start_span"": 188, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""beta interferon promoter"", ""start_span"": 228, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
A complementary DNA encoding a DNA - binding protein ( human X box binding protein, hXBP - 1) whose target is the human DR alpha X box and the 3 ' flanking region has now been cloned.	complementary DNA,2,19,Gene/Protein	DNA - binding protein,31,52,Gene/Protein	human X box binding protein,55,82,Gene/Protein	hXBP - 1,84,92,Gene/Protein	human DR alpha X box,114,134,Gene/Protein	3 ' flanking region,143,162,Gene/Protein	"[{""token"": ""complementary DNA"", ""start_span"": 2, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding protein"", ""start_span"": 31, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""human X box binding protein"", ""start_span"": 55, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""hXBP - 1"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""human DR alpha X box"", ""start_span"": 114, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""3 ' flanking region"", ""start_span"": 143, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
Domain B has been described as a B - cell - specific EB1 - responsive element ( P. M. Lieberman, J. M. Hardwick, and S. D. Hayward, J. Virol. 63: 3040 - 3050, 1989) activated synergistically by EB1 and R, an EBV early product encoded by the open reading frame BRLF1 ( M. A. Cox, J. Leahy, and J. M. Hardwick, J. Virol. 64: 313 - 321, 1990).	Domain B,0,8,Gene/Protein	B - cell - specific EB1 - responsive element,33,77,Gene/Protein	EB1,194,197,Gene/Protein	R,202,203,Gene/Protein	EBV early product,208,225,Gene/Protein	open reading frame BRLF1,241,265,Gene/Protein	"[{""token"": ""Domain B"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific EB1 - responsive element"", ""start_span"": 33, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""EB1"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""R"", ""start_span"": 202, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""EBV early product"", ""start_span"": 208, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""open reading frame BRLF1"", ""start_span"": 241, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
Moreover, there is no cooperation or synergy between R and EB1 when activating the B domain ( ZRE - B plus the R - responsive element) positioned as an enhancer.	R,53,54,Gene/Protein	EB1,59,62,Gene/Protein	B domain,83,91,Gene/Protein	ZRE - B,94,101,Gene/Protein	R - responsive element,111,133,Gene/Protein	enhancer,152,160,Gene/Protein	"[{""token"": ""R"", ""start_span"": 53, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""EB1"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""B domain"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""ZRE - B"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""R - responsive element"", ""start_span"": 111, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""enhancer"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
Strains with mutations in either gene of the regulatory pair ( phoP [ transcriptional activator] or phoQ [ membrane sensor kinase]) had increased sensitivities to defensin.	regulatory pair,45,60,Gene/Protein	phoP,63,67,Gene/Protein	transcriptional activator,70,95,Gene/Protein	phoQ,100,104,Gene/Protein	membrane sensor kinase,107,129,Gene/Protein	defensin,163,171,Gene/Protein	"[{""token"": ""regulatory pair"", ""start_span"": 45, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""phoP"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional activator"", ""start_span"": 70, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""phoQ"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""membrane sensor kinase"", ""start_span"": 107, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""defensin"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Defensin resistance is not the only virulence characteristic controlled by the PhoP - PhoQ regulon because mutations in pagC, as well as ones in the phoP locus that resulted in constitutive pag activation ( phenotype PhoPc), had no effect on defensin resistance, even though they rendered the organism avirulent and deficient in survival within macrophages.	PhoP - PhoQ regulon,79,98,Gene/Protein	pagC,120,124,Gene/Protein	phoP locus,149,159,Gene/Protein	pag,190,193,Gene/Protein	PhoPc,217,222,Gene/Protein	defensin,242,250,Gene/Protein	"[{""token"": ""PhoP - PhoQ regulon"", ""start_span"": 79, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""pagC"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""phoP locus"", ""start_span"": 149, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""pag"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""PhoPc"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""defensin"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Gene/Protein""}]"	train
Thus, the transcriptional activity of TCF - 1 alpha appears to depend on the TCF - 2 alpha and T alpha 1 ( CREB) transcription factors and the context of its binding site within the TCR alpha enhancer.	TCF - 1 alpha,38,51,Gene/Protein	TCF - 2 alpha,77,90,Gene/Protein	T alpha 1,95,104,Gene/Protein	CREB,107,111,Gene/Protein	transcription factors,113,134,Gene/Protein	TCR alpha enhancer,182,200,Gene/Protein	"[{""token"": ""TCF - 1 alpha"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 2 alpha"", ""start_span"": 77, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""T alpha 1"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""TCR alpha enhancer"", ""start_span"": 182, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Although anti - CD3 alone or fibronectin alone can not induce IL - 2 message by CD4 cells, the combination of anti - CD3 plus fibronectin induced IL - 2 message by CD4 cells.	anti - CD3,9,19,Gene/Protein	fibronectin,29,40,Gene/Protein	IL - 2,62,68,Gene/Protein	anti - CD3,110,120,Gene/Protein	fibronectin,126,137,Gene/Protein	IL - 2,146,152,Gene/Protein	"[{""token"": ""anti - CD3"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 110, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
Using a combination of transfection, protein - DNA binding, and in vitro transcription methods, we have discovered the novel T - cell - specific transcriptional activator TCF - 1 ( for T - Cell Factor - 1), which recognizes a T - cell - specific response element ( TCE) located within the IL - 2 promoter.	novel T - cell - specific transcriptional activator,119,170,Gene/Protein	TCF - 1,171,178,Gene/Protein	T - Cell Factor - 1,185,204,Gene/Protein	T - cell - specific response element,226,262,Gene/Protein	TCE,265,268,Gene/Protein	IL - 2 promoter,289,304,Gene/Protein	"[{""token"": ""novel T - cell - specific transcriptional activator"", ""start_span"": 119, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""T - Cell Factor - 1"", ""start_span"": 185, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific response element"", ""start_span"": 226, ""end_span"": 262, ""type"": ""Gene/Protein""}, {""token"": ""TCE"", ""start_span"": 265, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 289, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	train
Using constructs in which mRNA production controlled by a specific transcription factor could be readily measured we found that both cyclosporin A and FK506 completely inhibited transcription activated by NF - AT, NFIL2 A, NFIL2 B and partially inhibited transcription activated by NF kappa B.	mRNA,26,30,Gene/Protein	transcription factor,67,87,Gene/Protein	NF - AT,205,212,Gene/Protein	NFIL2 A,214,221,Gene/Protein	NFIL2 B,223,230,Gene/Protein	NF kappa B,282,292,Gene/Protein	"[{""token"": ""mRNA"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 67, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""NFIL2 A"", ""start_span"": 214, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""NFIL2 B"", ""start_span"": 223, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 282, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
( iv) No other EBV genes were required for EBNA - 2 transactivation of LMP1 since cotransfection of recombinant EBNA - 2 expression vectors and genomic LMP1 DNA fragments enhanced LMP1 expression in the EBV - negative B - lymphoma cell lines BJAB, Louckes, and BL30.	EBV genes,15,24,Gene/Protein	EBNA - 2,43,51,Gene/Protein	LMP1,71,75,Gene/Protein	recombinant EBNA - 2 expression vectors,100,139,Gene/Protein	LMP1 DNA fragments,152,170,Gene/Protein	LMP1,180,184,Gene/Protein	"[{""token"": ""EBV genes"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""EBNA - 2"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""recombinant EBNA - 2 expression vectors"", ""start_span"": 100, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""LMP1 DNA fragments"", ""start_span"": 152, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
In HIV - 1, the sequences that respond to these signaling events are found in the long terminal repeat ( LTR) and comprise the transcriptional enhancer, which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B).	long terminal repeat,82,102,Gene/Protein	LTR,105,108,Gene/Protein	transcriptional enhancer,127,151,Gene/Protein	conserved binding sites,172,195,Gene/Protein	nuclear factor kappa B,204,226,Gene/Protein	NF kappa B,229,239,Gene/Protein	"[{""token"": ""long terminal repeat"", ""start_span"": 82, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional enhancer"", ""start_span"": 127, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""conserved binding sites"", ""start_span"": 172, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 204, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""NF kappa B"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Acquisition of HSF3 DNA - binding activity in HD6 cells is accompanied by oligomerization from a non - DNA - binding dimer to a DNA - binding trimer, whereas the effect of heat shock on HSF1 is oligomerization of an inert monomer to a DNA - binding trimer.	HSF3,15,19,Gene/Protein	non - DNA - binding dimer,97,122,Gene/Protein	DNA - binding trimer,128,148,Gene/Protein	HSF1,186,190,Gene/Protein	inert monomer,216,229,Gene/Protein	DNA - binding trimer,235,255,Gene/Protein	"[{""token"": ""HSF3"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""non - DNA - binding dimer"", ""start_span"": 97, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding trimer"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""HSF1"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""inert monomer"", ""start_span"": 216, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""DNA - binding trimer"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand - induced tyrosine phosphorylation of the Janus protein - tyrosine kinase 3 ( Jak3) and signal transducers and activators of transcription ( Stat proteins).	Staphylococcal enterotoxins,0,27,Gene/Protein	interleukin 2 receptor,37,59,Gene/Protein	Janus protein - tyrosine kinase 3,124,157,Gene/Protein	Jak3,160,164,Gene/Protein	signal transducers and activators of transcription,170,220,Gene/Protein	Stat proteins,223,236,Gene/Protein	"[{""token"": ""Staphylococcal enterotoxins"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 2 receptor"", ""start_span"": 37, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Janus protein - tyrosine kinase 3"", ""start_span"": 124, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers and activators of transcription"", ""start_span"": 170, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 223, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
After 16 hr of exposure to SE, the expression of IL - 2R beta remained low, while that of IL2R alpha and IL2R gamma was further up - regulated, and ligand - induced tyrosine phosphorylation of Jak3 and Stat proteins was partly normalized.	SE,27,29,Gene/Protein	IL - 2R beta,49,61,Gene/Protein	IL2R alpha,90,100,Gene/Protein	IL2R gamma,105,115,Gene/Protein	Jak3,193,197,Gene/Protein	Stat proteins,202,215,Gene/Protein	"[{""token"": ""SE"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""IL2R alpha"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL2R gamma"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 202, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
Activation of JAK3, but not JAK1, is critical for IL - 2 - induced proliferation and STAT5 recruitment by a COOH - terminal region of the IL - 2 receptor beta - chain.	JAK3,14,18,Gene/Protein	JAK1,28,32,Gene/Protein	IL - 2,50,56,Gene/Protein	STAT5,85,90,Gene/Protein	COOH - terminal region,108,130,Gene/Protein	IL - 2 receptor beta - chain,138,166,Gene/Protein	"[{""token"": ""JAK3"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""COOH - terminal region"", ""start_span"": 108, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor beta - chain"", ""start_span"": 138, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
While homodimerizing cytokine receptors may transmit signal via a single form of JAK ( i. e. growth hormone receptors), several multicomponent cytokine receptors have been shown to require simultaneous activation of pairs of different JAK kinases ( i. e. interferon receptors).	homodimerizing cytokine receptors,6,39,Gene/Protein	JAK,81,84,Gene/Protein	growth hormone receptors,93,117,Gene/Protein	multicomponent cytokine receptors,128,161,Gene/Protein	JAK kinases,235,246,Gene/Protein	interferon receptors,255,275,Gene/Protein	"[{""token"": ""homodimerizing cytokine receptors"", ""start_span"": 6, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""growth hormone receptors"", ""start_span"": 93, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""multicomponent cytokine receptors"", ""start_span"": 128, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""JAK kinases"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""interferon receptors"", ""start_span"": 255, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	train
Furthermore, when human IL - 2R beta was stably expressed in murine BA / F3 cells, robust IL - 2 - induced proliferation and JAK3 activation occurred without detectable involvement of either JAK1, JAK2 or TYK2.	human IL - 2R beta,18,36,Gene/Protein	IL - 2,90,96,Gene/Protein	JAK3,125,129,Gene/Protein	JAK1,191,195,Gene/Protein	JAK2,197,201,Gene/Protein	TYK2,205,209,Gene/Protein	"[{""token"": ""human IL - 2R beta"", ""start_span"": 18, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""TYK2"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
We therefore propose that IL - 2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL - 2 - induced heterodimerization of IL - 2R beta and IL - 2R gamma.	IL - 2 receptor,26,41,Gene/Protein	JAK1,113,117,Gene/Protein	JAK3,122,126,Gene/Protein	IL - 2,137,143,Gene/Protein	IL - 2R beta,176,188,Gene/Protein	IL - 2R gamma,193,206,Gene/Protein	"[{""token"": ""IL - 2 receptor"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 176, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 193, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Lastly, the different mobilities of osteoblast nuclear extract - DNA complexes compared with T - cell nuclear extract - DNA complexes, along with the inability of OSF2 to be upregulated by retinoic acid, unlike the other PEBP2 alpha factors, suggest that OSF2 is a new member of this family of transcription factors.	osteoblast nuclear extract - DNA complexes,36,78,Gene/Protein	T - cell nuclear extract - DNA complexes,93,133,Gene/Protein	OSF2,163,167,Gene/Protein	PEBP2 alpha factors,221,240,Gene/Protein	OSF2,255,259,Gene/Protein	transcription factors,294,315,Gene/Protein	"[{""token"": ""osteoblast nuclear extract - DNA complexes"", ""start_span"": 36, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""T - cell nuclear extract - DNA complexes"", ""start_span"": 93, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""OSF2"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha factors"", ""start_span"": 221, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""OSF2"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 294, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
Thus, this study demonstrates that AML - 1B can increase gene expression of an osteoblast - specific gene through its binding to an osteoblast - specific cis - acting element and presents evidence that OSF2 is a member of the PEBP2 alpha / AML - 1 family of transcription factors.	AML - 1B,35,43,Gene/Protein	osteoblast - specific gene,79,105,Gene/Protein	osteoblast - specific cis - acting element,132,174,Gene/Protein	OSF2,202,206,Gene/Protein	PEBP2 alpha / AML - 1 family,226,254,Gene/Protein	transcription factors,258,279,Gene/Protein	"[{""token"": ""AML - 1B"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""osteoblast - specific gene"", ""start_span"": 79, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""osteoblast - specific cis - acting element"", ""start_span"": 132, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""OSF2"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""PEBP2 alpha / AML - 1 family"", ""start_span"": 226, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 258, ""end_span"": 279, ""type"": ""Gene/Protein""}]"	train
The three regions concerned are: 1) a region between - 73 and - 36, which is the minimal element inducible by LPS or TNF - alpha; 2) an element located between - 181 and - 73, which appeared to regulate the response to IFN - gamma and TNF - alpha negatively; and 3) a distal element upstream of - 224, which was inducible by IFN - gamma alone.	minimal element,81,96,Gene/Protein	TNF - alpha,117,128,Gene/Protein	IFN - gamma,219,230,Gene/Protein	TNF - alpha,235,246,Gene/Protein	distal element upstream,268,291,Gene/Protein	IFN - gamma,325,336,Gene/Protein	"[{""token"": ""minimal element"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 219, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 235, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""distal element upstream"", ""start_span"": 268, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 325, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	train
Males with X - linked severe combined immunodeficiency ( XSCID) have defects in the common cytokine receptor gamma chain ( gamma c) gene that encodes a shared, essential component of the receptors of interleukin - 2 ( IL - 2), IL - 4, IL - 7, IL - 9, and IL - 15.	interleukin - 2,200,215,Gene/Protein	IL - 2,218,224,Gene/Protein	IL - 4,227,233,Gene/Protein	IL - 7,235,241,Gene/Protein	IL - 9,243,249,Gene/Protein	IL - 15,255,262,Gene/Protein	"[{""token"": ""interleukin - 2"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 218, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 255, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
The only exception is represented by the P3HR1 cells, in which, however, the infection by the variant B does not determine induction of EBV antigens; ( 2) the presence of the EBV genome contributes to the susceptibility of the B cell lines to HHV - 6 infection, increasing the binding sites and the percentage of infectable cells, as detected by immunoelectron microscopy; and ( 3) HHV - 6 infected T cells, transfected with plasmids bearing the promoter regions of the EBV early genes BZLF1 and BMRF1, show a strong transactivation of these promoters.	EBV antigens,136,148,Gene/Protein	EBV genome,175,185,Gene/Protein	plasmids,425,433,Gene/Protein	promoter regions,446,462,Gene/Protein	BMRF1,496,501,Gene/Protein	promoters,542,551,Gene/Protein	"[{""token"": ""EBV antigens"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""EBV genome"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""plasmids"", ""start_span"": 425, ""end_span"": 433, ""type"": ""Gene/Protein""}, {""token"": ""promoter regions"", ""start_span"": 446, ""end_span"": 462, ""type"": ""Gene/Protein""}, {""token"": ""BMRF1"", ""start_span"": 496, ""end_span"": 501, ""type"": ""Gene/Protein""}, {""token"": ""promoters"", ""start_span"": 542, ""end_span"": 551, ""type"": ""Gene/Protein""}]"	train
To identify transcription factors binding to PRE - I, we screened a cDNA expression library from Jurkat T cells and isolated a cDNA encoding nuclear factor ( NF) - IL6 ( also known as C / EBP beta).	transcription factors,12,33,Gene/Protein	PRE - I,45,52,Gene/Protein	cDNA expression library,68,91,Gene/Protein	cDNA,127,131,Gene/Protein	nuclear factor,141,155,Gene/Protein	C / EBP beta,184,196,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 12, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""PRE - I"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""cDNA expression library"", ""start_span"": 68, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""cDNA"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP beta"", ""start_span"": 184, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Complex 2 corresponds to binding of transcription factor ( upstream stimulatory factor) to an E - box motif in the 5 ' portion of the NIP region.	Complex 2,0,9,Gene/Protein	transcription factor,36,56,Gene/Protein	upstream stimulatory factor,59,86,Gene/Protein	E - box motif,94,107,Gene/Protein	5 ' portion,115,126,Gene/Protein	NIP region,134,144,Gene/Protein	"[{""token"": ""Complex 2"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 36, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""upstream stimulatory factor"", ""start_span"": 59, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""E - box motif"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""5 ' portion"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""NIP region"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
CsA also suppressed E - selectin, but not vascular cell adhesion molecule - 1 ( VCAM - 1) expression in endothelial cells, even though the E - selectin promoter is activated by NF - kappa B rather than NFAT.	E - selectin,20,32,Gene/Protein	vascular cell adhesion molecule - 1,42,77,Gene/Protein	VCAM - 1,80,88,Gene/Protein	E - selectin promoter,139,160,Gene/Protein	NF - kappa B,177,189,Gene/Protein	NFAT,202,206,Gene/Protein	"[{""token"": ""E - selectin"", ""start_span"": 20, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""vascular cell adhesion molecule - 1"", ""start_span"": 42, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin promoter"", ""start_span"": 139, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
The changes in gene expression brought about by gamma interferon are thought to involve transient increases in the activities of cellular protein tyrosine kinases, including the Janus kinases Jak1 and Jak2, leading to tyrosine phosphorylation of the transcription factor Stat1.	gamma interferon,48,64,Gene/Protein	cellular protein tyrosine kinases,129,162,Gene/Protein	Janus kinases,178,191,Gene/Protein	Jak1,192,196,Gene/Protein	Jak2,201,205,Gene/Protein	transcription factor Stat1,250,276,Gene/Protein	"[{""token"": ""gamma interferon"", ""start_span"": 48, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""cellular protein tyrosine kinases"", ""start_span"": 129, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 178, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor Stat1"", ""start_span"": 250, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
We delineated an element conferring both DNA binding by the receptor in vitro and 1, 25 ( OH) 2D3 - mediated repression in vivo to a short 40 - bp region encompassing an important positive regulatory element, NF - AT - 1, which is bound by a T - cell - specific transcription factor, NFATp, as well as by AP - 1.	40 - bp region,139,153,Gene/Protein	positive regulatory element,180,207,Gene/Protein	NF - AT - 1,209,220,Gene/Protein	T - cell - specific transcription factor,242,282,Gene/Protein	NFATp,284,289,Gene/Protein	AP - 1,305,311,Gene/Protein	"[{""token"": ""40 - bp region"", ""start_span"": 139, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""positive regulatory element"", ""start_span"": 180, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT - 1"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""T - cell - specific transcription factor"", ""start_span"": 242, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 284, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 305, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
Dephosphorylation by in vitro treatment with calcineurin or alkaline phosphatase restores NFATp DNA binding activity and its ability to reconstitute an NFAT complex with Fos and Jun proteins.	calcineurin,45,56,Gene/Protein	alkaline phosphatase,60,80,Gene/Protein	NFATp,90,95,Gene/Protein	NFAT complex,152,164,Gene/Protein	Fos,170,173,Gene/Protein	Jun,178,181,Gene/Protein	"[{""token"": ""calcineurin"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""alkaline phosphatase"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""NFAT complex"", ""start_span"": 152, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Fos"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Jun"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR - 1.	regulatory element,2,20,Gene/Protein	human interleukin 2 gene promoter,28,61,Gene/Protein	binding site,67,79,Gene/Protein	zinc finger proteins,88,108,Gene/Protein	Sp1,109,112,Gene/Protein	EGR - 1,117,124,Gene/Protein	"[{""token"": ""regulatory element"", ""start_span"": 2, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""human interleukin 2 gene promoter"", ""start_span"": 28, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""zinc finger proteins"", ""start_span"": 88, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""EGR - 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
ER - mediated repression of GATA - 1 activity occurs on an artificial promoter containing a single GATA - binding site, as well as in the context of an intact promoter which is normally regulated by GATA - 1.	ER,0,2,Gene/Protein	GATA - 1,28,36,Gene/Protein	artificial promoter,59,78,Gene/Protein	GATA - binding site,99,118,Gene/Protein	intact promoter,152,167,Gene/Protein	GATA - 1,199,207,Gene/Protein	"[{""token"": ""ER"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""artificial promoter"", ""start_span"": 59, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""GATA - binding site"", ""start_span"": 99, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""intact promoter"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""GATA - 1"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
In addition, IL - 2 but not IL - 12 induced nuclear factors NF - kappa B and AP1, and regulation of the nuclear levels of these two DNA binding protein complexes is correlated with IFN - gamma and GM - CSF gene expression.	IL - 2,13,19,Gene/Protein	IL - 12,28,35,Gene/Protein	nuclear factors,44,59,Gene/Protein	NF - kappa B,60,72,Gene/Protein	AP1,77,80,Gene/Protein	DNA binding protein complexes,132,161,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factors"", ""start_span"": 44, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""DNA binding protein complexes"", ""start_span"": 132, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
We examined alpha A1 ( an alpha A - gene product) and alpha B1 and alpha B2 ( two alpha B - encoded isomers) for their effects on the GM - CSF promoter.	alpha A1,12,20,Gene/Protein	alpha A - gene product,26,48,Gene/Protein	alpha B1,54,62,Gene/Protein	alpha B2,67,75,Gene/Protein	alpha B - encoded isomers,82,107,Gene/Protein	GM - CSF promoter,134,151,Gene/Protein	"[{""token"": ""alpha A1"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""alpha A - gene product"", ""start_span"": 26, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""alpha B1"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""alpha B2"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""alpha B - encoded isomers"", ""start_span"": 82, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF promoter"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Gene/Protein""}]"	train
The Fc gamma RIC GIRE is homologous to the IFN - gamma activation sequence ( GAS) of the guanylate binding protein and to X box elements of class II MHC genes.	Fc gamma RIC GIRE,4,21,Gene/Protein	IFN - gamma activation sequence,43,74,Gene/Protein	GAS,77,80,Gene/Protein	guanylate binding protein,89,114,Gene/Protein	X box elements,122,136,Gene/Protein	class II MHC genes,140,158,Gene/Protein	"[{""token"": ""Fc gamma RIC GIRE"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma activation sequence"", ""start_span"": 43, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""GAS"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""guanylate binding protein"", ""start_span"": 89, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""X box elements"", ""start_span"": 122, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""class II MHC genes"", ""start_span"": 140, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
We have recently demonstrated that stimulation of human T and natural killer cells with IL - 12 induces tyrosine phosphorylation of the Janus family tyrosine kinase JAK2 and Tyk2, implicating these kinases in the immediate biochemical response to IL - 12.	IL - 12,88,95,Gene/Protein	Janus family tyrosine kinase,136,164,Gene/Protein	JAK2,165,169,Gene/Protein	Tyk2,174,178,Gene/Protein	kinases,198,205,Gene/Protein	IL - 12,247,254,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Janus family tyrosine kinase"", ""start_span"": 136, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""kinases"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 247, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Finally, we show by both footprint analysis and functional assays that the ability of the G + C - rich region to increase alpha - globin promoter activity from a stably integrated alpha - globin gene is mediated by its multiple binding sites for the transcription factor Sp1.	G + C - rich region,90,109,Gene/Protein	alpha - globin promoter,122,145,Gene/Protein	alpha - globin gene,180,199,Gene/Protein	multiple binding sites,219,241,Gene/Protein	transcription factor,250,270,Gene/Protein	Sp1,271,274,Gene/Protein	"[{""token"": ""G + C - rich region"", ""start_span"": 90, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin promoter"", ""start_span"": 122, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""alpha - globin gene"", ""start_span"": 180, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""multiple binding sites"", ""start_span"": 219, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 250, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 271, ""end_span"": 274, ""type"": ""Gene/Protein""}]"	train
LFA - 3 induced moderate levels of AP - 1, but did not influence the levels of NF - kappa B, while B7 costimulation strongly induced both AP - 1 and substantially enhanced NF - kappa B binding proteins.	LFA - 3,0,7,Gene/Protein	AP - 1,35,41,Gene/Protein	NF - kappa B,79,91,Gene/Protein	B7,99,101,Gene/Protein	AP - 1,138,144,Gene/Protein	NF - kappa B binding proteins,172,201,Gene/Protein	"[{""token"": ""LFA - 3"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""B7"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding proteins"", ""start_span"": 172, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
In this report, we show that in monocytes and T cells IL - 10 stimulates tyrosine phosphorylation of the signal transducers and activators of transcription, STAT1 alpha and STAT3, in a differential manner such that the relative formation of homo - and heterodimers varies between the two cell types.	IL - 10,54,61,Gene/Protein	signal transducers,105,123,Gene/Protein	activators of transcription,128,155,Gene/Protein	STAT1 alpha,157,168,Gene/Protein	STAT3,173,178,Gene/Protein	homo - and heterodimers,241,264,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""signal transducers"", ""start_span"": 105, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""activators of transcription"", ""start_span"": 128, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""STAT1 alpha"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""homo - and heterodimers"", ""start_span"": 241, ""end_span"": 264, ""type"": ""Gene/Protein""}]"	train
Because these are the characteristics of a signal transducer and activator of transcription ( Stat) protein, we determined whether antibodies to Stat proteins will interfere with gel mobility shift and found that antibodies to IL - 4 Stat, also known as Stat6, but not antibodies to other Stat proteins, interfere with the formation of the IL - 4 NAF complex.	antibodies to Stat proteins,131,158,Gene/Protein	antibodies to IL - 4 Stat,213,238,Gene/Protein	Stat6,254,259,Gene/Protein	antibodies,269,279,Gene/Protein	Stat proteins,289,302,Gene/Protein	IL - 4 NAF complex,340,358,Gene/Protein	"[{""token"": ""antibodies to Stat proteins"", ""start_span"": 131, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""antibodies to IL - 4 Stat"", ""start_span"": 213, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 269, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""Stat proteins"", ""start_span"": 289, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 NAF complex"", ""start_span"": 340, ""end_span"": 358, ""type"": ""Gene/Protein""}]"	train
Data is presented, using the potent and selective PKC inhibitor Ro 31 - 8425 and transient expression of a constitutively active ras mutant, which clearly shows that PKC is not downstream of p21ras in the induction of NF - AT and AP - 1 transcriptional activity and in the expression of IL - 2 in human Jurkat T cells.	PKC,50,53,Gene/Protein	PKC,166,169,Gene/Protein	p21ras,191,197,Gene/Protein	NF - AT,218,225,Gene/Protein	AP - 1,230,236,Gene/Protein	IL - 2,287,293,Gene/Protein	"[{""token"": ""PKC"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""p21ras"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 230, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Gene/Protein""}]"	train
Human T - cell leukemia virus type I Tax activation of NF - kappa B / Rel involves phosphorylation and degradation of I kappa B alpha and RelA ( p65) - mediated induction of the c - rel gene.	Tax,37,40,Gene/Protein	NF - kappa B / Rel,55,73,Gene/Protein	I kappa B alpha,118,133,Gene/Protein	RelA,138,142,Gene/Protein	p65,145,148,Gene/Protein	c - rel gene,178,190,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 118, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""c - rel gene"", ""start_span"": 178, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Erythropoietin ( Epo), granulocyte / macrophage colony stimulating factor ( GM - CSF), and interleukin 3 ( IL - 3) promoted the growth of NS - Meg cells.	Erythropoietin,0,14,Gene/Protein	Epo,17,20,Gene/Protein	granulocyte / macrophage colony stimulating factor,23,73,Gene/Protein	GM - CSF,76,84,Gene/Protein	interleukin 3,91,104,Gene/Protein	IL - 3,107,113,Gene/Protein	"[{""token"": ""Erythropoietin"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""Epo"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte / macrophage colony stimulating factor"", ""start_span"": 23, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 3"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
We have used mutants of these kinases and phosphatases ( gamma B * CaM - K and delta CaM - AI, respectively) to explore their relative role in cytokine gene transcription and their interactions with PKC - dependent signaling systems.	kinases,30,37,Gene/Protein	phosphatases,42,54,Gene/Protein	gamma B * CaM - K,57,74,Gene/Protein	delta CaM - AI,79,93,Gene/Protein	cytokine gene,143,156,Gene/Protein	PKC,199,202,Gene/Protein	"[{""token"": ""kinases"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""phosphatases"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""gamma B * CaM - K"", ""start_span"": 57, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""delta CaM - AI"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""cytokine gene"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Elf - 1 physically associated with HMG - I and with NF - kappa B p50 and c - Rel in vitro, suggesting that protein - protein interactions might functionally coordinate the actions of the upstream and downstream positive regulatory elements.	Elf - 1,0,7,Gene/Protein	HMG - I,35,42,Gene/Protein	NF - kappa B,52,64,Gene/Protein	p50,65,68,Gene/Protein	c - Rel,73,80,Gene/Protein	upstream and downstream positive regulatory elements,187,239,Gene/Protein	"[{""token"": ""Elf - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""HMG - I"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 52, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""upstream and downstream positive regulatory elements"", ""start_span"": 187, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
The increase in IL - 2 gene expression triggered by CD28 involves a kappa B - like sequence in the 5 ' - regulatory region of the IL - 2 promoter, called CD28 - responsive element.	IL - 2,16,22,Gene/Protein	CD28,52,56,Gene/Protein	kappa B - like sequence,68,91,Gene/Protein	5 ' - regulatory region,99,122,Gene/Protein	IL - 2 promoter,130,145,Gene/Protein	CD28 - responsive element,154,179,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - like sequence"", ""start_span"": 68, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""5 ' - regulatory region"", ""start_span"": 99, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 130, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""CD28 - responsive element"", ""start_span"": 154, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Antiandrogens result in protection of both the hinge region and C - terminus of the androgen receptor agonist proteolytic attack, whereas other studies showed that antiestrogens and antiprogestagens expose the C - terminal end of the ligand binding domain of their respective receptors to protease.	hinge region,47,59,Gene/Protein	C - terminus,64,76,Gene/Protein	androgen receptor,84,101,Gene/Protein	C - terminal end,210,226,Gene/Protein	ligand binding domain,234,255,Gene/Protein	protease,289,297,Gene/Protein	"[{""token"": ""hinge region"", ""start_span"": 47, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""C - terminus"", ""start_span"": 64, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""androgen receptor"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal end"", ""start_span"": 210, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""ligand binding domain"", ""start_span"": 234, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""protease"", ""start_span"": 289, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	train
Full activation of the MAP kinases that phosphorylate the Jun activation domain, JNK1 and JNK2, required costimulation of T cells with either TPA and Ca2 + ionophore or antibodies to TCR and CD28.	MAP kinases,23,34,Gene/Protein	Jun activation domain,58,79,Gene/Protein	JNK1,81,85,Gene/Protein	JNK2,90,94,Gene/Protein	TCR,183,186,Gene/Protein	CD28,191,195,Gene/Protein	"[{""token"": ""MAP kinases"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Jun activation domain"", ""start_span"": 58, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""JNK1"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""JNK2"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Again, in vitro supershift studies indicate that the presence of p50, p52, p65, and cRel correlates with positive function whereas the presence of only p50 and p52 correlates with negative function.	p50,65,68,Gene/Protein	p52,70,73,Gene/Protein	p65,75,78,Gene/Protein	cRel,84,88,Gene/Protein	p50,152,155,Gene/Protein	p52,160,163,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""cRel"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
By employing a derivative E box that binds ZEB but not E2A, we have shown that the repressor is active in B cells and the IgH enhancer is silenced in the absence of binding competition by bHLH proteins.	E box,26,31,Gene/Protein	ZEB,43,46,Gene/Protein	E2A,55,58,Gene/Protein	repressor,83,92,Gene/Protein	IgH enhancer,122,134,Gene/Protein	bHLH proteins,188,201,Gene/Protein	"[{""token"": ""E box"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""ZEB"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""E2A"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""repressor"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""bHLH proteins"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
The magnitude and time kinetics of the LIF effects were similar to interleukin 1 ( IL - 1), IL - 6, and tumor necrosis factor ( TNF), other cytokines known to induce HIV replication in this cell line.	LIF,39,42,Gene/Protein	interleukin 1,67,80,Gene/Protein	IL - 1,83,89,Gene/Protein	IL - 6,92,98,Gene/Protein	tumor necrosis factor,104,125,Gene/Protein	TNF,128,131,Gene/Protein	"[{""token"": ""LIF"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 1"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 83, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 104, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
We therefore reexamined this issue by using two different experimental approaches that allowed LMP1 - induced effects to be monitored immediately following expression of the viral protein and in the absence of selective pressures; activation of the NF - kappa B transcription factor and upregulation of the cell adhesion molecule ICAM - 1 were used as early indices of LMP1 function.	LMP1,95,99,Gene/Protein	NF - kappa B,249,261,Gene/Protein	transcription factor,262,282,Gene/Protein	cell adhesion molecule,307,329,Gene/Protein	ICAM - 1,330,338,Gene/Protein	LMP1,369,373,Gene/Protein	"[{""token"": ""LMP1"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 249, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 262, ""end_span"": 282, ""type"": ""Gene/Protein""}, {""token"": ""cell adhesion molecule"", ""start_span"": 307, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 330, ""end_span"": 338, ""type"": ""Gene/Protein""}, {""token"": ""LMP1"", ""start_span"": 369, ""end_span"": 373, ""type"": ""Gene/Protein""}]"	train
We have observed that the R24 mAb stimulates GD3 + T cell proliferation, cytotoxicity, and surface marker expression of IL - 2R alpha - chain, IL - 2R beta - chain, HLA - DR, CD11a, and CD11c.	R24 mAb,26,33,Gene/Protein	IL - 2R alpha - chain,120,141,Gene/Protein	IL - 2R beta - chain,143,163,Gene/Protein	HLA - DR,165,173,Gene/Protein	CD11a,175,180,Gene/Protein	CD11c,186,191,Gene/Protein	"[{""token"": ""R24 mAb"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R alpha - chain"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta - chain"", ""start_span"": 143, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DR"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""CD11a"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""CD11c"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Furthermore, the physical interaction of Tax with p100 leads to the inhibition of Tax - induced activation of the HTLV - I and human immunodeficiency virus type 1 long terminal repeats, reflecting p100 - mediated cytoplasmic sequestration of the normally nuclearly expressed Tax protein.	Tax,41,44,Gene/Protein	p100,50,54,Gene/Protein	Tax,82,85,Gene/Protein	human immunodeficiency virus type 1 long terminal repeats,127,184,Gene/Protein	p100,197,201,Gene/Protein	Tax protein,275,286,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""human immunodeficiency virus type 1 long terminal repeats"", ""start_span"": 127, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""Tax protein"", ""start_span"": 275, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
The Epstein - Barr virus ( EBV) transforming protein LMP1 appears to be a constitutively activated tumor necrosis factor receptor ( TNFR) on the basis of an intrinsic ability to aggregate in the plasma membrane and an association of its cytoplasmic carboxyl terminus ( CT) with TNFR - associated factors ( TRAFs).	constitutively activated tumor necrosis factor receptor,74,129,Gene/Protein	TNFR,132,136,Gene/Protein	cytoplasmic carboxyl terminus,237,266,Gene/Protein	CT,269,271,Gene/Protein	TNFR - associated factors,278,303,Gene/Protein	TRAFs,306,311,Gene/Protein	"[{""token"": ""constitutively activated tumor necrosis factor receptor"", ""start_span"": 74, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNFR"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic carboxyl terminus"", ""start_span"": 237, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""CT"", ""start_span"": 269, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""TNFR - associated factors"", ""start_span"": 278, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""TRAFs"", ""start_span"": 306, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
The IRF - 2 promoter region contains a CpG island, with several GC boxes, a putative NF - kappa B - binding site, and a CAAT box, but no TATA box.	IRF - 2,4,11,Gene/Protein	promoter region,12,27,Gene/Protein	GC boxes,64,72,Gene/Protein	NF - kappa B - binding site,85,112,Gene/Protein	CAAT box,120,128,Gene/Protein	TATA box,137,145,Gene/Protein	"[{""token"": ""IRF - 2"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 12, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""GC boxes"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B - binding site"", ""start_span"": 85, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""CAAT box"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
When the promoter region was linked with a heterologous reporter gene, we found that the promoter region is inducible by both interferons ( interferon - alpha and - gamma) and interferon regulatory factor 1.	promoter region,9,24,Gene/Protein	heterologous reporter gene,43,69,Gene/Protein	promoter region,89,104,Gene/Protein	interferons,126,137,Gene/Protein	interferon - alpha and - gamma,140,170,Gene/Protein	interferon regulatory factor 1,176,206,Gene/Protein	"[{""token"": ""promoter region"", ""start_span"": 9, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""heterologous reporter gene"", ""start_span"": 43, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""promoter region"", ""start_span"": 89, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""interferons"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""interferon - alpha and - gamma"", ""start_span"": 140, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""interferon regulatory factor 1"", ""start_span"": 176, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Whereas AP - 1, NF - kappa B, Oct, CREB and SP1 displayed normal binding activities in nuclear extracts, the binding of NF - AT to its IL - 2 promoter response element was barely detectable both before and after T cell stimulation.	AP - 1,8,14,Gene/Protein	Oct,30,33,Gene/Protein	CREB,35,39,Gene/Protein	SP1,44,47,Gene/Protein	NF - AT,120,127,Gene/Protein	IL - 2,135,141,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""Oct"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""SP1"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
Expression of interleukin 1beta and other cytokines, such as interleukin 6 and tumor necrosis factor alpha, has been shown to be dependent on the activation of the transcription factor, NFkappaB.	interleukin 1beta,14,31,Gene/Protein	cytokines,42,51,Gene/Protein	interleukin 6,61,74,Gene/Protein	tumor necrosis factor alpha,79,106,Gene/Protein	transcription factor,164,184,Gene/Protein	NFkappaB,186,194,Gene/Protein	"[{""token"": ""interleukin 1beta"", ""start_span"": 14, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 6"", ""start_span"": 61, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 79, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 164, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Although CD40 ligand ( CD40L) triggers a shift from dephosphorylated to phosphorylated pRB and proliferation of B cells, the addition of exogenous IL - 6 to CD40L - treated B cells does not alter either pRB or proliferation, as observed in MM cells.	CD40 ligand,9,20,Gene/Protein	CD40L,23,28,Gene/Protein	pRB,87,90,Gene/Protein	IL - 6,147,153,Gene/Protein	CD40L,157,162,Gene/Protein	pRB,203,206,Gene/Protein	"[{""token"": ""CD40 ligand"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""pRB"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""pRB"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
In spite of this similar downstream signalling, IL4 and IL13 used a different set of Janus kinases: IL13 is unable to activate JAK1 and JAK3.	IL4,48,51,Gene/Protein	IL13,56,60,Gene/Protein	Janus kinases,85,98,Gene/Protein	IL13,100,104,Gene/Protein	JAK1,127,131,Gene/Protein	JAK3,136,140,Gene/Protein	"[{""token"": ""IL4"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL13"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinases"", ""start_span"": 85, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL13"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Consistent with these results, quantitative DNase footprinting of the TNF - alpha promoter using increasing amounts of recombinant NFATp demonstrated that the - 76 site binds to NFATp with a higher affinity than the kappa 3 site.	DNase,44,49,Gene/Protein	TNF - alpha promoter,70,90,Gene/Protein	NFATp,131,136,Gene/Protein	- 76 site,159,168,Gene/Protein	NFATp,178,183,Gene/Protein	kappa 3 site,216,228,Gene/Protein	"[{""token"": ""DNase"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha promoter"", ""start_span"": 70, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""- 76 site"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""NFATp"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""kappa 3 site"", ""start_span"": 216, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
Nuclear factor of activated T cells - family proteins ( NFAT1 / NFATp, NFATc, NFAT3, and NFAT4 / NFATx / NFATc3) play a key role in the transcription of cytokine genes and other genes during the immune response.	Nuclear factor of activated T cells - family proteins,0,53,Gene/Protein	NFAT1 / NFATp,56,69,Gene/Protein	NFATc,71,76,Gene/Protein	NFAT3,78,83,Gene/Protein	NFAT4 / NFATx / NFATc3,89,111,Gene/Protein	cytokine genes,153,167,Gene/Protein	"[{""token"": ""Nuclear factor of activated T cells - family proteins"", ""start_span"": 0, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1 / NFATp"", ""start_span"": 56, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""NFATc"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""NFAT3"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""NFAT4 / NFATx / NFATc3"", ""start_span"": 89, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""cytokine genes"", ""start_span"": 153, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
There are four putative NF - kappa B binding sites ( kappa B - 1, kappa B - 2, kappa B - 3, kappa B - 4) in human TNF - alpha promoter.	NF - kappa B binding sites,24,50,Gene/Protein	kappa B - 1,53,64,Gene/Protein	kappa B - 2,66,77,Gene/Protein	kappa B - 3,79,90,Gene/Protein	kappa B - 4,92,103,Gene/Protein	human TNF - alpha promoter,108,134,Gene/Protein	"[{""token"": ""NF - kappa B binding sites"", ""start_span"": 24, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 1"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 2"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 3"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""kappa B - 4"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""human TNF - alpha promoter"", ""start_span"": 108, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
Expression of the MAP kinase - specific phosphatase, MKP - 1, which blocks ERK activation, inhibited IL - 2 promoter and NF - AT - driven transcription stimulated by a calcium ionophore and PMA, and in addition, MKP - 1 neutralized the transcriptional enhancement caused by active Raf - 1 and MEK1 expression.	MAP kinase - specific phosphatase,18,51,Gene/Protein	MKP - 1,53,60,Gene/Protein	ERK,75,78,Gene/Protein	IL - 2 promoter,101,116,Gene/Protein	NF - AT,121,128,Gene/Protein	MKP - 1,212,219,Gene/Protein	"[{""token"": ""MAP kinase - specific phosphatase"", ""start_span"": 18, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""MKP - 1"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 promoter"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""MKP - 1"", ""start_span"": 212, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Using these T cells as a model of IL - 12 signal transduction, we confirmed that these events involve members of the Janus kinase family of nonreceptor tyrosine kinases JAK2, TYK2, and signal transducer and activator of transcription 4.	IL - 12,34,41,Gene/Protein	Janus kinase family,117,136,Gene/Protein	nonreceptor tyrosine kinases,140,168,Gene/Protein	JAK2,169,173,Gene/Protein	TYK2,175,179,Gene/Protein	signal transducer and activator of transcription 4,185,235,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase family"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""nonreceptor tyrosine kinases"", ""start_span"": 140, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""JAK2"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""TYK2"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription 4"", ""start_span"": 185, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
We conclude that the effects of IFN - gamma on the expression of the transcription factors AP - 1 and NF - kappa B may be important for the modulatory effects of IFN - gamma on the cytokine expression in activated human monocytes.	IFN - gamma,32,43,Gene/Protein	transcription factors,69,90,Gene/Protein	AP - 1,91,97,Gene/Protein	NF - kappa B,102,114,Gene/Protein	IFN - gamma,162,173,Gene/Protein	cytokine,181,189,Gene/Protein	"[{""token"": ""IFN - gamma"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 69, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
As judged by supershifting the DNA - protein complexes with Abs recognizing specific components of the NF - kappa B / Rel protein family, the p50 / p65 ( Rel A) heterodimeric form of NF - kappa B is primarily affected.	DNA - protein complexes,31,54,Gene/Protein	Abs,60,63,Gene/Protein	NF - kappa B / Rel protein family,103,136,Gene/Protein	p50 / p65,142,151,Gene/Protein	Rel A,154,159,Gene/Protein	NF - kappa B,183,195,Gene/Protein	"[{""token"": ""DNA - protein complexes"", ""start_span"": 31, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Abs"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B / Rel protein family"", ""start_span"": 103, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""p50 / p65"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Rel A"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 183, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Antibodies against CRE - binding ( CREB) protein but not against c - Fos or c - Jun were able to supershift the DNA - protein complex, identifying the nature of the transcription factor which binds to ZII as a member of the CREB family of proteins.	c - Fos,65,72,Gene/Protein	c - Jun,76,83,Gene/Protein	DNA - protein complex,112,133,Gene/Protein	transcription factor,165,185,Gene/Protein	ZII,201,204,Gene/Protein	CREB family of proteins,224,247,Gene/Protein	"[{""token"": ""c - Fos"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""DNA - protein complex"", ""start_span"": 112, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 165, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""ZII"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""CREB family of proteins"", ""start_span"": 224, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	train
This raises the intriguing possibility that physical association of the HsN3 proteasome subunit with HTLV - I Tax coupled with the independent interaction of Tax with either p100 or p65 - I kappa B alpha targets these cytoplasmic NF - kappa B / Rel complexes to the proteasome for processing.	HsN3 proteasome subunit,72,95,Gene/Protein	HTLV - I Tax,101,113,Gene/Protein	Tax,158,161,Gene/Protein	I kappa B alpha,188,203,Gene/Protein	cytoplasmic NF - kappa B / Rel complexes,218,258,Gene/Protein	proteasome,266,276,Gene/Protein	"[{""token"": ""HsN3 proteasome subunit"", ""start_span"": 72, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""HTLV - I Tax"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B alpha"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic NF - kappa B / Rel complexes"", ""start_span"": 218, ""end_span"": 258, ""type"": ""Gene/Protein""}, {""token"": ""proteasome"", ""start_span"": 266, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
We provide evidence that Zta up - regulation of p53 leads to p53 - mediated interference with JAK / STAT activation of Qp.	Zta,25,28,Gene/Protein	p53,48,51,Gene/Protein	p53,61,64,Gene/Protein	JAK,94,97,Gene/Protein	/ STAT,98,104,Gene/Protein	Qp,119,121,Gene/Protein	"[{""token"": ""Zta"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""/ STAT"", ""start_span"": 98, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Qp"", ""start_span"": 119, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
We find that recruitment of EKLF to 5 ' HS2 requires the TATA box, but recruitment to 5 ' HS3 depends on the CACCC and TATA boxes of the beta - globin promoter.	EKLF,28,32,Gene/Protein	5 ' HS2,36,43,Gene/Protein	TATA box,57,65,Gene/Protein	5 ' HS3,86,93,Gene/Protein	TATA boxes,119,129,Gene/Protein	beta - globin promoter,137,159,Gene/Protein	"[{""token"": ""EKLF"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS2"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""TATA box"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""5 ' HS3"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""TATA boxes"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""beta - globin promoter"", ""start_span"": 137, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
We conclude that glucocorticoids differentially modulate TNFalpha and IL - 10 secretion by human monocytes in a LPS dose - dependent fashion and that the sensitivity of these cells to glucocorticoids is altered by TNFalpha or IL - 10 pretreatment; TNFalpha blocks their effects, whereas IL - 10 acts synergistically with glucocorticoids.	TNFalpha,57,65,Gene/Protein	IL - 10,70,77,Gene/Protein	TNFalpha,214,222,Gene/Protein	IL - 10,226,233,Gene/Protein	TNFalpha,248,256,Gene/Protein	IL - 10,287,294,Gene/Protein	"[{""token"": ""TNFalpha"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 248, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 287, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
Further, CTLA - 4 engagement inhibited progression through the cell cycle by inhibiting the production of cyclin D3, cyclin - dependent kinase ( cdk) 4, and cdk6 when the T cells were stimulated with anti - CD3 / CD28 and with anti - CD3 alone.	CTLA - 4,9,17,Gene/Protein	cyclin D3,106,115,Gene/Protein	cyclin - dependent kinase,117,142,Gene/Protein	cdk6,157,161,Gene/Protein	anti - CD3 / CD28,200,217,Gene/Protein	anti - CD3,227,237,Gene/Protein	"[{""token"": ""CTLA - 4"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D3"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinase"", ""start_span"": 117, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""cdk6"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3 / CD28"", ""start_span"": 200, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 227, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
In T lymphocytes, the hematopoietic cytokine interleukin - 2 ( IL - 2) uses phosphatidylinositol 3 - kinase ( PI 3 - kinase) - induced signaling pathways to regulate E2F transcriptional activity, a critical cell cycle checkpoint.	hematopoietic cytokine,22,44,Gene/Protein	interleukin - 2,45,60,Gene/Protein	IL - 2,63,69,Gene/Protein	phosphatidylinositol 3 - kinase,76,107,Gene/Protein	PI 3 - kinase,110,123,Gene/Protein	E2F,166,169,Gene/Protein	"[{""token"": ""hematopoietic cytokine"", ""start_span"": 22, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 45, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 76, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""E2F"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
A PMA responsive element was localized to a region between - 319 and - 219 bp upstream of the initiation codon and co - transfections with transcription factor expression plasmids for AP - 2 and Sp1 resulted in augmented ASM promoter activity, which was abolished when the binding sites for these two factors were deleted.	PMA responsive element,2,24,Gene/Protein	- 319 and - 219 bp upstream,59,86,Gene/Protein	transcription factor expression plasmids,139,179,Gene/Protein	AP - 2,184,190,Gene/Protein	Sp1,195,198,Gene/Protein	binding sites,273,286,Gene/Protein	"[{""token"": ""PMA responsive element"", ""start_span"": 2, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""- 319 and - 219 bp upstream"", ""start_span"": 59, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor expression plasmids"", ""start_span"": 139, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""binding sites"", ""start_span"": 273, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
Although MKK3, MKK4, and MKK6 all activated p38 MAPk in experimental models, only MKK3 was found to activate recombinant p38 MAPk in LPS - treated neutrophils.	MKK3,9,13,Gene/Protein	MKK4,15,19,Gene/Protein	MKK6,25,29,Gene/Protein	p38 MAPk,44,52,Gene/Protein	MKK3,82,86,Gene/Protein	p38 MAPk,121,129,Gene/Protein	"[{""token"": ""MKK3"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""MKK4"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""MKK6"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""MKK3"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""p38 MAPk"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
The I gamma 3 ECS lies upstream of the major I gamma 3 transcription initiation site and displays more than 90% identity with the corresponding human I gamma 1, I gamma 2, and I gamma 4 regions.	I gamma 3,4,13,Gene/Protein	ECS,14,17,Gene/Protein	major I gamma 3 transcription initiation site,39,84,Gene/Protein	human I gamma 1,144,159,Gene/Protein	I gamma 2,161,170,Gene/Protein	I gamma 4,176,185,Gene/Protein	"[{""token"": ""I gamma 3"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""ECS"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""major I gamma 3 transcription initiation site"", ""start_span"": 39, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""human I gamma 1"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""I gamma 2"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""I gamma 4"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
Electrophoretic mobility shift assays showed that p50 / p65 / c - Rel and STAT - 6 are effectively induced by CD40L and IL - 4, respectively, and bind to specific DNA motifs within the ECS.	p50 / p65 / c - Rel,50,69,Gene/Protein	STAT - 6,74,82,Gene/Protein	CD40L,110,115,Gene/Protein	IL - 4,120,126,Gene/Protein	DNA motifs,163,173,Gene/Protein	ECS,185,188,Gene/Protein	"[{""token"": ""p50 / p65 / c - Rel"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""STAT - 6"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""DNA motifs"", ""start_span"": 163, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""ECS"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
SH2 domain - containing protein 76 ( SLP - 76) interacts with the guanine nucleotide exchange factor Vav to activate the nuclear factor of activated cells ( NF - AT), and its expression is required for normal T cell development.	SH2 domain - containing protein 76,0,34,Gene/Protein	SLP - 76,37,45,Gene/Protein	guanine nucleotide exchange factor,66,100,Gene/Protein	Vav,101,104,Gene/Protein	nuclear factor of activated cells,121,154,Gene/Protein	NF - AT,157,164,Gene/Protein	"[{""token"": ""SH2 domain - containing protein 76"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""SLP - 76"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""guanine nucleotide exchange factor"", ""start_span"": 66, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Vav"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated cells"", ""start_span"": 121, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Several intracellular signaling proteins, such as CBL and VAV, were phosphorylated on tyrosine in response to CD80, CD86, and anti - CD28 mAb.	signaling proteins,22,40,Gene/Protein	CBL,50,53,Gene/Protein	VAV,58,61,Gene/Protein	CD80,110,114,Gene/Protein	CD86,116,120,Gene/Protein	anti - CD28 mAb,126,141,Gene/Protein	"[{""token"": ""signaling proteins"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CBL"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""VAV"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD28 mAb"", ""start_span"": 126, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
Apart from clear - cut defects in the synthesis of mRNAs for Th2 - type lymphokines, such as IL - 4, IL - 5, IL - 10 and IL - 13, in primary and secondary stimulations of spleen cells in vitro, of a distinct impaired deletion of V beta 11 + / CD4 + T lymphocytes from these mice was detected after superantigen injection.	mRNAs,51,56,Gene/Protein	Th2 - type lymphokines,61,83,Gene/Protein	IL - 4,93,99,Gene/Protein	IL - 5,101,107,Gene/Protein	IL - 10,109,116,Gene/Protein	IL - 13,121,128,Gene/Protein	"[{""token"": ""mRNAs"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Th2 - type lymphokines"", ""start_span"": 61, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IL - 5"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
The aberrant CD4 ( -) CD8 ( -) T cells from lpr / lpr and gld / gld mice, which have mutations in the genes encoding Fas and FasL, respectively, have an activated phenotype and constitutively express high levels of fasL mRNA, prompting us to ask what role if any the FLRE and Egr family proteins have in this aberrant expression of fasL.	Fas,117,120,Gene/Protein	FasL,125,129,Gene/Protein	fasL mRNA,215,224,Gene/Protein	FLRE,267,271,Gene/Protein	Egr family proteins,276,295,Gene/Protein	fasL,332,336,Gene/Protein	"[{""token"": ""Fas"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""FasL"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""fasL mRNA"", ""start_span"": 215, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""FLRE"", ""start_span"": 267, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""Egr family proteins"", ""start_span"": 276, ""end_span"": 295, ""type"": ""Gene/Protein""}, {""token"": ""fasL"", ""start_span"": 332, ""end_span"": 336, ""type"": ""Gene/Protein""}]"	train
Stimulation of lymphoid cells with interleukin - 1beta ( IL - 1beta) led to ROI production and NF - kappaB activation, which could both be blocked by antioxidants or FLAP inhibitors, confirming that 5 - LOX was the source of ROIs and was required for NF - kappaB activation in these cells.	interleukin - 1beta,35,54,Gene/Protein	IL - 1beta,57,67,Gene/Protein	NF - kappaB,95,106,Gene/Protein	FLAP,166,170,Gene/Protein	5 - LOX,199,206,Gene/Protein	NF - kappaB,251,262,Gene/Protein	"[{""token"": ""interleukin - 1beta"", ""start_span"": 35, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""FLAP"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""5 - LOX"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 251, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
Evidence for suppressed activity of the transcription factor NFAT1 at its proximal binding element P0 in the IL - 4 promoter associated with enhanced IL - 4 gene transcription in T cells of atopic patients.	transcription factor,40,60,Gene/Protein	NFAT1,61,66,Gene/Protein	proximal binding element,74,98,Gene/Protein	P0,99,101,Gene/Protein	IL - 4 promoter,109,124,Gene/Protein	IL - 4 gene,150,161,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 40, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""NFAT1"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""proximal binding element"", ""start_span"": 74, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""P0"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 promoter"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 gene"", ""start_span"": 150, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
A Taq I polymorphism was identified which enabled chicken IL2 to be mapped to chromosome 4, linked to ANX5, with synteny with mouse chromosome 3 and human chromosome 4.	Taq I polymorphism,2,20,Gene/Protein	IL2,58,61,Gene/Protein	chromosome 4,78,90,Gene/Protein	ANX5,102,106,Gene/Protein	mouse chromosome 3,126,144,Gene/Protein	human chromosome 4,149,167,Gene/Protein	"[{""token"": ""Taq I polymorphism"", ""start_span"": 2, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""chromosome 4"", ""start_span"": 78, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""ANX5"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""mouse chromosome 3"", ""start_span"": 126, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""human chromosome 4"", ""start_span"": 149, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
LSF ( also known as LBP - 1, UBP, and CP - 2) has been shown to repress LTR transcription in vitro, but transient expression of LSF has no effect on LTR activity in vivo.	LSF,0,3,Gene/Protein	LBP - 1,20,27,Gene/Protein	UBP,29,32,Gene/Protein	CP - 2,38,44,Gene/Protein	LSF,128,131,Gene/Protein	LTR,149,152,Gene/Protein	"[{""token"": ""LSF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""LBP - 1"", ""start_span"": 20, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""UBP"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CP - 2"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""LSF"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
The visualization of heavy and light chain genes in B - lymphoid cells showed that the three Ig genes are differentially and nonrandomly distributed in different nuclear subvolumes: the kappa genes were found to be preferentially confined to an outer nuclear volume, whereas the gamma and lambda genes consistently occupied more central positions within the nucleus, the lambda genes being more interior when compared with the gamma genes.	heavy and light chain genes,21,48,Gene/Protein	Ig genes,93,101,Gene/Protein	kappa genes,186,197,Gene/Protein	gamma and lambda genes,279,301,Gene/Protein	lambda genes,371,383,Gene/Protein	gamma genes,427,438,Gene/Protein	"[{""token"": ""heavy and light chain genes"", ""start_span"": 21, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Ig genes"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""kappa genes"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""gamma and lambda genes"", ""start_span"": 279, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""lambda genes"", ""start_span"": 371, ""end_span"": 383, ""type"": ""Gene/Protein""}, {""token"": ""gamma genes"", ""start_span"": 427, ""end_span"": 438, ""type"": ""Gene/Protein""}]"	train
NF - kappa B activation was independent of the transmembrane domain of CD40, suggesting that it is independent of p23, a molecule that associates with CD40 in a region other than the cytoplasmic domain.	NF - kappa B,0,12,Gene/Protein	transmembrane domain,47,67,Gene/Protein	CD40,71,75,Gene/Protein	p23,114,117,Gene/Protein	CD40,151,155,Gene/Protein	cytoplasmic domain,183,201,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane domain"", ""start_span"": 47, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""p23"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""cytoplasmic domain"", ""start_span"": 183, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
IL - 2 and IL - 7 were equivalent in their ability to induce tyrosine phosphorylation of STAT5A and STAT5B and to facilitate binding of these STATs to an immobilized GAS element.	IL - 2,0,6,Gene/Protein	IL - 7,11,17,Gene/Protein	STAT5A,89,95,Gene/Protein	STAT5B,100,106,Gene/Protein	STATs,142,147,Gene/Protein	immobilized GAS element,154,177,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""STAT5A"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""STAT5B"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""STATs"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""immobilized GAS element"", ""start_span"": 154, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Interestingly, co - immunoprecipitation analysis also revealed that Tax mutant IEXC29S is unable to interact with NGFI - A / Egr - 1, whereas Tax mutant IEXL320G is able to interact with NGFI - A / Egr - 1.	Tax,68,71,Gene/Protein	IEXC29S,79,86,Gene/Protein	NGFI - A / Egr - 1,114,132,Gene/Protein	Tax,142,145,Gene/Protein	IEXL320G,153,161,Gene/Protein	NGFI - A / Egr - 1,187,205,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""IEXC29S"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 114, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Tax"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""IEXL320G"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""NGFI - A / Egr - 1"", ""start_span"": 187, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
However, NF - YB did interact with the C - terminal Tax1 mutants M22 ( 130TL - AS) and M47 ( 319LL - RS).	NF - YB,9,16,Gene/Protein	C - terminal Tax1 mutants,39,64,Gene/Protein	M22,65,68,Gene/Protein	130TL - AS,71,81,Gene/Protein	M47,87,90,Gene/Protein	319LL - RS,93,103,Gene/Protein	"[{""token"": ""NF - YB"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""C - terminal Tax1 mutants"", ""start_span"": 39, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""M22"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""130TL - AS"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""M47"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""319LL - RS"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
In murine Ba / F3 cells transfected with the human G - CSFR and NFS - 60 cells constitutively expressing the murine G - CSFR, G - CSF induced tyrosine phosphorylation and activation of Jak1, Jak2, and Tyk2.	human G - CSFR,45,59,Gene/Protein	murine G - CSFR,109,124,Gene/Protein	G - CSF,126,133,Gene/Protein	Jak1,185,189,Gene/Protein	Jak2,191,195,Gene/Protein	Tyk2,201,205,Gene/Protein	"[{""token"": ""human G - CSFR"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""murine G - CSFR"", ""start_span"": 109, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Jak1"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""Jak2"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""Tyk2"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
Following neutrophil stimulation with proinflammatory agonists ( such as lipopolysaccharide [ LPS], tumor necrosis factor - alpha [ TNF - alpha], and fMet - Leu - Phe) that induce the production of cytokines and chemokines in these cells, NF - kappaB / Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF - kappaB DNA binding activity, as determined in gel mobility shift assays.	tumor necrosis factor - alpha,100,129,Gene/Protein	TNF - alpha,132,143,Gene/Protein	cytokines,198,207,Gene/Protein	chemokines,212,222,Gene/Protein	NF - kappaB / Rel proteins,239,265,Gene/Protein	NF - kappaB,339,350,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 100, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 132, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 198, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB / Rel proteins"", ""start_span"": 239, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 339, ""end_span"": 350, ""type"": ""Gene/Protein""}]"	train
Stimulation of CD2 or TCR / CD3 induced activation of the nuclear factor of activated T cells ( NFAT), the binding site of which is included in the IL - 2 gene promoter.	CD2,15,18,Gene/Protein	TCR / CD3,22,31,Gene/Protein	nuclear factor of activated T cells,58,93,Gene/Protein	NFAT,96,100,Gene/Protein	binding site,107,119,Gene/Protein	IL - 2 gene promoter,148,168,Gene/Protein	"[{""token"": ""CD2"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""TCR / CD3"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 58, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""binding site"", ""start_span"": 107, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 gene promoter"", ""start_span"": 148, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Interaction of transcription factors RFX1 and MIBP1 with the gamma motif of the negative regulatory element of the hepatitis B virus core promoter.	transcription factors,15,36,Gene/Protein	RFX1,37,41,Gene/Protein	MIBP1,46,51,Gene/Protein	gamma motif,61,72,Gene/Protein	negative regulatory element,80,107,Gene/Protein	hepatitis B virus core promoter,115,146,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 15, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""RFX1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""MIBP1"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""gamma motif"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""negative regulatory element"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""hepatitis B virus core promoter"", ""start_span"": 115, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
However, V3 - BH10 enhanced IL - 2 - induced mRNA expression of c - fos but not c - myc or junB.	V3 - BH10,9,18,Gene/Protein	IL - 2,28,34,Gene/Protein	- induced mRNA,35,49,Gene/Protein	c - fos,64,71,Gene/Protein	c - myc,80,87,Gene/Protein	junB,91,95,Gene/Protein	"[{""token"": ""V3 - BH10"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""- induced mRNA"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""c - fos"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""junB"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
One of the latter elements, the IgH 3 ' enhancer, is of particular interest: ( 1) it is B cell - specific and active only in late B cell development; ( 2) in rodent plasmacytomas and in some human Burkitt ' s lymphomas it is part of a locus control region ( LCR) that is involved in deregulation of the c - myc oncogene as a result of translocation into the IgH locus; and ( 3) it has been implicated in the mechanisms that control Ig gene class switch recombination.	IgH 3 ' enhancer,32,48,Gene/Protein	locus control region,235,255,Gene/Protein	LCR,258,261,Gene/Protein	c - myc oncogene,303,319,Gene/Protein	IgH locus,358,367,Gene/Protein	Ig gene class,432,445,Gene/Protein	"[{""token"": ""IgH 3 ' enhancer"", ""start_span"": 32, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""locus control region"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""LCR"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""c - myc oncogene"", ""start_span"": 303, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""IgH locus"", ""start_span"": 358, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""Ig gene class"", ""start_span"": 432, ""end_span"": 445, ""type"": ""Gene/Protein""}]"	train
The expression and binding activity of the Nfil3 protein ( also called E4bp4), but not of Hlf, Dbp, or Tef, was found to be regulated by IL - 3 in mouse pro - B cell lines ( Baf - 3 and FL5. 12).	Nfil3 protein,43,56,Gene/Protein	E4bp4,71,76,Gene/Protein	Hlf,90,93,Gene/Protein	Dbp,95,98,Gene/Protein	Tef,103,106,Gene/Protein	IL - 3,137,143,Gene/Protein	"[{""token"": ""Nfil3 protein"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""E4bp4"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""Hlf"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Dbp"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Tef"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 3"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
Co - ligation of the A6H antigen and the CD3 complex induced expression of the transcription factor AP - 1 in CD4 + T cells, whereas no increase in NF - kappa B and octamer - binding ( Oct) proteins was seen compared to T cells stimulated with anti - CD3 alone.	A6H,21,24,Gene/Protein	CD3 complex,41,52,Gene/Protein	transcription factor,79,99,Gene/Protein	AP - 1,100,106,Gene/Protein	NF - kappa B,148,160,Gene/Protein	anti - CD3,244,254,Gene/Protein	"[{""token"": ""A6H"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CD3 complex"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 79, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""anti - CD3"", ""start_span"": 244, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
In mobility shift assays, a nuclear factor from THP - 1 and U - 937 cells was identified that binds to several AP - 2 response elements within the B2 promoter, but does not react with AP - 2 antibodies, and has a DNA sequence binding affinity profile that differs from AP - 2.	nuclear factor,28,42,Gene/Protein	AP - 2 response elements,111,135,Gene/Protein	B2 promoter,147,158,Gene/Protein	AP - 2 antibodies,184,201,Gene/Protein	DNA sequence,213,225,Gene/Protein	AP - 2,269,275,Gene/Protein	"[{""token"": ""nuclear factor"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 response elements"", ""start_span"": 111, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""B2 promoter"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2 antibodies"", ""start_span"": 184, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""DNA sequence"", ""start_span"": 213, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""AP - 2"", ""start_span"": 269, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	train
The upstream regions UAS3 ( - 1168 to - 440) and UAS2 ( - 352 to - 264) both functioned in a cell lineage - independent manner and were together responsible for the bulk of Wp activity in non - B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.	UAS3,21,25,Gene/Protein	- 1168 to - 440,28,43,Gene/Protein	UAS2,49,53,Gene/Protein	- 352 to - 264,56,70,Gene/Protein	YY1 binding site,253,269,Gene/Protein	UAS2,273,277,Gene/Protein	"[{""token"": ""UAS3"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""- 1168 to - 440"", ""start_span"": 28, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""UAS2"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""- 352 to - 264"", ""start_span"": 56, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""YY1 binding site"", ""start_span"": 253, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""UAS2"", ""start_span"": 273, ""end_span"": 277, ""type"": ""Gene/Protein""}]"	train
NLS peptide - mediated disruption of the nuclear import of these transcription factors results in inhibition of I kappa B alpha and IL - 2 gene expression, processes dependent on NF - kappa B or the combination of NF - kappa B, AP - 1, and NFAT.	NLS,0,3,Gene/Protein	transcription factors,65,86,Gene/Protein	NF - kappa B,179,191,Gene/Protein	NF - kappa B,214,226,Gene/Protein	AP - 1,228,234,Gene/Protein	NFAT,240,244,Gene/Protein	"[{""token"": ""NLS"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 65, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 214, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
Restoration of the CCAAT box at - 70 bp, or insertion of an EKLF binding site at - 85 bp or - 95 bp in the promoter significantly increased delta globin gene expression in hAEC.	CCAAT box,19,28,Gene/Protein	- 70 bp,32,39,Gene/Protein	EKLF binding site,60,77,Gene/Protein	- 85 bp,81,88,Gene/Protein	- 95 bp,92,99,Gene/Protein	promoter,107,115,Gene/Protein	"[{""token"": ""CCAAT box"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""- 70 bp"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""EKLF binding site"", ""start_span"": 60, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""- 85 bp"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""- 95 bp"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""promoter"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	train
At the same time there was no change in the level of expression of the cell surface antigenes CD33, CD34, CD45, CD71 and glycophorin A.	cell surface antigenes,71,93,Gene/Protein	CD33,94,98,Gene/Protein	CD34,100,104,Gene/Protein	CD45,106,110,Gene/Protein	CD71,112,116,Gene/Protein	glycophorin A,121,134,Gene/Protein	"[{""token"": ""cell surface antigenes"", ""start_span"": 71, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""CD33"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""CD71"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""glycophorin A"", ""start_span"": 121, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
In addition, Ras ( G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the beta - casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5 - mediated gene expression.	erythropoietin receptor mutant,54,84,Gene/Protein	Ras,98,101,Gene/Protein	beta - casein promoter,149,171,Gene/Protein	mutant erythropoietin receptor,179,209,Gene/Protein	Ras,251,254,Gene/Protein	Stat5,258,263,Gene/Protein	"[{""token"": ""erythropoietin receptor mutant"", ""start_span"": 54, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein promoter"", ""start_span"": 149, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""mutant erythropoietin receptor"", ""start_span"": 179, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""Ras"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""Stat5"", ""start_span"": 258, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
We have determined how the phosphorylation of the retinoblastoma family ( pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B - cells during cell cycle exit triggered by alpha - interferon ( alpha - IFN).	retinoblastoma family,50,71,Gene/Protein	pRb,74,77,Gene/Protein	p107,79,83,Gene/Protein	p130,89,93,Gene/Protein	alpha - interferon,194,212,Gene/Protein	alpha - IFN,215,226,Gene/Protein	"[{""token"": ""retinoblastoma family"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""pRb"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""p107"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""p130"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""alpha - interferon"", ""start_span"": 194, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""alpha - IFN"", ""start_span"": 215, ""end_span"": 226, ""type"": ""Gene/Protein""}]"	train
Fusion of the upstream portion of the delta promoter to the truncated beta globin promoter yielded a modest increase in promoter strength relative to the truncated beta gene promoter, indicating the presence of a positive transcriptional element ( s) in the upstream delta globin regulatory region.	upstream portion,14,30,Gene/Protein	delta promoter,38,52,Gene/Protein	beta globin promoter,70,90,Gene/Protein	truncated beta gene promoter,154,182,Gene/Protein	positive transcriptional element,213,245,Gene/Protein	upstream delta globin regulatory region,258,297,Gene/Protein	"[{""token"": ""upstream portion"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""delta promoter"", ""start_span"": 38, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""beta globin promoter"", ""start_span"": 70, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""truncated beta gene promoter"", ""start_span"": 154, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""positive transcriptional element"", ""start_span"": 213, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""upstream delta globin regulatory region"", ""start_span"": 258, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	train
Together, these results show that activated HLA - DRA expression in response to TPA treatment is strictly dependent on PKC activation acting on the X2 box of the DRA promoter and that selective inhibition of PKC enzymatic activity does not influence subcellular localization of expressed PKC isoenzymes.	HLA - DRA,44,53,Gene/Protein	PKC,119,122,Gene/Protein	X2 box,148,154,Gene/Protein	DRA promoter,162,174,Gene/Protein	PKC,208,211,Gene/Protein	PKC isoenzymes,288,302,Gene/Protein	"[{""token"": ""HLA - DRA"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""X2 box"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""DRA promoter"", ""start_span"": 162, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""PKC isoenzymes"", ""start_span"": 288, ""end_span"": 302, ""type"": ""Gene/Protein""}]"	train
To study the influence of NFkappaB activity on apoptosis mediated by TRAIL, CD95, TNFalpha, or doxorubicin, NFkappaB activation was inhibited using the proteasome inhibitor N - acetyl - L - leucinyl - L - leucinyl - L - norleucinal or transient overexpression of mutant IkappaBalpha.	NFkappaB,26,34,Gene/Protein	TRAIL,69,74,Gene/Protein	TNFalpha,82,90,Gene/Protein	NFkappaB,108,116,Gene/Protein	proteasome,152,162,Gene/Protein	mutant IkappaBalpha,263,282,Gene/Protein	"[{""token"": ""NFkappaB"", ""start_span"": 26, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""TRAIL"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""NFkappaB"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""proteasome"", ""start_span"": 152, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""mutant IkappaBalpha"", ""start_span"": 263, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	train
However, its interactions with these histone acetyltransferases are not equivalent, as CBP and p300, but not P / CAF, utilize EKLF as a substrate for in vitro acetylation within its trans - activation region.	histone acetyltransferases,37,63,Gene/Protein	CBP,87,90,Gene/Protein	p300,95,99,Gene/Protein	P / CAF,109,116,Gene/Protein	EKLF,126,130,Gene/Protein	activation region,190,207,Gene/Protein	"[{""token"": ""histone acetyltransferases"", ""start_span"": 37, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CBP"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""p300"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""P / CAF"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""EKLF"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""activation region"", ""start_span"": 190, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	train
Other bacterial toxins, tumor necrosis factor - alpha ( TNF), interleukin - 1 ( IL - 1), T cell mitogens, UV light, gamma rays and oxidative stress were reported to induce NF - kappa B.	tumor necrosis factor - alpha,24,53,Gene/Protein	TNF,56,59,Gene/Protein	interleukin - 1,62,77,Gene/Protein	IL - 1,80,86,Gene/Protein	T cell mitogens,89,104,Gene/Protein	NF - kappa B,172,184,Gene/Protein	"[{""token"": ""tumor necrosis factor - alpha"", ""start_span"": 24, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""TNF"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""T cell mitogens"", ""start_span"": 89, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
In previous transfection analyses using the chloramphenicol acetyltransferase reporter gene system, we determined that linker substitution ( LS) mutations between - 201 and - 130 ( relative to the transcription start site) of the human immunodeficiency virus type 1 long terminal repeat ( LTR) caused moderate decreases in LTR transcriptional activity in a T - cell line ( S. L. Zeichner, J. Y. H. Kim, and J. C. Alwine, J. Virol. 65: 2436 - 2444, 1991).	chloramphenicol acetyltransferase,44,77,Gene/Protein	reporter gene,78,91,Gene/Protein	- 201 and - 130,163,178,Gene/Protein	long terminal repeat,266,286,Gene/Protein	LTR,289,292,Gene/Protein	LTR,323,326,Gene/Protein	"[{""token"": ""chloramphenicol acetyltransferase"", ""start_span"": 44, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""reporter gene"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""- 201 and - 130"", ""start_span"": 163, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 266, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 289, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 323, ""end_span"": 326, ""type"": ""Gene/Protein""}]"	train
Cross competition experiments with an octamer sequence from the Ig heavy chain promoter, the BAT box, and a TA - rich sequence present in the CD21 promoter revealed that all three sequences bound the same nuclear proteins suggesting that the BAT box binding proteins were Oct - 1 and Oct - 2.	BAT box,93,100,Gene/Protein	CD21 promoter,142,155,Gene/Protein	nuclear proteins,205,221,Gene/Protein	BAT box binding proteins,242,266,Gene/Protein	Oct - 1,272,279,Gene/Protein	Oct - 2,284,291,Gene/Protein	"[{""token"": ""BAT box"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CD21 promoter"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""nuclear proteins"", ""start_span"": 205, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""BAT box binding proteins"", ""start_span"": 242, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 272, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 284, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Cotransfection of an hGATA - 3 expression plasmid with a reporter plasmid whose transcription is directed by the HIV - 1 LTR resulted in 6 - to 10 - fold stimulation of LTR - mediated transcription, whereas site specific mutation of these GATA sites resulted in virtual abrogation of the activation by hGATA - 3.	hGATA - 3 expression plasmid,21,49,Gene/Protein	reporter plasmid,57,73,Gene/Protein	HIV - 1 LTR,113,124,Gene/Protein	LTR,169,172,Gene/Protein	GATA sites,239,249,Gene/Protein	hGATA - 3,302,311,Gene/Protein	"[{""token"": ""hGATA - 3 expression plasmid"", ""start_span"": 21, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""reporter plasmid"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 LTR"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""GATA sites"", ""start_span"": 239, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""hGATA - 3"", ""start_span"": 302, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
A T cell - specific protein Neg - 1 and a ubiquitous protein Neg - 2 binding to NRE - I and NRE - II, respectively, were identified.	T cell - specific protein,2,27,Gene/Protein	Neg - 1,28,35,Gene/Protein	ubiquitous protein,42,60,Gene/Protein	Neg - 2,61,68,Gene/Protein	NRE - I,80,87,Gene/Protein	NRE - II,92,100,Gene/Protein	"[{""token"": ""T cell - specific protein"", ""start_span"": 2, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""Neg - 1"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitous protein"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Neg - 2"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NRE - I"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NRE - II"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Gene/Protein""}]"	train
We furthermore demonstrate that this process involves activation of the transcription factor NF - chi B and, to a lesser extent, of NF - IL6, while the activity of the transcription factor AP - 1, shown to otherwise confer IL - 6 inducibility, appeared to be unaffected by LTB4.	transcription factor,72,92,Gene/Protein	NF - chi B,93,103,Gene/Protein	NF - IL6,132,140,Gene/Protein	transcription factor,168,188,Gene/Protein	AP - 1,189,195,Gene/Protein	IL - 6,223,229,Gene/Protein	"[{""token"": ""transcription factor"", ""start_span"": 72, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""NF - chi B"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 168, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 189, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
After the DNA fragment containing the CAG repeats is amplified by the polymerase chain reaction, a primer extension is carried out; the extension of the end - labelled reverse primer adjacent to 3 ' end of CAG repeats stops at the first T after CAG repeats with the incorporation of dideoxy ATP in the reaction mixture.	DNA fragment,10,22,Gene/Protein	CAG repeats,38,49,Gene/Protein	end - labelled reverse primer,153,182,Gene/Protein	3 ' end,195,202,Gene/Protein	CAG repeats,206,217,Gene/Protein	CAG repeats,245,256,Gene/Protein	"[{""token"": ""DNA fragment"", ""start_span"": 10, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CAG repeats"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""end - labelled reverse primer"", ""start_span"": 153, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""3 ' end"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""CAG repeats"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""CAG repeats"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Gene/Protein""}]"	train
It is evident that assembly of the surface domain of TF with VIIa to form the binary TF. VIIa complex induces a significant increase in the Kcat of the catalytic domain of VIIa for small peptidyl substrates and more profoundly for protein substrate.	surface domain,35,49,Gene/Protein	TF,53,55,Gene/Protein	VIIa,61,65,Gene/Protein	catalytic domain,152,168,Gene/Protein	VIIa,172,176,Gene/Protein	protein substrate,231,248,Gene/Protein	"[{""token"": ""surface domain"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""VIIa"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""catalytic domain"", ""start_span"": 152, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""VIIa"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""protein substrate"", ""start_span"": 231, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
A DNA probe that spanned a domain conserved among the proto - oncogene c - rel, the Drosophila morphogen dorsal, and the p50 DNA binding subunit of NF - kappa B was generated from Jurkat T cell complementary DNA with the polymerase chain reaction ( PCR) and degenerate oligonucleotides.	DNA probe,2,11,Gene/Protein	proto - oncogene c - rel,54,78,Gene/Protein	Drosophila morphogen dorsal,84,111,Gene/Protein	p50 DNA binding subunit,121,144,Gene/Protein	NF - kappa B,148,160,Gene/Protein	Jurkat T cell complementary DNA,180,211,Gene/Protein	"[{""token"": ""DNA probe"", ""start_span"": 2, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""proto - oncogene c - rel"", ""start_span"": 54, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila morphogen dorsal"", ""start_span"": 84, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""p50 DNA binding subunit"", ""start_span"": 121, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 148, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Jurkat T cell complementary DNA"", ""start_span"": 180, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
The human T cell - specific transcription factor TCF - 1 alpha plays a key role in the tissue - specific activation of the T cell receptor ( TCR) C alpha enhancer and binds to pyrimidine - rich elements ( 5 ' - PyCTTTG - 3 ') present in a variety of other T cell - specific control regions.	human T cell - specific transcription factor,4,48,Gene/Protein	TCF - 1 alpha,49,62,Gene/Protein	T cell receptor,123,138,Gene/Protein	TCR,141,144,Gene/Protein	pyrimidine - rich elements,176,202,Gene/Protein	T cell - specific control regions,256,289,Gene/Protein	"[{""token"": ""human T cell - specific transcription factor"", ""start_span"": 4, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""TCF - 1 alpha"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 123, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""pyrimidine - rich elements"", ""start_span"": 176, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""T cell - specific control regions"", ""start_span"": 256, ""end_span"": 289, ""type"": ""Gene/Protein""}]"	train
The induction of AP1 by okadaic acid suggests that protein phosphatases 1 and 2A ( PP1 and PP2A) may be involved in T cell activation as important negative regulators of the transcription factor AP1.	AP1,17,20,Gene/Protein	protein phosphatases 1 and 2A,51,80,Gene/Protein	PP1,83,86,Gene/Protein	PP2A,91,95,Gene/Protein	transcription factor,174,194,Gene/Protein	AP1,195,198,Gene/Protein	"[{""token"": ""AP1"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""protein phosphatases 1 and 2A"", ""start_span"": 51, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 174, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
The fusion cDNA results from an interstitial deletion between a previously unknown locus, SIL ( SCL interrupting locus), and the 5 ' untranslated region of SCL.	fusion cDNA,4,15,Gene/Protein	unknown locus,75,88,Gene/Protein	SIL,90,93,Gene/Protein	SCL interrupting locus,96,118,Gene/Protein	5 ' untranslated region,129,152,Gene/Protein	SCL,156,159,Gene/Protein	"[{""token"": ""fusion cDNA"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""unknown locus"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""SIL"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""SCL interrupting locus"", ""start_span"": 96, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""5 ' untranslated region"", ""start_span"": 129, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""SCL"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Further, 1, 25 ( OH) 2D3 inhibited the transcriptional activity of NF - kappa B in Jurkat cells transiently transfected with a construct containing four tandem repeats of the NF - kappa B binding sequence of the immunoglobulin kappa light chain gene linked to the chloramphenicol acetyltransferase reporter gene.	NF - kappa B,67,79,Gene/Protein	construct,127,136,Gene/Protein	tandem repeats,153,167,Gene/Protein	NF - kappa B binding sequence,175,204,Gene/Protein	immunoglobulin kappa light chain gene,212,249,Gene/Protein	chloramphenicol acetyltransferase reporter gene,264,311,Gene/Protein	"[{""token"": ""NF - kappa B"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""construct"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""tandem repeats"", ""start_span"": 153, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding sequence"", ""start_span"": 175, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin kappa light chain gene"", ""start_span"": 212, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""chloramphenicol acetyltransferase reporter gene"", ""start_span"": 264, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
Exposure of activated human T lymphocytes or of a natural killer cell line ( NKL) to IL - 2 leads to the phosphorylation of Stat1 alpha, Stat1 beta, and Stat3, as well as of two Stat - related proteins, p94 and p95.	IL - 2,85,91,Gene/Protein	Stat1 alpha,124,135,Gene/Protein	Stat3,153,158,Gene/Protein	Stat - related proteins,178,201,Gene/Protein	p94,203,206,Gene/Protein	p95,211,214,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Stat1 alpha"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""Stat - related proteins"", ""start_span"": 178, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""p94"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""p95"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
The present study verified the ability of IL - 2 to cause tyrosine phosphorylation and activation of JAK1 and JAK3, but demonstrated that IL - 2 stimulated JAK3 to a significantly larger extent than JAK1 in human T lymphocytes and the YT cell line.	IL - 2,42,48,Gene/Protein	JAK1,101,105,Gene/Protein	JAK3,110,114,Gene/Protein	IL - 2,138,144,Gene/Protein	JAK3,156,160,Gene/Protein	JAK1,199,203,Gene/Protein	"[{""token"": ""IL - 2"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""JAK1"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
In most cases, the transcriptional factor NF - kappa B is a heterodimer consisting of two subunits, p50 and p65, which are encoded by two distinct genes of the Rel family.	transcriptional factor,19,41,Gene/Protein	NF - kappa B,42,54,Gene/Protein	heterodimer,60,71,Gene/Protein	p50,100,103,Gene/Protein	p65,108,111,Gene/Protein	Rel family,160,170,Gene/Protein	"[{""token"": ""transcriptional factor"", ""start_span"": 19, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""heterodimer"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Rel family"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
The lack of Jak3 expression correlated with impaired B cell signaling, as demonstrated by the inability of IL - 4 to activate Stat6 in the EBV - transformed cell line from the patient. These observations indicate that the functions of gamma c are dependent on Jak3 and that Jak3 is essential for lymphoid development and signaling.	Jak3,12,16,Gene/Protein	IL - 4,107,113,Gene/Protein	Stat6,126,131,Gene/Protein	gamma c,235,242,Gene/Protein	Jak3,260,264,Gene/Protein	Jak3,274,278,Gene/Protein	"[{""token"": ""Jak3"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""Stat6"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""gamma c"", ""start_span"": 235, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 260, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""Jak3"", ""start_span"": 274, ""end_span"": 278, ""type"": ""Gene/Protein""}]"	train
Integration of the signals generated by TCR and CD28 engagement occurs along this pathway, which then bifurcates to induce I kappa B phosphorylation and NF - kappa B activation on the one hand, and JNK activation and c - Jun phosphorylation on the other.	TCR,40,43,Gene/Protein	CD28,48,52,Gene/Protein	I kappa B,123,132,Gene/Protein	NF - kappa B,153,165,Gene/Protein	JNK,198,201,Gene/Protein	c - Jun,217,224,Gene/Protein	"[{""token"": ""TCR"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""I kappa B"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
To understand the role of MARs in IgH enhancer regulation, we have identified a novel MAR - binding protein, MAR - BP1, from soluble nuclear matrix preparations based on its ability to bind to the MARs associated with the IgH enhancer.	MARs,26,30,Gene/Protein	IgH enhancer,34,46,Gene/Protein	MAR - binding protein,86,107,Gene/Protein	MAR - BP1,109,118,Gene/Protein	MARs,197,201,Gene/Protein	IgH enhancer,222,234,Gene/Protein	"[{""token"": ""MARs"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""MAR - binding protein"", ""start_span"": 86, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""MAR - BP1"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""MARs"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""IgH enhancer"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	train
As neutralizing anti - IL - 6 Abs effectively down - regulated the early induction of STAT proteins and as exogenously added IL - 6 rapidly activated DNA binding similar to TCR - mediated bindings, it can be concluded that IL - 6 is the factor responsible for the activation of STAT proteins in a primary T cell response.	neutralizing anti - IL - 6 Abs,3,33,Gene/Protein	STAT proteins,86,99,Gene/Protein	IL - 6,125,131,Gene/Protein	TCR,173,176,Gene/Protein	IL - 6,223,229,Gene/Protein	STAT proteins,278,291,Gene/Protein	"[{""token"": ""neutralizing anti - IL - 6 Abs"", ""start_span"": 3, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 278, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
